assays_chmbl_d,assays_cnfdnc_scr,assays_cll_d,assays_src_d,assays_ss_strn,assays_ss_ctgr,assays_src_ss_d,assays_ss_tp,assays_ss_d,assays_crtd_b,assays_b_frmt,assays_tss_d,assays_rltnshp_tp,assays_ss_rgnsm,assays_ss_tss,assays_ss_tx_d,assays_ss_cll_tp,assays_ss_tst_tp,assays_vrnt_d,assays_dc_d,assays_td,assays_ss_sbclllr_frctn,assays_dscrptn
CHEMBL618647,1,,1,,,,A,7524,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr
CHEMBL618648,1,,1,,,,A,7525,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig
CHEMBL618649,1,,1,,,,A,7526,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr
CHEMBL618650,1,,1,,,,A,7527,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr
CHEMBL618651,1,,1,,,,A,7528,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig
CHEMBL876497,1,,1,,,,A,7529,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr
CHEMBL618652,1,,1,,,,A,7530,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr
CHEMBL618653,1,,1,,,,A,7531,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig
CHEMBL618654,1,,1,,,,A,7532,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr
CHEMBL618655,1,,1,,,,A,7533,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6351,50597,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested
CHEMBL618656,1,,1,,,,A,7534,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1465,50597,,Compound was tested for solubility in water
CHEMBL618657,0,,1,,,,P,7535,Intermediate,BAO_0000100,,U,,,,,,,5182,22229,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration)
CHEMBL618658,1,,1,,,,A,7536,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17847,50597,,Solubility was determined
CHEMBL618659,1,,1,,,,A,7537,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15339,50597,,solubility in water (ug/mL) at 37 degree C.
CHEMBL618660,1,,1,,,,A,7538,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5202,50597,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes
CHEMBL618661,1,,1,,,,A,7539,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1088,50597,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay
CHEMBL873807,1,,1,,,,A,7540,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3169,50597,,Half life in rats
CHEMBL618662,1,,1,,,,A,7541,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5353,50597,,Half life in Dawley rat
CHEMBL618663,1,,1,,,,A,7542,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2864,50597,,Half life period after 3 mg/kg iv administration
CHEMBL618664,1,,1,,,,A,7543,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2864,50597,,Half life period after 3 mg/kg iv administration in rat
CHEMBL618665,1,,1,,,,A,7544,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2864,50597,,Half life period after 3 mg/kg iv administration in the rat
CHEMBL876498,1,,1,,,,A,7545,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6362,50597,,Half life period in female Sprague-Dawley rats
CHEMBL618666,1,,1,,,,A,7546,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6249,50597,,Half life period in rat
CHEMBL620440,1,,1,,,,A,7547,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3169,50597,,Half-life in rats was determined
CHEMBL620441,1,,1,,,,A,7548,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3169,50597,,Half-life in rats with metabolic oxidation
CHEMBL620442,1,,1,,,,A,7549,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3169,50597,,Half-life in rats
CHEMBL620443,1,,1,,,,A,7550,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17260,50597,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat
CHEMBL620444,1,,1,,,,A,7551,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17260,50597,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat
CHEMBL620445,1,,1,,,,A,7552,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17260,50597,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat
CHEMBL620446,1,,1,,,,A,7553,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17260,50597,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat
CHEMBL620447,1,,1,,,,A,7554,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,2879,50597,,Biological half-life measured in plasma of rat
CHEMBL621129,1,,1,,,,A,7555,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,2879,50597,,Biological half-life measured in plasma of rat; 22-25
CHEMBL621130,1,,1,,,,A,7556,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,2879,50597,,Biological half-life measured in plasma of rat; 9-16
CHEMBL873808,1,,1,,,,A,7557,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3184,50597,,Compound was evaluated for its half life when administered intravenously in rat
CHEMBL876598,1,,1,,,,A,7558,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4891,50597,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h
CHEMBL621131,1,,1,,,,A,7559,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,429,50597,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg
CHEMBL621132,1,,1,,,,A,7560,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5656,50597,,Half life (T1/2) after oral administration in rat
CHEMBL621133,1,,1,,,,A,7561,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4413,50597,,Half life of compound after iv administration of 20 mg/kg dose in rat
CHEMBL621312,1,,1,,,,A,7562,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3598,50597,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg
CHEMBL621313,1,,1,,,,A,7563,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17267,50597,,Half life of compound was determined in rat
CHEMBL621314,1,,1,,,,A,7564,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,4727,50597,,Half life of compound was determined in rat blood
CHEMBL621315,1,,1,,,,A,7565,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17651,50597,,Half life at 1 mg/kg was determined in rat
CHEMBL621316,1,,1,,,,A,7566,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17651,50597,,Half life at 10 mg/kg was determined in rat
CHEMBL621317,1,,1,,,,A,7567,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,401,50597,,Half life in rats
CHEMBL621318,1,,1,,,,A,7568,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4942,50597,,Half life in rats in hours
CHEMBL621319,1,,1,,,,A,7569,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17735,50597,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined
CHEMBL621377,1,,1,,,,A,7570,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6056,50597,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat
CHEMBL621378,1,,1,,,,A,7571,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5213,50597,,Half life was determined
CHEMBL876599,1,,1,,,,A,7572,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6616,50597,,Half life after i.v. administration
CHEMBL621379,1,,1,,,,A,7573,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5937,50597,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg
CHEMBL621380,1,,1,,,,A,7574,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5819,50597,,Half life in rat plasma
CHEMBL621381,1,,1,,,,A,7575,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5819,50597,,Half life in rat plasma; Not detected
CHEMBL618515,1,,1,,,,A,7576,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6803,50597,,Half life in rats
CHEMBL618516,1,,1,,,,A,7577,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17804,50597,,Half life period of compound was determined after peroral administration
CHEMBL618517,1,,1,,,,A,7578,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17804,50597,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration
CHEMBL618518,1,,1,,,,A,7579,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5948,50597,,Half life period in rat
CHEMBL618519,1,,1,,,,A,7580,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1916,50597,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration
CHEMBL618698,1,,1,,,,A,7581,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1916,50597,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration
CHEMBL618862,1,,1,,,,A,7582,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1916,50597,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available
CHEMBL618863,1,,1,,,,A,7583,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4890,50597,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats
CHEMBL618864,1,,1,,,,A,7584,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17764,50597,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg
CHEMBL618865,1,,1,,,,A,7585,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4727,50597,,Half life time in rat the dose of 2 mg/kg
CHEMBL618866,1,,1,,,,A,7586,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17509,50597,,Half-life 24 hr after 10 mg/kg iv administration in rats
CHEMBL618867,1,,1,,,,A,7587,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17509,50597,,Half-life 24 hr after 2 mg/kg iv administration in rats
CHEMBL875828,1,,1,,,,A,7588,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6597,50597,,Half-life consistent with the observed metabolic steady state in rats
CHEMBL618868,1,,1,,,,A,7589,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17735,50597,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined
CHEMBL618869,1,,1,,,,A,7590,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6597,50597,,Half-life for oxidative metabolic stability was determined using male human
CHEMBL618870,1,,1,,,,A,7591,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17670,50597,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously"
CHEMBL618871,1,,1,,,,A,7592,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1696,50597,,Half-life in rat plasma
CHEMBL618872,1,,1,,,,A,7593,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1742,50597,,Half-life in rat plasma was determined
CHEMBL873816,1,,1,,,,A,7594,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17800,50597,,Half-life in rats was determined
CHEMBL618873,0,,1,,,,A,7595,Autocuration,BAO_0000218,,U,,,,,,,12923,22224,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog
CHEMBL621602,0,,1,,,,A,7596,Autocuration,BAO_0000019,,U,,,,,,,11954,22224,,Area under curve after oral dose of 0.1 mg//kg
CHEMBL621603,0,,1,,,,A,7597,Autocuration,BAO_0000218,,U,,,,,,,11954,22224,,Area under curve after oral dose of 0.3 mg/kg
CHEMBL621604,0,,1,,,,A,7598,Autocuration,BAO_0000218,,U,,,,,,,11954,22224,,Area under curve after oral dose of 1 mg/kg
CHEMBL621605,0,,1,,,,A,7599,Autocuration,BAO_0000218,,U,,,,,,,11954,22224,,Area under curve after oral dose of 10 mg/kg
CHEMBL621606,0,,1,,,,A,7600,Autocuration,BAO_0000218,,U,,,,,,,11954,22224,,Area under curve after oral dose of 23.4 mg/kg
CHEMBL621607,0,,1,,,,A,7601,Autocuration,BAO_0000218,,U,,,,,,,11954,22224,,Area under curve after oral dose of 3 mg/kg
CHEMBL621608,0,,1,,,,A,7602,Autocuration,BAO_0000218,,U,,,,,,,11954,22224,,Area under curve after oral dose of 3.87 mg/kg
CHEMBL621609,0,,1,,,,A,7603,Autocuration,BAO_0000019,,U,,,,,,,5237,22224,,Area under curve was determined
CHEMBL621610,0,,1,,,,A,7604,Autocuration,BAO_0000218,,U,,,,,,,4026,22224,,Area under curve at a dose of 10 mg/kg
CHEMBL621611,1,,1,,,,A,7605,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5237,50597,,Area under curve was determined; ND=No data
CHEMBL621612,1,,1,,,,A,7606,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14793,50597,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours
CHEMBL622308,1,,1,,,,A,7607,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14793,50597,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours
CHEMBL622309,1,,1,,,,A,7608,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14793,50597,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours
CHEMBL622310,1,,1,,,,A,7609,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14793,50597,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours
CHEMBL622311,1,,1,,,,A,7610,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14793,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours
CHEMBL622312,1,,1,,,,A,7611,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14793,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated
CHEMBL622931,1,,1,,,,A,7612,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14793,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours
CHEMBL622932,1,,1,,,,A,7613,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14793,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated
CHEMBL622736,1,,1,,,,A,7614,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14793,50597,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours
CHEMBL622737,1,,1,,,,A,7615,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14793,50597,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours
CHEMBL622738,1,,1,,,,A,7616,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14793,50597,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours
CHEMBL622739,1,,1,,,,A,7617,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14793,50597,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours
CHEMBL622740,1,,1,,,,A,7618,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14793,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours
CHEMBL622741,1,,1,,,,A,7619,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14793,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours
CHEMBL622742,1,,1,,,,A,7620,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14793,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours
CHEMBL622743,1,,1,,,,A,7621,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14793,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours
CHEMBL622744,1,,1,,,,A,7622,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,,,11637,50594,,AUC in mice
CHEMBL624134,0,,1,,,,A,7623,Autocuration,BAO_0000019,,U,,,,,,,11149,22224,,Area under curve was measured from the graph obtained from concentration Vs time
CHEMBL624135,0,,1,,,,A,7624,Autocuration,BAO_0000019,,U,,,,,,,10016,22224,,Area under curve value of compound per hour after oral administration
CHEMBL624136,1,,1,,,,A,7625,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17796,50597,,Area under curve was determined after oral administration in rats
CHEMBL624137,1,,1,,,,A,7626,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17796,50597,,Area under curve was determined after oral administration in rats; No data
CHEMBL624320,1,,1,,,,A,7627,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17796,50597,,Area under curve was determined after oral administration in rats;No data
CHEMBL624321,1,,1,,,,A,7628,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12923,50588,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog
CHEMBL624322,1,,1,,,,A,7629,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15372,50597,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats
CHEMBL624323,1,,1,,,,A,7630,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15372,50597,,Area under curve was determined for the compound after iv dose of 5.06 in rats
CHEMBL624324,1,,1,,,,A,7631,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15372,50597,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats
CHEMBL624325,1,,1,,,,A,7632,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15372,50597,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats
CHEMBL624326,1,,1,,,,A,7633,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15372,50597,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats
CHEMBL624327,1,,1,,,,A,7634,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15372,50597,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats
CHEMBL624328,1,,1,,,,A,7635,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15372,50597,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats
CHEMBL627848,1,,1,,,,A,7636,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14169,50588,,Area under curve was determined in Dogs after peroral administration
CHEMBL627849,1,,1,,,,A,7637,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14169,50597,,Area under curve was determined in Rats after peroral administration
CHEMBL627850,1,,1,,,,A,7638,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14258,50597,,Area under curve was determined in carotid blood of rat when administered intradermally
CHEMBL627851,1,,1,,,,A,7639,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14258,50597,,Area under curve was determined in portal blood of rat when administered intradermally
CHEMBL627852,1,,1,,,,A,7640,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15011,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg
CHEMBL627853,1,,1,,,,A,7641,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15011,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg
CHEMBL627854,1,,1,,,,A,7642,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15011,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample)
CHEMBL627855,1,,1,,,,A,7643,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15011,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg
CHEMBL627856,1,,1,,,,A,7644,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15011,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr)
CHEMBL875339,1,,1,,,,A,7645,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15011,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg
CHEMBL627857,1,,1,,,,A,7646,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15011,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr)
CHEMBL627858,1,,1,,,,A,7647,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration
CHEMBL627859,1,,1,,,,A,7648,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ
CHEMBL627860,1,,1,,,,A,7649,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ
CHEMBL627019,1,,1,,,,A,7650,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ
CHEMBL627020,1,,1,,,,A,7651,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ
CHEMBL627021,1,,1,,,,A,7652,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ
CHEMBL627022,1,,1,,,,A,7653,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ
CHEMBL627023,1,,1,,,,A,7654,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ
CHEMBL627024,1,,1,,,,A,7655,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ
CHEMBL627025,1,,1,,,,A,7656,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ
CHEMBL627026,1,,1,,,,A,7657,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ
CHEMBL627027,1,,1,,,,A,7658,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ
CHEMBL627028,1,,1,,,,A,7659,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ
CHEMBL627029,1,,1,,,,A,7660,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ
CHEMBL627030,1,,1,,,,A,7661,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ
CHEMBL627031,1,,1,,,,A,7662,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ
CHEMBL627032,1,,1,,,,A,7663,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ
CHEMBL627033,1,,1,,,,A,7664,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ
CHEMBL627034,1,,1,,,,A,7665,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ
CHEMBL627035,1,,1,,,,A,7666,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ
CHEMBL627036,1,,1,,,,A,7667,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ
CHEMBL875340,1,,1,,,,A,7668,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ
CHEMBL627037,1,,1,,,,A,7669,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ
CHEMBL627038,1,,1,,,,A,7670,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ
CHEMBL627039,1,,1,,,,A,7671,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ
CHEMBL627040,1,,1,,,,A,7672,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ
CHEMBL624663,1,,1,,,,A,7673,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ
CHEMBL625963,1,,1,,,,A,7674,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ
CHEMBL876799,1,,1,,,,A,7675,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ
CHEMBL626133,1,,1,,,,A,7676,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ
CHEMBL626134,1,,1,,,,A,7677,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10130,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ
CHEMBL626135,1,,1,,,,A,7678,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6295,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg
CHEMBL626136,1,,1,,,,A,7679,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6296,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg
CHEMBL626137,1,,1,,,,A,7680,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6296,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit
CHEMBL626138,1,,1,,,,A,7681,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6295,50597,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg
CHEMBL626139,1,,1,,,,A,7682,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6296,50597,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg
CHEMBL626140,1,,1,,,,A,7683,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17260,50597,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat
CHEMBL626141,1,,1,,,,A,7684,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17260,50597,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat
CHEMBL626142,1,,1,,,,A,7685,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17686,50597,,C24h in rat p.o. at 20 mg/kg concentration
CHEMBL627930,1,,1,,,,A,7686,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr
CHEMBL627931,1,,1,,,,A,7687,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig
CHEMBL627932,1,,1,,,,A,7688,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr
CHEMBL627933,1,,1,,,,A,7689,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr
CHEMBL627934,1,,1,,,,A,7690,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig
CHEMBL627935,1,,1,,,,A,7691,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr
CHEMBL627936,1,,1,,,,A,7692,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP
CHEMBL627937,1,,1,,,,A,7693,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP
CHEMBL627938,1,,1,,,,A,7694,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP
CHEMBL627939,1,,1,,,,A,7695,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig
CHEMBL627940,1,,1,,,,A,7696,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP
CHEMBL627941,1,,1,,,,A,7697,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP
CHEMBL876800,1,,1,,,,A,7698,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP
CHEMBL627942,1,,1,,,,A,7699,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP
CHEMBL627943,1,,1,,,,A,7700,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP
CHEMBL627944,1,,1,,,,A,7701,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min
CHEMBL627945,1,,1,,,,A,7702,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr
CHEMBL628584,1,,1,,,,A,7703,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr
CHEMBL628585,1,,1,,,,A,7704,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA at 15 min
CHEMBL628586,1,,1,,,,A,7705,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr
CHEMBL628587,1,,1,,,,A,7706,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA at 30 min
CHEMBL628588,1,,1,,,,A,7707,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr
CHEMBL628589,1,,1,,,,A,7708,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min
CHEMBL625304,1,,1,,,,A,7709,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min
CHEMBL625305,1,,1,,,,A,7710,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr
CHEMBL625306,1,,1,,,,A,7711,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr
CHEMBL625307,1,,1,,,,A,7712,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min
CHEMBL625308,1,,1,,,,A,7713,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min
CHEMBL627740,1,,1,,,,A,7714,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr
CHEMBL627741,1,,1,,,,A,7715,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr
CHEMBL627742,1,,1,,,,A,7716,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP
CHEMBL627743,1,,1,,,,A,7717,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip
CHEMBL627744,1,,1,,,,A,7718,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9866,50597,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig
CHEMBL627745,1,,1,,,,A,7719,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP
CHEMBL627746,1,,1,,,,A,7720,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP
CHEMBL627747,1,,1,,,,A,7721,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP
CHEMBL876810,1,,1,,,,A,7722,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig
CHEMBL627748,1,,1,,,,A,7723,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP
CHEMBL627749,1,,1,,,,A,7724,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP
CHEMBL627750,1,,1,,,,A,7725,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP
CHEMBL618728,1,,1,,,,A,7726,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP
CHEMBL618729,1,,1,,,,A,7727,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP
CHEMBL618730,1,,1,,,,A,7728,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA at 15 min
CHEMBL618731,1,,1,,,,A,7729,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr
CHEMBL618732,1,,1,,,,A,7730,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA at 30 min
CHEMBL618733,1,,1,,,,A,7731,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr
CHEMBL618734,1,,1,,,,A,7732,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min
CHEMBL618735,1,,1,,,,A,7733,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr
CHEMBL876602,1,,1,,,,A,7734,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min
CHEMBL618736,1,,1,,,,A,7735,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr
CHEMBL618737,1,,1,,,,A,7736,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min
CHEMBL618738,1,,1,,,,A,7737,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr
CHEMBL618739,1,,1,,,,A,7738,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min
CHEMBL618740,1,,1,,,,A,7739,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr
CHEMBL618741,1,,1,,,,A,7740,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP
CHEMBL618742,1,,1,,,,A,7741,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip
CHEMBL618743,1,,1,,,,A,7742,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,9866,50597,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig
CHEMBL618744,1,,1,,,,A,7743,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17752,50597,,Half-life from rat plasma at a single oral dose of 25 mg/kg
CHEMBL618745,1,,1,,,,A,7744,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5610,50597,,Half-life in male rat
CHEMBL620479,1,,1,,,,A,7745,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5939,50597,,Half-life in rat after peroral administration at 10 mg/kg concentration
CHEMBL620480,1,,1,,,,A,7746,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5939,50597,,Half-life in rat after peroral administration at 5 mg/kg concentration
CHEMBL620481,1,,1,,,,A,7747,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17771,50597,,Half-life in rat at a dose of 3 mg/kg
CHEMBL620482,1,,1,,,,A,7748,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1974,50597,,Half-life was evaluated in rats
CHEMBL876603,1,,1,,,,A,7749,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4239,50597,,Half-life was measured in rat
CHEMBL620483,1,,1,,,,A,7750,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6681,50597,,Half-life period for the compound was determined in rats at 50 mg/kg dose
CHEMBL620484,1,,1,,,,A,7751,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17752,50597,,Half-life period in rats after intravenous administration at 5 mg/kg
CHEMBL620485,1,,1,,,,A,7752,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6046,50597,,Half-life period in rat at 10 mg/kg
CHEMBL620486,1,,1,,,,A,7753,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose"
CHEMBL620487,1,,1,,,,A,7754,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose"
CHEMBL620488,1,,1,,,,A,7755,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose"
CHEMBL620489,1,,1,,,,A,7756,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4727,50597,,Half-life time in rat the dose of 2 mg/kg
CHEMBL620490,1,,1,,,,A,7757,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1088,50597,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats
CHEMBL620491,1,,1,,,,A,7758,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5610,50597,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg
CHEMBL876604,1,,1,,,,A,7759,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,3032,50597,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)"
CHEMBL620492,1,,1,,,,A,7760,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5199,50597,,Oral half life was determined
CHEMBL620493,1,,1,,,,A,7761,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14941,50597,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration"
CHEMBL620494,1,,1,,,,A,7762,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4408,50597,,Pharmacokinetic property (t1/2) in rat
CHEMBL620495,1,,1,,,,A,7763,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,2552,50597,,Plasma elimination half-life was determined
CHEMBL620496,1,,1,,,,A,7764,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5199,50597,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).
CHEMBL620497,1,,1,,,,A,7765,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15662,50597,,Plasma half life was observed after intravenous administration in rat
CHEMBL620498,1,,1,,,,A,7766,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1465,50597,,Plasma half-life was determined
CHEMBL620499,1,,1,,,,A,7767,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1446,50597,,Plasma half-life following oral administration in Fisher rats
CHEMBL620500,1,,1,,,,A,7768,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6824,50597,,Plasma half-life in rat
CHEMBL873809,1,,1,,,,A,7769,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17533,50597,,Plasmatic Half-life after intravenous administration to rat
CHEMBL620501,1,,1,,,,A,7770,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5979,50597,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat
CHEMBL620502,1,,1,,,,A,7771,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4689,50597,,Terminal half life after intravenous administration (1 mg/kg) in rat
CHEMBL620503,1,,1,,,,A,7772,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4689,50597,,Terminal half life in Rat at a oral dose of 5 mg/kg
CHEMBL620504,1,,1,,,,A,7773,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2463,50597,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration
CHEMBL876605,1,,1,,,,A,7774,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4883,50597,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat
CHEMBL620505,1,,1,,,,A,7775,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4883,50597,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat
CHEMBL873811,1,,1,,,,A,7776,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15662,50597,,plasma half life was observed after intravenous administration in rat
CHEMBL624016,1,,1,,,,A,7777,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3598,50597,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg
CHEMBL624017,1,,1,,,,A,7778,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4576,50597,,Half life of compound determined in rat
CHEMBL624018,1,,1,,,,A,7779,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4576,50597,,Mean residence time determined in rat
CHEMBL624019,1,,1,,,,A,7780,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4576,50597,,Plasma half life determined in rat
CHEMBL624020,1,,1,,,,A,7781,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,4910,50597,,Compound was evaluated for Tmax in brain after intravenous administration in male rats
CHEMBL624201,1,,1,,,,A,7782,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4891,50597,,Compound was evaluated for pharmacokinetic parameter maximum time period
CHEMBL872528,1,,1,,,,A,7783,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,429,50597,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg
CHEMBL624202,1,,1,,,,A,7784,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat
CHEMBL624203,1,,1,,,,A,7785,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat
CHEMBL624350,1,,1,,,,A,7786,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat
CHEMBL621320,1,,1,,,,A,7787,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat
CHEMBL621321,1,,1,,,,A,7788,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17582,50597,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats
CHEMBL621322,1,,1,,,,A,7789,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4026,50597,,Maximum time (Tmax) required to reach Cmax in rats
CHEMBL621323,1,,1,,,,A,7790,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4890,50597,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats
CHEMBL621324,1,,1,,,,A,7791,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6571,50597,,Maximum time of clearance of compound in rats after peroral administration
CHEMBL621325,1,,1,,,,A,7792,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4727,50597,,Maximum time at the dose of 2 mg/kg in rat
CHEMBL875837,1,,1,,,,A,7793,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17651,50597,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg
CHEMBL621326,1,,1,,,,A,7794,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17651,50597,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg
CHEMBL621327,1,,1,,,,A,7795,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14465,50597,,Tmax in Guinea pig (PO dose)
CHEMBL621328,1,,1,,,,A,7796,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14941,50597,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration"
CHEMBL621329,1,,1,,,,A,7797,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5960,50597,,Pharmacokinetic parameter (Tmax) in rat
CHEMBL621330,1,,1,,,,A,7798,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5022,50597,,Pharmacokinetic parameter (Tmax) was estimated
CHEMBL621331,1,,1,,,,A,7799,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4408,50597,,Pharmacokinetic property (Tmax) in rat
CHEMBL621332,1,,1,,,,A,7800,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5983,50597,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.
CHEMBL621333,1,,1,,,,A,7801,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4689,50597,,T max in Rat at a oral dose of 5 mg/kg
CHEMBL621334,1,,1,,,,A,7802,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,T max was determined at 10 mg/kg po dose in rats
CHEMBL621335,1,,1,,,,A,7803,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15011,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr)
CHEMBL621336,1,,1,,,,A,7804,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14180,50588,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs
CHEMBL621337,1,,1,,,,A,7805,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14180,50597,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats
CHEMBL621338,1,,1,,,,A,7806,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14599,50588,,Area under curve was measured after i.v. administration into Beagle dog.
CHEMBL875838,1,,1,,,,A,7807,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14599,50588,,Area under curve was measured after iv administration into Beagle dog
CHEMBL621339,1,,1,,,,A,7808,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14599,50588,,Area under curve was measured after po administration into Beagle dog
CHEMBL621340,1,,1,,,,A,7809,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14599,50588,,Area under curve was measured after po administration into Beagle dog.
CHEMBL621341,0,,1,,,,A,7810,Autocuration,BAO_0000218,,U,,,,,,,15675,22224,,Area under curve was measured at peroral dose of 3 mg/kg
CHEMBL621342,0,,1,,,,A,7811,Autocuration,BAO_0000019,,U,,,,,,,12706,22224,,Area under curve was measured by using concentration Vs time
CHEMBL621343,0,,1,,,,A,7812,Autocuration,BAO_0000019,,U,,,,,,,12706,22224,,Area under curve was measured by using concentration Vs time; not tested
CHEMBL621344,1,,1,,,,A,7813,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,9750,50594,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg)
CHEMBL621345,1,,1,,,,A,7814,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,9750,50594,,Area under curve(AUC) was measured in mice after oral administration.
CHEMBL621346,0,,1,,,,A,7815,Autocuration,BAO_0000019,,U,,,,,,,14691,22224,,Area under curve(AUC) value of the compound
CHEMBL621347,0,,1,,,,A,7816,Autocuration,BAO_0000218,,U,,,,,,,14691,22224,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration
CHEMBL621348,1,,1,,,,A,7817,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14691,50588,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration
CHEMBL621349,0,,1,,,,A,7818,Autocuration,BAO_0000019,178.0,U,,Blood,,,,,2939,22224,,Area under curve(carotid artery) was determined by the availability in blood
CHEMBL621350,0,,1,,,,A,7819,Autocuration,BAO_0000019,178.0,U,,Blood,,,,,2939,22224,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data
CHEMBL875839,0,,1,,,,A,7820,Autocuration,BAO_0000019,178.0,U,,Blood,,,,,2939,22224,,Area under curve(carotid artery) was determined by the availability in blood; No data
CHEMBL620211,0,,1,,,,A,7821,Autocuration,BAO_0000019,178.0,U,,Blood,,,,,2939,22224,,Area under curve(portal vein) was determined by the availability in blood
CHEMBL620212,0,,1,,,,A,7822,Autocuration,BAO_0000019,178.0,U,,Blood,,,,,2939,22224,,Area under curve(portal vein) was determined by the availability in blood; ND means no data
CHEMBL620213,0,,1,,,,A,7823,Autocuration,BAO_0000019,178.0,U,,Blood,,,,,2939,22224,,Area under curve(portal vein) was determined by the availability in blood; No data
CHEMBL620214,1,,1,,,,A,7824,Intermediate,BAO_0000218,1969.0,N,Macaca mulatta,Plasma,9544.0,,,,9552,50797,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose"
CHEMBL620215,1,,1,,,,A,7825,Intermediate,BAO_0000218,1969.0,N,Macaca mulatta,Plasma,9544.0,,,,9552,50797,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose"
CHEMBL620216,1,,1,,,,A,7826,Intermediate,BAO_0000218,1969.0,N,Macaca mulatta,Plasma,9544.0,,,,9552,50797,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose
CHEMBL620888,1,,1,,,,A,7827,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,9552,50588,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose"
CHEMBL620889,1,,1,,,,A,7828,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,9552,50588,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose"
CHEMBL620890,0,,1,,,,A,7829,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,9552,22224,,Area under plasma concentration vs time curve observed in rats for 0-3 h
CHEMBL620891,1,,1,,,,A,7830,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,11911,50597,,Area under plasma time curve determined in male rat
CHEMBL620892,0,,1,,,,A,7831,Autocuration,BAO_0000019,,U,,,,,,,16618,22224,,Area under the MAP curve measured over 5 min.
CHEMBL621079,1,,1,,,,A,7832,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14387,50594,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice
CHEMBL621080,1,,1,,,,A,7833,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14387,50594,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice
CHEMBL621081,1,,1,,,,A,7834,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12836,50588,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose
CHEMBL621082,1,,1,,,,A,7835,Intermediate,BAO_0000218,,N,Cricetinae,,10026.0,,,,12836,100712,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose
CHEMBL621083,1,,1,,,,A,7836,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12836,50597,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose
CHEMBL621084,1,,1,,,,A,7837,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14339,50588,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs
CHEMBL621085,1,,1,,,,A,7838,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14339,50588,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs
CHEMBL621086,1,,1,,,,A,7839,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14339,50588,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs
CHEMBL621087,1,,1,,,,A,7840,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,10524,50588,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg)
CHEMBL622607,1,,1,,,,A,7841,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,9994,50588,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg)
CHEMBL622608,1,,1,,,,A,7842,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,11325,50588,,Serum AUC in marmosets (IV dose)
CHEMBL624481,0,,1,,,,A,7843,Autocuration,BAO_0000019,,U,,,,,,,12536,22224,,Area under the curve after intravenous administration at a dose of 10 umol/kg
CHEMBL624482,0,,1,,,,A,7844,Autocuration,BAO_0000019,,U,,,,,,,12536,22224,,Area under the curve after intravenous administration at a dose of 2 umol/kg
CHEMBL624483,0,,1,,,,A,7845,Autocuration,BAO_0000019,,U,,,,,,,12536,22224,,Area under the curve after intravenous administration at a dose of 4 umol/kg
CHEMBL624484,0,,1,,,,A,7846,Autocuration,BAO_0000019,,U,,,,,,,12536,22224,,Area under the curve after intravenous administration at a dose of 40 umol/kg
CHEMBL624485,0,,1,,,,A,7847,Autocuration,BAO_0000019,,U,,,,,,,12536,22224,,Area under the curve after intravenous administration at a dose of 5 umol/kg
CHEMBL624486,1,,1,,,,A,7848,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15556,50597,,Area under the curve for fumarate salt was evaluated in F344 Rats.
CHEMBL624487,0,,1,,,,A,7849,Autocuration,BAO_0000019,,U,,,,,,,2809,22224,,Area under the curve for the compound was calculated.
CHEMBL624488,0,,1,,,,A,7850,Autocuration,BAO_0000019,,U,,,,,,,9511,22224,,Area under the curve in concentration/ time
CHEMBL624489,1,,1,,,,A,7851,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12818,50597,,Area under the curve administered intraintestinal in rats.
CHEMBL625184,1,,1,,,,A,7852,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12818,50597,,Area under the curve administered intravenously in rats.
CHEMBL625185,0,,1,,,,A,7853,Autocuration,BAO_0000019,,U,,,,,,,15118,22224,,Area under the curve during intravenous administration
CHEMBL875954,0,,1,,,,A,7854,Autocuration,BAO_0000019,,U,,,,,,,15118,22224,,Area under the curve during intravenous administration; Not determined
CHEMBL625186,0,,1,,,,A,7855,Autocuration,BAO_0000019,,U,,,,,,,15118,22224,,Area under the curve during systemic administration
CHEMBL625187,0,,1,,,,A,7856,Autocuration,BAO_0000019,,U,,,,,,,15118,22224,,Area under the curve during systemic administration; Not determined
CHEMBL625188,0,,1,,,,A,7857,Autocuration,BAO_0000019,,U,,,,,,,2632,22224,,Area under the curve was calculated for the compound.
CHEMBL625189,1,,1,,,,A,7858,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14346,50588,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs
CHEMBL625190,1,,1,,,,A,7859,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14346,50588,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs
CHEMBL621733,1,,1,,,,A,7860,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats
CHEMBL621734,1,,1,,,,A,7861,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats
CHEMBL621735,1,,1,,,,A,7862,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11149,50597,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats
CHEMBL621736,1,,1,,,,A,7863,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17796,50597,,Clearance of the drug was measured in the plasma of rat; No data
CHEMBL621737,1,,1,,,,A,7864,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5247,50597,,The pharmacokinetic parameter plasma clearance in vivo in rats
CHEMBL621738,1,,1,,,,A,7865,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4727,50597,,Plasma clearance at the dose of 2 mg/kg in rat
CHEMBL622806,1,,1,,,,A,7866,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5654,50597,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration
CHEMBL623519,1,,1,,,,A,7867,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5654,50597,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration
CHEMBL623520,1,,1,,,,A,7868,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17260,50597,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat
CHEMBL623521,1,,1,,,,A,7869,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17065,50597,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats
CHEMBL623522,1,,1,,,,A,7870,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17671,50597,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg
CHEMBL623523,1,,1,,,,A,7871,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6672,50597,,Clearance rate in rat
CHEMBL623690,1,,1,,,,A,7872,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6673,50597,,Clearance rate in rat
CHEMBL623691,1,,1,,,,A,7873,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL623692,1,,1,,,,A,7874,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL623693,1,,1,,,,A,7875,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL623694,1,,1,,,,A,7876,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL623695,1,,1,,,,A,7877,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4413,50597,,Clearance of compound after iv administration of 20 mg/kg dose in rat
CHEMBL623696,1,,1,,,,A,7878,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats
CHEMBL623697,1,,1,,,,A,7879,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats
CHEMBL623698,0,,1,,,,A,7880,Intermediate,BAO_0000218,1969.0,U,Macaca mulatta,Plasma,9544.0,,In vivo,,5005,22224,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po
CHEMBL623699,0,,1,,,,A,7881,Intermediate,BAO_0000218,1969.0,U,Rattus norvegicus,Plasma,10116.0,,In vivo,,5005,22224,,Compound was tested for its plasma clearance rate in Sprague Dawley rats
CHEMBL623700,1,,1,,,,A,7882,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15765,50597,,Mean (%CV) PK parameters for CL(mL/min/kg).
CHEMBL623701,1,,1,,,,A,7883,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3747,50597,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat
CHEMBL623702,1,,1,,,,A,7884,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16366,50597,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered
CHEMBL623703,1,,1,,,,A,7885,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4199,50597,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats
CHEMBL623704,1,,1,,,,A,7886,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17267,50597,,Plasma clearance in rat was determined
CHEMBL623705,1,,1,,,,A,7887,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6535,50597,,Plasma clearance in rat after administration of 2 mg/kg iv
CHEMBL623706,1,,1,,,,A,7888,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6535,50597,,Plasma clearance in rat after administration of 2 mg/kg iv
CHEMBL623707,1,,1,,,,A,7889,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,Plasma clearance was determined
CHEMBL623708,1,,1,,,,A,7890,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5960,50597,,Plasma clearance in rat
CHEMBL623709,1,,1,,,,A,7891,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5937,50597,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg
CHEMBL623710,1,,1,,,,A,7892,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5871,50597,,Plasma clearance in rat by iv administration
CHEMBL623711,1,,1,,,,A,7893,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5874,50597,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg
CHEMBL623712,1,,1,,,,A,7894,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6504,50597,,Plasma clearance in rat p.o.
CHEMBL623713,1,,1,,,,A,7895,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6803,50597,,Plasma clearance in rats
CHEMBL623714,1,,1,,,,A,7896,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,Plasma clearance was determined; ND denotes no data
CHEMBL623715,1,,1,,,,A,7897,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,Plasma clearance was determined; ND denotes not determined
CHEMBL623716,1,,1,,,,A,7898,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1916,50597,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration
CHEMBL622980,1,,1,,,,A,7899,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5199,50597,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).
CHEMBL622981,1,,1,,,,A,7900,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16367,50597,,Plasma administration to rats
CHEMBL622982,1,,1,,,,A,7901,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6362,50597,,Plasma clearance of the compound in female Sprague-Dawley rats
CHEMBL622983,1,,1,,,,A,7902,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15662,50597,,Plasma clearance was observed after intravenous administration in rat
CHEMBL622984,1,,1,,,,A,7903,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6215,50597,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat
CHEMBL622985,1,,1,,,,A,7904,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1466,50597,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat
CHEMBL623631,1,,1,,,,A,7905,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15662,50597,,plasma clearance was observed after intravenous administration in rat
CHEMBL623632,1,,1,,,,A,7906,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4723,50597,,In vivo CL/F determined
CHEMBL623633,1,,1,,,,A,7907,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2792,50597,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats
CHEMBL623634,1,,1,,,,A,7908,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2792,50597,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats
CHEMBL623635,1,,1,,,,A,7909,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5213,50597,,Compound was tested for the lower blood clearance in rat
CHEMBL621195,1,,1,,,,A,7910,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4687,50597,,Evaluated for the low clearance in rat (in vivo)
CHEMBL621196,1,,1,,,,A,7911,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3371,50597,,Pharmacokinetic property (CLb)of the compound was determined in rat
CHEMBL875287,1,,1,,,,A,7912,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4690,50597,,Rapid clearance after intravenous administration in rat was determined
CHEMBL621197,1,,1,,,,A,7913,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5702,50597,,Clearance measured in rat
CHEMBL621198,1,,1,,,,A,7914,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,740,50597,,Compound was evaluated for plasma clearance in rat
CHEMBL621199,1,,1,,,,A,7915,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4853,50597,,Low plasma clearance was calculated in rat
CHEMBL621200,1,,1,,,,A,7916,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5789,50597,,Pharmacokinetic property (Clp) in rat
CHEMBL621201,1,,1,,,,A,7917,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4527,50597,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined
CHEMBL621202,1,,1,,,,A,7918,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4527,50597,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined
CHEMBL621203,1,,1,,,,A,7919,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Plasma clearance after IV dosing at 0.5 mg/kg in rat
CHEMBL621204,1,,1,,,,A,7920,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Plasma clearance after IV dosing at 1 mg/kg in rat
CHEMBL621205,1,,1,,,,A,7921,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP
CHEMBL621206,1,,1,,,,A,7922,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP
CHEMBL621207,1,,1,,,,A,7923,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP
CHEMBL621208,1,,1,,,,A,7924,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP
CHEMBL621209,1,,1,,,,A,7925,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig
CHEMBL876484,1,,1,,,,A,7926,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP
CHEMBL621210,1,,1,,,,A,7927,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP
CHEMBL621211,1,,1,,,,A,7928,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP
CHEMBL621212,1,,1,,,,A,7929,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP
CHEMBL621213,1,,1,,,,A,7930,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA at 15 min
CHEMBL621214,1,,1,,,,A,7931,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr
CHEMBL621215,1,,1,,,,A,7932,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA at 30 min
CHEMBL621216,1,,1,,,,A,7933,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr
CHEMBL621217,1,,1,,,,A,7934,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr
CHEMBL621218,1,,1,,,,A,7935,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min
CHEMBL621219,1,,1,,,,A,7936,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr
CHEMBL621220,1,,1,,,,A,7937,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min
CHEMBL621221,1,,1,,,,A,7938,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr
CHEMBL621222,1,,1,,,,A,7939,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min
CHEMBL621223,1,,1,,,,A,7940,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr
CHEMBL876485,1,,1,,,,A,7941,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min
CHEMBL621224,1,,1,,,,A,7942,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP
CHEMBL621225,1,,1,,,,A,7943,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip
CHEMBL621226,1,,1,,,,A,7944,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9866,50597,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig
CHEMBL621227,1,,1,,,,A,7945,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP
CHEMBL621228,1,,1,,,,A,7946,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP
CHEMBL621229,1,,1,,,,A,7947,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP
CHEMBL621230,1,,1,,,,A,7948,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig
CHEMBL621231,1,,1,,,,A,7949,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data
CHEMBL621232,1,,1,,,,A,7950,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP
CHEMBL621233,1,,1,,,,A,7951,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP
CHEMBL621234,1,,1,,,,A,7952,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP
CHEMBL621235,1,,1,,,,A,7953,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data
CHEMBL621236,1,,1,,,,A,7954,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP
CHEMBL621237,1,,1,,,,A,7955,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip
CHEMBL876486,1,,1,,,,A,7956,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,9866,50597,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig
CHEMBL622436,1,,1,,,,A,7957,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,9866,50597,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr
CHEMBL622437,1,,1,,,,A,7958,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,9866,50597,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr
CHEMBL622438,1,,1,,,,A,7959,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,9866,50597,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr
CHEMBL622439,1,,1,,,,A,7960,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min
CHEMBL622440,1,,1,,,,A,7961,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig
CHEMBL622441,1,,1,,,,A,7962,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig
CHEMBL622442,1,,1,,,,A,7963,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP
CHEMBL622443,1,,1,,,,A,7964,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP
CHEMBL622444,1,,1,,,,A,7965,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP
CHEMBL622445,1,,1,,,,A,7966,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP
CHEMBL622446,1,,1,,,,A,7967,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP
CHEMBL622447,1,,1,,,,A,7968,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP
CHEMBL622448,1,,1,,,,A,7969,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP
CHEMBL622449,1,,1,,,,A,7970,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data
CHEMBL622450,1,,1,,,,A,7971,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr
CHEMBL622451,1,,1,,,,A,7972,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr
CHEMBL622452,1,,1,,,,A,7973,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA at 15 min
CHEMBL622453,1,,1,,,,A,7974,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr
CHEMBL622454,1,,1,,,,A,7975,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA at 30 min
CHEMBL622455,1,,1,,,,A,7976,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr
CHEMBL876024,1,,1,,,,A,7977,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min
CHEMBL622456,1,,1,,,,A,7978,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,T max was determined at 3 mg/kg po dose in rats
CHEMBL622457,1,,1,,,,A,7979,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15078,50597,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL622458,1,,1,,,,A,7980,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15078,50597,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose"
CHEMBL622459,1,,1,,,,A,7981,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15022,50597,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg
CHEMBL873343,1,,1,,,,A,7982,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15022,50597,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg
CHEMBL622460,1,,1,,,,A,7983,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15022,50597,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg
CHEMBL622461,1,,1,,,,A,7984,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4576,50597,,Time for maximum plasma concentration determined in rat
CHEMBL622462,1,,1,,,,A,7985,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6681,50597,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose
CHEMBL622463,1,,1,,,,A,7986,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat
CHEMBL622464,1,,1,,,,A,7987,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat
CHEMBL622465,1,,1,,,,A,7988,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg
CHEMBL622466,1,,1,,,,A,7989,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat
CHEMBL622467,1,,1,,,,A,7990,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg
CHEMBL622468,1,,1,,,,A,7991,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6824,50597,,Time of maximum plasma concentration in rat
CHEMBL876025,1,,1,,,,A,7992,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6685,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose"
CHEMBL622469,1,,1,,,,A,7993,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6685,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose"
CHEMBL622470,1,,1,,,,A,7994,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6685,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable"
CHEMBL622471,1,,1,,,,A,7995,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15662,50597,,Time required to reach maximum concentration (Cmax) after oral administration in rat
CHEMBL622472,1,,1,,,,A,7996,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1742,50597,,Time required to reach maximum concentration in rat plasma
CHEMBL622473,1,,1,,,,A,7997,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2774,50597,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.
CHEMBL624282,1,,1,,,,A,7998,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5199,50597,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats
CHEMBL624283,1,,1,,,,A,7999,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12873,50597,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg
CHEMBL624284,1,,1,,,,A,8000,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12873,50597,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg
CHEMBL624285,1,,1,,,,A,8001,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1916,50597,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration
CHEMBL624286,1,,1,,,,A,8002,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16367,50597,,Time to reach Cmax after oral administration to rats
CHEMBL624287,1,,1,,,,A,8003,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16366,50597,,Time to reach Cmax when a dose of 1 mg/kg is administered orally
CHEMBL624288,1,,1,,,,A,8004,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,216,50597,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4
CHEMBL624289,1,,1,,,,A,8005,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6410,50597,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable
CHEMBL873344,1,,1,,,,A,8006,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6410,50597,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg
CHEMBL619623,1,,1,,,,A,8007,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6215,50597,,Tmax after peroral administration (10 mg/kg) was determined in rat
CHEMBL621399,1,,1,,,,A,8008,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3598,50597,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg
CHEMBL621400,1,,1,,,,A,8009,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4527,50597,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined
CHEMBL621401,1,,1,,,,A,8010,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17670,50597,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously"
CHEMBL621402,1,,1,,,,A,8011,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1465,50597,,Tmax was determined
CHEMBL621403,1,,1,,,,A,8012,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2552,50597,,Tmax was determined
CHEMBL621121,1,,1,,,,A,8013,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5656,50597,,Tmax after oral administration in rat
CHEMBL872525,1,,1,,,,A,8014,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17764,50597,,Tmax after peroral administration in rats at 2.4 uM/kg
CHEMBL621122,1,,1,,,,A,8015,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5610,50597,,Tmax in male rat
CHEMBL621123,1,,1,,,,A,8016,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6046,50597,,Tmax in rat at 10 mg/kg
CHEMBL621124,1,,1,,,,A,8017,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5874,50597,,Tmax in rat by po administration at a dose of 40 mg/kg
CHEMBL621125,1,,1,,,,A,8018,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17596,50597,,Tmax in rats
CHEMBL621126,1,,1,,,,A,8019,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17804,50597,,Tmax was measured in rats after peroral administration at 5 mg/kg
CHEMBL621127,1,,1,,,,A,8020,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1908,50597,,Tmax value after oral dose at a dose of 10 mg/kg in rats.
CHEMBL621128,1,,1,,,,A,8021,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2959,50597,,Tmax value after administration of 20 mg/Kg oral dose in rat
CHEMBL618263,1,,1,,,,A,8022,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6757,50597,,Tmax value at a dose of 10 mg/kg in male SD rats
CHEMBL618264,1,,1,,,,A,8023,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6757,50597,,Tmax value at a dose of 100 mg/kg in male SD rats
CHEMBL618265,1,,1,,,,A,8024,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6757,50597,,Tmax value at a dose of 50 mg/kg in male SD rats
CHEMBL618266,1,,1,,,,A,8025,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4186,50597,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route
CHEMBL618267,1,,1,,,,A,8026,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15662,50597,,time required to reach maximum concentration (Cmax) after oral administration in rat
CHEMBL618450,1,,1,,,,A,8027,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,429,50597,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr )
CHEMBL618451,1,,1,,,,A,8028,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,429,50597,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr)
CHEMBL618452,1,,1,,,,A,8029,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5546,50597,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration
CHEMBL618453,1,,1,,,,A,8030,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,3173,50597,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po
CHEMBL618454,1,,1,,,,A,8031,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,3173,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po
CHEMBL618455,1,,1,,,,A,8032,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,3173,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested
CHEMBL618456,1,,1,,,,A,8033,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4257,50597,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose
CHEMBL618457,1,,1,,,,A,8034,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6011,50597,,Compound distribution in rat tissues was determined
CHEMBL618458,1,,1,,,,A,8035,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5472,50597,,Volume of distribution was evaluated in rat
CHEMBL618459,1,,1,,,,A,8036,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats
CHEMBL876733,1,,1,,,,A,8037,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats
CHEMBL618460,1,,1,,,,A,8038,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14346,50588,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs
CHEMBL618461,1,,1,,,,A,8039,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats
CHEMBL618462,0,,1,,,,A,8040,Autocuration,BAO_0000019,,U,,,,,,,15469,22224,,Area under the curve was determined after oral administration (300 uM/Kg)
CHEMBL618463,1,,1,,,,A,8041,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats
CHEMBL618464,1,,1,,,,A,8042,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats
CHEMBL618465,1,,1,,,,A,8043,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats
CHEMBL618466,1,,1,,,,A,8044,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats
CHEMBL618467,1,,1,,,,A,8045,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14346,50597,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats
CHEMBL618468,1,,1,,,,A,8046,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15372,50597,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats
CHEMBL618469,1,,1,,,,A,8047,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,12935,50588,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg
CHEMBL618470,1,,1,,,,A,8048,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,12935,50588,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg
CHEMBL618471,0,,1,,,,A,8049,Autocuration,BAO_0000218,,U,,,,,,,14813,22224,,Plasma drug AUC in rat (PO dose)
CHEMBL618472,1,,1,,,,A,8050,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15792,50594,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.
CHEMBL618473,0,,1,,,,A,8051,Autocuration,BAO_0000218,,U,,,,,,,3579,22224,,Area under was determined at a dose of 30 mg/kg
CHEMBL621699,1,,1,,,,A,8052,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,12487,50506,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret
CHEMBL621700,1,,1,,,,A,8053,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12487,50597,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat
CHEMBL621701,1,,1,,,,A,8054,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12487,50597,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat
CHEMBL621702,1,,1,,,,A,8055,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,12487,50506,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret
CHEMBL621703,1,,1,,,,A,8056,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12487,50588,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog
CHEMBL621704,1,,1,,,,A,8057,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12487,50588,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog
CHEMBL624259,1,,1,,,,A,8058,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12902,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)"
CHEMBL624260,1,,1,,,,A,8059,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12902,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)"
CHEMBL624430,1,,1,,,,A,8060,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12902,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)"
CHEMBL624431,1,,1,,,,A,8061,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12902,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)"
CHEMBL624432,1,,1,,,,A,8062,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12902,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)"
CHEMBL624433,1,,1,,,,A,8063,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12902,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)"
CHEMBL624434,1,,1,,,,A,8064,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12902,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)"
CHEMBL624435,1,,1,,,,A,8065,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12902,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)"
CHEMBL618570,1,,1,,,,A,8066,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose
CHEMBL618571,1,,1,,,,A,8067,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP)
CHEMBL618572,1,,1,,,,A,8068,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose
CHEMBL618573,1,,1,,,,A,8069,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP)
CHEMBL619267,1,,1,,,,A,8070,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose
CHEMBL619431,1,,1,,,,A,8071,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP)
CHEMBL619432,1,,1,,,,A,8072,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose
CHEMBL619433,1,,1,,,,A,8073,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP)
CHEMBL619434,0,,1,,,,A,8074,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,,,13298,22224,,AUC in mice after oral dose (50 mg/kg)
CHEMBL619435,1,,1,,,,A,8075,Intermediate,BAO_0000218,1977.0,N,Mus musculus,Serum,10090.0,,,,12226,50594,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum
CHEMBL619436,0,,1,,,,A,8076,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,12634,22224,,AUC (0-4 hr) ug/ml/h
CHEMBL619437,1,,1,,,,A,8077,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14810,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported
CHEMBL619438,0,,1,,,,A,8078,Autocuration,BAO_0000218,,U,,,,,,,13889,22224,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration
CHEMBL619439,1,,1,,,,A,8079,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10018,50594,,Compound was evaluated for Area under curve in mice
CHEMBL619440,1,,1,,,,A,8080,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8758,50597,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po
CHEMBL619441,0,,1,,,,F,8081,Autocuration,BAO_0000218,,U,,,,,,,8758,22224,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po
CHEMBL619442,1,,1,,,,A,8082,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8758,50597,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po
CHEMBL875156,0,,1,,,,A,8083,Autocuration,BAO_0000019,,U,,,,,,,2249,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1
CHEMBL619443,0,,1,,,,A,8084,Autocuration,BAO_0000019,,U,,,,,,,2249,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4
CHEMBL619444,0,,1,,,,A,8085,Autocuration,BAO_0000019,,U,,,,,,,2249,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1
CHEMBL623464,0,,1,,,,A,8086,Autocuration,BAO_0000019,,U,,,,,,,2249,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4
CHEMBL623465,1,,1,,,,A,8087,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15115,50594,,Compound was evaluated for area under curve when administered through oral route in mouse
CHEMBL623466,1,,1,,,,A,8088,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data
CHEMBL623467,1,,1,,,,A,8089,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data
CHEMBL623468,1,,1,,,,A,8090,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6249,50597,,Plasma clearance in rat
CHEMBL622660,1,,1,,,,A,8091,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2463,50597,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration
CHEMBL622661,1,,1,,,,A,8092,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4969,50597,,Plasma clearance rate in Sprague-Dawley rats
CHEMBL622662,1,,1,,,,F,8093,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17720,50597,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration
CHEMBL622663,1,,1,,,,A,8094,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3457,50597,,Pharmacokinetic property (total body clearance) in rat
CHEMBL622664,1,,1,,,,A,8095,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5983,50597,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.
CHEMBL622665,1,,1,,,,A,8096,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6295,50597,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg
CHEMBL622666,1,,1,,,,A,8097,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6296,50597,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg
CHEMBL621615,1,,1,,,,A,8098,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17686,50597,,Cl in rat i.v. at 2 mg/kg concentration
CHEMBL621616,1,,1,,,,A,8099,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17764,50597,,Clearance of compound after intravenous administration in rats at 24 uM/kg
CHEMBL621617,1,,1,,,,A,8100,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5503,50597,,Clearance was determined
CHEMBL621618,1,,1,,,,A,8101,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4368,50597,,Clearance by intravenous administration of 3.4 mg/kg in rat
CHEMBL621619,1,,1,,,,A,8102,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6005,50597,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg
CHEMBL621620,1,,1,,,,A,8103,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5031,50597,,Clearance rate after i.v. administration in rats
CHEMBL621786,1,,1,,,,A,8104,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4890,50597,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats
CHEMBL621787,1,,1,,,,A,8105,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5182,50597,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat
CHEMBL621788,1,,1,,,,A,8106,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5979,50597,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat
CHEMBL621789,1,,1,,,,A,8107,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5656,50597,,Clearance (Cl) after oral administration in rat
CHEMBL621790,1,,1,,,,A,8108,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17804,50597,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg
CHEMBL621791,1,,1,,,,A,8109,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4839,50597,,Compound was tested for plasma clearance in rat
CHEMBL621792,1,,1,,,,A,8110,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vitro,,5041,50597,Microsomes,In vitro microsome metabolism clearance in rat was determined
CHEMBL621793,1,,1,,,,A,8111,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vitro,,5041,50597,Microsomes,In vitro microsome metabolism clearance in rat was determined; ND denotes no data
CHEMBL621794,1,,1,,,,A,8112,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat
CHEMBL621795,1,,1,,,,A,8113,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5496,50597,,In vivo plasma clearance was determined
CHEMBL621796,1,,1,,,,A,8114,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5739,50597,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats
CHEMBL621797,1,401.0,1,,,,A,8115,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,Hepatocyte,In vivo,,5676,50597,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.
CHEMBL621798,1,,1,,,,A,8116,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4239,50597,,Pharmacokinetic property (Plasma clearance) was measured in rat
CHEMBL621799,1,,1,,,,A,8117,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5676,50597,,Pharmacokinetic property (clearance) in rat i.v.
CHEMBL621800,1,,1,,,,A,8118,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1918,50597,,"Plasma Clearance was evaluated in rats, iv"
CHEMBL621801,1,,1,,,,A,8119,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17800,50597,,Plasma clearance (in vivo) in rats was determined
CHEMBL621802,1,,1,,,,A,8120,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6056,50597,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat
CHEMBL618596,1,,1,,,,A,8121,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5496,50597,,Plasma clearance was determined
CHEMBL618597,1,,1,,,,A,8122,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5939,50597,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration
CHEMBL618598,1,,1,,,,A,8123,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5939,50597,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration
CHEMBL618599,1,,1,,,,A,8124,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17752,50597,,Plasma clearance in rats
CHEMBL618600,1,,1,,,,A,8125,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4576,50597,,Plasma clearance rate determined in rat
CHEMBL618601,1,,1,,,,A,8126,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6011,50597,,Plasma clearance was determined in rat
CHEMBL618602,1,,1,,,,A,8127,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5510,50597,,Plasma clearance was determined
CHEMBL618603,1,,1,,,,A,8128,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5948,50597,,Plasma clearance value in rat
CHEMBL618604,1,,1,,,,A,8129,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,Ex vivo,,6125,50597,,Clearance rate constant using isolated perfused rat liver (IPRL) assay
CHEMBL618605,1,,1,,,,A,8130,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4839,50597,,Clearance in rat
CHEMBL618606,1,,1,,,,A,8131,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17686,50597,,Total body clearance in rat i.v. at 2 mg/kg concentration
CHEMBL618607,1,,1,,,,A,8132,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6571,50597,,Clearance of compound in rats after intravenous administration
CHEMBL618608,1,,1,,,,A,8133,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3364,50597,,Clearance after iv administration to rats
CHEMBL618609,1,,1,,,,A,8134,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg
CHEMBL618610,1,,1,,,,A,8135,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg
CHEMBL618611,1,,1,,,,A,8136,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg
CHEMBL618612,1,,1,,,,A,8137,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg
CHEMBL618613,1,,1,,,,A,8138,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg
CHEMBL621076,1,,1,,,,A,8139,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg
CHEMBL621077,1,,1,,,,A,8140,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg
CHEMBL621078,1,,1,,,,A,8141,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17670,50597,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously"
CHEMBL621251,1,,1,,,,A,8142,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5970,50597,,Clearance in rat
CHEMBL621252,1,,1,,,,A,8143,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6495,50597,,Clearance in rat after oral administration at 10 mg/kg
CHEMBL621253,1,,1,,,,A,8144,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4590,50597,,Clearance in rat.
CHEMBL621254,1,,1,,,,A,8145,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6193,50597,,Clearance rate following an oral dose of 20 mg/kg in rats
CHEMBL621255,1,,1,,,,A,8146,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2832,50597,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.
CHEMBL621256,1,,1,,,,A,8147,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1052,50597,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing
CHEMBL621257,1,,1,,,,A,8148,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr
CHEMBL621258,1,,1,,,,A,8149,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min
CHEMBL621259,1,,1,,,,A,8150,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr
CHEMBL621260,1,,1,,,,A,8151,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min
CHEMBL876494,1,,1,,,,A,8152,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr
CHEMBL621261,1,,1,,,,A,8153,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min
CHEMBL621262,1,,1,,,,A,8154,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr
CHEMBL621263,1,,1,,,,A,8155,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP
CHEMBL621264,1,,1,,,,A,8156,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9866,50597,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip
CHEMBL621265,1,,1,,,,A,8157,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP
CHEMBL621266,1,,1,,,,A,8158,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig
CHEMBL621267,1,,1,,,,A,8159,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP
CHEMBL621268,1,,1,,,,A,8160,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP
CHEMBL621269,1,,1,,,,A,8161,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr
CHEMBL621270,1,,1,,,,A,8162,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr
CHEMBL621271,1,,1,,,,A,8163,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min
CHEMBL621272,1,,1,,,,A,8164,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min
CHEMBL621273,1,,1,,,,A,8165,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr
CHEMBL621274,1,,1,,,,A,8166,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr
CHEMBL876495,1,,1,,,,A,8167,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min
CHEMBL621275,1,,1,,,,A,8168,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min
CHEMBL621276,1,,1,,,,A,8169,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip
CHEMBL621277,1,,1,,,,A,8170,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9866,50597,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig
CHEMBL621278,1,,1,,,,A,8171,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,9866,50597,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr
CHEMBL621279,1,,1,,,,A,8172,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,9866,50597,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr
CHEMBL621280,1,,1,,,,A,8173,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,9866,50597,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added)
CHEMBL621281,1,,1,,,,A,8174,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP
CHEMBL621282,1,,1,,,,A,8175,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data
CHEMBL621283,1,,1,,,,A,8176,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data
CHEMBL621284,1,,1,,,,A,8177,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP
CHEMBL621285,1,,1,,,,A,8178,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min
CHEMBL621286,1,,1,,,,A,8179,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr
CHEMBL623220,1,,1,,,,A,8180,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr
CHEMBL623221,1,,1,,,,A,8181,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip
CHEMBL876029,1,,1,,,,A,8182,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,9866,50597,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig
CHEMBL623222,1,,1,,,,A,8183,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,9866,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min
CHEMBL623223,1,,1,,,,A,8184,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,9866,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr
CHEMBL621445,1,,1,,,,A,8185,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,9866,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data
CHEMBL621446,1,,1,,,,A,8186,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL621447,1,,1,,,,A,8187,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue
CHEMBL619681,1,,1,,,,A,8188,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL619682,1,,1,,,,A,8189,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue
CHEMBL619683,1,,1,,,,A,8190,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL619684,1,,1,,,,A,8191,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL619685,1,,1,,,,A,8192,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue
CHEMBL619686,1,,1,,,,A,8193,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL619687,1,,1,,,,A,8194,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue
CHEMBL619688,1,,1,,,,A,8195,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL619689,1,,1,,,,A,8196,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL619690,1,,1,,,,A,8197,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue
CHEMBL619691,1,,1,,,,A,8198,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL619692,1,,1,,,,A,8199,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6062,50597,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg
CHEMBL619693,1,,1,,,,A,8200,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3598,50597,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg
CHEMBL619694,1,,1,,,,A,8201,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1908,50597,,Vc value after IV dose at a dose of 5 mg/kg in rats.
CHEMBL619695,1,,1,,,,A,8202,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17596,50597,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration
CHEMBL619696,1,,1,,,,A,8203,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4891,50597,,Compound was evaluated for pharmacokinetic parameter volume of distribution
CHEMBL619697,1,,1,,,,A,8204,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,740,50597,,Compound was evaluated for volume of distribution in rat
CHEMBL619698,1,,1,,,,A,8205,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16366,50597,,Steady state volume distribution was determined; steady state(ss)
CHEMBL619699,1,,1,,,,A,8206,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3364,50597,,Steady state volume of distribution after iv administration to rats
CHEMBL619700,1,,1,,,,A,8207,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2552,50597,,Steady state volume of distribution dosing at 3 mg/kg iv
CHEMBL619701,1,,1,,,,A,8208,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,406,50597,,The compound was evaluated for volume of distribution in rat
CHEMBL619702,1,,1,,,,A,8209,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12500,50597,,The compound was tested for volume of distribution in rat
CHEMBL620335,1,,1,,,,A,8210,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12500,50597,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg
CHEMBL620336,1,,1,,,,A,8211,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5656,50597,,Volume distribution (VD) after oral administration in rat
CHEMBL620337,1,,1,,,,A,8212,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17671,50597,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg
CHEMBL620520,1,,1,,,,A,8213,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1094,50597,,Volume distribution in rat
CHEMBL620521,1,,1,,,,A,8214,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5833,50597,,Volume distribution in rat
CHEMBL875825,1,,1,,,,A,8215,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5939,50597,,Volume distribution in rat after peroral administration at 10 mg/kg
CHEMBL620522,1,,1,,,,A,8216,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5939,50597,,Volume distribution in rat after peroral administration at 5 mg/kg
CHEMBL620523,1,,1,,,,A,8217,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6005,50597,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg
CHEMBL620524,1,,1,,,,A,8218,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1696,50597,,Volume of distribution in rat.
CHEMBL620525,1,,1,,,,A,8219,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6672,50597,,Volume of distribution in rat
CHEMBL620526,1,,1,,,,A,8220,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6673,50597,,Volume of distribution in rat
CHEMBL620527,1,,1,,,,A,8221,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5871,50597,,Volume of distribution in rat by iv administration
CHEMBL620528,1,,1,,,,A,8222,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6803,50597,,Volume of distribution in rats
CHEMBL620529,1,,1,,,,A,8223,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5199,50597,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).
CHEMBL620530,1,,1,,,,A,8224,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4727,50597,,Volume distribution at the dose of 2 mg/kg in rat
CHEMBL620531,1,,1,,,,A,8225,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16367,50597,,Steady state volume of distribution was determined
CHEMBL620532,0,,1,,,,A,8226,Intermediate,BAO_0000218,,U,Macaca mulatta,,9544.0,,In vivo,,5005,22224,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po
CHEMBL620533,0,,1,,,,A,8227,Intermediate,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,5005,22224,,Compound was tested for its plasma volume distribution in Sprague Dawley rats
CHEMBL620534,0,,1,,,,A,8228,Intermediate,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,5005,22224,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined
CHEMBL620535,1,,1,,,,A,8229,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15765,50597,,Mean (%CV) PK parameters for Vdss(mL/kg).
CHEMBL875826,1,,1,,,,A,8230,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats
CHEMBL620536,1,,1,,,,A,8231,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats
CHEMBL620537,1,,1,,,,A,8232,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat
CHEMBL618526,1,,1,,,,A,8233,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined
CHEMBL618527,1,,1,,,,A,8234,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5739,50597,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats
CHEMBL618528,1,,1,,,,A,8235,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5789,50597,,Pharmacokinetic property (Vdss) in rat
CHEMBL618529,1,,1,,,,A,8236,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4239,50597,,Pharmacokinetic property (vdss) was measured in rat
CHEMBL618530,1,,1,,,,A,8237,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4709,50597,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat
CHEMBL618531,1,,1,,,,A,8238,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6642,50597,,Volume of distribution in rat
CHEMBL618532,1,,1,,,,A,8239,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5247,50597,,The pharmacokinetic parameter volume of distribution in vivo in rats
CHEMBL618533,1,,1,,,,F,8240,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17720,50597,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration
CHEMBL618534,1,,1,,,,A,8241,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17686,50597,,Vdss in rat i.v. at 2 mg/kg concentration
CHEMBL618535,1,,1,,,,A,8242,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4689,50597,,Volume distribution after intravenous administration (1 mg/kg) in rat
CHEMBL618536,1,,1,,,,A,8243,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5654,50597,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration
CHEMBL618537,1,,1,,,,A,8244,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5654,50597,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration
CHEMBL618538,1,,1,,,,A,8245,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4527,50597,,Volume distribution at a dose of 10 uM/kg in rat was determined
CHEMBL618539,1,,1,,,,A,8246,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4521,50597,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration
CHEMBL618540,1,,1,,,,A,8247,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6057,50597,,Volume distribution was calculated in rat
CHEMBL618541,1,,1,,,,A,8248,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5510,50597,,Volume distribution was determined
CHEMBL618542,1,,1,,,,A,8249,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2938,50597,,Volume of distribution after intravenous administration was evaluated in rat
CHEMBL622544,1,,1,,,,A,8250,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6679,50597,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration
CHEMBL622545,1,,1,,,,A,8251,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable"
CHEMBL622546,1,,1,,,,A,8252,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable"
CHEMBL622547,1,,1,,,,A,8253,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose"
CHEMBL622548,1,,1,,,,A,8254,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5145,50597,,Volume of distribution in steady state was determined in rat
CHEMBL622549,1,,1,,,,A,8255,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6467,50597,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration
CHEMBL622550,1,,1,,,,A,8256,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6467,50597,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined
CHEMBL622551,1,,1,,,,A,8257,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15115,50594,,Compound was evaluated for area under curve when administered through oral route to mouse
CHEMBL622552,1,,1,,,,A,8258,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8758,50597,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po
CHEMBL622553,1,,1,,,,A,8259,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8758,50597,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po
CHEMBL622554,0,,1,,,,F,8260,Autocuration,BAO_0000218,,U,,,,,In vivo,,8267,22224,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs
CHEMBL622555,1,,1,,,,A,8261,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8267,50588,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs
CHEMBL622556,1,,1,,,,A,8262,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14239,50594,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice
CHEMBL622557,1,,1,,,,A,8263,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14239,50594,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice
CHEMBL622558,1,,1,,,,A,8264,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,,,10754,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice
CHEMBL622559,1,,1,,,,A,8265,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,,,10754,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice
CHEMBL622560,1,,1,,,,A,8266,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,10754,50588,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.
CHEMBL622561,1,,1,,,,A,8267,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14681,50597,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose
CHEMBL622562,1,,1,,,,A,8268,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14681,50597,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. 
CHEMBL622563,1,,1,,,,A,8269,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14681,50597,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose
CHEMBL622564,0,,1,,,,A,8270,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Concentration of compound in Central nervous system
CHEMBL622565,0,,1,,,,A,8271,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Concentration of compound in Central nervous system; Not detectable
CHEMBL622566,1,,1,,,,A,8272,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13318,50594,,"Concentration of diester in the blood, following oral administration in mice"
CHEMBL624515,1,,1,,,,A,8273,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13318,50594,,"Concentration of monoester in the blood, following oral administration in mice"
CHEMBL624516,1,,1,,,,A,8274,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13318,50594,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice
CHEMBL624517,0,,1,,,,A,8275,Autocuration,BAO_0000019,,U,,,,,,,15692,22224,,Evaluated for Pharmacokinetic property: Area under the curve
CHEMBL624518,1,,1,,,,A,8276,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice
CHEMBL624519,1,,1,,,,A,8277,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice
CHEMBL624520,1,,1,,,,A,8278,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve
CHEMBL624521,1,,1,,,,A,8279,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve
CHEMBL624522,1,,1,,,,A,8280,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve
CHEMBL624523,1,,1,,,,A,8281,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve
CHEMBL624409,1,,1,,,,A,8282,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)"
CHEMBL624410,1,,1,,,,A,8283,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)"
CHEMBL624411,1,,1,,,,A,8284,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)"
CHEMBL623531,1,,1,,,,A,8285,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)"
CHEMBL623532,1,,1,,,,A,8286,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)"
CHEMBL623533,1,,1,,,,A,8287,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)"
CHEMBL623534,1,,1,,,,A,8288,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)"
CHEMBL623535,1,,1,,,,A,8289,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve
CHEMBL623536,1,,1,,,,A,8290,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve
CHEMBL623537,1,,1,,,,A,8291,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve
CHEMBL623538,1,,1,,,,A,8292,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve
CHEMBL623539,1,,1,,,,A,8293,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve
CHEMBL623540,1,,1,,,,A,8294,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve
CHEMBL623541,1,,1,,,,A,8295,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined."
CHEMBL623542,1,,1,,,,A,8296,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)"
CHEMBL623543,1,,1,,,,A,8297,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)"
CHEMBL623544,1,,1,,,,A,8298,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined"
CHEMBL623545,1,,1,,,,A,8299,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)"
CHEMBL623546,1,,1,,,,A,8300,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)"
CHEMBL623547,1,,1,,,,A,8301,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5408,50597,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats
CHEMBL623548,1,,1,,,,A,8302,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6827,50597,,High i.v. clearance in Dawley rats
CHEMBL623549,1,,1,,,,A,8303,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vitro,,17538,50597,Microsomes,In vitro clearance in rat liver microsomes
CHEMBL623550,1,,1,,,,A,8304,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vitro,,6331,50597,Microsomes,Intrinsic clearance in rat liver microsomes was determined
CHEMBL875276,1,401.0,1,,,,A,8305,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,Hepatocyte,In vitro,,5948,50597,,Intrinsic clearance in rat hepatocytes was determined
CHEMBL621872,1,,1,,,,A,8306,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4026,50597,,Plasma Clearance was determined
CHEMBL621873,1,,1,,,,A,8307,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6647,50597,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined
CHEMBL621874,1,,1,,,,A,8308,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1696,50597,,Plasma clearance in rat.
CHEMBL621875,1,,1,,,,A,8309,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6597,50597,,Plasma clearance in rats
CHEMBL621876,1,,1,,,,A,8310,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,347,50597,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats
CHEMBL621877,1,,1,,,,A,8311,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16423,50597,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration
CHEMBL621878,1,,1,,,,A,8312,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2879,50597,,Plasma clearance was measured in rat
CHEMBL621879,1,,1,,,,A,8313,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4883,50597,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg
CHEMBL621880,1,,1,,,,A,8314,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5328,50597,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally"
CHEMBL621881,1,,1,,,,A,8315,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5160,50597,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg
CHEMBL621882,1,,1,,,,A,8316,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17582,50597,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats
CHEMBL875283,1,,1,,,,A,8317,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17651,50597,,Total clearance at 1 mg/kg was determined in rat
CHEMBL621883,1,,1,,,,A,8318,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17651,50597,,Total clearance at 10 mg/kg was determined in rat
CHEMBL621884,1,,1,,,,A,8319,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6596,50597,,Clearance in rat
CHEMBL621885,1,,1,,,,A,8320,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4796,50597,,Plasma clearance rate determined in rats
CHEMBL621886,1,,1,,,,A,8321,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6850,50597,,Clearance of compound in rat was evaluated
CHEMBL621887,1,,1,,,,A,8322,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5932,50597,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose
CHEMBL621888,1,,1,,,,A,8323,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3371,50597,,Pharmacokinetic property (blood clearance) in rat
CHEMBL621889,1,,1,,,,A,8324,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2083,50597,,Plasma clearance in rat
CHEMBL621890,1,,1,,,,A,8325,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4942,50597,,Plasma clearance in rats
CHEMBL621891,1,,1,,,,A,8326,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vitro,,6838,50597,Microsomes,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes
CHEMBL621892,1,,1,,,,A,8327,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5353,50597,,Clearance in Dawley rat
CHEMBL621893,1,,1,,,,A,8328,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6641,50597,,Clearance rat
CHEMBL621894,1,,1,,,,A,8329,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6641,50597,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.)
CHEMBL621895,1,,1,,,,A,8330,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6641,50597,,Clearance rat; Not determined
CHEMBL875284,1,,1,,,,A,8331,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6444,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.
CHEMBL618699,1,,1,,,,A,8332,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6444,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined
CHEMBL618700,1,,1,,,,A,8333,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6444,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined
CHEMBL618701,1,,1,,,,A,8334,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6211,50597,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats
CHEMBL876600,1,,1,,,,A,8335,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12873,50597,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv"
CHEMBL618702,1,,1,,,,A,8336,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6570,50597,,Clearance of compound in rat after 1 mg/kg i.v. administration
CHEMBL618703,1,,1,,,,A,8337,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3341,50597,,Compound was evaluated for Hepatic clearance in rat
CHEMBL618704,1,,1,,,,A,8338,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4891,50597,,In vivo clearance after 5 mg/kg dose
CHEMBL618705,1,,1,,,,A,8339,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1094,50597,,Compound was tested for plasma clearance in rats
CHEMBL618706,1,,1,,,,A,8340,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2938,50597,,Hepatic clearance after intravenous administration was evaluated in rat
CHEMBL618707,1,,1,,,,A,8341,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17853,50597,,Lower clearance in rat (i.v.) at 0.5 mpk
CHEMBL618708,1,,1,,,,A,8342,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6049,50597,,Pharmacokinetic parameter expressed as plasma clearance in rat
CHEMBL618709,1,,1,,,,A,8343,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5789,50597,,Pharmacokinetic property (Clp) in rat
CHEMBL618710,1,,1,,,,A,8344,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4514,50597,,Plasma clearance in Sprague-Dawley rats
CHEMBL618711,1,,1,,,,A,8345,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6448,50597,,Plasma clearance (Clp) in rat
CHEMBL618712,1,,1,,,,A,8346,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6062,50597,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg
CHEMBL618713,1,,1,,,,A,8347,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5710,50597,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound
CHEMBL618714,1,,1,,,,A,8348,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4709,50597,,Plasma clearance after intravenous administration of 1 mg/kg in rat
CHEMBL618715,1,,1,,,,A,8349,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4521,50597,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration
CHEMBL618716,1,,1,,,,A,8350,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1742,50597,,Plasma clearance in rat was determined
CHEMBL876601,1,,1,,,,A,8351,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6057,50597,,Plasma clearance measured in rat
CHEMBL618717,1,,1,,,,A,8352,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6057,50597,,Plasma clearance was calculated in rat
CHEMBL618718,1,,1,,,,A,8353,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5145,50597,,Plasma clearance in rat
CHEMBL618719,1,,1,,,,A,8354,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5833,50597,,Plasma clearance in rat
CHEMBL618720,1,,1,,,,A,8355,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6453,50597,,Plasma clearance in rat
CHEMBL618721,1,,1,,,,A,8356,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6640,50597,,Plasma clearance in rat
CHEMBL621477,1,,1,,,,A,8357,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6305,50597,,Plasma clearance in rats
CHEMBL621478,1,,1,,,,A,8358,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6642,50597,,Plasma clearance in rat
CHEMBL621479,1,,1,,,,A,8359,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5472,50597,,Plasma clearance was evaluated in rat
CHEMBL621480,1,,1,,,,A,8360,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5472,50597,,Plasma clearance was evaluated in rat; Not tested
CHEMBL621481,1,,1,,,,A,8361,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5144,50597,,Plasma clearance rate was determined for the compound in rat
CHEMBL621482,1,,1,,,,A,8362,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable"
CHEMBL621483,1,,1,,,,A,8363,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable"
CHEMBL621484,1,,1,,,,A,8364,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose"
CHEMBL621485,1,,1,,,,A,8365,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue
CHEMBL621486,1,,1,,,,A,8366,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL621487,1,,1,,,,A,8367,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL621488,1,,1,,,,A,8368,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue
CHEMBL621489,1,,1,,,,A,8369,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL621490,1,,1,,,,A,8370,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue
CHEMBL621491,1,,1,,,,A,8371,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL621492,1,,1,,,,A,8372,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL621493,1,,1,,,,A,8373,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue
CHEMBL621494,1,,1,,,,A,8374,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL621495,1,,1,,,,A,8375,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue
CHEMBL621496,1,,1,,,,A,8376,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL621497,1,,1,,,,A,8377,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL621498,1,,1,,,,A,8378,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue
CHEMBL621499,1,,1,,,,A,8379,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL618634,1,,1,,,,A,8380,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue
CHEMBL618635,1,,1,,,,A,8381,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL618636,1,,1,,,,A,8382,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL619737,1,,1,,,,A,8383,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue
CHEMBL619738,1,,1,,,,A,8384,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL624329,1,,1,,,,A,8385,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue
CHEMBL624330,1,,1,,,,A,8386,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL624331,1,,1,,,,A,8387,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL624332,1,,1,,,,A,8388,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue
CHEMBL624333,1,,1,,,,A,8389,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL624334,1,,1,,,,A,8390,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue
CHEMBL624335,1,,1,,,,A,8391,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL620016,1,,1,,,,A,8392,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL620169,1,,1,,,,A,8393,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue
CHEMBL620170,1,,1,,,,A,8394,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL620171,1,,1,,,,A,8395,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue
CHEMBL620172,1,,1,,,,A,8396,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL620173,1,,1,,,,A,8397,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue
CHEMBL620174,1,,1,,,,A,8398,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue
CHEMBL620175,1,,1,,,,A,8399,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue
CHEMBL620176,1,,1,,,,A,8400,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue
CHEMBL620177,1,,1,,,,A,8401,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,13950,50597,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue
CHEMBL620178,1,,1,,,,A,8402,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue
CHEMBL620179,1,,1,,,,A,8403,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue
CHEMBL620180,1,,1,,,,A,8404,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue
CHEMBL620181,1,,1,,,,A,8405,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6570,50597,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration
CHEMBL620182,1,,1,,,,A,8406,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6571,50597,,Volume of distribution of compound in rats after intravenous administration
CHEMBL620183,1,,1,,,,A,8407,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6453,50597,,Volume of distribution in rat
CHEMBL620184,1,,1,,,,A,8408,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6444,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.
CHEMBL620185,1,,1,,,,A,8409,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6444,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined
CHEMBL620186,1,,1,,,,A,8410,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6444,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined
CHEMBL620187,1,,1,,,,A,8411,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5353,50597,,Volume of distribution was determined in Dawley rat
CHEMBL620188,1,,1,,,,A,8412,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat
CHEMBL620189,1,,1,,,,A,8413,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Volume of distribution was reported in Sprague-Dawley rat
CHEMBL620190,1,,1,,,,A,8414,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6641,50597,,Volumes of distribution in rat after peroral administration
CHEMBL620191,1,,1,,,,A,8415,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6641,50597,,Volumes of distribution in rat after po administration
CHEMBL620192,1,,1,,,,A,8416,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6641,50597,,Volumes of distribution in rat after po administration; Not determined
CHEMBL620193,1,,1,,,,A,8417,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5676,50597,,Pharmacokinetic property (Volume) in rat i.v.
CHEMBL620194,1,,1,,,,A,8418,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6410,50597,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously
CHEMBL876730,1,,1,,,,A,8419,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17670,50597,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously"
CHEMBL620195,1,,1,,,,A,8420,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6495,50597,,Volume distribution in rat after oral administration at 10 mg/kg
CHEMBL620196,1,,1,,,,A,8421,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5408,50597,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats
CHEMBL620197,1,,1,,,,A,8422,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4883,50597,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg
CHEMBL620198,1,,1,,,,A,8423,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6647,50597,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined
CHEMBL620199,1,,1,,,,A,8424,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6495,50597,,Volume of distribution in rats
CHEMBL620200,1,,1,,,,A,8425,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats
CHEMBL620201,1,,1,,,,A,8426,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats
CHEMBL620202,1,,1,,,,A,8427,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat
CHEMBL620203,1,,1,,,,A,8428,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat
CHEMBL620204,1,,1,,,,A,8429,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value
CHEMBL620205,1,,1,,,,A,8430,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat
CHEMBL624664,1,,1,,,,A,8431,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5960,50597,,Pharmacokinetic parameter (Vss) in rat
CHEMBL624665,1,,1,,,,A,8432,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5676,50597,,Pharmacokinetic property (Volume) in rat i.v.
CHEMBL624666,1,,1,,,,A,8433,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5948,50597,,Pharmacokinetic property (Vss) in rat
CHEMBL624667,1,,1,,,,A,8434,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5979,50597,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat
CHEMBL624668,1,,1,,,,A,8435,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat
CHEMBL624669,1,,1,,,,A,8436,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL624670,1,,1,,,,A,8437,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL624671,1,,1,,,,A,8438,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL624672,1,,1,,,,A,8439,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6448,50597,,Steady state volume distribution in rat
CHEMBL624673,1,,1,,,,A,8440,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12873,50597,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv."
CHEMBL624674,1,,1,,,,A,8441,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4576,50597,,Steady state volume of distribution determined in rat
CHEMBL624675,1,,1,,,,A,8442,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17582,50597,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats
CHEMBL621728,1,,1,,,,A,8443,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1466,50597,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat
CHEMBL621729,1,,1,,,,A,8444,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5182,50597,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined
CHEMBL621730,1,,1,,,,A,8445,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5182,50597,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated
CHEMBL621731,1,,1,,,,A,8446,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6535,50597,,Volume distribution in rat after administration of 2 mg/kg iv
CHEMBL621732,1,,1,,,,A,8447,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6535,50597,,Volume distribution in rat after administration of 2 mg/kg iv
CHEMBL621908,1,,1,,,,A,8448,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,Volume in steady state distribution value was determined
CHEMBL875347,1,,1,,,,A,8449,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,Volume in steady state distribution value was determined; ND denotes no data
CHEMBL621909,1,,1,,,,A,8450,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,Volume in steady state distribution value was determined; ND denotes not determined
CHEMBL621910,1,,1,,,,A,8451,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17065,50597,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats
CHEMBL621911,1,,1,,,,A,8452,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6597,50597,,Volume of distribution at steady state was evaluated in rats
CHEMBL621912,1,,1,,,,A,8453,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15662,50597,,Volume of distribution at steady state was observed after intravenous administration in rat
CHEMBL621913,1,,1,,,,A,8454,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6485,50597,,Volume of distribution in steady state was determined in rat
CHEMBL621914,1,,1,,,,A,8455,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17655,50597,,Volume of distribution in steady state was determined in rat
CHEMBL621915,1,,1,,,,A,8456,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6616,50597,,Volume of distribution after i.v. administration
CHEMBL621916,1,,1,,,,A,8457,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1916,50597,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration
CHEMBL621917,1,,1,,,,A,8458,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution"
CHEMBL621918,1,,1,,,,A,8459,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol."
CHEMBL621919,1,,1,,,,A,8460,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,16438,50594,,Biodistribution of compound (oxidized form) in spleen tissue
CHEMBL621920,1,,1,,,,A,8461,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol."
CHEMBL621921,1,,1,,,,A,8462,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution"
CHEMBL622401,1,,1,,,,A,8463,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO"
CHEMBL875348,1,,1,,,,A,8464,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol."
CHEMBL622402,1,,1,,,,A,8465,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution"
CHEMBL622403,1,,1,,,,A,8466,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,16438,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood
CHEMBL622404,1,,1,,,,A,8467,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO"
CHEMBL622405,1,,1,,,,A,8468,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,In vivo,,16438,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues
CHEMBL622406,1,,1,,,,A,8469,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO"
CHEMBL622407,1,,1,,,,A,8470,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO"
CHEMBL622408,1,,1,,,,A,8471,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,16438,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues
CHEMBL622409,1,,1,,,,A,8472,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO"
CHEMBL622410,1,,1,,,,A,8473,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO"
CHEMBL622411,1,,1,,,,A,8474,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,16438,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney
CHEMBL627864,1,,1,,,,A,8475,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO"
CHEMBL627865,1,,1,,,,A,8476,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO"
CHEMBL627866,1,,1,,,,A,8477,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,16438,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver
CHEMBL627751,1,,1,,,,A,8478,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO"
CHEMBL627752,1,,1,,,,A,8479,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,16438,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen
CHEMBL627753,1,,1,,,,A,8480,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO"
CHEMBL627754,1,,1,,,,A,8481,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,16438,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO"
CHEMBL627755,1,,1,,,,A,8482,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12467,50594,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells
CHEMBL627756,1,,1,,,,A,8483,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY)
CHEMBL627757,1,,1,,,,A,8484,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL627758,1,,1,,,,A,8485,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL627759,1,,1,,,,A,8486,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL627760,1,,1,,,,A,8487,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL627761,1,,1,,,,A,8488,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL876811,1,,1,,,,A,8489,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY)
CHEMBL627762,1,,1,,,,A,8490,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL627763,1,,1,,,,A,8491,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL627764,1,,1,,,,A,8492,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL627765,1,,1,,,,A,8493,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL627766,1,,1,,,,A,8494,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL627767,1,,1,,,,A,8495,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY)
CHEMBL627768,1,,1,,,,A,8496,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL628422,1,,1,,,,A,8497,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL628423,1,,1,,,,A,8498,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL628424,1,,1,,,,A,8499,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5089,50597,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat
CHEMBL628425,1,,1,,,,A,8500,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5089,50597,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat
CHEMBL628426,1,,1,,,,A,8501,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4257,50597,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose
CHEMBL628427,1,,1,,,,A,8502,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6679,50597,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration
CHEMBL626938,1,,1,,,,A,8503,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5546,50597,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration
CHEMBL626939,1,,1,,,,A,8504,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6141,50597,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats
CHEMBL626940,1,,1,,,,A,8505,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat
CHEMBL626941,1,,1,,,,A,8506,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat
CHEMBL626942,1,,1,,,,A,8507,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Plasma clearance was reported in Sprague-Dawley rat
CHEMBL876812,1,,1,,,,A,8508,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4689,50597,,Plasma clearance after intravenous administration (1 mg/kg) in rat
CHEMBL626943,1,,1,,,,A,8509,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6848,50597,,Plasma clearance of compound in rats was evaluated
CHEMBL626944,1,,1,,,,A,8510,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6848,50597,,Plasma clearance of compound in rats was evaluated; ND indicates not determined
CHEMBL626945,1,,1,,,,A,8511,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6467,50597,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration
CHEMBL626946,1,,1,,,,A,8512,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6467,50597,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined
CHEMBL626856,1,,1,,,,A,8513,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4956,50597,,Plasma clearance rate in Sprague-Dawley rats
CHEMBL626857,1,,1,,,,A,8514,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5529,50597,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg)
CHEMBL626858,1,,1,,,,A,8515,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,406,50597,,The compound was evaluated for plasma clearance in rat
CHEMBL627018,1,,1,,,,A,8516,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17655,50597,,Total plasma clearance in rat
CHEMBL625331,1,,1,,,,A,8517,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,3293,50597,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.
CHEMBL625332,1,,1,,,,A,8518,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,4075,50597,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined
CHEMBL877590,1,,1,,,,A,8519,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,C max was determined at 10 mg/kg po dose in rats
CHEMBL625333,1,,1,,,,A,8520,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,C max was determined at 3 mg/kg po dose in rats
CHEMBL625334,1,,1,,,,A,8521,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17594,50597,,Cmax after repeated oral dose of compound at 1 mg/kg in rats
CHEMBL625335,1,,1,,,,A,8522,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17594,50597,,Cmax after single intravenous bolus of 1 mg/kg in rats
CHEMBL625336,1,,1,,,,A,8523,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4762,50597,,Cmax of compound at 5 mg/kg after po administration was determined in rat
CHEMBL625337,1,,1,,,,A,8524,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17509,50597,,Cmax 24 hr after 10 mg/kg oral administration in rats
CHEMBL625338,1,,1,,,,A,8525,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17509,50597,,Cmax 24 hr after 2 mg/kg oral administration in rats
CHEMBL625339,1,,1,,,,A,8526,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1466,50597,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat
CHEMBL625340,1,,1,,,,A,8527,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6535,50597,,Cmax in rat after administration of 2 mg/kg iv
CHEMBL625341,1,,1,,,,A,8528,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6535,50597,,Cmax in rat after administration of 2 mg/kg iv
CHEMBL622687,1,,1,,,,A,8529,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3169,50597,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg
CHEMBL622688,1,,1,,,,A,8530,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6515,50597,,Cmax wa determined in rat plasma at 30 mg/kg after po administration
CHEMBL622689,1,,1,,,,A,8531,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11149,50597,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats
CHEMBL620295,1,,1,,,,A,8532,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11149,50597,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats
CHEMBL620296,1,,1,,,,A,8533,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17858,50597,,Cmax after 10 mg/kg oral administration in rat
CHEMBL620297,1,,1,,,,A,8534,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Cmax after IV dosing at 0.5 mg/kg in rat; no data
CHEMBL620298,1,,1,,,,A,8535,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Cmax after IV dosing at 1 mg/kg in rat; no data
CHEMBL620299,1,,1,,,,A,8536,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4426,50597,,Cmax after oral administration at 20 mpk in rats
CHEMBL620300,1,,1,,,,A,8537,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4426,50597,,Cmax after oral administration at 20 mpk in rats; Not performed.
CHEMBL620301,1,,1,,,,A,8538,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4426,50597,,Cmax after oral administration at 20 mpk in rats d; Not performed.
CHEMBL620302,1,,1,,,,A,8539,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5656,50597,,Cmax after oral administration in rat
CHEMBL620303,1,,1,,,,A,8540,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Cmax after oral administration at a dose of 2 mg/kg in rat
CHEMBL620304,1,,1,,,,A,8541,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Cmax after oral administration at a dose of 4 mg/kg in rat
CHEMBL620305,1,,1,,,,A,8542,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6113,50597,,Cmax in rats after 20 mg/kg oral dose
CHEMBL620306,1,,1,,,,A,8543,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17764,50597,,Cmax after peroral administration in rats at 2.4 uM/kg
CHEMBL620307,1,,1,,,,A,8544,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4756,50597,,Cmax at the dose of 2 mg/Kg administered perorally in rats
CHEMBL620308,1,,1,,,,A,8545,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4756,50597,,Cmax at the dose of 5 mg/Kg administered perorally in rats
CHEMBL620309,1,,1,,,,A,8546,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6402,50597,,Cmax by administering at 20 mg/kg p.o. in rats
CHEMBL620310,1,,1,,,,A,8547,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5610,50597,,Cmax in male rat
CHEMBL620311,1,,1,,,,A,8548,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5207,50597,,Cmax in rat
CHEMBL620312,1,,1,,,,A,8549,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6011,50597,,Cmax in rat
CHEMBL620313,1,,1,,,,A,8550,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6504,50597,,Cmax in rat
CHEMBL620314,1,,1,,,,A,8551,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6046,50597,,Cmax in rat at 10 mg/kg
CHEMBL620315,1,,1,,,,A,8552,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6504,50597,,Cmax in rat at the dose of 1 mg/kg i.v.
CHEMBL620316,1,,1,,,,A,8553,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5874,50597,,Cmax in rat by po administration at a dose of 40 mg/kg
CHEMBL620317,1,,1,,,,A,8554,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17686,50597,,Cmax in rat p.o. at 20 mg/kg concentration
CHEMBL620318,1,,1,,,,A,8555,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5836,50597,,Cmax in rats
CHEMBL620319,1,,1,,,,A,8556,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17596,50597,,Cmax in rats
CHEMBL620320,1,,1,,,,A,8557,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16423,50597,,Cmax was evaluated after 20 uM/kg of peroral administration
CHEMBL620321,1,,1,,,,A,8558,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17804,50597,,Cmax was measured in rats after peroral administration at 3 mg/kg
CHEMBL620322,1,,1,,,,A,8559,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1908,50597,,Cmax value after oral dose at a dose of 10 mg/kg in rats.
CHEMBL620323,1,,1,,,,A,8560,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue
CHEMBL620324,1,,1,,,,A,8561,Intermediate,BAO_0000218,1870.0,N,Rattus norvegicus,Frontal cortex,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue
CHEMBL620325,1,,1,,,,A,8562,Intermediate,BAO_0000218,1870.0,N,Rattus norvegicus,Frontal cortex,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue
CHEMBL620326,1,,1,,,,A,8563,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue
CHEMBL620327,1,,1,,,,A,8564,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue
CHEMBL620328,1,,1,,,,A,8565,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue
CHEMBL620329,1,,1,,,,A,8566,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue
CHEMBL620330,1,,1,,,,A,8567,Intermediate,BAO_0000218,1891.0,N,Rattus norvegicus,Midbrain,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue
CHEMBL875286,1,,1,,,,A,8568,Intermediate,BAO_0000218,1891.0,N,Rattus norvegicus,Midbrain,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue
CHEMBL620331,1,,1,,,,A,8569,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue
CHEMBL620332,1,,1,,,,A,8570,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue
CHEMBL620333,1,,1,,,,A,8571,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue
CHEMBL620334,1,,1,,,,A,8572,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,,,13950,50597,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue
CHEMBL621015,1,,1,,,,A,8573,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL621016,1,,1,,,,A,8574,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL621191,1,,1,,,,A,8575,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL621192,1,,1,,,,A,8576,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL621193,1,,1,,,,A,8577,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL621194,1,,1,,,,A,8578,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL624204,1,,1,,,,A,8579,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL624205,1,,1,,,,A,8580,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.
CHEMBL624206,1,,1,,,,A,8581,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL624207,1,,1,,,,A,8582,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL624208,1,,1,,,,A,8583,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL624209,1,,1,,,,A,8584,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL624210,1,,1,,,,A,8585,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL624211,1,,1,,,,A,8586,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL624212,1,,1,,,,A,8587,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL624213,1,,1,,,,A,8588,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL876611,1,,1,,,,A,8589,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL624214,1,,1,,,,A,8590,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min
CHEMBL624215,1,,1,,,,A,8591,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16434,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL624216,1,,1,,,,A,8592,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL624217,1,,1,,,,A,8593,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL624218,1,,1,,,,A,8594,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL624219,1,,1,,,,A,8595,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL624220,1,,1,,,,A,8596,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL624221,1,,1,,,,A,8597,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,16435,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL624222,1,,1,,,,A,8598,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL624223,1,,1,,,,A,8599,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL624224,1,,1,,,,A,8600,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL624225,1,,1,,,,A,8601,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL622420,1,,1,,,,A,8602,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17764,50597,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg
CHEMBL622421,1,,1,,,,A,8603,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5031,50597,,Volume of steady state distribution after i.v. administration in rats
CHEMBL622422,1,,1,,,,A,8604,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6215,50597,,Vss after intravenous administration (5.0 mg/kg) was determined in rat
CHEMBL622423,1,,1,,,,A,8605,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17671,50597,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg
CHEMBL622424,1,,1,,,,A,8606,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17752,50597,,Vss was determined
CHEMBL622425,1,,1,,,,A,8607,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6596,50597,,Vss in rat
CHEMBL876612,1,,1,,,,A,8608,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16423,50597,,Vss was evaluated after 10 uM/kg of intra arterial administration
CHEMBL622426,1,,1,,,,A,8609,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15662,50597,,volume of distribution at steady state was observed after intravenous administration in rat
CHEMBL622427,1,,1,,,,A,8610,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6062,50597,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg
CHEMBL622428,1,,1,,,,A,8611,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5874,50597,,Pharmacokinetic (PK) parameter Vz in rat
CHEMBL622429,1,,1,,,,A,8612,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4942,50597,,Volume distribution in rats
CHEMBL622430,1,,1,,,,A,8613,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17796,50597,,Volume of distribution in rat; No data
CHEMBL622431,1,,1,,,,A,8614,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4890,50597,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats
CHEMBL622432,1,,1,,,,A,8615,Intermediate,BAO_0000218,2116.0,N,Rattus norvegicus,Ileum,10116.0,,,,15765,50597,,% absorption predicted from in vitro rat ileum transport studies
CHEMBL622433,1,,1,,,,A,8616,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg
CHEMBL622434,1,,1,,,,A,8617,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg
CHEMBL622435,1,,1,,,,A,8618,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg
CHEMBL618748,1,,1,,,,A,8619,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.)
CHEMBL618749,1,,1,,,,A,8620,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg
CHEMBL618750,1,,1,,,,A,8621,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg
CHEMBL618751,1,,1,,,,A,8622,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg
CHEMBL618752,1,,1,,,,A,8623,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13569,50597,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg
CHEMBL618753,1,,1,,,,A,8624,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4576,50597,,Oral bioavailability in rat
CHEMBL618754,1,,1,,,,A,8625,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,750,50597,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations
CHEMBL618755,1,,1,,,,A,8626,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,750,50597,,Oral bioavailability in rat
CHEMBL618756,1,,1,,,,A,8627,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4590,50597,,Oral bioavailability in rat
CHEMBL618757,1,,1,,,,A,8628,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1716,50597,,Oral bioavailability in rat
CHEMBL618758,1,,1,,,,A,8629,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1974,50597,,Bioavailability in rat
CHEMBL621088,1,,1,,,,A,8630,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4502,50597,,Oral bioavailability in rat (dose 30 mg/kg)
CHEMBL621089,1,,1,,,,A,8631,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3371,50597,,Pharmacokinetic property (cLogP) in rat
CHEMBL621090,1,,1,,,,F,8632,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,9099,50597,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally
CHEMBL621091,1,,1,,,,F,8633,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,9099,50597,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally
CHEMBL876731,1,,1,,,,A,8634,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4590,50597,,Clearance in rat.
CHEMBL621092,1,,1,,,,A,8635,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3184,50597,,Compound was evaluated for its clearance when administered intravenously in rat
CHEMBL621093,1,,1,,,,A,8636,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16456,50597,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg
CHEMBL621094,1,,1,,,,A,8637,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4199,50597,,Blood: Brain distribution ratio is determined in rat
CHEMBL621095,1,,1,,,,A,8638,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4199,50597,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable
CHEMBL621096,1,,1,,,,A,8639,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4199,50597,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable
CHEMBL621097,1,,1,,,,A,8640,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL621098,1,,1,,,,F,8641,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent dose excreted in 0-48 hours administered ip to male rat
CHEMBL621099,1,,1,,,,A,8642,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621100,1,,1,,,,A,8643,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621101,1,,1,,,,A,8644,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL621102,1,,1,,,,A,8645,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL876732,1,,1,,,,A,8646,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621103,1,,1,,,,A,8647,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621104,1,,1,,,,A,8648,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621105,1,,1,,,,A,8649,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL621106,1,,1,,,,A,8650,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621107,1,,1,,,,A,8651,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621108,1,,1,,,,A,8652,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621109,1,,1,,,,A,8653,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621110,1,,1,,,,A,8654,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL621111,1,,1,,,,A,8655,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL622541,1,,1,,,,A,8656,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY)
CHEMBL622542,1,,1,,,,A,8657,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL622543,1,,1,,,,A,8658,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL624412,1,,1,,,,A,8659,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL624413,1,,1,,,,A,8660,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL624414,1,,1,,,,A,8661,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL624415,1,,1,,,,A,8662,Intermediate,BAO_0000218,2048.0,N,Mus musculus,Lung,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY)
CHEMBL624416,1,,1,,,,A,8663,Intermediate,BAO_0000218,2048.0,N,Mus musculus,Lung,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL624417,1,,1,,,,A,8664,Intermediate,BAO_0000218,2048.0,N,Mus musculus,Lung,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL624418,1,,1,,,,A,8665,Intermediate,BAO_0000218,2048.0,N,Mus musculus,Lung,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL624419,1,,1,,,,A,8666,Intermediate,BAO_0000218,2048.0,N,Mus musculus,Lung,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL624420,1,,1,,,,A,8667,Intermediate,BAO_0000218,2048.0,N,Mus musculus,Lung,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL624421,1,,1,,,,A,8668,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY)
CHEMBL624422,1,,1,,,,A,8669,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL624423,1,,1,,,,A,8670,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL625123,1,,1,,,,A,8671,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL625124,1,,1,,,,A,8672,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL625125,1,,1,,,,A,8673,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL625126,1,,1,,,,A,8674,Intermediate,BAO_0000218,14.0,N,Mus musculus,Zone of skin,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY)
CHEMBL626947,1,,1,,,,A,8675,Intermediate,BAO_0000218,14.0,N,Mus musculus,Zone of skin,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL626948,1,,1,,,,A,8676,Intermediate,BAO_0000218,14.0,N,Mus musculus,Zone of skin,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL626949,1,,1,,,,A,8677,Intermediate,BAO_0000218,14.0,N,Mus musculus,Zone of skin,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL626950,1,,1,,,,A,8678,Intermediate,BAO_0000218,14.0,N,Mus musculus,Zone of skin,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL626951,1,,1,,,,A,8679,Intermediate,BAO_0000218,14.0,N,Mus musculus,Zone of skin,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL626952,1,,1,,,,A,8680,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY)
CHEMBL626953,1,,1,,,,A,8681,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL626954,1,,1,,,,A,8682,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL626955,1,,1,,,,A,8683,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL626956,1,,1,,,,A,8684,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL626957,1,,1,,,,A,8685,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL626958,1,,1,,,,A,8686,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY)
CHEMBL626959,1,,1,,,,A,8687,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL626960,1,,1,,,,A,8688,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL626961,1,,1,,,,A,8689,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL627589,1,,1,,,,A,8690,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY)
CHEMBL627590,1,,1,,,,A,8691,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,17208,50594,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY)
CHEMBL627591,1,,1,,,,A,8692,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,3132,50594,,Time taken for EC90 was determined when tested in mouse
CHEMBL627592,1,,1,,,,A,8693,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,3132,50594,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg
CHEMBL627593,1,,1,,,,A,8694,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,16597,50594,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2)
CHEMBL627594,1,,1,,,,A,8695,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,5727,50594,,Half life in mice
CHEMBL876813,1,,1,,,,A,8696,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,5302,50594,,Half life period in mouse after 10 mg/Kg dose
CHEMBL627595,1,,1,,,,A,8697,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,5302,50594,,Half life period in mouse after 10 mg/kg dose
CHEMBL627596,1,,1,,,,A,8698,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,6348,50594,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration
CHEMBL627597,1,,1,,,,A,8699,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5964,50597,,Cmax value at 5 mg/kg po was determined in rat
CHEMBL627598,1,,1,,,,A,8700,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6078,50597,,Cmax value evaluated in rat
CHEMBL627599,1,,1,,,,A,8701,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,5206,50597,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain
CHEMBL627600,1,,1,,,,A,8702,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2959,50597,,Cmax value after administration of 20 mg/Kg oral dose in rat
CHEMBL627601,1,,1,,,,A,8703,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5964,50597,,Cmax value at 1 mg/kg po in rat
CHEMBL627776,1,,1,,,,A,8704,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5964,50597,,Cmax value at 5 mg/kg po in rat
CHEMBL627777,1,,1,,,,A,8705,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6757,50597,,Cmax value at a dose of 10 mg/kg in male SD rats
CHEMBL627778,1,,1,,,,A,8706,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6757,50597,,Cmax value at a dose of 100 mg/kg in male SD rats
CHEMBL627779,1,,1,,,,A,8707,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6757,50597,,Cmax value at a dose of 50 mg/kg in male SD rats
CHEMBL876814,1,,1,,,,A,8708,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17617,50597,,Cmax value in rats at 10 mg/kg
CHEMBL627780,1,,1,,,,A,8709,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1445,50597,,Cmax value was evaluated in rats at a dose of 20 mg/kg
CHEMBL627781,1,,1,,,,A,8710,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6082,50597,,Cmax value was determined after peroral administration of 20 mg/kg in rat
CHEMBL627782,1,,1,,,,A,8711,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1446,50597,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500
CHEMBL627783,1,,1,,,,A,8712,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5407,50597,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats
CHEMBL627784,1,,1,,,,A,8713,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2690,50597,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration
CHEMBL627785,1,,1,,,,A,8714,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats
CHEMBL627786,1,,1,,,,A,8715,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats
CHEMBL627787,1,,1,,,,A,8716,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4891,50597,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration
CHEMBL627788,1,,1,,,,A,8717,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2807,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr
CHEMBL626579,1,,1,,,,A,8718,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2807,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr
CHEMBL626580,1,,1,,,,A,8719,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2807,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr
CHEMBL876815,1,,1,,,,A,8720,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3634,50597,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg
CHEMBL626581,1,,1,,,,A,8721,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1881,50597,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr
CHEMBL626582,1,,1,,,,A,8722,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1881,50597,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr
CHEMBL626583,1,,1,,,,A,8723,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,429,50597,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg
CHEMBL626205,1,,1,,,,A,8724,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat
CHEMBL626206,1,,1,,,,A,8725,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat
CHEMBL626207,1,,1,,,,A,8726,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat
CHEMBL623882,1,,1,,,,A,8727,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat
CHEMBL623883,1,,1,,,,A,8728,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17582,50597,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose
CHEMBL623884,1,,1,,,,A,8729,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17582,50597,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose
CHEMBL623885,1,,1,,,,A,8730,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,3032,50597,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)"
CHEMBL623886,1,,1,,,,A,8731,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6295,50597,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg
CHEMBL623887,1,,1,,,,A,8732,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6619,50597,,Maximal concentration in rat was determined
CHEMBL623888,1,,1,,,,A,8733,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6616,50597,,Maximal concentration after i.v. administration
CHEMBL623889,1,,1,,,,A,8734,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,3249,50597,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg
CHEMBL623890,1,,1,,,,A,8735,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17791,50597,,Maximal plasma concentration in rat after oral administration at 50 mg/kg
CHEMBL623891,1,,1,,,,A,8736,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17791,50597,,Cmax in rat plasma after oral dose (50 mg/Kg)
CHEMBL623892,1,,1,,,,A,8737,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1360,50597,,Maximal plasma concentration was determined.
CHEMBL623893,1,,1,,,,A,8738,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2552,50597,,Maximal plasma drug concentration was determined
CHEMBL877616,1,,1,,,,A,8739,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6571,50597,,Maximal concentration in rats after peroral administration
CHEMBL623894,1,,1,,,,A,8740,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6570,50597,,Maximum concentration in rat after 2 mg/kg peroral administration
CHEMBL623895,1,,1,,,,A,8741,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6567,50597,,Maximum concentration in rat plasma after 5 mg/kg oral gavage
CHEMBL623896,1,,1,,,,A,8742,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3031,50597,,Maximum concentration of compound in rat was evaluated.
CHEMBL623897,1,,1,,,,A,8743,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3436,50597,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats
CHEMBL623898,1,,1,,,,A,8744,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3436,50597,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats
CHEMBL623899,1,,1,,,,A,8745,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2083,50597,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat
CHEMBL623900,1,,1,,,,A,8746,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3436,50597,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats
CHEMBL623901,1,,1,,,,A,8747,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4527,50597,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined
CHEMBL623902,1,,1,,,,A,8748,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1974,50597,,Maximum concentration was evaluated in rats
CHEMBL623903,1,,1,,,,A,8749,Intermediate,BAO_0000218,1359.0,N,Rattus norvegicus,Cerebrospinal fluid,10116.0,,In vivo,,3307,50597,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats
CHEMBL623904,1,,1,,,,A,8750,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,3307,50597,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats
CHEMBL877617,1,,1,,,,A,8751,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1916,50597,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration
CHEMBL623905,1,,1,,,,A,8752,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1500,50597,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats
CHEMBL623906,1,,1,,,,A,8753,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1500,50597,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats
CHEMBL623907,1,,1,,,,A,8754,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4186,50597,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route
CHEMBL623908,1,,1,,,,A,8755,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL623909,1,,1,,,,A,8756,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.
CHEMBL623910,1,,1,,,,A,8757,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL623911,1,,1,,,,A,8758,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.
CHEMBL623912,1,,1,,,,A,8759,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL624616,1,,1,,,,A,8760,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL624617,1,,1,,,,A,8761,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL624618,1,,1,,,,A,8762,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL624619,1,,1,,,,A,8763,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL624794,1,,1,,,,A,8764,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL624795,1,,1,,,,A,8765,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL623921,1,,1,,,,A,8766,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL623922,1,,1,,,,A,8767,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL623923,1,,1,,,,A,8768,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min
CHEMBL623924,1,,1,,,,A,8769,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL623925,1,,1,,,,A,8770,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL623926,1,,1,,,,A,8771,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL623927,1,,1,,,,A,8772,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL623928,1,,1,,,,A,8773,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL623929,1,,1,,,,A,8774,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL623930,1,,1,,,,A,8775,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL623931,1,,1,,,,A,8776,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL622165,1,,1,,,,A,8777,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL621249,1,,1,,,,A,8778,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL621250,1,,1,,,,A,8779,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL621448,1,,1,,,,A,8780,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL621449,1,,1,,,,A,8781,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL621450,1,,1,,,,A,8782,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL621451,1,,1,,,,A,8783,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.
CHEMBL621452,1,,1,,,,A,8784,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL621453,1,,1,,,,A,8785,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL621454,1,,1,,,,A,8786,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL621455,1,,1,,,,A,8787,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL621456,1,,1,,,,A,8788,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL625145,1,,1,,,,A,8789,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL875847,1,,1,,,,A,8790,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL625146,1,,1,,,,A,8791,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL625147,1,,1,,,,A,8792,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL625148,1,,1,,,,A,8793,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min
CHEMBL625149,1,,1,,,,A,8794,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16434,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL625150,1,,1,,,,A,8795,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL625151,1,,1,,,,A,8796,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL625152,1,,1,,,,A,8797,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL625153,1,,1,,,,A,8798,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL625154,1,,1,,,,A,8799,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL625155,1,,1,,,,A,8800,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,16435,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL625156,1,,1,,,,A,8801,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL624354,1,,1,,,,A,8802,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624355,1,,1,,,,A,8803,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624356,1,,1,,,,A,8804,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624357,1,,1,,,,A,8805,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,,,11977,50597,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624358,1,,1,,,,A,8806,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624359,1,,1,,,,A,8807,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624360,1,,1,,,,A,8808,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624361,1,,1,,,,A,8809,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL624362,1,,1,,,,A,8810,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624363,1,,1,,,,A,8811,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,,,11977,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624364,1,,1,,,,A,8812,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624365,1,,1,,,,A,8813,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624366,1,,1,,,,A,8814,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624367,1,,1,,,,A,8815,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624368,1,,1,,,,A,8816,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624369,1,,1,,,,A,8817,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL624370,1,,1,,,,A,8818,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL625069,1,,1,,,,A,8819,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL625070,1,,1,,,,A,8820,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL626051,1,,1,,,,A,8821,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL626052,1,,1,,,,A,8822,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL626053,1,,1,,,,A,8823,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL626054,1,,1,,,,A,8824,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL626055,1,,1,,,,A,8825,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL626056,1,,1,,,,A,8826,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL626057,1,,1,,,,A,8827,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL625193,1,,1,,,,A,8828,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL625194,1,,1,,,,A,8829,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL625195,1,,1,,,,A,8830,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL625196,1,,1,,,,A,8831,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL625197,1,,1,,,,A,8832,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL625198,1,,1,,,,A,8833,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL627929,1,,1,,,,A,8834,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL627074,1,,1,,,,A,8835,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL627075,1,,1,,,,A,8836,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL627076,1,,1,,,,A,8837,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL627077,1,,1,,,,A,8838,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL627078,1,,1,,,,A,8839,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL627079,1,,1,,,,A,8840,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL873824,1,,1,,,,A,8841,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,4573,50594,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice
CHEMBL627080,1,,1,,,,A,8842,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,3132,50594,,Half life in mouse plasma was determined at dose 25 mg/kg
CHEMBL627081,1,,1,,,,A,8843,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,17718,50594,,Half life was determined
CHEMBL627082,1,,1,,,,A,8844,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,17728,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration
CHEMBL627083,1,,1,,,,A,8845,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,5961,50594,,Half-life in male mice after 1 mg/kg intravenous dose
CHEMBL627085,1,,1,,,,A,8847,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,,,17731,50594,,Half life in mice plasma
CHEMBL627086,1,,1,,,,A,8848,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,17592,50594,,Half life in mouse
CHEMBL627087,1,,1,,,,A,8849,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,3132,50594,,Half life in mouse plasma at dose 25 mg/kg
CHEMBL627088,1,,1,,,,A,8850,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,17729,50594,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined
CHEMBL627089,1,,1,,,,A,8851,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,17729,50594,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined
CHEMBL627090,1,,1,,,,A,8852,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,17729,50594,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined
CHEMBL627091,1,,1,,,,A,8853,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,3277,50594,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4)
CHEMBL627092,1,,1,,,,A,8854,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,3760,50594,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice"
CHEMBL876785,1,,1,,,,A,8855,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,3760,50594,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice"
CHEMBL627093,1,,1,,,,A,8856,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,2862,50594,,Half-life by iv administration in mouse
CHEMBL627094,1,,1,,,,A,8857,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,2862,50594,,Half-life by oral administration in mouse
CHEMBL627095,1,,1,,,,A,8858,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,5980,50594,,Half-life in mice
CHEMBL627096,1,,1,,,,A,8859,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,6159,50594,,Half-life using mouse brain homogenate
CHEMBL627097,1,,1,,,,A,8860,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,6254,50594,,Half-life was measured in mice
CHEMBL627098,1,,1,,,,A,8861,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,6062,50594,,Half-life was measured in mouse after an iv dose of 1 mg/kg
CHEMBL627099,1,,1,,,,A,8862,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,,,1574,50594,,Half-life period was determined in mouse blood
CHEMBL627100,1,,1,,,,A,8863,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,56,50594,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain"
CHEMBL627101,1,,1,,,,A,8864,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,,,993,50594,,Plasma half life in mouse
CHEMBL627102,1,,1,,,,A,8865,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,6652,50594,,Stability of the peptide in the presence of mouse serum
CHEMBL627103,1,,1,,,,A,8866,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,17852,50594,,Terminal half life of compound was determined in mouse
CHEMBL627104,1,,1,,,,A,8867,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,2675,50594,,Terminal half life was evaluated in mice after intravenous administration
CHEMBL627105,1,,1,,,,A,8868,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,2675,50594,,Terminal half life was evaluated in mice after oral administration
CHEMBL876786,1,,1,,,,A,8869,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,499,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.
CHEMBL873825,1,,1,,,,A,8870,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,499,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.
CHEMBL627106,1,,1,,,,A,8871,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,499,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data
CHEMBL626336,1,,1,,,,A,8872,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14239,50594,,half life period is evaluated by administering intravenously at 25 mg/kg in mice
CHEMBL877462,1,,1,,,,A,8873,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,5506,50594,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice"
CHEMBL626337,1,,1,,,,A,8874,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,5506,50594,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable"
CHEMBL626338,1,,1,,,,A,8875,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,17734,50594,,Half life after intraperitoneal administration of 100 mg/kg in mice
CHEMBL626339,1,,1,,,,A,8876,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,17728,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration
CHEMBL626340,1,,1,,,,A,8877,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,17728,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration
CHEMBL625377,1,,1,,,,A,8878,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,17728,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration
CHEMBL625378,1,,1,,,,A,8879,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,17728,50594,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration
CHEMBL625379,1,,1,,,,A,8880,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,17728,50594,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration
CHEMBL625380,0,,1,,,,A,8881,Autocuration,BAO_0000251,,U,Sus scrofa,,9823.0,,,,14294,22224,Microsomes,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak)
CHEMBL625381,0,,1,,,,A,8882,Autocuration,BAO_0000251,,U,Sus scrofa,,9823.0,,,,14294,22224,Microsomes,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak)
CHEMBL625382,0,,1,,,,A,8883,Autocuration,BAO_0000019,,U,Sus scrofa,,9823.0,,,,6056,22224,,Stability to porcine renal DHP-I
CHEMBL873828,0,,1,,,,A,8884,Autocuration,BAO_0000218,,U,Sus scrofa,,9823.0,,In vivo,,1317,22224,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg
CHEMBL625383,0,,1,,,,A,8885,Autocuration,BAO_0000218,,U,Sus scrofa,,9823.0,,In vivo,,1317,22224,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg
CHEMBL625384,0,,1,,,,A,8886,Autocuration,BAO_0000019,,U,Sus scrofa,,9823.0,,,,5229,22224,,Half-life of the parent prodrug in porcine esterase solution
CHEMBL625385,0,,1,,,,A,8887,Autocuration,BAO_0000019,,U,Sus scrofa,,9823.0,,,,4231,22224,,"First order rate constant, k was determined in in pig liver Esterase"
CHEMBL625386,0,,1,,,,A,8888,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,,,4231,22224,,Half life of the in pig liver Esterase
CHEMBL623571,0,,1,,,,A,8889,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,,,5318,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase
CHEMBL623572,0,,1,,,,A,8890,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,,,5318,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase
CHEMBL623573,0,,1,,,,A,8891,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,,,5318,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase
CHEMBL623574,0,,1,,,,A,8892,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,,,3305,22224,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay
CHEMBL623575,0,,1,,,,A,8893,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,,,3305,22224,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined
CHEMBL623749,0,,1,,,,A,8894,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,,,2842,22224,,Half-life in the presence of pig liver esterase(PLE) was evaluated.
CHEMBL623750,0,,1,,,,A,8895,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,,,2842,22224,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable
CHEMBL623751,0,,1,,,,A,8896,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,In vitro,,889,22224,,Half-life in vitro in pig liver
CHEMBL623752,0,,1,,,,A,8897,Autocuration,BAO_0000221,2107.0,U,Sus scrofa,Liver,9823.0,,,,1904,22224,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase
CHEMBL623753,1,,1,,,,A,8898,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4186,50597,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route
CHEMBL623754,1,,1,,,,A,8899,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2774,50597,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.
CHEMBL623755,1,,1,,,,A,8900,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1742,50597,,Maximum concentration in rat plasma was determined
CHEMBL623756,1,,1,,,,A,8901,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3169,50597,,Maximum concentration in rats
CHEMBL623757,1,,1,,,,A,8902,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3169,50597,,Maximum concentration in rats at 1-2 hours
CHEMBL623758,1,,1,,,,A,8903,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2081,50597,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally
CHEMBL623759,1,,1,,,,A,8904,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,3307,50597,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats
CHEMBL623760,1,,1,,,,A,8905,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4727,50597,,Maximum concentration at the dose of 2 mg/kg in rat
CHEMBL623761,1,,1,,,,A,8906,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6597,50597,,Maximum concentration was evaluated in rats
CHEMBL623762,1,,1,,,,A,8907,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16365,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat
CHEMBL877594,1,,1,,,,A,8908,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16365,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat
CHEMBL623763,1,,1,,,,A,8909,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16365,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg
CHEMBL623764,1,,1,,,,A,8910,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16365,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg
CHEMBL623765,1,,1,,,,A,8911,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16365,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat
CHEMBL623766,1,,1,,,,A,8912,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,2591,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration
CHEMBL623767,1,,1,,,,A,8913,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,2591,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration
CHEMBL623768,1,,1,,,,A,8914,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,2591,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration
CHEMBL623769,1,,1,,,,A,8915,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5978,50597,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat
CHEMBL623770,1,,1,,,,A,8916,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5978,50597,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat
CHEMBL623771,1,,1,,,,A,8917,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5978,50597,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat
CHEMBL623772,1,,1,,,,A,8918,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5978,50597,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat
CHEMBL623773,1,,1,,,,A,8919,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5978,50597,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat
CHEMBL623774,1,,1,,,,A,8920,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5978,50597,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat
CHEMBL623775,1,,1,,,,A,8921,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5978,50597,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat
CHEMBL623776,1,,1,,,,A,8922,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14465,50597,,Cmax in rat (PO dose)
CHEMBL622191,1,,1,,,,A,8923,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4723,50597,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL622192,1,,1,,,,A,8924,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4723,50597,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL622193,1,,1,,,,A,8925,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4576,50597,,Maximum plasma concentration determined in rat
CHEMBL622194,1,,1,,,,A,8926,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12873,50597,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg
CHEMBL622195,1,,1,,,,A,8927,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12873,50597,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg
CHEMBL622196,1,,1,,,,A,8928,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6824,50597,,Maximum plasma concentration in rat
CHEMBL622197,1,,1,,,,A,8929,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17065,50597,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats
CHEMBL622198,1,,1,,,,A,8930,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2932,50597,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min
CHEMBL622199,1,,1,,,,A,8931,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2932,50597,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min
CHEMBL622200,1,,1,,,,A,8932,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2879,50597,,Maximum plasma concentration of compound was measured in rat
CHEMBL622201,1,,1,,,,A,8933,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2864,50597,,Maximum plasma concentration after 20 mg/kg oral administration in rat
CHEMBL623990,1,,1,,,,A,8934,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16367,50597,,Maximum plasma concentration after oral administration to rats
CHEMBL623991,1,,1,,,,A,8935,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17717,50597,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11
CHEMBL623992,1,,1,,,,A,8936,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17717,50597,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously"
CHEMBL623993,1,,1,,,,A,8937,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17717,50597,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11
CHEMBL623994,1,,1,,,,A,8938,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17717,50597,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control
CHEMBL623995,1,,1,,,,F,8939,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17720,50597,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration
CHEMBL623996,1,,1,,,,F,8940,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17720,50597,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration
CHEMBL623997,1,,1,,,,F,8941,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17720,50597,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration
CHEMBL623998,1,,1,,,,A,8942,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4516,50597,,Maximum plasma concentration dosed orally in rats
CHEMBL623999,1,,1,,,,A,8943,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4516,50597,,Maximum plasma concentration dosed orally in rats after 6 hours
CHEMBL624000,1,,1,,,,A,8944,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4516,50597,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected
CHEMBL624001,1,,1,,,,A,8945,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5199,50597,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats
CHEMBL624002,1,,1,,,,A,8946,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17538,50597,,Maximum plasma concentration in rat after po administration
CHEMBL624003,1,,1,,,,A,8947,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6685,50597,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose"
CHEMBL624004,1,,1,,,,A,8948,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6685,50597,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose"
CHEMBL624005,1,,1,,,,A,8949,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL624006,1,,1,,,,A,8950,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL624007,1,,1,,,,A,8951,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL624008,1,,1,,,,A,8952,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL624009,1,,1,,,,A,8953,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL874387,1,,1,,,,A,8954,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL624010,1,,1,,,,A,8955,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL624011,1,,1,,,,A,8956,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.
CHEMBL624012,1,,1,,,,A,8957,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL624013,1,,1,,,,A,8958,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL624736,1,,1,,,,A,8959,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL624737,1,,1,,,,A,8960,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL624738,1,,1,,,,A,8961,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL624739,1,,1,,,,A,8962,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min
CHEMBL624740,1,,1,,,,A,8963,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16434,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL624896,1,,1,,,,A,8964,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL624897,1,,1,,,,A,8965,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL624108,1,,1,,,,A,8966,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL624109,1,,1,,,,A,8967,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL624110,1,,1,,,,A,8968,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL624111,1,,1,,,,A,8969,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL624112,1,,1,,,,A,8970,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL624113,1,,1,,,,A,8971,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL619709,1,,1,,,,A,8972,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL619710,1,,1,,,,A,8973,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,16435,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL619711,1,,1,,,,A,8974,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL619712,1,,1,,,,A,8975,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL619713,1,,1,,,,A,8976,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL619714,1,,1,,,,A,8977,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL619715,1,,1,,,,A,8978,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL619716,1,,1,,,,A,8979,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL619717,1,,1,,,,A,8980,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL619718,1,,1,,,,A,8981,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.
CHEMBL619719,1,,1,,,,A,8982,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL875329,1,,1,,,,A,8983,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL619720,1,,1,,,,A,8984,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL619721,1,,1,,,,A,8985,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL619722,1,,1,,,,A,8986,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL619723,1,,1,,,,A,8987,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL619724,1,,1,,,,A,8988,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL619725,1,,1,,,,A,8989,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL619726,1,,1,,,,A,8990,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL619727,1,,1,,,,A,8991,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min
CHEMBL619728,1,,1,,,,A,8992,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16434,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL619729,1,,1,,,,A,8993,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL619730,1,,1,,,,A,8994,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL619731,1,,1,,,,A,8995,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL619732,1,,1,,,,A,8996,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL619733,1,,1,,,,A,8997,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL619734,1,,1,,,,A,8998,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL619735,1,,1,,,,A,8999,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL875330,1,,1,,,,A,9000,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL628465,1,,1,,,,A,9001,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL628466,1,,1,,,,A,9002,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL628467,1,,1,,,,A,9003,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL628468,1,,1,,,,A,9004,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL628469,1,,1,,,,A,9005,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL628470,1,,1,,,,A,9006,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL628471,1,,1,,,,A,9007,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL628472,1,,1,,,,A,9008,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL625191,1,,1,,,,A,9009,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL625192,1,,1,,,,A,9010,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL875337,1,,1,,,,A,9011,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats)
CHEMBL626341,1,,1,,,,A,9012,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL626342,1,,1,,,,A,9013,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621943,1,,1,,,,A,9014,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,11977,50597,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats)
CHEMBL621944,1,,1,,,,A,9015,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3748,50597,,Half life in rats
CHEMBL621945,1,,1,,,,A,9016,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15765,50597,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily
CHEMBL621946,1,,1,,,,A,9017,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4871,50597,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver)
CHEMBL621947,1,,1,,,,A,9018,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4871,50597,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined
CHEMBL621948,1,,1,,,,A,9019,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4872,50597,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver)
CHEMBL621949,1,,1,,,,A,9020,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4872,50597,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined
CHEMBL621950,1,,1,,,,A,9021,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5413,50597,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL)
CHEMBL621951,1,,1,,,,A,9022,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5413,50597,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined
CHEMBL621952,1,,1,,,,A,9023,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,15272,50597,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound
CHEMBL621953,1,,1,,,,A,9024,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,4689,50597,,Stability (%) in rat liver microsomes
CHEMBL621954,1,,1,,,,A,9025,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6057,50597,,Area under curve was calculated after intravenous administration
CHEMBL621955,1,,1,,,,A,9026,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6057,50597,,Area under the curve was calculated after iv administration in rat
CHEMBL621956,1,,1,,,,A,9027,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6057,50597,,Area under the curve was calculated in rat after peroral administration
CHEMBL621957,1,,1,,,,A,9028,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6211,50597,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats
CHEMBL621958,1,,1,,,,A,9029,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5710,50597,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg
CHEMBL621959,1,,1,,,,A,9030,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5710,50597,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg
CHEMBL621960,1,,1,,,,A,9031,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17853,50597,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk
CHEMBL621961,1,,1,,,,A,9032,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17853,50597,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk
CHEMBL621962,1,,1,,,,A,9033,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15765,50597,,p value of the compound
CHEMBL876787,1,,1,,,,F,9034,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15765,50597,,p value of the compound
CHEMBL621963,1,,1,,,,A,9035,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15765,50597,,p value of the compound
CHEMBL622637,1,,1,,,,A,9036,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,,,6175,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation)
CHEMBL622638,1,,1,,,,A,9037,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,,,6175,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation)
CHEMBL626561,1,,1,,,,A,9038,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,,,6175,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation)
CHEMBL626562,0,,1,,,,F,9039,Autocuration,BAO_0000019,,U,Oryctolagus cuniculus,,9986.0,,,,7991,22224,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic)
CHEMBL626563,0,,1,,,,A,9040,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,,,429,22224,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr )
CHEMBL626564,0,,1,,,,A,9041,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,,,429,22224,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr )
CHEMBL626565,0,,1,,,,A,9042,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,6253,22224,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample
CHEMBL626566,0,,1,,,,A,9043,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,6253,22224,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample
CHEMBL626567,0,,1,,,,A,9044,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,3615,22224,,Clearance rate in rabbits
CHEMBL626568,0,,1,,,,A,9045,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,4059,22224,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.
CHEMBL626569,0,,1,,,,A,9046,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,5124,22224,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg
CHEMBL626570,0,,1,,,,A,9047,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,5124,22224,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg
CHEMBL626571,0,,1,,,,A,9048,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,5124,22224,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg
CHEMBL626572,0,,1,,,,A,9049,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,429,22224,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg
CHEMBL626573,0,,1,,,,A,9050,Autocuration,BAO_0000218,1969.0,U,Oryctolagus cuniculus,Plasma,9986.0,,In vivo,,4059,22224,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.
CHEMBL626574,0,,1,,,,A,9051,Autocuration,BAO_0000251,2107.0,U,Oryctolagus cuniculus,Liver,9986.0,,,,9659,22224,Microsomes,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2
CHEMBL626575,0,,1,,,,A,9052,Autocuration,BAO_0000251,2107.0,U,Oryctolagus cuniculus,Liver,9986.0,,,,9659,22224,Microsomes,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide
CHEMBL626576,0,,1,,,,A,9053,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,,,3639,22224,,Dose at which bioavailability of intravenously administered compound was tested in rabbit
CHEMBL626577,0,,1,,,,A,9054,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,,,3639,22224,,Dose at which bioavailability of perorally administered compound was tested in rabbit
CHEMBL626578,0,,1,,,,A,9055,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,3639,22224,,The compound was tested for its bioavailability in rabbit (by oral dosage).
CHEMBL625263,0,,1,,,,A,9056,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,5124,22224,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg
CHEMBL625264,0,,1,,,,A,9057,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,5124,22224,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg
CHEMBL625265,0,,1,,,,A,9058,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,5124,22224,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg
CHEMBL625266,0,,1,,,,A,9059,Autocuration,BAO_0000251,,U,Oryctolagus cuniculus,,9986.0,,,,14294,22224,Microsomes,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak)
CHEMBL876796,0,,1,,,,A,9060,Autocuration,BAO_0000251,,U,Oryctolagus cuniculus,,9986.0,,,,14294,22224,Microsomes,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak)
CHEMBL625267,0,,1,,,,A,9061,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,429,22224,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg
CHEMBL625268,0,,1,,,,A,9062,Autocuration,BAO_0000218,1969.0,U,Oryctolagus cuniculus,Plasma,9986.0,,In vivo,,5124,22224,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg
CHEMBL625269,0,,1,,,,A,9063,Autocuration,BAO_0000218,1969.0,U,Oryctolagus cuniculus,Plasma,9986.0,,In vivo,,5124,22224,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg
CHEMBL624689,0,,1,,,,A,9064,Autocuration,BAO_0000218,1969.0,U,Oryctolagus cuniculus,Plasma,9986.0,,In vivo,,5124,22224,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg
CHEMBL624690,0,,1,,,,A,9065,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,429,22224,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg
CHEMBL624691,0,,1,,,,A,9066,Autocuration,BAO_0000218,1088.0,U,Oryctolagus cuniculus,Urine,9986.0,,,,429,22224,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr )
CHEMBL624692,0,,1,,,,A,9067,Autocuration,BAO_0000218,1088.0,U,Oryctolagus cuniculus,Urine,9986.0,,,,429,22224,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr)
CHEMBL624693,0,,1,,,,A,9068,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,4059,22224,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.
CHEMBL624694,0,,1,,,,A,9069,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,4137,22224,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog
CHEMBL877596,0,,1,,,,A,9070,Autocuration,BAO_0000221,,U,Oryctolagus cuniculus,,9986.0,,In vitro,,11672,22224,,In vitro Biological half-life in crude homogenate of rabbit renal cortex
CHEMBL624695,0,,1,,,,A,9071,Autocuration,BAO_0000019,,U,Oryctolagus cuniculus,,9986.0,,,,12886,22224,,Time within which only 10% of the drug was degraded
CHEMBL624696,0,,1,,,,A,9072,Autocuration,BAO_0000221,2107.0,U,Oryctolagus cuniculus,Liver,9986.0,,,,3853,22224,,Half life period in rabbit liver homogenate
CHEMBL624697,0,,1,,,,A,9073,Autocuration,BAO_0000019,,U,Oryctolagus cuniculus,,9986.0,,,,3615,22224,,Half life value in rabbits
CHEMBL624698,0,,1,,,,A,9074,Autocuration,BAO_0000218,178.0,U,Oryctolagus cuniculus,Blood,9986.0,,In vivo,,6253,22224,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample
CHEMBL624699,0,,1,,,,A,9075,Autocuration,BAO_0000218,178.0,U,Oryctolagus cuniculus,Blood,9986.0,,In vivo,,6253,22224,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample
CHEMBL624700,0,,1,,,,A,9076,Autocuration,BAO_0000218,,U,Oryctolagus cuniculus,,9986.0,,In vivo,,6077,22224,,Half-life period in rabbits following intravenous administration at 2 mg/kg
CHEMBL622903,1,,1,,,,A,9077,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17617,50597,,AUC 0-8 hr value in rats at 10 mg/kg
CHEMBL622904,1,,1,,,,A,9078,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17594,50597,,AUC after administration at 2000 mg/kg/day in rats
CHEMBL622905,1,,1,,,,A,9079,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6149,50597,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.
CHEMBL622906,1,,1,,,,A,9080,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17260,50597,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat
CHEMBL622907,1,,1,,,,A,9081,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17260,50597,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat
CHEMBL622908,1,,1,,,,A,9082,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6644,50597,,AUC in rat after oral administration at 10.5 mg/kg dose
CHEMBL622909,1,,1,,,,A,9083,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6644,50597,,AUC in rat after oral administration at 11.2 mg/kg dose
CHEMBL622910,1,,1,,,,A,9084,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6644,50597,,AUC in rat after oral administration at 9.7 mg/kg dose
CHEMBL622911,1,,1,,,,A,9085,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,6495,50597,,AUC in rat brain after oral administration at 10 mg/kg
CHEMBL622912,1,,1,,,,A,9086,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6504,50597,,AUC in rat p.o.
CHEMBL622913,1,,1,,,,A,9087,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17686,50597,,AUC in rat p.o. at 20 mg/kg concentration
CHEMBL622914,1,,1,,,,A,9088,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6495,50597,,AUC in rat plasma after oral administration at 10 mg/kg
CHEMBL622915,1,,1,,,,A,9089,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,216,50597,,AUC in rats
CHEMBL622916,1,,1,,,,A,9090,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1908,50597,,AUC value after IV dose at a dose of 5 mg/kg in rats.
CHEMBL622917,1,,1,,,,A,9091,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1908,50597,,AUC value after oral dose at a dose of 10 mg/kg in rats.
CHEMBL622918,1,,1,,,,A,9092,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6685,50597,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable"
CHEMBL622919,1,,1,,,,A,9093,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,216,50597,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given
CHEMBL622920,1,,1,,,,A,9094,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6049,50597,,Maximum plasma concentration was evaluated in rat
CHEMBL622921,1,,1,,,,A,9095,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2463,50597,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration
CHEMBL622922,1,,1,,,,A,9096,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6679,50597,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration
CHEMBL622923,1,,1,,,,A,9097,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6681,50597,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose
CHEMBL877604,1,,1,,,,A,9098,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4890,50597,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats
CHEMBL622924,1,,1,,,,A,9099,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6410,50597,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg
CHEMBL622925,1,,1,,,,A,9100,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6410,50597,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg
CHEMBL622926,1,,1,,,,A,9101,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16366,50597,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally
CHEMBL623625,1,,1,,,,A,9102,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6227,50597,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg
CHEMBL623626,1,,1,,,,A,9103,Expert,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,3598,50597,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg
CHEMBL623627,1,,1,,,,A,9104,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1465,50597,,Maximum plasma drug concentration was determined
CHEMBL623628,1,,1,,,,A,9105,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4368,50597,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat
CHEMBL623629,1,,1,,,,A,9106,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15662,50597,,Mean peak plasma concentration was observed after intravenous administration in rat
CHEMBL623630,1,,1,,,,A,9107,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15662,50597,,Mean peak plasma concentration was observed after oral administration in rat
CHEMBL623804,1,,1,,,,A,9108,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5355,50597,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats
CHEMBL623805,1,,1,,,,A,9109,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5355,50597,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats
CHEMBL623806,1,,1,,,,A,9110,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,1567,50597,,Peak oral plasma concentration was determined in rats by oral administration
CHEMBL623807,1,,1,,,,A,9111,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4026,50597,,Peak plasma concentration (Cmax) was determined
CHEMBL623808,1,,1,,,,A,9112,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6193,50597,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats
CHEMBL623809,1,,1,,,,A,9113,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4026,50597,,Peak plasma concentration (Cmax) in rats
CHEMBL623810,1,,1,,,,A,9114,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6485,50597,,Peak plasma concentration at 1 mg/kg peroral administration
CHEMBL623811,1,,1,,,,A,9115,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17655,50597,,Peak plasma concentration in rat
CHEMBL623812,1,,1,,,,A,9116,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14941,50597,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration"
CHEMBL877605,1,,1,,,,A,9117,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5394,50597,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg
CHEMBL623813,1,,1,,,,A,9118,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4408,50597,,Pharmacokinetic property (Cmax) in rat
CHEMBL623814,1,,1,,,,A,9119,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5983,50597,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.
CHEMBL623815,1,,1,,,,A,9120,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4878,50597,,Cmax in rat after 3mg/kg oral dose
CHEMBL623816,1,,1,Sprague-Dawley,,,A,9121,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5862,50597,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose
CHEMBL623145,1,,1,,,,A,9122,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4517,50597,,Cmax in rats after 20 mg/kg oral dose
CHEMBL623146,1,,1,,,,A,9123,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5932,50597,,Cmax in rat plasma after 30mg/kg oral dose
CHEMBL623147,1,,1,,,,A,9124,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5436,50597,,Plasma concentration after oral administration of 100 mg/kg to rats
CHEMBL623042,1,,1,,,,A,9125,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,4910,50597,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats
CHEMBL623043,1,,1,,,,A,9126,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4950,50597,,Tested for the Cmax in rat at 10 mg/kg per orally
CHEMBL623044,1,,1,,,,A,9127,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15078,50597,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL623045,1,,1,,,,A,9128,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15078,50597,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose"
CHEMBL623046,1,,1,,,,A,9129,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3360,50597,,Bioavailability as oral Cmax in rats at 30 mins
CHEMBL623226,1,,1,,,,A,9130,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3360,50597,,Bioavailability as oral Cmax in rats at 6hr
CHEMBL623227,1,,1,,,,A,9131,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15022,50597,,The maximum concentration of compound was measured at the dose of 100 umol/kg
CHEMBL623228,1,,1,,,,A,9132,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15022,50597,,The maximum concentration of compound was measured at the dose of 300 umol/kg
CHEMBL623229,1,,1,,,,A,9133,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15022,50597,,The maximum concentration of compound was measured at the dose of 30 umol/kg
CHEMBL623230,1,,1,,,,A,9134,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5160,50597,,The maximum plasma levels for the compounds were determined by LC-MS.
CHEMBL623231,1,,1,,,,A,9135,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15662,50597,,mean peak plasma concentration was observed after intravenous administration in rat
CHEMBL623232,1,,1,,,,A,9136,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15662,50597,,mean peak plasma concentration was observed after oral administration in rat
CHEMBL623233,1,,1,,,,A,9137,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4709,50597,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat
CHEMBL623234,1,,1,,,,A,9138,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3535,50597,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr
CHEMBL623235,1,,1,,,,A,9139,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3535,50597,,Concentration in plasma (portal) following oral dose in rats at 1 hr
CHEMBL623236,1,,1,,,,A,9140,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3535,50597,,Concentration in plasma (portal) following oral dose in rats at 2 hr
CHEMBL623237,1,,1,,,,A,9141,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3535,50597,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr
CHEMBL623238,1,,1,,,,A,9142,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3535,50597,,Concentration in plasma (systemic) following oral dose in rats at 1 hr
CHEMBL623239,1,,1,,,,A,9143,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3535,50597,,Concentration in plasma (systemic) following oral dose in rats at 2 hr
CHEMBL623240,0,,1,,,,A,9144,Intermediate,BAO_0000218,1969.0,U,Rattus norvegicus,Plasma,10116.0,,In vivo,,5005,22224,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo
CHEMBL623241,1,,1,,,,A,9145,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,,,6326,50597,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours"
CHEMBL623242,1,,1,,,,A,9146,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,,,6326,50597,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours"
CHEMBL874394,1,,1,,,,A,9147,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6326,50597,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours"
CHEMBL623243,1,,1,,,,A,9148,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6326,50597,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours"
CHEMBL623244,1,,1,,,,A,9149,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17411,50597,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL623245,1,,1,,,,A,9150,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL623246,1,,1,,,,A,9151,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL623247,1,,1,,,,A,9152,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL623248,1,,1,,,,A,9153,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL623249,1,,1,,,,A,9154,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,16435,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL625072,1,,1,,,,A,9155,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL625073,1,,1,,,,A,9156,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL625074,1,,1,,,,A,9157,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL625075,1,,1,,,,A,9158,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL625076,1,,1,,,,A,9159,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.
CHEMBL625077,1,,1,,,,A,9160,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL625078,1,,1,,,,A,9161,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL874395,1,,1,,,,A,9162,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.
CHEMBL625079,1,,1,,,,A,9163,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL625080,1,,1,,,,A,9164,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL625081,1,,1,,,,A,9165,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL625082,1,,1,,,,A,9166,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL625083,1,,1,,,,A,9167,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL625084,1,,1,,,,A,9168,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL625085,1,,1,,,,A,9169,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL625086,1,,1,,,,A,9170,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL625087,1,,1,,,,A,9171,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL625088,1,,1,,,,A,9172,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min
CHEMBL622205,1,,1,,,,A,9173,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16434,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL622206,1,,1,,,,A,9174,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL622207,1,,1,,,,A,9175,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL622366,1,,1,,,,A,9176,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL622367,1,,1,,,,A,9177,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL875331,1,,1,,,,A,9178,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL622368,1,,1,,,,A,9179,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,16435,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL622369,1,,1,,,,A,9180,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL622370,1,,1,,,,A,9181,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL622371,1,,1,,,,A,9182,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL622372,1,,1,,,,A,9183,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL622373,1,,1,,,,A,9184,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL622374,1,,1,,,,A,9185,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL622375,1,,1,,,,A,9186,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL622376,1,,1,,,,A,9187,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.
CHEMBL622377,1,,1,,,,A,9188,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL622378,1,,1,,,,A,9189,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL622379,1,,1,,,,A,9190,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL622380,1,,1,,,,A,9191,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL622381,1,,1,,,,A,9192,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL622382,1,,1,,,,A,9193,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL622383,1,,1,,,,A,9194,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min
CHEMBL875332,1,,1,,,,A,9195,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,,,6175,50597,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation)
CHEMBL622384,1,,1,,,,A,9196,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,,,6175,50597,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation)
CHEMBL622385,1,,1,,,,A,9197,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,,,6175,50597,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation)
CHEMBL622386,1,,1,,,,A,9198,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,,,6175,50597,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation)
CHEMBL622387,1,,1,,,,A,9199,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10839,50597,,The compound was tested for the plasma binding in rat
CHEMBL622388,1,,1,,,,A,9200,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16459,50597,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)"
CHEMBL622389,1,,1,,,,A,9201,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16459,50597,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)"
CHEMBL622390,1,,1,,,,A,9202,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16459,50597,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)"
CHEMBL622391,1,,1,,,,A,9203,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16459,50597,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg)
CHEMBL622392,1,,1,,,,A,9204,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16459,50597,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg)
CHEMBL622393,1,,1,,,,A,9205,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16459,50597,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg)
CHEMBL622394,1,,1,,,,A,9206,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3278,50597,,Plasma level at 2 hr after administration of the compound
CHEMBL622395,1,,1,,,,A,9207,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3278,50597,,plasma level at 2 hr after administration of the compound
CHEMBL622396,1,,1,,,,A,9208,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,4684,50597,,Stability in rat serum measured as % recovery at 1 min
CHEMBL624894,1,,1,,,,A,9209,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,4684,50597,,Stability in rat serum measured as % recovery at 10 min
CHEMBL624895,1,,1,,,,A,9210,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,4684,50597,,Stability in rat serum measured as % recovery at 10 mins
CHEMBL624058,1,,1,,,,A,9211,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,4684,50597,,Stability in rat serum measured as % recovery at 2 hr
CHEMBL624059,1,,1,,,,A,9212,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,4684,50597,,Stability in rat serum measured as % recovery at 3 min
CHEMBL624060,1,,1,,,,A,9213,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,4684,50597,,Stability in rat serum measured as % recovery at 3 mins
CHEMBL624061,1,,1,,,,A,9214,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,4684,50597,,Stability in rat serum measured as % recovery at 5 min
CHEMBL624062,1,,1,,,,A,9215,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,4684,50597,,Stability in rat serum measured as % recovery at 5 mins
CHEMBL624063,1,,1,,,,A,9216,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16456,50597,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg
CHEMBL624064,1,,1,,,,A,9217,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16456,50597,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg
CHEMBL624065,1,,1,,,,A,9218,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,723,50597,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma
CHEMBL624066,1,,1,,,,A,9219,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,723,50597,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.
CHEMBL877490,1,,1,,,,A,9220,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5160,50597,,Half life tested in mature male rat at a dose of 30 mg/kg
CHEMBL874442,1,,1,,,,A,9221,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4709,50597,,Half life after intravenous administration of 1 mg/kg in rat
CHEMBL626890,1,,1,,,,A,9222,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5633,50597,,Half life period after administration (30 mg/kg) in rat
CHEMBL626891,1,,1,,,,A,9223,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5302,50597,,Half life period in rat after 5 mg/Kg dose
CHEMBL626892,1,,1,,,,A,9224,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5302,50597,,Half life period in rat after 5 mg/kg dose
CHEMBL626893,1,,1,,,,A,9225,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Half life period was determined
CHEMBL626894,1,,1,,,,A,9226,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Half life period was evaluated in rat
CHEMBL626895,1,,1,,,,A,9227,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Half life period was evaluated in rat; 0.5-1.0
CHEMBL626896,1,,1,,,,A,9228,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Half life period was evaluated in rat; 5.9-7.5
CHEMBL626897,1,,1,,,,A,9229,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14512,50597,,Half-life in rat plasma
CHEMBL626898,1,,1,,,,A,9230,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6230,50597,,Half-life time in rat was determined
CHEMBL626899,1,,1,,,,A,9231,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3364,50597,,Terminal half-life after iv administration to rats
CHEMBL626900,1,,1,,,,A,9232,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6874,50597,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats
CHEMBL626901,1,,1,,,,A,9233,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,857,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg
CHEMBL626902,1,,1,,,,A,9234,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,858,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv)
CHEMBL626903,1,,1,,,,A,9235,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,858,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv)
CHEMBL874443,1,,1,,,,A,9236,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5355,50597,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats
CHEMBL626904,1,,1,,,,A,9237,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5355,50597,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats
CHEMBL626905,1,,1,,,,A,9238,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6305,50597,,Half life in rats
CHEMBL873830,1,,1,,,,A,9239,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,13501,50597,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat
CHEMBL626906,1,,1,,,,A,9240,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17594,50597,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats
CHEMBL631076,1,,1,,,,A,9241,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4186,50597,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route
CHEMBL631077,1,,1,,,,A,9242,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,2932,50597,,Biological half-life was measured in plasma of rats
CHEMBL631078,1,,1,,,,A,9243,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17065,50597,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats
CHEMBL631079,1,,1,,,,A,9244,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15765,50597,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.
CHEMBL631080,1,,1,,,,A,9245,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2713,50597,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats
CHEMBL631081,1,,1,,,,A,9246,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats
CHEMBL631239,1,,1,,,,A,9247,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats
CHEMBL631240,1,,1,,,,A,9248,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,740,50597,,Compound was evaluated for plasma half life in rat
CHEMBL631241,1,,1,,,,A,9249,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6597,50597,,AUC value at a dose of 5 mg/kg (p.o.) in rats
CHEMBL631242,1,,1,,,,A,9250,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,2959,50597,,AUC value after administration of 20 mg/Kg oral dose in rat
CHEMBL631243,1,,1,,,,A,9251,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17594,50597,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats
CHEMBL874444,1,,1,,,,A,9252,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17596,50597,,AUC0-96 after administration at 50 mg/kg
CHEMBL631244,1,,1,,,,A,9253,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17594,50597,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats
CHEMBL631245,1,,1,,,,A,9254,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3293,50597,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats."
CHEMBL627162,1,,1,,,,A,9255,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6757,50597,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats
CHEMBL627163,1,,1,,,,A,9256,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6757,50597,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats
CHEMBL627164,1,,1,,,,A,9257,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6757,50597,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats
CHEMBL627165,1,,1,,,,A,9258,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,5979,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney
CHEMBL627166,1,,1,,,,A,9259,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5979,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver
CHEMBL627167,1,,1,,,,A,9260,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5979,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung
CHEMBL627822,1,,1,,,,A,9261,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4026,50597,,Area under curve (AUC) at a dose of 30 mg/kg in rats
CHEMBL627823,1,,1,,,,A,9262,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5355,50597,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats
CHEMBL627824,1,,1,,,,A,9263,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5355,50597,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats
CHEMBL627825,1,,1,,,,A,9264,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5355,50597,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats
CHEMBL627826,1,,1,,,,A,9265,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5633,50597,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat
CHEMBL627827,1,,1,,,,A,9266,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1716,50597,,Area under curve (Pharmacokinetic property) was determined
CHEMBL627828,1,,1,,,,A,9267,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1716,50597,,Area under curve (Pharmacokinetic property) of the compound; Not determined
CHEMBL627829,1,,1,,,,A,9268,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4689,50597,,Area under curve after intravenous administration (1 mg/kg) in rat
CHEMBL627830,1,,1,,,,A,9269,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4527,50597,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined
CHEMBL627831,1,,1,,,,A,9270,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4527,50597,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined
CHEMBL627832,1,,1,,,,A,9271,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15662,50597,,Area under curve in male SD rats was observed after oral administration in rat
CHEMBL627833,1,,1,,,,A,9272,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4413,50597,,Area under curve of compound after iv administration of 20 mg/kg dose in rat
CHEMBL627834,1,,1,,,,A,9273,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3598,50597,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg
CHEMBL628004,1,,1,,,,A,9274,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3598,50597,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg
CHEMBL628005,1,,1,,,,A,9275,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5964,50597,,Area under curve at 5 mg/kg po was determined in rat
CHEMBL628006,1,,1,,,,A,9276,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4689,50597,,Area under curve in Rat at a oral dose of 5 mg/kg
CHEMBL628007,1,,1,,,,A,9277,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4186,50597,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route
CHEMBL625676,1,,1,,,,A,9278,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,Area under curve was determined
CHEMBL631309,1,,1,,,,A,9279,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17858,50597,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr
CHEMBL631310,1,,1,,,,A,9280,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17804,50597,,Area under curve after intravenous administration at 3 mg/kg
CHEMBL631311,1,,1,,,,A,9281,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6106,50597,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h
CHEMBL631312,1,,1,,,,A,9282,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5964,50597,,Area under curve at 4 hr in rat
CHEMBL631313,1,,1,,,,A,9283,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4026,50597,,Area under curve at a dose of 30 mg/kg
CHEMBL631314,1,,1,,,,A,9284,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4756,50597,,Area under curve at the dose of 2 mg/Kg administered perorally in rats
CHEMBL631315,1,,1,,,,A,9285,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4756,50597,,Area under curve at the dose of 5 mg/Kg administered perorally in rats
CHEMBL631316,1,,1,,,,A,9286,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5862,50597,,Area under curve for a 2-mpk po dose in SD rats
CHEMBL631317,1,,1,,,,A,9287,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5862,50597,,Area under curve in SD rats
CHEMBL874471,1,,1,,,,A,9288,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6644,50597,,Area under curve in rat after oral administration at 13 mg/kg dose
CHEMBL631318,1,,1,,,,A,9289,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5871,50597,,Area under curve in rat by po administration at 0-24 hr
CHEMBL631319,1,,1,,,,A,9290,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5919,50597,,Area under curve in rat plasma
CHEMBL631320,1,,1,,,,A,9291,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5939,50597,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg
CHEMBL631321,1,,1,,,,A,9292,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5939,50597,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg
CHEMBL631322,1,,1,,,,A,9293,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10,50597,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously
CHEMBL631323,1,,1,,,,A,9294,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11149,50597,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats
CHEMBL631324,1,,1,,,,A,9295,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5302,50597,,Area under curve value in rat at a dose of 5 mg/kg
CHEMBL631325,1,,1,,,,A,9296,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17796,50597,,Area under curve was determined after oral administration in rats
CHEMBL631326,1,,1,,,,A,9297,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4890,50597,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats
CHEMBL631327,1,,1,,,,A,9298,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6011,50597,,Area under curve was determined after peroral administration in rat
CHEMBL631328,1,,1,,,,A,9299,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5375,50597,,Area under curve was determined at a dose 30 mpk administered orally.
CHEMBL631329,1,,1,,,,A,9300,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17764,50597,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg
CHEMBL627217,1,,1,,,,A,9301,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4368,50597,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat
CHEMBL626352,1,,1,,,,A,9302,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5610,50597,,Area under curve was determined in male rat
CHEMBL626353,1,,1,,,,A,9303,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5833,50597,,Area under curve was determined in rat after PO administration
CHEMBL626354,1,,1,,,,A,9304,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4257,50597,,Area under curve was determined in rat after a 3 mg/kg of oral dose
CHEMBL626355,1,,1,,,,A,9305,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5937,50597,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg
CHEMBL626356,1,,1,,,,A,9306,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5932,50597,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg
CHEMBL626357,1,,1,,,,A,9307,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5932,50597,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active
CHEMBL626358,1,,1,,,,A,9308,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17411,50597,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL626359,1,,1,,,,A,9309,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17411,50597,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL626360,1,,1,,,,A,9310,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17771,50597,,Peak plasma concentration in rat at a dose of 3 mg/kg
CHEMBL626361,1,,1,,,,A,9311,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1628,50597,,Plasma concentration at 2 hr in rats was evaluated.
CHEMBL626362,1,,1,,,,A,9312,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1628,50597,,Plasma concentration at 2 hr in rats was evaluated; Not available
CHEMBL626363,1,,1,,,,A,9313,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17411,50597,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL626970,1,,1,,,,A,9314,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats
CHEMBL626971,1,,1,,,,A,9315,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats
CHEMBL626972,1,,1,,,,A,9316,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4910,50597,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats
CHEMBL626973,1,,1,,,,A,9317,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4910,50597,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats
CHEMBL626974,1,,1,,,,A,9318,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4910,50597,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats
CHEMBL874592,1,,1,,,,A,9319,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4910,50597,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats
CHEMBL626975,1,,1,,,,A,9320,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C
CHEMBL626976,1,,1,,,,A,9321,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound
CHEMBL626977,1,,1,,,,A,9322,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined
CHEMBL626978,1,,1,,,,A,9323,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested
CHEMBL626979,1,,1,,,,A,9324,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16427,50597,,PK study was carried to determine the relative absorption ranking in rat.
CHEMBL626980,1,,1,,,,A,9325,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4689,50597,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg
CHEMBL626981,1,,1,,,,A,9326,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g"
CHEMBL626982,1,,1,,,,A,9327,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g"
CHEMBL626983,1,,1,,,,A,9328,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g"
CHEMBL622522,1,,1,,,,A,9329,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g"
CHEMBL622523,1,,1,,,,A,9330,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g"
CHEMBL622524,1,,1,,,,A,9331,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g"
CHEMBL622525,1,,1,,,,A,9332,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g"
CHEMBL622526,1,,1,,,,A,9333,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g"
CHEMBL619849,1,,1,,,,A,9334,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g"
CHEMBL619850,1,,1,,,,A,9335,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g"
CHEMBL623864,1,,1,,,,A,9336,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g"
CHEMBL623865,1,,1,,,,A,9337,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g"
CHEMBL623866,1,,1,,,,A,9338,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g"
CHEMBL623867,1,,1,,,,A,9339,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g"
CHEMBL877615,1,,1,,,,A,9340,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g"
CHEMBL623868,1,,1,,,,A,9341,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g"
CHEMBL623869,1,,1,,,,A,9342,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g"
CHEMBL623870,1,,1,,,,A,9343,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g"
CHEMBL623871,1,,1,,,,A,9344,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min
CHEMBL623872,1,,1,,,,A,9345,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16434,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL622129,1,,1,,,,A,9346,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL622130,1,,1,,,,A,9347,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL622131,1,,1,,,,A,9348,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL622132,1,,1,,,,A,9349,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL622133,1,,1,,,,A,9350,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL622134,1,,1,,,,A,9351,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL622135,1,,1,,,,A,9352,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL622136,1,,1,,,,A,9353,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,16435,50597,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL622137,1,,1,,,,A,9354,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL622138,1,,1,,,,A,9355,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL623017,1,,1,,,,A,9356,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL623018,1,,1,,,,A,9357,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL623019,1,,1,,,,A,9358,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL623020,1,,1,,,,A,9359,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL623021,1,,1,,,,A,9360,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.
CHEMBL623022,1,,1,,,,A,9361,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.
CHEMBL623023,1,,1,,,,A,9362,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL623024,1,,1,,,,A,9363,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL623025,1,,1,,,,A,9364,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL620545,1,,1,,,,A,9365,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL620546,1,,1,,,,A,9366,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL620547,1,,1,,,,A,9367,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL620548,1,,1,,,,A,9368,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL620549,1,,1,,,,A,9369,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL620550,1,,1,,,,A,9370,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL620551,1,,1,,,,A,9371,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min
CHEMBL620552,1,,1,,,,A,9372,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16434,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL620553,1,,1,,,,A,9373,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL620554,1,,1,,,,A,9374,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL875845,1,,1,,,,A,9375,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL620555,1,,1,,,,A,9376,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL620556,1,,1,,,,A,9377,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL620557,1,,1,,,,A,9378,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,16435,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL620558,1,,1,,,,A,9379,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL620559,1,,1,,,,A,9380,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL622939,1,,1,,,,A,9381,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL622940,1,,1,,,,A,9382,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL622941,1,,1,,,,A,9383,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL622942,1,,1,,,,A,9384,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL622943,1,,1,,,,A,9385,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL622944,1,,1,,,,A,9386,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.
CHEMBL622945,1,,1,,,,A,9387,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL622946,1,,1,,,,A,9388,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL622947,1,,1,,,,A,9389,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3341,50597,,Compound was evaluated for terminal half life in rat
CHEMBL622948,1,,1,,,,A,9390,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,3634,50597,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve
CHEMBL622949,1,,1,,,,A,9391,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,3634,50597,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve
CHEMBL622950,1,,1,,,,A,9392,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4839,50597,,Compound was tested for its half life in rat
CHEMBL622951,0,,1,,,,A,9393,Intermediate,BAO_0000218,1969.0,U,Macaca mulatta,Plasma,9544.0,,In vivo,,5005,22224,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.
CHEMBL622952,0,,1,,,,A,9394,Intermediate,BAO_0000366,1969.0,U,Rattus norvegicus,Plasma,10116.0,,,,5005,22224,,Compound was tested for its plasma half life in Sprague Dawley rats
CHEMBL622953,0,,1,,,,A,9395,Intermediate,BAO_0000366,1969.0,U,Rattus norvegicus,Plasma,10116.0,,,,5005,22224,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined
CHEMBL873818,1,,1,,,,A,9396,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1094,50597,,Compound was tested for plasma half-life period in rat
CHEMBL622954,1,,1,,,,A,9397,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5031,50597,,Elimination half life after i.v. administration of compound in rats
CHEMBL622955,1,,1,,,,A,9398,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Elimination half-life after IV dosing at 0.5 mg/kg in rat
CHEMBL875229,1,,1,,,,A,9399,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Elimination half-life after IV dosing at 1 mg/kg in rat
CHEMBL622956,1,,1,,,,A,9400,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat
CHEMBL622957,1,,1,,,,A,9401,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat
CHEMBL622958,1,,1,,,,A,9402,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,5408,50597,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined
CHEMBL622959,1,,1,,,,A,9403,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5408,50597,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma
CHEMBL622960,1,,1,,,,A,9404,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,5408,50597,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain
CHEMBL622961,1,,1,,,,A,9405,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5408,50597,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma
CHEMBL622962,1,,1,,,,A,9406,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4687,50597,,Evaluated for the half life in rat (in vivo)
CHEMBL622963,1,,1,,,,A,9407,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6640,50597,,Hafl life in rat
CHEMBL622964,1,,1,,,,A,9408,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6640,50597,,Hafl life rat
CHEMBL622965,1,,1,,,,A,9409,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6641,50597,,Hafl life rat
CHEMBL622966,1,,1,,,,A,9410,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6640,50597,,Hafl life rat; Not determined
CHEMBL622967,1,,1,,,,A,9411,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6641,50597,,Hafl life rat; Not determined
CHEMBL622968,1,,1,,,,A,9412,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,17411,50597,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL622969,1,,1,,,,A,9413,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,17411,50597,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL875327,1,,1,,,,A,9414,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,17411,50597,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL628638,1,,1,,,,A,9415,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6570,50597,,Half life in rat after 1 mg/kg i.v. administration
CHEMBL628639,1,,1,,,,A,9416,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6570,50597,,Half life in rat after 2 mg/kg peroral administration
CHEMBL625840,1,,1,,,,A,9417,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17411,50597,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL625841,1,,1,,,,A,9418,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4722,50597,,Half life of 10 mg/kg oral dose determined in rats
CHEMBL625842,1,,1,,,,A,9419,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL625843,1,,1,,,,A,9420,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL625844,1,,1,,,,A,9421,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL873822,1,,1,,,,A,9422,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL625845,1,,1,,,,A,9423,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL627059,1,,1,,,,A,9424,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL627060,1,,1,,,,A,9425,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL627061,1,,1,,,,A,9426,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat
CHEMBL627709,1,,1,,,,A,9427,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4762,50597,,Half life of compound at 5 mg/kg after po administration was determined in rat
CHEMBL627710,1,,1,,,,A,9428,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5327,50597,,Half life of compound determined after intravenous administration to rat
CHEMBL627711,1,,1,,,,A,9429,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4847,50597,,Half life of compound was determined in rat
CHEMBL627712,1,,1,,,,A,9430,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17720,50597,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration
CHEMBL627713,1,,1,,,,A,9431,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4723,50597,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL627714,1,,1,,,,A,9432,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4723,50597,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL627889,0,,1,,,,A,9433,Intermediate,BAO_0000218,,U,Macaca fascicularis,,9541.0,,In vivo,,4256,22224,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey
CHEMBL627890,0,,1,,,,A,9434,Intermediate,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,4256,22224,,Half life determined in rat by intravenous administration
CHEMBL627891,1,,1,,,,A,9435,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4722,50597,,Half life determined in rats after iv administration
CHEMBL627892,1,,1,,,,A,9436,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6535,50597,,Half life in rat plasma after administration of 2 mg/kg iv
CHEMBL627893,1,,1,,,,A,9437,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6535,50597,,Half life in rat plasma after administration of 2 mg/kg iv
CHEMBL627894,1,,1,,,,A,9438,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1435,50597,,Half life in rat plasma was determined
CHEMBL627895,1,,1,,,,A,9439,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1435,50597,,Half life in rat plasma was determined; NA means not applicable
CHEMBL627896,1,,1,,,,A,9440,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5206,50597,,Half life in rat was tested
CHEMBL627897,1,,1,,,,A,9441,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6080,50597,,Half life measured in rat plasma
CHEMBL627898,1,,1,,,,A,9442,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4449,50597,,Half life recorded in rats
CHEMBL627899,1,,1,,,,A,9443,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6057,50597,,Half life was calculated
CHEMBL873823,1,,1,,,,A,9444,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6057,50597,,Half life was calculated in rat
CHEMBL627900,1,,1,,,,A,9445,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3747,50597,,Half life was determined
CHEMBL627901,1,,1,,,,A,9446,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17858,50597,,Half life after 10 mg/kg oral administration in rat
CHEMBL627902,1,,1,,,,A,9447,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Half life after administering orally a dose of 10 mg/kg to a fasting rat
CHEMBL627903,1,,1,,,,A,9448,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Half life after administering orally a dose of 30 mg/kg
CHEMBL627904,1,,1,,,,A,9449,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5031,50597,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats
CHEMBL627905,1,,1,,,,A,9450,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4722,50597,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours
CHEMBL627906,1,,1,,,,A,9451,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6078,50597,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat
CHEMBL627907,1,,1,,,,A,9452,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6078,50597,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat
CHEMBL876783,1,,1,,,,A,9453,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6078,50597,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg
CHEMBL627908,1,,1,,,,A,9454,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6078,50597,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined
CHEMBL627909,1,,1,,,,A,9455,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17065,50597,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats
CHEMBL627910,1,,1,,,,A,9456,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1353,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats
CHEMBL627911,1,,1,,,,A,9457,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1353,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1)
CHEMBL627912,1,,1,,,,A,9458,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1353,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2)
CHEMBL627913,1,,1,,,,A,9459,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1353,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5)
CHEMBL627914,1,,1,,,,A,9460,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1353,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10)
CHEMBL627915,1,,1,,,,A,9461,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16423,50597,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration
CHEMBL627916,1,,1,,,,A,9462,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16423,50597,,Area under the curve was evaluated after 20 uM/kg of peroral administration
CHEMBL627917,1,,1,,,,A,9463,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6062,50597,,Area under the curve was measured in rat after an iv dose of 1 mg/kg
CHEMBL627918,1,,1,,,,A,9464,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6056,50597,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat
CHEMBL627919,1,,1,,,,A,9465,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5182,50597,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat
CHEMBL627920,1,,1,,,,A,9466,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6410,50597,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg
CHEMBL627921,1,,1,,,,A,9467,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6410,50597,,Area under the curve was evaluated at an oral dose of 30 mg/kg
CHEMBL627922,1,,1,,,,A,9468,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4723,50597,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL876784,1,,1,,,,A,9469,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4723,50597,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL627923,1,,1,,,,A,9470,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4723,50597,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL626208,1,,1,,,,A,9471,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4723,50597,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL626209,1,,1,,,,A,9472,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4723,50597,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL626210,1,,1,,,,A,9473,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4723,50597,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL627994,1,,1,,,,A,9474,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,2463,50597,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration
CHEMBL627995,1,,1,,,,A,9475,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4709,50597,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat
CHEMBL627996,1,,1,,,,A,9476,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4075,50597,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined
CHEMBL627997,1,,1,,,,A,9477,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5394,50597,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured
CHEMBL627998,1,,1,,,,A,9478,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2661,50597,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats
CHEMBL628640,1,,1,,,,A,9479,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2661,50597,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats
CHEMBL628641,1,,1,,,,A,9480,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2661,50597,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats
CHEMBL628642,1,,1,,,,A,9481,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2661,50597,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats
CHEMBL628643,1,,1,,,,A,9482,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Compound was evaluated for area under the curve expressed as (h*ug/ml)
CHEMBL628644,1,,1,,,,A,9483,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2591,50597,,Compound was tested for area under curve in rat
CHEMBL628645,1,,1,,,,A,9484,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6567,50597,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours
CHEMBL628646,1,,1,,,,A,9485,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6211,50597,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats
CHEMBL628647,1,,1,,,,A,9486,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5529,50597,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg)
CHEMBL628648,1,,1,,,,A,9487,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5408,50597,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined
CHEMBL625358,1,,1,,,,A,9488,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5408,50597,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma
CHEMBL625359,1,,1,,,,A,9489,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5408,50597,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain
CHEMBL625360,1,,1,,,,A,9490,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5408,50597,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma
CHEMBL625361,1,,1,,,,A,9491,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,429,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr )
CHEMBL625362,1,,1,,,,A,9492,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,429,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr )
CHEMBL625363,1,,1,,,,A,9493,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,429,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr)
CHEMBL625364,1,,1,,,,A,9494,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4796,50597,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats
CHEMBL625365,1,,1,,,,A,9495,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5974,50597,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat
CHEMBL625366,1,,1,,,,A,9496,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5974,50597,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat
CHEMBL625367,1,,1,,,,A,9497,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5974,50597,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat
CHEMBL625368,1,,1,,,,A,9498,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g"
CHEMBL625369,1,,1,,,,A,9499,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g"
CHEMBL625370,1,,1,,,,A,9500,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g"
CHEMBL625371,1,,1,,,,A,9501,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g"
CHEMBL625372,1,,1,,,,A,9502,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g"
CHEMBL625373,1,,1,,,,A,9503,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g"
CHEMBL625374,1,,1,,,,A,9504,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g"
CHEMBL877593,1,,1,,,,A,9505,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g"
CHEMBL625375,1,,1,,,,A,9506,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g"
CHEMBL625376,1,,1,,,,A,9507,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g"
CHEMBL621973,1,,1,,,,A,9508,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g"
CHEMBL621974,1,,1,,,,A,9509,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g"
CHEMBL621975,1,,1,,,,A,9510,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g"
CHEMBL622166,1,,1,,,,A,9511,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g"
CHEMBL622167,1,,1,,,,A,9512,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g"
CHEMBL622168,1,,1,,,,A,9513,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g"
CHEMBL622169,1,,1,,,,A,9514,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g"
CHEMBL622170,1,,1,,,,A,9515,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g"
CHEMBL622171,1,,1,,,,A,9516,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g"
CHEMBL622172,1,,1,,,,A,9517,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g"
CHEMBL622173,1,,1,,,,A,9518,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g"
CHEMBL622174,1,,1,,,,A,9519,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g"
CHEMBL622175,1,,1,,,,A,9520,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g"
CHEMBL622176,1,,1,,,,A,9521,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g"
CHEMBL622177,1,,1,,,,A,9522,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g"
CHEMBL622178,1,,1,,,,A,9523,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g"
CHEMBL622179,1,,1,,,,A,9524,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g"
CHEMBL622180,1,,1,,,,A,9525,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g"
CHEMBL622181,1,,1,,,,A,9526,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL622182,1,,1,,,,A,9527,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL622183,1,,1,,,,A,9528,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL622184,1,,1,,,,A,9529,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL622185,1,,1,,,,A,9530,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL622186,1,,1,,,,A,9531,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL622187,1,,1,,,,A,9532,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL625002,1,,1,,,,A,9533,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min
CHEMBL622090,1,,1,,,,A,9534,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min
CHEMBL622091,1,,1,,,,A,9535,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL622092,1,,1,,,,A,9536,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL622093,1,,1,,,,A,9537,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL622094,1,,1,,,,A,9538,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL622095,1,,1,,,,A,9539,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL622264,1,,1,,,,A,9540,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL622265,1,,1,,,,A,9541,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL622266,1,,1,,,,A,9542,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL622267,1,,1,,,,A,9543,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL622268,1,,1,,,,A,9544,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL622269,1,,1,,,,A,9545,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL625071,1,,1,,,,A,9546,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL621621,1,,1,,,,A,9547,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL621622,1,,1,,,,A,9548,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.
CHEMBL621623,1,,1,,,,A,9549,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL621624,1,,1,,,,A,9550,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL621625,1,,1,,,,A,9551,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL621626,1,,1,,,,A,9552,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL621627,1,,1,,,,A,9553,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL621628,1,,1,,,,A,9554,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL875328,1,,1,,,,A,9555,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL621629,1,,1,,,,A,9556,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL621630,1,,1,,,,A,9557,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL621631,1,,1,,,,A,9558,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min
CHEMBL621632,1,,1,,,,A,9559,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16434,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL621633,1,,1,,,,A,9560,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL621634,1,,1,,,,A,9561,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL621635,1,,1,,,,A,9562,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL621636,1,,1,,,,A,9563,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL621637,1,,1,,,,A,9564,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL621638,1,,1,,,,A,9565,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,16435,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL618883,1,,1,,,,A,9566,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL618884,1,,1,,,,A,9567,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.
CHEMBL628627,1,,1,,,,A,9568,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL628628,1,,1,,,,A,9569,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL628629,1,,1,,,,A,9570,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.
CHEMBL628630,1,,1,,,,A,9571,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Half life after administering orally a dose of 3 mg/kg
CHEMBL628631,1,,1,,,,A,9572,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Half life after administering orally a dose of 3 mg/kg to a fasting rat
CHEMBL628632,1,,1,,,,A,9573,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Half life after administering intravenously a dose of 1 mg/kg
CHEMBL628633,1,,1,,,,A,9574,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,526,50597,,Half life after oral dosing in rats
CHEMBL628634,1,,1,,,,A,9575,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat
CHEMBL627789,1,,1,,,,A,9576,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4368,50597,,Half life by intravenous administration of 3.4 mg/kg in rat
CHEMBL627790,1,,1,,,,A,9577,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3371,50597,,Half life in rat
CHEMBL627791,1,,1,,,,A,9578,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6448,50597,,Half life in rat
CHEMBL627792,1,,1,,,,A,9579,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6453,50597,,Half life in rat
CHEMBL627793,1,,1,,,,A,9580,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4353,50597,,Half life in rat after intravenous administration of the compound
CHEMBL627794,1,,1,,,,A,9581,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4353,50597,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life
CHEMBL627795,1,,1,,,,A,9582,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4353,50597,,Half life in rat after po administration of the compound
CHEMBL627796,1,,1,,,,A,9583,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4353,50597,,Half life in rat after po administration of the compound; ND means Not determined
CHEMBL875335,1,,1,,,,A,9584,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4353,50597,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life
CHEMBL627797,1,,1,,,,A,9585,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4353,50597,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life
CHEMBL627798,1,,1,,,,A,9586,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5789,50597,,Half life in rat i.v.
CHEMBL627799,1,,1,,,,A,9587,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17686,50597,,Half life in rat i.v. at 2 mg/kg concentration
CHEMBL627800,1,,1,,,,A,9588,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6495,50597,,Half life in rats
CHEMBL627801,1,,1,,,,A,9589,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,484,50597,,Half life in rats after intravenous administration
CHEMBL627802,1,,1,,,,A,9590,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6467,50597,,Half life in rats at the dose of 1.0 mpk by i.v. administration
CHEMBL627803,1,,1,,,,A,9591,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6642,50597,,Half life in rat
CHEMBL873820,1,,1,,,,A,9592,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16367,50597,,Half life was evaluated after intravenous administration to rats
CHEMBL627804,1,,1,,,,A,9593,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1369,50597,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO)
CHEMBL627805,1,,1,,,,A,9594,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5472,50597,,Half life was evaluated in rat
CHEMBL627806,1,,1,,,,A,9595,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6049,50597,,Half life was evaluated in rat
CHEMBL627107,1,,1,,,,A,9596,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5472,50597,,Half life was evaluated in rat; Not tested
CHEMBL627108,1,,1,,,,A,9597,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16366,50597,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats
CHEMBL627109,1,,1,,,,A,9598,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,11149,50597,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats
CHEMBL627110,1,,1,,,,A,9599,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11149,50597,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats
CHEMBL627111,0,,1,,,,A,9600,Intermediate,BAO_0000218,,U,Primates,,9443.0,,In vivo,,2891,22224,,Half life was measured in monkey at dose of 10 mg/kg by po administration
CHEMBL627112,0,,1,,,,A,9601,Intermediate,BAO_0000218,,U,Primates,,9443.0,,In vivo,,2891,22224,,Half life was measured in monkey at dose of 10 mg/kg by po administration
CHEMBL627113,0,,1,,,,A,9602,Intermediate,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,2891,22224,,Half life was measured in rat at dose of 30 mg/kg by iv administration
CHEMBL627114,0,,1,,,,A,9603,Intermediate,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,2891,22224,,Half life was measured in rat at dose of 30 mg/kg by po administration
CHEMBL627115,1,,1,,,,A,9604,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4026,50597,,Half life (t1/2) was determined
CHEMBL627116,1,,1,,,,A,9605,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4527,50597,,Half life period at a dose of 10 uM/kg in rat was determined
CHEMBL627117,1,,1,,,,A,9606,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4527,50597,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined
CHEMBL627118,1,,1,,,,A,9607,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5503,50597,,Half life period was determined
CHEMBL627119,1,,1,,,,A,9608,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4426,50597,,Half life period after intravenous administration at 20 mpk in rats
CHEMBL627120,1,,1,,,,A,9609,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4426,50597,,Half life period after intravenous administration at 20 mpk in rats; Not performed.
CHEMBL626922,1,,1,,,,A,9610,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6109,50597,,Half life period after intravenous administration in rat
CHEMBL626923,1,,1,,,,A,9611,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5654,50597,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration
CHEMBL626924,1,,1,,,,A,9612,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5654,50597,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration
CHEMBL626925,1,,1,,,,A,9613,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4755,50597,,Half life period in 80% rat plasma at 37 degree Centigrade
CHEMBL626926,1,,1,,,,A,9614,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5862,50597,,Half life period in SD rats
CHEMBL626927,1,,1,,,,A,9615,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1515,50597,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4)
CHEMBL626928,1,,1,,,,A,9616,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1515,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4)
CHEMBL626929,1,,1,,,,A,9617,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1515,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data
CHEMBL626930,1,,1,,,,A,9618,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1515,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data
CHEMBL626931,1,,1,,,,A,9619,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5960,50597,,Half life period in rat
CHEMBL626932,1,,1,,,,A,9620,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6103,50597,,Half life period in rat
CHEMBL626933,1,,1,,,,A,9621,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6317,50597,,Half life period in rat
CHEMBL873826,1,,1,,,,A,9622,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6644,50597,,Half life period in rat after oral administration at 10.5 mg/kg dose
CHEMBL626934,1,,1,,,,A,9623,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6644,50597,,Half life period in rat after oral administration at 11.2 mg/kg dose
CHEMBL626935,1,,1,,,,A,9624,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6644,50597,,Half life period in rat after oral administration at 13 mg/kg dose
CHEMBL626936,1,,1,,,,A,9625,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6644,50597,,Half life period in rat after oral administration at 9.7 mg/kg dose
CHEMBL626937,1,,1,,,,A,9626,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5974,50597,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat
CHEMBL625906,1,,1,,,,A,9627,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6295,50597,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg
CHEMBL625907,1,,1,,,,A,9628,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6296,50597,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg
CHEMBL625908,1,,1,,,,A,9629,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16427,50597,,PK study was carried to determine AUC (area under curve) value in rat
CHEMBL625909,1,,1,,,,A,9630,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16367,50597,,Pharmacokinetic parameter AUC after intravenous administration to rats
CHEMBL625910,1,,1,,,,A,9631,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16367,50597,,Pharmacokinetic parameter AUC after oral administration to rats
CHEMBL625911,1,,1,,,,A,9632,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16365,50597,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg
CHEMBL625912,1,,1,,,,A,9633,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16365,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat
CHEMBL626538,1,,1,,,,A,9634,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16365,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat
CHEMBL876794,1,,1,,,,A,9635,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16365,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally
CHEMBL626539,1,,1,,,,A,9636,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16365,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally
CHEMBL626540,1,,1,,,,A,9637,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16365,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat
CHEMBL626541,1,,1,,,,A,9638,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5394,50597,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg
CHEMBL626542,1,,1,,,,A,9639,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5394,50597,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg
CHEMBL626543,1,,1,,,,A,9640,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2792,50597,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats
CHEMBL626544,1,,1,,,,A,9641,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2792,50597,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats
CHEMBL626545,1,,1,,,,A,9642,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2792,50597,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats
CHEMBL626546,1,,1,,,,A,9643,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2792,50597,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats
CHEMBL626547,1,,1,,,,A,9644,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5334,50597,,Pharmacokinetic parameter area under curve was reported
CHEMBL626548,1,,1,,,,A,9645,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4408,50597,,Pharmacokinetic property (AUC) in rat
CHEMBL626549,1,,1,,,,A,9646,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5983,50597,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.
CHEMBL626550,1,,1,,,,A,9647,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4397,50597,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.
CHEMBL626551,1,,1,,,,A,9648,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4397,50597,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested
CHEMBL623777,1,,1,,,,A,9649,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5491,50597,,Pharmacokinetic property was determined
CHEMBL623778,1,,1,,,,A,9650,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5491,50597,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg
CHEMBL623779,1,,1,,,,A,9651,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5491,50597,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested
CHEMBL623780,1,,1,,,,A,9652,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4199,50597,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats
CHEMBL622015,1,,1,,,,A,9653,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4199,50597,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats
CHEMBL622016,1,,1,,,,A,9654,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4199,50597,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats
CHEMBL622017,1,,1,,,,A,9655,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5173,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h"
CHEMBL622018,1,,1,,,,A,9656,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5173,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h"
CHEMBL622019,1,,1,,,,A,9657,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5173,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h"
CHEMBL622020,1,,1,,,,A,9658,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5173,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h"
CHEMBL622021,1,,1,,,,A,9659,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16366,50597,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously
CHEMBL622022,1,,1,,,,A,9660,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16366,50597,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally
CHEMBL622023,1,,1,,,,A,9661,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5327,50597,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat
CHEMBL622024,1,,1,,,,A,9662,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6681,50597,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose
CHEMBL622693,1,,1,,,,A,9663,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12873,50597,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound)
CHEMBL622694,1,,1,,,,A,9664,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12873,50597,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound)
CHEMBL622695,1,,1,,,,A,9665,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6685,50597,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose"
CHEMBL622696,1,,1,,,,A,9666,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6685,50597,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose"
CHEMBL622697,1,,1,,,,A,9667,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6685,50597,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose"
CHEMBL622874,1,,1,,,,A,9668,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6619,50597,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)"
CHEMBL622875,1,,1,,,,A,9669,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6619,50597,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)"
CHEMBL622876,1,,1,,,,A,9670,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10363,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant
CHEMBL622877,1,,1,,,,A,9671,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4796,50597,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats
CHEMBL622878,1,,1,,,,A,9672,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats
CHEMBL622879,1,,1,,,,A,9673,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4910,50597,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats
CHEMBL877602,1,,1,,,,A,9674,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4839,50597,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve
CHEMBL622880,1,,1,,,,A,9675,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL622881,1,,1,,,,A,9676,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose"
CHEMBL622882,1,,1,,,,A,9677,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL622883,1,,1,,,,A,9678,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose"
CHEMBL622884,1,,1,,,,A,9679,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g"
CHEMBL622885,1,,1,,,,A,9680,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,11450,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g"
CHEMBL622886,1,,1,,,,A,9681,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8151,50597,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.
CHEMBL622887,1,,1,,,,A,9682,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8151,50597,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg
CHEMBL622888,1,,1,,,,A,9683,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8151,50597,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg
CHEMBL622889,1,,1,,,,A,9684,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622890,1,,1,,,,A,9685,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622891,1,,1,,,,A,9686,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL877603,1,,1,,,,A,9687,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622892,1,,1,,,,A,9688,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622893,1,,1,,,,A,9689,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622894,1,,1,,,,A,9690,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622895,1,,1,,,,A,9691,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622896,1,,1,,,,A,9692,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,8677,50597,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.
CHEMBL622897,1,,1,,,,A,9693,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622898,1,,1,,,,A,9694,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622899,1,,1,,,,A,9695,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622900,1,,1,,,,A,9696,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL624114,1,,1,,,,A,9697,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL624115,1,,1,,,,A,9698,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL624116,1,,1,,,,A,9699,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL624117,1,,1,,,,A,9700,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL624118,1,,1,,,,A,9701,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL624119,1,,1,,,,A,9702,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL624120,1,,1,,,,A,9703,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL624121,1,,1,,,,A,9704,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL624122,1,,1,,,,A,9705,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL624123,1,,1,,,,A,9706,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL624124,1,,1,,,,A,9707,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL624125,1,,1,,,,A,9708,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL624126,1,,1,,,,A,9709,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL624127,1,,1,,,,A,9710,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL624128,1,,1,,,,A,9711,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL624129,1,,1,,,,A,9712,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL624130,1,,1,,,,A,9713,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622340,1,,1,,,,A,9714,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622341,1,,1,,,,A,9715,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622342,1,,1,,,,A,9716,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622343,1,,1,,,,A,9717,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622344,1,,1,,,,A,9718,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622345,1,,1,,,,A,9719,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622346,1,,1,,,,A,9720,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622347,1,,1,,,,A,9721,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622348,1,,1,,,,A,9722,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622349,1,,1,,,,A,9723,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622350,1,,1,,,,A,9724,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.
CHEMBL622351,1,,1,,,,A,9725,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.
CHEMBL622352,1,,1,,,,A,9726,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.
CHEMBL622353,1,,1,,,,A,9727,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.
CHEMBL622354,1,,1,,,,A,9728,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.
CHEMBL622355,1,,1,,,,A,9729,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.
CHEMBL622356,1,,1,,,,A,9730,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.
CHEMBL622357,1,,1,,,,A,9731,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.
CHEMBL622358,1,,1,,,,A,9732,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.
CHEMBL622359,1,,1,,,,A,9733,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.
CHEMBL874393,1,,1,,,,A,9734,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.
CHEMBL622872,1,,1,,,,A,9735,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL622873,1,,1,,,,A,9736,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min
CHEMBL623047,1,,1,,,,A,9737,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL623048,1,,1,,,,A,9738,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL623049,1,,1,,,,A,9739,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL623050,1,,1,,,,A,9740,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL623051,1,,1,,,,A,9741,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL623052,1,,1,,,,A,9742,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL626343,1,,1,,,,A,9743,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL626344,1,,1,,,,A,9744,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.
CHEMBL626345,1,,1,,,,A,9745,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.
CHEMBL626346,1,,1,,,,A,9746,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.
CHEMBL626347,1,,1,,,,A,9747,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min
CHEMBL626348,1,,1,,,,A,9748,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min
CHEMBL626349,1,,1,,,,A,9749,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16434,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min
CHEMBL626350,1,,1,,,,F,9750,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min
CHEMBL626351,1,,1,,,,A,9751,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min
CHEMBL627650,1,,1,,,,A,9752,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min
CHEMBL627651,1,,1,,,,F,9753,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min
CHEMBL627652,1,,1,,,,A,9754,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min
CHEMBL627653,1,,1,,,,A,9755,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16435,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min
CHEMBL627654,1,,1,,,,A,9756,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval
CHEMBL627835,1,,1,,,,A,9757,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval
CHEMBL627836,1,,1,,,,A,9758,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval
CHEMBL627837,1,,1,,,,A,9759,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval
CHEMBL627838,1,,1,,,,A,9760,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval
CHEMBL875338,1,,1,,,,A,9761,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval
CHEMBL627839,1,,1,,,,A,9762,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval
CHEMBL627840,1,,1,,,,A,9763,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval
CHEMBL627841,1,,1,,,,A,9764,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval
CHEMBL627842,1,,1,,,,A,9765,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval
CHEMBL627843,1,,1,,,,A,9766,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval
CHEMBL627844,1,,1,,,,A,9767,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval
CHEMBL627845,1,,1,,,,A,9768,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval
CHEMBL627846,1,,1,,,,A,9769,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5874,50597,,Half life period in rat by iv administration at a dose of 3 mg/kg
CHEMBL627847,1,,1,,,,A,9770,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1515,50597,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4)
CHEMBL873821,1,,1,,,,A,9771,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1515,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4)
CHEMBL626079,1,,1,,,,A,9772,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1515,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data
CHEMBL626080,1,,1,,,,A,9773,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1515,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data
CHEMBL626081,1,,1,,,,A,9774,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5491,50597,,Half life period was evaluated in rat plasma
CHEMBL875344,1,,1,,,,A,9775,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5491,50597,,Half life period was evaluated in rat plasma; Not tested
CHEMBL626082,1,,1,,,,A,9776,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1918,50597,,Half life period was evaluated in rats
CHEMBL626250,1,,1,,,,A,9777,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1918,50597,,"Half life period was evaluated in rats, iv"
CHEMBL626251,1,,1,,,,A,9778,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6113,50597,,Half life period after intravenous administration at 5 mg/kg in rat
CHEMBL626252,1,,1,,,,A,9779,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5546,50597,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration
CHEMBL626253,1,,1,,,,A,9780,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5553,50597,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg
CHEMBL626254,1,,1,,,,A,9781,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4188,50597,,Half life stability of compound was evaluated in rat plasma
CHEMBL626255,1,,1,,,,A,9782,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6215,50597,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat
CHEMBL626256,1,,1,,,,A,9783,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6141,50597,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats
CHEMBL626257,1,,1,,,,A,9784,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5182,50597,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat
CHEMBL626258,1,,1,,,,A,9785,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5182,50597,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated
CHEMBL626259,1,,1,,,,A,9786,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5710,50597,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.
CHEMBL626260,1,,1,,,,A,9787,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5789,50597,,Half in rat i.v.
CHEMBL875345,1,,1,,,,A,9788,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6011,50597,,Half period in rat after intravenous administration
CHEMBL626261,1,,1,,,,A,9789,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17594,50597,,Half-life after repeated oral dose of compound at 1 mg/kg in rats
CHEMBL626262,1,,1,,,,A,9790,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vitro,,12357,50597,,Half-life measured in in vitro Cathepsin B assay in rat liver
CHEMBL626263,1,,1,,,,A,9791,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5210,50597,,Half-life of compound was determined in rats
CHEMBL625270,1,,1,,,,A,9792,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17596,50597,,Half-life at 10 mg/kg in rat upon intravenous administration
CHEMBL625271,1,,1,,,,A,9793,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6672,50597,,Half-life determined in rat
CHEMBL625272,1,,1,,,,A,9794,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6673,50597,,Half-life determined in rat
CHEMBL625273,1,,1,,,,A,9795,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,4910,50597,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats
CHEMBL625274,1,,1,,,,A,9796,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,3741,50597,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma"
CHEMBL625275,1,,1,,,,A,9797,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17671,50597,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg
CHEMBL625276,1,,1,,,,A,9798,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4910,50597,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats
CHEMBL625277,1,,1,,,,A,9799,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17537,50597,,Half-life in rat plasma
CHEMBL625278,1,,1,,,,A,9800,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4965,50597,,Half-life in rat plasma was determined
CHEMBL625279,1,,1,,,,A,9801,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17537,50597,,Half-life in rat plasma; Not tested
CHEMBL625280,1,,1,,,,A,9802,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,6124,50597,,Half-life in rat serum
CHEMBL876797,1,,1,,,,A,9803,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,6124,50597,,Half-life in rat serum; na is not available
CHEMBL625281,1,,1,,,,A,9804,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6078,50597,,Half-life was calculated in rat
CHEMBL873827,1,,1,,,,A,9805,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17668,50597,,Half-life was calculated in rat plasma
CHEMBL625282,1,,1,,,,A,9806,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3185,50597,,Half-life was determined
CHEMBL625283,1,,1,,,,A,9807,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4883,50597,,Half-life was determined
CHEMBL625284,1,,1,,,,A,9808,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2959,50597,,Half-life after administration of 20 mg/Kg oral dose in rat
CHEMBL625285,1,,1,,,,A,9809,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4029,50597,,Half-life after administration of 3.2 mg/kg intravenously in male rat
CHEMBL625286,1,,1,,,,A,9810,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4029,50597,,Half-life after intravenous administration in female rat
CHEMBL625287,1,,1,,,,A,9811,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4029,50597,,Half-life after intravenous administration in male rat
CHEMBL625288,1,,1,,,,A,9812,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6180,50597,,Half-life after intravenous dose in rat
CHEMBL625289,1,,1,,,,A,9813,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,1557,50597,,Half-life in a rat liver homogenate preparation
CHEMBL625290,1,,1,,,,A,9814,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,12500,50597,,Half-life in plasma of rat
CHEMBL876798,1,,1,,,,A,9815,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,12500,50597,,Half-life in plasma of rat at dose of 3-10 mgkg
CHEMBL625291,1,,1,,,,A,9816,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5064,50597,,Half-life in rat
CHEMBL625292,1,,1,,,,A,9817,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5145,50597,,Half-life in rat
CHEMBL625293,1,,1,,,,A,9818,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5147,50597,,Half-life in rat
CHEMBL622832,1,,1,,,,A,9819,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5833,50597,,Half-life in rat
CHEMBL622833,1,,1,,,,A,9820,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6596,50597,,Half-life in rat
CHEMBL622834,1,,1,,,,A,9821,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17655,50597,,Half-life in rat
CHEMBL622835,1,,1,,,,A,9822,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6495,50597,,Half-life in rat after oral administration at 10 mg/kg
CHEMBL622836,1,,1,,,,A,9823,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17538,50597,,Half-life in rat after po administration at a dose of 10 mg/kg
CHEMBL622837,1,,1,,,,A,9824,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17538,50597,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined
CHEMBL622838,1,,1,,,,A,9825,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,10,50597,,Half-life in rat at 3 mg/kg dose administered intravenously
CHEMBL622839,1,,1,,,,A,9826,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,17669,50597,,Half-life in rat brain homogenate
CHEMBL622840,1,,1,,,,A,9827,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17065,50597,,Half-life in rat plasma
CHEMBL622841,1,,1,,,,A,9828,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4333,50597,,Half-life in rats
CHEMBL622842,1,,1,,,,A,9829,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6827,50597,,Half-life in Dawley rats
CHEMBL622843,1,,1,,,,A,9830,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vitro,,889,50597,,Half-life in vitro in rat plasma
CHEMBL622844,1,,1,,,,A,9831,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vitro,,889,50597,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours
CHEMBL622845,1,,1,,,,A,9832,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3747,50597,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat"
CHEMBL622846,1,,1,,,,A,9833,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15022,50597,,The area under the curve of compound was measured at the dose of 100 umol/kg
CHEMBL622847,1,,1,,,,A,9834,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15022,50597,,The area under the curve of compound was measured at the dose of 300 umol/kg
CHEMBL622848,1,,1,,,,A,9835,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15022,50597,,The area under the curve of compound was measured at the dose of 30 umol/kg
CHEMBL622849,1,,1,,,,A,9836,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3360,50597,,Bioavailability as oral AUC in rats
CHEMBL622850,1,,1,,,,A,9837,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5334,50597,,The plasma concentration versus time curve (AUC) was determined
CHEMBL876807,1,,1,,,,A,9838,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17411,50597,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL622851,1,,1,,,,A,9839,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17411,50597,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL622852,1,,1,,,,A,9840,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17411,50597,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL622853,1,,1,,,,A,9841,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6570,50597,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours
CHEMBL622854,1,,1,,,,A,9842,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6570,50597,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours
CHEMBL622855,1,,1,,,,A,9843,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17411,50597,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg
CHEMBL622856,1,,1,,,,A,9844,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14941,50597,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration"
CHEMBL622857,1,,1,,,,A,9845,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14941,50597,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration"
CHEMBL622858,1,,1,,,,A,9846,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17538,50597,,AUC in rat after po administration at a dose of 10 mg/kg
CHEMBL622859,1,,1,,,,A,9847,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17752,50597,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg
CHEMBL622860,1,,1,,,,A,9848,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17509,50597,,Area under curve value 24 hr after 10 mg/kg iv administration in rats
CHEMBL622861,1,,1,,,,A,9849,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17509,50597,,Area under curve value 24 hr after 10 mg/kg oral administration in rats
CHEMBL622862,1,,1,,,,A,9850,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17509,50597,,Area under curve value 24 hr after 2 mg/kg iv administration in rats
CHEMBL622863,1,,1,,,,A,9851,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17509,50597,,Area under curve value 24 hr after 2 mg/kg oral administration in rats
CHEMBL623817,1,,1,,,,A,9852,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17509,50597,,Area under curve value 6 hr after po administration in rat
CHEMBL623818,1,,1,,,,A,9853,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17717,50597,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11
CHEMBL623819,1,,1,,,,A,9854,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17717,50597,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously"
CHEMBL623820,1,,1,,,,A,9855,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17717,50597,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11
CHEMBL623821,1,,1,,,,A,9856,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17717,50597,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control
CHEMBL623822,1,,1,,,,A,9857,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6642,50597,,AUC normalized for dose (AUCN) in rat
CHEMBL623823,1,,1,,,,A,9858,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6640,50597,,Area under curve in rat after p.o. administration
CHEMBL623824,1,,1,,,,A,9859,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6641,50597,,Area under curve in rat after p.o. administration
CHEMBL623825,1,,1,,,,A,9860,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6641,50597,,Area under curve in rat after p.o. administration; Not determined
CHEMBL622070,1,,1,,,,A,9861,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6641,50597,,Area under curve in rat after peroral administration
CHEMBL622071,1,,1,,,,A,9862,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3603,50597,,Area under curve (carotid artery) value of the compound
CHEMBL622072,1,,1,,,,A,9863,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3550,50597,,Bioavailability expressed as the area under curve of rat carotid artery
CHEMBL622073,1,,1,,,,A,9864,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15662,50597,,Area under curve in male SD rats was observed after intravenous administration in rat
CHEMBL622074,1,,1,,,,A,9865,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17720,50597,,Area under curve of the compound was determined
CHEMBL622075,1,,1,,,,A,9866,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5407,50597,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax
CHEMBL622076,1,,1,,,,A,9867,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17752,50597,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg
CHEMBL622077,1,,1,,,,A,9868,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17752,50597,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg
CHEMBL622078,1,,1,,,,A,9869,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3603,50597,,Area under curve (portal vein) value of the compound
CHEMBL622079,1,,1,,,,A,9870,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3550,50597,,Bioavailability expressed as the area under curve of rat portal vein
CHEMBL622080,1,,1,,,,A,9871,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17655,50597,,Area Under plasma concentration time curve in rat upon peroral administration
CHEMBL877612,1,,1,,,,A,9872,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17582,50597,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats
CHEMBL622081,1,,1,,,,A,9873,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17582,50597,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats
CHEMBL622082,1,,1,,,,A,9874,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Compound was evaluated for oral bioavailability in rats
CHEMBL622083,1,,1,,,,A,9875,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Compound was evaluated for oral bioavailability in rats after iv administration
CHEMBL622084,1,,1,,,,A,9876,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Compound was evaluated for oral bioavailability in rats; 30-80
CHEMBL622085,1,,1,,,,A,9877,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Compound was evaluated for oral bioavailability in rats; 50-60
CHEMBL622086,1,,1,,,,A,9878,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Compound was evaluated for oral bioavailability in rats; no data
CHEMBL622087,1,,1,,,,A,9879,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17791,50597,,Compound was evaluated for oral bioavailability in rats; peptide
CHEMBL622088,1,,1,,,,A,9880,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7768,50597,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03"
CHEMBL622089,1,,1,,,,A,9881,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7768,50597,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03"
CHEMBL623685,1,,1,,,,A,9882,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7768,50597,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15"
CHEMBL623686,1,,1,,,,A,9883,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7768,50597,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87"
CHEMBL623687,1,,1,,,,A,9884,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL623688,1,,1,,,,A,9885,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL623689,1,,1,,,,A,9886,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622485,1,,1,,,,A,9887,Intermediate,BAO_0000218,945.0,N,Rattus norvegicus,Stomach,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622486,1,,1,,,,A,9888,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL877613,1,,1,,,,A,9889,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622487,1,,1,,,,A,9890,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622488,1,,1,,,,A,9891,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622489,1,,1,,,,A,9892,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8677,50597,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)"
CHEMBL622490,1,,1,,,,A,9893,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,6899,50597,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine
CHEMBL622491,1,,1,,,,A,9894,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,6899,50597,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available
CHEMBL622492,1,,1,,,,A,9895,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,6899,50597,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver
CHEMBL622493,1,,1,,,,A,9896,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,6899,50597,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine
CHEMBL622494,1,,1,,,,A,9897,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,6899,50597,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available
CHEMBL622495,1,,1,,,,A,9898,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,8677,50597,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)"
CHEMBL622496,1,,1,,,,A,9899,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6899,50597,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney
CHEMBL622497,1,,1,,,,A,9900,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,6899,50597,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine
CHEMBL622498,1,,1,,,,A,9901,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2189,50597,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats
CHEMBL624918,1,,1,,,,A,9902,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,2189,50597,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats
CHEMBL624919,1,,1,,,,A,9903,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,2189,50597,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data
CHEMBL624920,1,,1,,,,A,9904,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat blood after 5 min of administration
CHEMBL624921,1,,1,,,,A,9905,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat blood after 5 min of administration.
CHEMBL624922,1,,1,,,,A,9906,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat brain after 5 min of administration
CHEMBL624923,1,,1,,,,A,9907,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat heart after 5 min of administration
CHEMBL624924,1,,1,,,,A,9908,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat heart after 5 min of administration.
CHEMBL624925,1,,1,,,,A,9909,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat kidney after 5 min of administration
CHEMBL624926,1,,1,,,,A,9910,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat kidney after 5 min of administration.
CHEMBL624927,1,,1,,,,A,9911,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat liver after 5 min of administration
CHEMBL874402,1,,1,,,,A,9912,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat liver after 5 min of administration.
CHEMBL624928,1,,1,,,,A,9913,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat lung after 5 min of administration
CHEMBL624929,1,,1,,,,A,9914,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat lung after 5 min of administration.
CHEMBL624930,1,,1,,,,A,9915,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat muscle after 5 min of administration
CHEMBL624931,1,,1,,,,A,9916,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,10839,50597,,Biodistribution of compound in rat muscle after 5 min of administration.
CHEMBL624932,1,,1,,,,A,9917,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,4043,50597,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL624933,1,,1,,,,A,9918,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,4043,50597,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL624934,1,,1,,,,A,9919,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,4043,50597,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL624935,1,,1,,,,A,9920,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,4043,50597,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL624936,1,,1,,,,A,9921,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4043,50597,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL624937,1,,1,,,,A,9922,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4043,50597,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL624938,1,,1,,,,A,9923,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,4043,50597,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL624939,1,,1,,,,A,9924,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,4043,50597,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL624940,1,,1,,,,A,9925,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4043,50597,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL874403,1,,1,,,,A,9926,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4043,50597,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells
CHEMBL624941,1,,1,,,,A,9927,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1446,50597,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95
CHEMBL624942,1,,1,,,,A,9928,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,9971,50597,,Dose required to lower urine osmolality to 300 mOsm/kg in rat
CHEMBL624943,1,,1,,,,A,9929,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,9971,50597,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested
CHEMBL624944,1,,1,,,,A,9930,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5765,50597,,% Bioavailability after 1 day of the drug administration in rats
CHEMBL624945,1,,1,,,,A,9931,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5765,50597,,% Bioavailability after 4 day of the drug administration in rats
CHEMBL624946,1,,1,,,,A,9932,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4257,50597,,Absolute bioavailability was evaluated in rat
CHEMBL624947,1,,1,,,,A,9933,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval
CHEMBL624948,1,,1,,,,A,9934,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval
CHEMBL624949,1,,1,,,,A,9935,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval
CHEMBL622025,1,,1,,,,A,9936,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval
CHEMBL622026,1,,1,,,,A,9937,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval
CHEMBL622027,1,,1,,,,A,9938,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval
CHEMBL622028,1,,1,,,,A,9939,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval
CHEMBL622029,1,,1,,,,A,9940,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval
CHEMBL622208,1,,1,,,,A,9941,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval
CHEMBL622209,1,,1,,,,A,9942,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval
CHEMBL622210,1,,1,,,,A,9943,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval
CHEMBL622211,1,,1,,,,A,9944,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval
CHEMBL622212,1,,1,,,,A,9945,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval
CHEMBL622213,1,,1,,,,A,9946,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval
CHEMBL874404,1,,1,,,,A,9947,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval
CHEMBL620452,1,,1,,,,A,9948,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval
CHEMBL620453,1,,1,,,,A,9949,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval
CHEMBL620454,1,,1,,,,A,9950,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval
CHEMBL624067,1,,1,,,,A,9951,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval
CHEMBL624068,1,,1,,,,A,9952,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval
CHEMBL624069,1,,1,,,,A,9953,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval
CHEMBL624070,1,,1,,,,A,9954,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval
CHEMBL624071,1,,1,,,,A,9955,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval
CHEMBL624072,1,,1,,,,A,9956,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval
CHEMBL624073,1,,1,,,,A,9957,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval
CHEMBL624788,1,,1,,,,A,9958,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval
CHEMBL624789,1,,1,,,,A,9959,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval
CHEMBL624790,1,,1,,,,A,9960,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval
CHEMBL624791,1,,1,,,,A,9961,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval
CHEMBL624792,1,,1,,,,A,9962,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval
CHEMBL624793,1,,1,,,,A,9963,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval
CHEMBL877491,1,,1,,,,A,9964,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval
CHEMBL624957,1,,1,,,,A,9965,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval
CHEMBL624958,1,,1,,,,A,9966,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval
CHEMBL624959,1,,1,,,,A,9967,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,13091,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval
CHEMBL624960,1,,1,,,,A,9968,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11977,50597,,Dissociation constant was determined
CHEMBL624961,1,,1,,,,A,9969,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14941,50597,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration"
CHEMBL624962,1,,1,,,,A,9970,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL624963,1,,1,,,,A,9971,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose"
CHEMBL624964,1,,1,,,,A,9972,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4755,50597,,Observed rate constant in 80% rat plasma at 37 degree Centigrade
CHEMBL624965,1,,1,,,,A,9973,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,589,50597,,LogP value was evaluated in the in situ rat gut perfusion assay
CHEMBL624966,1,,1,,,,A,9974,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17582,50597,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats
CHEMBL624967,1,,1,,,,A,9975,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5031,50597,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats
CHEMBL624968,1,,1,,,,A,9976,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17764,50597,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg
CHEMBL624969,1,,1,,,,A,9977,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17720,50597,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration
CHEMBL624970,1,,1,,,,F,9978,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2862,50597,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose
CHEMBL624971,1,,1,,,,A,9979,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16423,50597,,Half-life was evaluated after 10 uM/kg of intra arterial administration
CHEMBL624972,1,,1,,,,A,9980,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16423,50597,,Half-life was evaluated after 20 uM/kg of peroral administration
CHEMBL624973,1,,1,,,,A,9981,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6005,50597,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg
CHEMBL624974,1,,1,,,,A,9982,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,2938,50597,,Half-life was evaluated in plasma of rat
CHEMBL624975,1,,1,,,,A,9983,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6410,50597,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg
CHEMBL877492,1,,1,,,,A,9984,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6410,50597,,Half-life was evaluated in rats at an oral dose of 30 mg/kg
CHEMBL624976,1,,1,,,,A,9985,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6062,50597,,Half-life was measured in rat after an iv dose of 1 mg/kg
CHEMBL624977,1,,1,,,,A,9986,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6571,50597,,Half-life period of compound in rats after peroral administration
CHEMBL626848,1,,1,,,,A,9987,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,3136,50597,,Half-life period of compound was measured in rat plasma.
CHEMBL626849,1,,1,,,,A,9988,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,3136,50597,,Half-life period of compound was measured in rat plasma; ND is not determined
CHEMBL626850,1,,1,,,,A,9989,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,3136,50597,,Half-life period of compound was measured in rat plasma; not determined
CHEMBL626851,1,,1,,,,A,9990,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4521,50597,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration
CHEMBL626852,1,,1,,,,A,9991,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5871,50597,,Half-life period in rat by iv administration
CHEMBL626853,1,,1,,,,A,9992,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6077,50597,,Half-life period in rats following intravenous administration at 2 mg/kg
CHEMBL626854,1,,1,,,,A,9993,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6679,50597,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration
CHEMBL627486,1,,1,,,,A,9994,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5144,50597,,Half-life period was determined for the compound in rat
CHEMBL627487,1,,1,,,,A,9995,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4498,50597,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously"
CHEMBL627488,1,,1,,,,A,9996,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4498,50597,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally"
CHEMBL627489,1,,1,,,,A,9997,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1908,50597,,Half-life value after IV dose at a dose of 5 mg/kg in rats.
CHEMBL627490,1,,1,,,,A,9998,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6211,50597,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats
CHEMBL873829,1,,1,,,,A,9999,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5529,50597,,Half-life was determined in rat after intravenous administration (0.5 mg/kg)
CHEMBL627655,1,,1,,,,A,10000,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6444,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.
CHEMBL625994,1,,1,,,,A,10001,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6444,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined
CHEMBL625995,1,,1,,,,A,10002,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6444,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined
CHEMBL625996,1,,1,,,,A,10003,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5207,50597,,Half-life in rat
CHEMBL625850,1,,1,,,,A,10004,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vitro,,530,50597,,In vitro half life in rat plasma
CHEMBL625851,1,,1,,,,A,10005,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vitro,,1116,50597,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma"
CHEMBL625852,1,,1,,,,A,10006,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vitro,,3219,50597,,In vitro half life in rat
CHEMBL625853,1,,1,,,,A,10007,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6109,50597,,In vivo half life period after intravenous administration in rat
CHEMBL625854,1,,1,,,,A,10008,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17582,50597,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats
CHEMBL874450,1,,1,,,,A,10009,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17582,50597,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats
CHEMBL625855,1,,1,,,,A,10010,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat
CHEMBL625856,1,,1,,,,A,10011,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat
CHEMBL625857,1,,1,,,,A,10012,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat
CHEMBL873831,1,,1,,,,A,10013,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat
CHEMBL625858,1,,1,,,,A,10014,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17853,50597,,Longer half-life in rat (i.v.) at 0.5 mpk
CHEMBL625859,1,,1,,,,A,10015,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17853,50597,,Longer half-life in rat (p.o.) at 2.0 mpk
CHEMBL625860,1,,1,,,,A,10016,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3457,50597,,Pharmacokinetic property (half life) in rat
CHEMBL625861,1,,1,,,,A,10017,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats
CHEMBL625862,1,,1,,,,A,10018,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats
CHEMBL625863,1,,1,,,,A,10019,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats
CHEMBL625864,1,,1,,,,A,10020,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats
CHEMBL625865,1,,1,,,,A,10021,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5739,50597,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats
CHEMBL625866,1,,1,,,,A,10022,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15765,50597,,Pharmacokinetic half time was determined intravenously in rats.
CHEMBL625867,1,,1,,,,A,10023,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,6567,50597,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours
CHEMBL625868,1,,1,,,,A,10024,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,2448,50597,,Plasma half life of hydrolysis of the compound
CHEMBL625869,1,,1,,,,A,10025,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5423,50597,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat
CHEMBL874451,1,,1,,,,A,10026,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4853,50597,,Plasma half life period was calculated in rat
CHEMBL625870,1,,1,,,,A,10027,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4514,50597,,Plasma half-life in Sprague-Dawley rats
CHEMBL625871,1,,1,,,,A,10028,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4514,50597,,Plasma half-life in Sprague-Dawley rats; Not determined
CHEMBL625872,1,,1,,,,A,10029,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1500,50597,,Plasma half-life in rats
CHEMBL625873,1,,1,,,,A,10030,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,1500,50597,,Plasma half-life in rats; <MQL
CHEMBL625874,1,,1,,,,A,10031,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5334,50597,,Plasma half-life period (0-8 h) was determined
CHEMBL625875,1,,1,,,,A,10032,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5334,50597,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat
CHEMBL625876,1,,1,,,,A,10033,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5334,50597,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat
CHEMBL631258,1,,1,,,,A,10034,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5334,50597,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat
CHEMBL631259,1,,1,,,,A,10035,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4956,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound
CHEMBL631260,1,,1,,,,A,10036,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4956,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined
CHEMBL631261,1,,1,,,,A,10037,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7768,50597,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03"
CHEMBL631262,1,,1,,,,A,10038,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7768,50597,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48"
CHEMBL631263,1,,1,,,,A,10039,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7768,50597,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1"
CHEMBL631264,1,,1,,,,A,10040,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7768,50597,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008"
CHEMBL631265,1,,1,,,,A,10041,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7768,50597,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22"
CHEMBL631266,1,,1,,,,A,10042,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7768,50597,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97"
CHEMBL631267,1,,1,,,,A,10043,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7768,50597,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13"
CHEMBL631268,1,,1,,,,A,10044,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7768,50597,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37"
CHEMBL631269,1,,1,,,,A,10045,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7768,50597,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04"
CHEMBL631270,1,,1,,,,A,10046,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7768,50597,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94"
CHEMBL631271,1,,1,,,,A,10047,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,7768,50597,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02"
CHEMBL631272,1,,1,,,,A,10048,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,7768,50597,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63"
CHEMBL631273,1,,1,,,,A,10049,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,7768,50597,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55"
CHEMBL631274,1,,1,,,,A,10050,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,7768,50597,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38"
CHEMBL631275,1,,1,,,,A,10051,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,7768,50597,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82"
CHEMBL626984,1,,1,,,,A,10052,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,7768,50597,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2"
CHEMBL626985,1,,1,,,,A,10053,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,7768,50597,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29"
CHEMBL626986,1,,1,,,,A,10054,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7768,50597,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02"
CHEMBL626987,1,,1,,,,A,10055,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7768,50597,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93"
CHEMBL626988,1,,1,,,,A,10056,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7768,50597,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53"
CHEMBL626989,1,,1,,,,A,10057,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7768,50597,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62"
CHEMBL626990,1,,1,,,,A,10058,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7768,50597,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41"
CHEMBL626991,1,,1,,,,A,10059,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7768,50597,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23"
CHEMBL626992,1,,1,,,,A,10060,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7768,50597,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82"
CHEMBL626993,1,,1,,,,A,10061,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,7768,50597,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03"
CHEMBL874593,1,,1,,,,A,10062,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,7768,50597,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77"
CHEMBL626994,1,,1,,,,A,10063,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,7768,50597,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42"
CHEMBL626995,1,,1,,,,A,10064,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,7768,50597,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58"
CHEMBL626190,1,,1,,,,A,10065,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,7768,50597,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87"
CHEMBL626191,1,,1,,,,A,10066,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,7768,50597,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31"
CHEMBL626364,1,,1,,,,A,10067,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,7768,50597,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22"
CHEMBL626365,1,,1,,,,A,10068,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,7768,50597,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499"
CHEMBL626366,1,,1,,,,A,10069,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,7768,50597,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96"
CHEMBL626367,1,,1,,,,A,10070,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,7768,50597,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8"
CHEMBL626368,1,,1,,,,A,10071,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,7768,50597,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159"
CHEMBL626369,1,,1,,,,A,10072,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,7768,50597,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84"
CHEMBL626370,1,,1,,,,A,10073,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,7768,50597,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207"
CHEMBL626371,1,,1,,,,A,10074,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4498,50597,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously"
CHEMBL626372,1,,1,,,,A,10075,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4498,50597,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally"
CHEMBL626373,1,,1,,,,A,10076,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3603,50597,,Bioavailability after a dose of 10 mg/kg p.o.
CHEMBL626374,1,,1,,,,A,10077,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6215,50597,,Bioavailability after peroral administration (10 mg/kg) was determined in rat
CHEMBL626375,1,,1,,,,A,10078,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5710,50597,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.
CHEMBL626376,1,,1,,,,A,10079,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5710,50597,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg)
CHEMBL626377,1,,1,,,,A,10080,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5676,50597,,Bioavailability in rat po was determined
CHEMBL626378,1,,1,,,,A,10081,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17667,50597,,Bioavailability of compound at 10 mg/kg in rat after oral administration
CHEMBL626379,1,,1,,,,A,10082,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17667,50597,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration
CHEMBL626380,1,,1,,,,A,10083,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6848,50597,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.)
CHEMBL626381,1,,1,,,,A,10084,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6848,50597,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.)
CHEMBL626382,1,,1,,,,A,10085,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17267,50597,,Bioavailability in rat
CHEMBL626383,1,,1,,,,A,10086,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6362,50597,,Bioavailability in rat (Sprague-Dawley) (female)
CHEMBL874652,1,,1,,,,A,10087,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17671,50597,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg
CHEMBL626384,1,,1,,,,A,10088,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17671,50597,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg)
CHEMBL626385,1,,1,,,,A,10089,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4333,50597,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr
CHEMBL626386,1,,1,,,,A,10090,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6077,50597,,Bioavailability in rat at an oral dose of 2 mg/kg
CHEMBL626387,1,,1,,,,A,10091,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3278,50597,,Bioavailability in rat
CHEMBL626388,1,,1,,,,A,10092,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5964,50597,,Bioavailability in rat
CHEMBL626389,1,,1,,,,A,10093,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4884,50597,,Bioavailability in rat
CHEMBL626390,1,,1,,,,A,10094,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4905,50597,,Bioavailability in rat
CHEMBL626391,1,,1,,,,A,10095,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4884,50597,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300
CHEMBL626392,1,,1,,,,A,10096,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6850,50597,,Bioavailability in rat
CHEMBL626393,1,,1,,,,A,10097,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2864,50597,,Oral bioavailability in rat
CHEMBL623026,1,,1,,,,A,10098,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5780,50597,,Bioavailability was determined in rat
CHEMBL623027,1,,1,,,,A,10099,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1465,50597,,Bioavailability
CHEMBL623028,1,,1,,,,A,10100,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5199,50597,,Bioavailability
CHEMBL623029,1,,1,,,,A,10101,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5765,50597,,Bioavailability in rat after 1 day dosing
CHEMBL623030,1,,1,,,,A,10102,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5765,50597,,Bioavailability in rat after 4 day dosing
CHEMBL623031,1,,1,,,,A,10103,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data
CHEMBL623032,1,,1,,,,A,10104,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Bioavailability after IV dosing at 1 mg/kg in rat; no data
CHEMBL623033,1,,1,,,,A,10105,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Bioavailability after oral administration at a dose of 2 mg/kg in rat
CHEMBL623034,1,,1,,,,A,10106,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6518,50597,,Bioavailability after oral administration at a dose of 4 mg/kg in rat
CHEMBL623035,1,,1,,,,A,10107,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2083,50597,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat
CHEMBL623036,1,,1,,,,A,10108,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17260,50597,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat
CHEMBL623037,1,,1,,,,A,10109,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4956,50597,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.)
CHEMBL623038,1,,1,,,,A,10110,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4368,50597,,Bioavailability by intravenous administration of 3.4 mg/kg in rat
CHEMBL874385,1,,1,,,,A,10111,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17752,50597,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg
CHEMBL623039,1,,1,,,,A,10112,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1446,50597,,Bioavailability in rat (Fisher) (fasted)
CHEMBL623040,0,,1,,,,A,10113,Intermediate,BAO_0000218,,U,Primates,,9443.0,,In vivo,,2891,22224,,Bioavailability in monkey after po administration of 10 mg/kg dose
CHEMBL623041,0,,1,,,,A,10114,Intermediate,BAO_0000218,,U,Primates,,9443.0,,In vivo,,2891,22224,,Oral bioavailability in monkey (dose 10 mg/kg)
CHEMBL623741,1,,1,,,,A,10115,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6672,50597,,Bioavailability in rat
CHEMBL623742,1,,1,,,,A,10116,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6673,50597,,Bioavailability in rat
CHEMBL623743,1,,1,,,,A,10117,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17655,50597,,Bioavailability in rat
CHEMBL623744,1,,1,,,,A,10118,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17796,50597,,Bioavailability in rat
CHEMBL623745,1,,1,,,,A,10119,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17853,50597,,Bioavailability in rat (dose 2.0 mg/kg p.o.)
CHEMBL623746,1,,1,,,,A,10120,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4521,50597,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.)
CHEMBL623747,1,,1,,,,A,10121,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4940,50597,,Oral bioavailability in rat (dose 5 mg/kg p.o.)
CHEMBL623748,0,,1,,,,A,10122,Intermediate,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,2891,22224,,Bioavailability in rat after po administration of 30 mg/kg dose
CHEMBL623916,0,,1,,,,A,10123,Intermediate,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,2891,22224,,Bioavailability in rat after po administration of 30 mg/kg dose
CHEMBL623917,1,,1,,,,A,10124,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4521,50597,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration
CHEMBL623918,1,,1,,,,A,10125,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17686,50597,,Bioavailability in rat (dose 2 mg/kg i.v.)
CHEMBL874386,1,,1,,,,A,10126,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17796,50597,,Bioavailability in rat
CHEMBL623919,1,,1,,,,A,10127,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17796,50597,,Bioavailability in rat; Only traces detected in rat plasma
CHEMBL623920,1,,1,,,,A,10128,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5064,50597,,Bioavailability in rat
CHEMBL623148,1,,1,,,,A,10129,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5147,50597,,Bioavailability upon oral administration of compound
CHEMBL623149,1,,1,,,,A,10130,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1916,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg)
CHEMBL623150,1,,1,,,,A,10131,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6049,50597,,Bioavailability in rat
CHEMBL623151,1,,1,,,,A,10132,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1445,50597,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state"
CHEMBL623152,1,,1,,,,A,10133,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1445,50597,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state"
CHEMBL623153,1,,1,,,,F,10134,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2862,50597,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose
CHEMBL623154,1,,1,,,,F,10135,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2862,50597,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose
CHEMBL623155,1,,1,,,,A,10136,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4194,50597,,In vitro and metabolic stability was determined
CHEMBL623156,1,,1,,,,A,10137,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4194,50597,,In vitro metabolic stability in rat hepatocytes
CHEMBL623157,1,,1,,,,A,10138,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5486,50597,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein
CHEMBL623158,1,401.0,1,,,,A,10139,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,Hepatocyte,In vitro,,17582,50597,,Metabolic rate for compound was observed in rat hepatocytes
CHEMBL623159,1,,1,,,,A,10140,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5600,50597,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes
CHEMBL874390,1,,1,,,,A,10141,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14294,50597,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak)
CHEMBL623160,1,,1,,,,A,10142,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14294,50597,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak)
CHEMBL623161,1,,1,,,,A,10143,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14294,50597,,Metabolism of compound in rat S9 microsomes; Trace
CHEMBL623162,1,,1,,,,A,10144,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17847,50597,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes
CHEMBL623163,1,,1,,,,A,10145,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA
CHEMBL623164,1,,1,,,,A,10146,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT
CHEMBL623165,1,,1,,,,A,10147,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA
CHEMBL623166,1,,1,,,,A,10148,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC
CHEMBL624983,1,,1,,,,A,10149,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA
CHEMBL624984,1,,1,,,,A,10150,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE
CHEMBL624985,1,,1,,,,A,10151,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA
CHEMBL622970,1,,1,,,,A,10152,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT
CHEMBL622971,1,,1,,,,A,10153,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection
CHEMBL622972,1,,1,,,,A,10154,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection
CHEMBL622973,1,,1,,,,A,10155,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection
CHEMBL622974,1,,1,,,,A,10156,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection
CHEMBL622975,1,,1,,,,A,10157,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection
CHEMBL622976,1,,1,,,,A,10158,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection
CHEMBL622977,1,,1,,,,A,10159,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE
CHEMBL624351,1,,1,,,,A,10160,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA
CHEMBL624352,1,,1,,,,A,10161,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT
CHEMBL624353,1,,1,,,,A,10162,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA
CHEMBL622397,1,,1,,,,A,10163,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC
CHEMBL622398,1,,1,,,,A,10164,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA
CHEMBL622399,1,,1,,,,A,10165,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE
CHEMBL622400,1,,1,,,,A,10166,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA
CHEMBL628428,1,,1,,,,A,10167,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA
CHEMBL628590,1,,1,,,,A,10168,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT
CHEMBL628591,1,,1,,,,A,10169,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection
CHEMBL628592,1,,1,,,,A,10170,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection
CHEMBL628593,1,,1,,,,A,10171,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection
CHEMBL875333,1,,1,,,,A,10172,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection
CHEMBL628594,1,,1,,,,A,10173,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection
CHEMBL628595,1,,1,,,,A,10174,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,4969,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration
CHEMBL628596,1,,1,,,,A,10175,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6737,50597,,Stability in rat plasma was determined
CHEMBL628597,1,,1,,,,A,10176,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,6737,50597,,Stability in rat plasma was determined; ND= no data
CHEMBL628598,1,,1,,,,A,10177,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5089,50597,,Tested for plasma half life period in rat (0-8 hr)
CHEMBL628599,1,,1,,,,A,10178,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,5089,50597,,Tested for plasma half life period in rat (0-8 hr); Not determined
CHEMBL628600,1,,1,,,,A,10179,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1466,50597,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat
CHEMBL628601,1,,1,,,,A,10180,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1466,50597,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat
CHEMBL628602,1,,1,,,,A,10181,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4950,50597,,Tested for the half life in rat
CHEMBL628603,1,,1,,,,A,10182,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vitro,,2412,50597,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase
CHEMBL628604,1,,1,,,,A,10183,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vitro,,2412,50597,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined
CHEMBL628605,1,,1,,,,A,10184,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vitro,,2412,50597,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase
CHEMBL628606,1,,1,,,,A,10185,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vitro,,2412,50597,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined
CHEMBL628607,1,,1,,,,A,10186,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vitro,,2412,50597,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase
CHEMBL628608,1,,1,,,,A,10187,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15022,50597,,The biological half life the compound was measured at the dose of 100 umol/kg
CHEMBL628609,1,,1,,,,A,10188,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15022,50597,,The biological half life the compound was measured at the dose of 30 umol/kg
CHEMBL628610,1,,1,,,,A,10189,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,406,50597,,The compound was evaluated for plasma half life period in rat
CHEMBL873819,1,,1,,,,A,10190,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15078,50597,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL628611,1,,1,,,,A,10191,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15078,50597,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose"
CHEMBL628612,1,,1,,,,A,10192,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5247,50597,,The pharmacokinetic parameter half-life period in vivo in rats
CHEMBL628613,1,,1,,,,A,10193,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,"The pharmacokinetic property, Half-life was determined"
CHEMBL628614,1,,1,,,,A,10194,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,"The pharmacokinetic property, Half-life in rat in vivo"
CHEMBL628615,1,,1,,,,A,10195,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,"The pharmacokinetic property, Half-life was determined; ND denotes no data"
CHEMBL628616,1,,1,,,,A,10196,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5041,50597,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined"
CHEMBL627924,1,,1,,,,A,10197,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,3918,50597,,The plasma half life period in rats
CHEMBL627925,1,,1,,,,A,10198,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,2906,50597,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay
CHEMBL627926,1,,1,,,,A,10199,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6467,50597,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined
CHEMBL627927,1,,1,,,,A,10200,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,t1/2 (apparent elimination)of the compound was determined
CHEMBL627928,1,,1,,,,A,10201,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,3788,50597,,t1/2 value in rat
CHEMBL627539,1,,1,,,,A,10202,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17796,50597,,Half life in rat
CHEMBL876790,1,,1,,,,A,10203,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12873,50597,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv"
CHEMBL858186,1,,1,,,,A,10204,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5983,50597,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.
CHEMBL627540,1,,1,,,,A,10205,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15765,50597,,Half-life period in fasted rats
CHEMBL627541,1,,1,,,,A,10206,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats
CHEMBL627715,1,,1,,,,A,10207,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats
CHEMBL627716,1,,1,,,,A,10208,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,429,50597,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg
CHEMBL627717,1,,1,,,,A,10209,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17655,50597,,Maximum time required to achieve Cmax was determined in rat
CHEMBL627718,1,,1,,,,A,10210,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11
CHEMBL627719,1,,1,,,,A,10211,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11
CHEMBL627720,1,,1,,,,A,10212,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control
CHEMBL627721,1,,1,,,,A,10213,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6570,50597,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration
CHEMBL627722,1,,1,,,,A,10214,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6570,50597,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6
CHEMBL627723,1,,1,,,,A,10215,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL626058,1,,1,,,,A,10216,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL626059,1,,1,,,,A,10217,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL626060,1,,1,,,,A,10218,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL626061,1,,1,,,,A,10219,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17720,50597,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration
CHEMBL876791,1,,1,,,,A,10220,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4723,50597,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL626062,1,,1,,,,A,10221,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4723,50597,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats
CHEMBL626063,1,,1,,,,A,10222,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4756,50597,,Tmax at the dose of 2 mg/Kg administered perorally in rats
CHEMBL626064,1,,1,,,,A,10223,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4756,50597,,Tmax at the dose of 5 mg/Kg administered perorally in rats
CHEMBL626065,1,,1,,,,A,10224,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17720,50597,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration
CHEMBL626066,1,,1,,,,A,10225,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17720,50597,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration
CHEMBL626067,1,,1,,,,A,10226,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1466,50597,,tmax upon peroral administration of 10.0 mg/Kg dose in rat
CHEMBL626068,1,,1,,,,F,10227,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide
CHEMBL626069,1,,1,,,,F,10228,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate
CHEMBL626070,1,,1,,,,F,10229,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of 3-methoxyacetaminophen glucuronide
CHEMBL626071,1,,1,,,,F,10230,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of N-methoxyacetaminophen glucuronide
CHEMBL626072,1,,1,,,,F,10231,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of N-methoxyacetaminophen sulfate
CHEMBL626073,1,,1,,,,F,10232,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of acetaminophen
CHEMBL626741,1,,1,,,,A,10233,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,7768,50597,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22"
CHEMBL626742,1,,1,,,,A,10234,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17655,50597,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro"
CHEMBL626743,1,,1,,,,A,10235,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17735,50597,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats
CHEMBL876792,1,,1,,,,A,10236,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5960,50597,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS
CHEMBL626744,1,,1,,,,A,10237,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17735,50597,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined
CHEMBL626745,1,,1,,,,A,10238,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7116,50597,,Compound was tested for antidiuretic activity in rats
CHEMBL626746,1,,1,,,,A,10239,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,4878,50597,,AUC in rat after 3mg/kg oral dose
CHEMBL626747,1,,1,,,,A,10240,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5939,50597,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg
CHEMBL626748,1,,1,,,,A,10241,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5939,50597,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg
CHEMBL626749,1,,1,,,,A,10242,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16367,50597,,Bioavailability administered orally at a dose of 10 mg/kg to rats
CHEMBL626750,1,,1,,,,A,10243,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16366,50597,,Oral Bioavailability was determined
CHEMBL626751,1,,1,,,,A,10244,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4426,50597,,Oral bioavailability in rat
CHEMBL626913,1,,1,,,,A,10245,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4426,50597,,Oral bioavailability in rat; Not performed.
CHEMBL626914,1,,1,,,,A,10246,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5041,50597,,Bioavailability
CHEMBL626915,1,,1,,,,A,10247,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5041,50597,,Bioavailability was determined; ND denotes no data
CHEMBL626916,1,,1,,,,A,10248,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1500,50597,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats
CHEMBL626917,1,,1,,,,A,10249,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1500,50597,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats
CHEMBL626918,1,,1,,,,A,10250,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17409,50597,,Binding towards rat plasma protein at 10 uM
CHEMBL626919,1,,1,,,,A,10251,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17409,50597,,Binding towards rat plasma protein at 100 uM
CHEMBL626920,1,,1,,,,A,10252,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2959,50597,,Bioavailability in rat (dose 20 mg/kg p.o.)
CHEMBL621976,1,,1,,,,A,10253,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13501,50597,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat
CHEMBL877599,1,,1,,,,A,10254,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6567,50597,,Bioavailability in rat after 5 mg/kg oral gavage
CHEMBL621977,1,,1,,,,A,10255,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6571,50597,,Bioavailability in rat
CHEMBL621978,1,,1,,,,A,10256,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6715,50597,,Bioavailability in rat (dose 1 mg/kg i.v.)
CHEMBL621979,1,,1,,,,A,10257,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6715,50597,,Bioavailability in rat (dose 3 mg/kg p.o.)
CHEMBL621980,1,,1,,,,A,10258,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2932,50597,,Oral bioavailability in rat
CHEMBL621981,1,,1,,,,A,10259,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4171,50597,,Bioavailability of the compound in rats after administration of 30 mg/kg
CHEMBL621982,1,,1,,,,A,10260,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17509,50597,,Bioavailability after administration of 10 mg/kg in rats
CHEMBL882953,1,,1,,,,A,10261,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17509,50597,,Bioavailability after administration of 2 mg/kg in rats
CHEMBL621983,1,,1,,,,A,10262,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4527,50597,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined
CHEMBL621984,1,,1,,,,A,10263,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4026,50597,,Bioavailability in dogs was determined; high
CHEMBL621985,1,,1,,,,A,10264,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6659,50597,,Bioavailability in monkey after intravenous administration at 1 mpk
CHEMBL621986,1,,1,,,,A,10265,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6659,50597,,Bioavailability in monkey after peroral administration at 10 mpk
CHEMBL621987,1,,1,,,,A,10266,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6659,50597,,Bioavailability in rat after intravenous administration at 1 mpk
CHEMBL877600,1,,1,,,,F,10267,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6659,50597,,Bioavailability in rat after intravenous administration at 2 mpk
CHEMBL621988,1,,1,,,,A,10268,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6659,50597,,Bioavailability in rat after peroral administration at 30 mpk
CHEMBL621989,1,,1,,,,F,10269,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6659,50597,,Bioavailability in rat after peroral administration at at 100 mpk
CHEMBL621990,1,,1,,,,A,10270,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6597,50597,,Bioavailability in rats was evaluated
CHEMBL621991,1,,1,,,,A,10271,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1202,50597,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr
CHEMBL621992,1,,1,,,,A,10272,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1202,50597,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr
CHEMBL621993,1,,1,,,,A,10273,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1202,50597,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr
CHEMBL621994,1,,1,,,,A,10274,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1202,50597,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr
CHEMBL621995,1,,1,,,,A,10275,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5207,50597,,Bioavailability in rat
CHEMBL621996,1,,1,,,,A,10276,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5970,50597,,Bioavailability in rat
CHEMBL621997,1,,1,,,,A,10277,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17538,50597,,Oral bioavailability in rat (dose 10 mg/kg)
CHEMBL621998,1,,1,,,,A,10278,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17538,50597,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined
CHEMBL621999,1,,1,,,,A,10279,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1466,50597,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat
CHEMBL622000,1,,1,,,,A,10280,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2879,50597,,Oral bioavailability in rat
CHEMBL622001,1,,1,,,,A,10281,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2879,50597,,Bioavailability was measured in rat after oral administration; 2-4
CHEMBL622002,1,,1,,,,A,10282,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2879,50597,,Bioavailability was measured in rat after oral administration; 3-7
CHEMBL622003,1,,1,,,,A,10283,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3777,50597,,Bioavailability in rat (intraduodenal administration)
CHEMBL877601,1,,1,,,,A,10284,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3777,50597,,Bioavailability in rat (intraduodenal administration)
CHEMBL624871,1,,1,,,,A,10285,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3777,50597,,Oral bioavailability in rat
CHEMBL622004,1,,1,,,,A,10286,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3777,50597,,Oral bioavailability in rat
CHEMBL882954,1,,1,,,,A,10287,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5423,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.)
CHEMBL622005,1,,1,,,,A,10288,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally
CHEMBL622006,1,,1,,,,A,10289,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16365,50597,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat
CHEMBL622007,1,,1,,,,A,10290,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4239,50597,,Bioavailability was measured in rat
CHEMBL622008,1,,1,,,,A,10291,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5438,50597,,Bioavailability was reported
CHEMBL622009,1,,1,,,,A,10292,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.)
CHEMBL622010,1,,1,,,,A,10293,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg)
CHEMBL622011,1,,1,,,,A,10294,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4199,50597,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats
CHEMBL622012,1,,1,,,,A,10295,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4199,50597,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.)
CHEMBL622013,1,,1,,,,A,10296,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4199,50597,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose )
CHEMBL622014,1,,1,,,,A,10297,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4890,50597,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats
CHEMBL624749,1,,1,,,,A,10298,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2792,50597,,Bioavailability was determined at 3 mg/kg po dose in rats
CHEMBL624750,1,,1,,,,A,10299,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5529,50597,,Oral bioavailability in rat (dose 2 mg/kg)
CHEMBL624751,1,,1,,,,A,10300,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose"
CHEMBL624752,1,,1,,,,A,10301,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable"
CHEMBL624753,1,,1,,,,A,10302,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6685,50597,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable"
CHEMBL624754,1,,1,,,,A,10303,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6005,50597,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg
CHEMBL624755,1,,1,,,,A,10304,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6410,50597,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable
CHEMBL624756,1,,1,,,,A,10305,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6410,50597,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg
CHEMBL624757,1,,1,,,,A,10306,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6103,50597,,Bioavailability in rat
CHEMBL624758,1,,1,,,,A,10307,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6410,50597,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable
CHEMBL622270,1,,1,,,,A,10308,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6410,50597,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg
CHEMBL622271,1,,1,,,,A,10309,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5353,50597,,Bioavailability in rat (Sprague-Dawley)
CHEMBL622272,1,,1,,,,A,10310,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4727,50597,,Bioavailability in rat at the dose of 2 mg/kg
CHEMBL622273,1,,1,,,,A,10311,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17804,50597,,Oral bioavailability in rat
CHEMBL622274,1,,1,,,,A,10312,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5809,50597,,Bioavailability in rat (cannulated) (dose 2 mg/kg)
CHEMBL622275,1,,1,,,,A,10313,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17804,50597,,Bioavailability value of compound in rats was determined after peroral administration
CHEMBL622276,1,,1,,,,A,10314,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3634,50597,,Oral bioavailability in rat (dose 20 mg/kg)
CHEMBL622277,1,,1,,,,A,10315,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3341,50597,,Oral bioavailability in rat
CHEMBL622278,1,,1,,,,A,10316,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2690,50597,,Oral bioavailability in rat (dose 5 mg/kg)
CHEMBL622279,1,,1,,,,A,10317,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3184,50597,,Oral bioavailability in rat
CHEMBL622280,1,,1,,,,A,10318,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,740,50597,,Oral bioavailability in rat
CHEMBL624083,1,,1,,,,A,10319,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1806,50597,,Compound was evaluated for oral bioavailability in rats; 15-27 %
CHEMBL624084,1,,1,,,,A,10320,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4891,50597,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h
CHEMBL624085,1,,1,,,,A,10321,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3634,50597,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F)
CHEMBL624086,1,,1,,,,A,10322,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,64,50597,,Compound was tested for bioavailability in rats
CHEMBL624087,1,,1,,,,A,10323,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4839,50597,,Bioavailability in rat
CHEMBL624088,1,,1,,,,A,10324,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1094,50597,,Oral bioavailability in rat
CHEMBL624089,0,,1,,,,A,10325,Intermediate,BAO_0000218,,U,Macaca mulatta,,9544.0,,In vivo,,5005,22224,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.
CHEMBL624090,0,,1,,,,A,10326,Intermediate,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,5005,22224,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.)
CHEMBL624091,1,,1,,,,A,10327,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4687,50597,,Evaluated for the bioavailability in rat (in vivo)
CHEMBL624092,1,,1,,,,A,10328,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17804,50597,,F value of compound in rats was determined after peroral administration
CHEMBL624093,1,,1,,,,A,10329,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat
CHEMBL624094,1,,1,,,,A,10330,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat
CHEMBL624095,1,,1,,,,A,10331,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat
CHEMBL624096,1,,1,,,,A,10332,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5974,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat
CHEMBL624097,1,,1,,,,A,10333,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1088,50597,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)"
CHEMBL624098,1,,1,,,,A,10334,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1742,50597,,Maximum fall in carotid flow in rat
CHEMBL874392,1,,1,,,,A,10335,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4689,50597,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat
CHEMBL624099,1,,1,,,,A,10336,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2463,50597,,Oral bioavailability in rat (dose 5 mg/kg)
CHEMBL624100,1,,1,,,,A,10337,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5654,50597,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration
CHEMBL624101,1,,1,,,,A,10338,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5654,50597,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration
CHEMBL624102,1,,1,,,,A,10339,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6874,50597,,Oral bioavailability in rat (male Wistar)
CHEMBL624103,1,,1,,,,A,10340,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5633,50597,,Oral bioavailability after administration (30 mg/kg) in rat; good
CHEMBL624104,1,,1,,,,A,10341,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5496,50597,,Oral bioavailability at the dose of 2 mg/kg in rat
CHEMBL624105,1,,1,,,,A,10342,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2358,50597,,Oral bioavailability determined in rats
CHEMBL624106,1,,1,,,,A,10343,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16456,50597,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.)
CHEMBL624107,1,,1,,,,A,10344,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5302,50597,,Oral bioavailability in rat (dose single 10 mg/kg)
CHEMBL623943,1,,1,,,,A,10345,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5302,50597,,Oral bioavailability in rat (dose single 10 mg/kg)
CHEMBL623944,1,,1,,,,A,10346,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5302,50597,,Oral bioavailability in rat (dose 5 mg/kg
CHEMBL623945,1,,1,,,,A,10347,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection
CHEMBL623946,1,,1,,,,A,10348,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE
CHEMBL623947,1,,1,,,,A,10349,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA
CHEMBL623948,1,,1,,,,A,10350,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT
CHEMBL623949,1,,1,,,,A,10351,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA
CHEMBL623950,1,,1,,,,A,10352,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC
CHEMBL874398,1,,1,,,,A,10353,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA
CHEMBL623951,1,,1,,,,A,10354,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE
CHEMBL623952,1,,1,,,,A,10355,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA
CHEMBL623953,1,,1,,,,A,10356,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT
CHEMBL623954,1,,1,,,,A,10357,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection
CHEMBL623955,1,,1,,,,A,10358,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection
CHEMBL623956,1,,1,,,,A,10359,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection
CHEMBL627807,1,,1,,,,A,10360,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection
CHEMBL627808,1,,1,,,,A,10361,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection
CHEMBL627809,1,,1,,,,A,10362,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection
CHEMBL627810,1,,1,,,,A,10363,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE
CHEMBL627811,1,,1,,,,A,10364,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA"
CHEMBL627812,1,,1,,,,A,10365,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT"
CHEMBL627813,1,,1,,,,A,10366,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA"
CHEMBL627814,1,,1,,,,A,10367,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC"
CHEMBL875336,1,,1,,,,A,10368,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA"
CHEMBL627815,1,,1,,,,A,10369,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE"
CHEMBL627816,1,,1,,,,A,10370,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA"
CHEMBL627817,1,,1,,,,A,10371,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT"
CHEMBL627818,1,,1,,,,A,10372,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection"
CHEMBL627819,1,,1,,,,A,10373,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection"
CHEMBL627820,1,,1,,,,A,10374,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection"
CHEMBL627821,1,,1,,,,A,10375,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE"
CHEMBL628464,1,,1,,,,A,10376,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA
CHEMBL626239,1,,1,,,,A,10377,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT
CHEMBL626240,1,,1,,,,A,10378,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA
CHEMBL626241,1,,1,,,,A,10379,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC
CHEMBL626242,1,,1,,,,A,10380,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA
CHEMBL626243,1,,1,,,,A,10381,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE
CHEMBL626244,1,,1,,,,A,10382,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA
CHEMBL626907,1,,1,,,,A,10383,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection
CHEMBL626908,1,,1,,,,A,10384,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection
CHEMBL626909,1,,1,,,,A,10385,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection
CHEMBL626910,1,,1,,,,A,10386,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection
CHEMBL875342,1,,1,,,,F,10387,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of acetaminophen cysteine conjugate
CHEMBL626911,1,,1,,,,F,10388,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of acetaminophen glucuronide
CHEMBL626912,1,,1,,,,F,10389,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of acetaminophen sulfate
CHEMBL627065,1,,1,,,,F,10390,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7449,50597,,Percent total excretion of acetaminophen-mercapturic acid
CHEMBL627066,1,,1,,,,A,10391,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,3172,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally
CHEMBL627067,1,,1,,,,A,10392,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16456,50597,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg
CHEMBL627068,0,,1,,,,A,10393,Autocuration,BAO_0000218,2385.0,U,ratrat,Muscle tissue,8656.0,,In vivo,,10839,22224,,Biodistribution of compound in rat muscle after 5 min of administration
CHEMBL627069,0,,1,,,,A,10394,Autocuration,BAO_0000218,2385.0,U,ratrat,Muscle tissue,8656.0,,In vivo,,10839,22224,,Biodistribution of compound in rat muscle after 5 min of administration.
CHEMBL627070,0,,1,,,,A,10395,Autocuration,BAO_0000218,,U,Ovis aries,,9940.0,,In vivo,,5334,22224,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female)
CHEMBL627071,0,,1,,,,A,10396,Autocuration,BAO_0000218,,U,Ovis aries,,9940.0,,In vivo,,5334,22224,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female)
CHEMBL627072,0,,1,,,,A,10397,Autocuration,BAO_0000218,,U,Ovis aries,,9940.0,,In vivo,,5334,22224,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female)
CHEMBL627073,0,,1,,,,A,10398,Autocuration,BAO_0000218,,U,Ovis aries,,9940.0,,In vivo,,5334,22224,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female)
CHEMBL625387,0,,1,,,,A,10399,Autocuration,BAO_0000218,,U,Ovis aries,,9940.0,,In vivo,,5334,22224,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female)
CHEMBL625388,0,,1,,,,A,10400,Autocuration,BAO_0000218,,U,Ovis aries,,9940.0,,In vivo,,5334,22224,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female)
CHEMBL625389,0,,1,,,,A,10401,Autocuration,BAO_0000218,1969.0,U,Ovis aries,Plasma,9940.0,,In vivo,,5334,22224,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female)
CHEMBL875343,0,,1,,,,A,10402,Autocuration,BAO_0000218,1969.0,U,Ovis aries,Plasma,9940.0,,In vivo,,5334,22224,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female)
CHEMBL876795,1,,1,,,,A,10403,Intermediate,BAO_0000218,,N,Serpentes,,8570.0,,,,1735,50497,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE)
CHEMBL626552,1,,1,,,,A,10404,Intermediate,BAO_0000218,,N,Serpentes,,8570.0,,,,1469,50497,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg
CHEMBL626553,1,,1,,,,A,10405,Intermediate,BAO_0000218,,N,Serpentes,,8570.0,,,,1336,50497,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase
CHEMBL626554,0,,1,,,,A,10406,Autocuration,BAO_0000366,1969.0,U,Homo sapiens,Plasma,9606.0,,,,12403,22224,,The human biological plasma half life of the compound
CHEMBL626555,1,,1,,,,A,10407,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8151,50597,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg
CHEMBL626556,1,,1,,,,A,10408,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound
CHEMBL626557,1,,1,,,,A,10409,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound
CHEMBL626558,1,,1,,,,A,10410,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound
CHEMBL626559,1,,1,,,,A,10411,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound
CHEMBL626560,1,,1,,,,A,10412,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound
CHEMBL876803,1,,1,,,,A,10413,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound
CHEMBL627964,1,,1,,,,A,10414,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound
CHEMBL627965,1,,1,,,,A,10415,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound
CHEMBL627966,1,,1,,,,A,10416,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound
CHEMBL627967,1,,1,,,,A,10417,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound
CHEMBL627968,1,,1,,,,A,10418,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound
CHEMBL627969,1,,1,,,,A,10419,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound
CHEMBL627970,1,,1,,,,A,10420,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8004,50597,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound
CHEMBL627971,1,,1,,,,A,10421,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8004,50597,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound
CHEMBL627972,1,,1,,,,A,10422,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8004,50597,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound
CHEMBL856029,9,,1,,,,B,10423,Expert,BAO_0000357,,D,Homo sapiens,,9606.0,,,,15917,180,,Dissociation constant against binding to human cyclophilin A
CHEMBL627973,8,,1,,,,B,10424,Expert,BAO_0000019,,H,Bos taurus,,9913.0,,,,12396,11591,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II
CHEMBL627974,0,,1,,,,A,10425,Autocuration,BAO_0000019,,U,,,,,,,7065,22224,,-Log C was determined by performing the electroshock minimum test
CHEMBL627975,0,,1,,,,A,10426,Autocuration,BAO_0000019,,U,,,,,,,7065,22224,,-Log C was determined by performing the foot shock test
CHEMBL627976,0,,1,,,,A,10427,Autocuration,BAO_0000019,,U,,,,,,,7065,22224,,-Log C was determined by performing the incl screen test
CHEMBL627977,0,,1,,,,A,10428,Autocuration,BAO_0000019,,U,,,,,,,7065,22224,,-Log C was determined by performing the maximum electroshock test
CHEMBL627978,0,,1,,,,A,10429,Autocuration,BAO_0000019,,U,,,,,,,7065,22224,,-Log C was determined by performing the pentylenetetrazole test
CHEMBL627979,0,,1,,,,A,10430,Autocuration,BAO_0000019,,U,,,,,,,12415,22224,,Tested for experimental arotinoid inhibitory dose
CHEMBL876804,0,,1,,,,A,10431,Autocuration,BAO_0000019,,U,,,,,,,10256,22224,,Negative log transformed activity
CHEMBL627980,0,,1,,,,A,10432,Autocuration,BAO_0000019,,U,,,,,,,7991,22224,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)"
CHEMBL627981,1,,1,,,,A,10433,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,,,14342,50512,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor
CHEMBL627982,1,,1,,,,A,10434,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,,,14342,50512,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor
CHEMBL627983,1,,1,,,,A,10435,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,,,14342,50512,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor
CHEMBL627984,1,,1,,,,A,10436,Intermediate,BAO_0000218,2116.0,N,Cavia porcellus,Ileum,10141.0,,,,14342,50512,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor
CHEMBL627985,0,,1,,,,P,10437,Autocuration,BAO_0000100,,U,,,,,,,6047,22229,,Solubility in water was determined; values expressed as -log
CHEMBL627986,0,,1,,,,A,10438,Autocuration,BAO_0000019,,U,,,,,,,17269,22224,,Ratio of Kcat to that of Km was determined
CHEMBL627987,0,,1,,,,A,10439,Autocuration,BAO_0000019,,U,,,,,,,10026,22224,,Observed first order rate constant
CHEMBL627988,0,,1,,,,A,10440,Autocuration,BAO_0000019,,U,,,,,,,14583,22224,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours
CHEMBL627989,1,,1,,,,A,10441,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats
CHEMBL627990,1,,1,,,,A,10442,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2661,50597,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats
CHEMBL876805,1,,1,,,,A,10443,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4029,50597,,Oral Bioavailability after administration of 10 mg/kg in male rat
CHEMBL627991,1,,1,,,,A,10444,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17735,50597,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.)
CHEMBL627992,1,,1,,,,A,10445,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4576,50597,,Oral bioavailability in rat
CHEMBL627993,1,,1,,,,A,10446,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17582,50597,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats
CHEMBL622817,1,,1,,,,A,10447,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17651,50597,,Oral bioavailability at 1 mg/kg was determined in rat
CHEMBL622818,1,,1,,,,A,10448,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17651,50597,,Oral bioavailability at 10 mg/kg was determined in rat
CHEMBL622819,1,,1,,,,A,10449,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17670,50597,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally"
CHEMBL872267,1,,1,,,,A,10450,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5045,50597,,Oral bioavailability in rat
CHEMBL622820,1,,1,,,,A,10451,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1696,50597,,Oral bioavailability in rat
CHEMBL622821,1,,1,,,,A,10452,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17764,50597,,Oral bioavailability after intravenous administration in rats at 24 uM/kg
CHEMBL622822,1,,1,,,,A,10453,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6448,50597,,Oral bioavailability in rat
CHEMBL622823,1,,1,,,,A,10454,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6596,50597,,Oral bioavailability in rat
CHEMBL622824,1,,1,,,,A,10455,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17547,50597,,Oral bioavailability in rat
CHEMBL622825,1,,1,,,,A,10456,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17771,50597,,Oral bioavailability in rat at a dose of 3 mg/kg
CHEMBL622901,1,,1,,,,A,10457,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6495,50597,,Oral bioavailability in rat after oral administration at 10 mg/kg
CHEMBL622902,1,,1,,,,A,10458,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4558,50597,,Oral bioavailability in rat
CHEMBL621844,1,,1,,,,A,10459,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17596,50597,,Oral bioavailability in rat
CHEMBL621845,1,,1,,,,A,10460,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6827,50597,,Oral bioavailability in Dawley rats
CHEMBL621846,1,,1,,,,A,10461,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4026,50597,,Oral bioavailability
CHEMBL621847,1,,1,,,,A,10462,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,10,50597,,Oral bioavailability in rat (dose 30 mg/kg)
CHEMBL877609,1,,1,,,,A,10463,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11
CHEMBL621848,1,,1,,,,A,10464,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Bioavailability in rat (dose 3 mg/kg i.v.)
CHEMBL621849,1,,1,,,,A,10465,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11
CHEMBL622030,1,,1,,,,A,10466,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Oral bioavailability in rat (dose 60 mg/kg p.o.)
CHEMBL622031,1,,1,,,,A,10467,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4796,50597,,Percent oral bioavailability determined in rats
CHEMBL622032,1,,1,,,,A,10468,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4883,50597,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg
CHEMBL622033,1,,1,,,,A,10469,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2137,50597,,The compound was evaluated for bioavailability in rats; 32-51
CHEMBL622034,1,,1,,,,A,10470,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2959,50597,,Bioavailability in rat (dose 20 mg/kg p.o.)
CHEMBL622035,1,,1,,,,A,10471,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1361,50597,,Oral bioavailability in rat
CHEMBL882966,1,,1,,,,A,10472,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4727,50597,,Bioavailability percent in rat at the dose of 2 mg/kg
CHEMBL622036,1,,1,,,,A,10473,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16423,50597,,Bioavailability was evaluated after 20 uM/kg of peroral administration
CHEMBL622037,1,,1,,,,A,10474,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5206,50597,,Oral bioavailability in rat
CHEMBL622038,1,,1,,,,A,10475,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6448,50597,,Oral bioavailability in rat
CHEMBL622039,1,,1,,,,A,10476,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17723,50597,,Bioavailability in rats
CHEMBL622040,1,,1,,,,A,10477,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ
CHEMBL622041,1,,1,,,,A,10478,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ
CHEMBL622042,1,,1,,,,A,10479,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ
CHEMBL622043,1,,1,,,,A,10480,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ
CHEMBL622044,1,,1,,,,A,10481,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ
CHEMBL622045,1,,1,,,,A,10482,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ
CHEMBL622046,1,,1,,,,A,10483,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ
CHEMBL622047,1,,1,,,,A,10484,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ
CHEMBL877610,1,,1,,,,A,10485,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ
CHEMBL622048,1,,1,,,,A,10486,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ
CHEMBL622049,1,,1,,,,A,10487,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ
CHEMBL622050,1,,1,,,,A,10488,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ
CHEMBL622051,1,,1,,,,A,10489,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ
CHEMBL622052,1,,1,,,,A,10490,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ
CHEMBL622053,1,,1,,,,A,10491,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ
CHEMBL622054,1,,1,,,,A,10492,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ
CHEMBL622055,1,,1,,,,A,10493,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ
CHEMBL622056,1,,1,,,,A,10494,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5237,50597,,Oral bioavailability in rats was determined; High
CHEMBL622057,1,,1,,,,A,10495,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5503,50597,,Oral bioavailability in the rat was determined
CHEMBL628008,1,,1,,,,A,10496,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15765,50597,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.
CHEMBL622058,1,,1,,,,A,10497,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15660,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.)
CHEMBL622059,1,,1,,,,A,10498,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL622060,1,,1,,,,A,10499,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL622061,1,,1,,,,A,10500,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL622062,1,,1,,,,A,10501,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5978,50597,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat
CHEMBL622063,1,,1,,,,A,10502,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5656,50597,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat
CHEMBL877611,1,,1,,,,A,10503,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3598,50597,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg
CHEMBL622064,1,,1,,,,A,10504,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4216,50597,,Oral bioavailability of compound in Sprague Dawley rats
CHEMBL622065,1,,1,,,,A,10505,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17839,50597,,Oral bioavailability of compound in rat
CHEMBL622066,1,,1,,,,A,10506,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6570,50597,,Oral bioavailability in rat (dose 2 mg/kg)
CHEMBL622067,1,,1,,,,A,10507,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5334,50597,,Oral bioavailability of compound in rat was determined
CHEMBL622068,1,,1,,,,A,10508,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6886,50597,,Oral bioavailability of compound in rats
CHEMBL622069,1,,1,,,,A,10509,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5210,50597,,Oral bioavailability of compound was determined in rats
CHEMBL624796,1,,1,,,,A,10510,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4170,50597,,Oral bioavailability at a dose of 30 mg/kg in rats
CHEMBL624797,1,,1,,,,A,10511,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6028,50597,,Oral bioavailability in rat (dose 10 mg/kg)
CHEMBL623053,1,,1,,,,A,10512,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6028,50597,,Oral bioavailability in rat (dose 10 mg/kg)
CHEMBL623054,1,,1,,,,A,10513,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6078,50597,,Oral bioavailability evaluated in rat
CHEMBL623055,1,,1,,,,A,10514,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6168,50597,,Oral bioavailability in fasted rat
CHEMBL623056,1,,1,,,,A,10515,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6168,50597,,Oral bioavailability in fed rat
CHEMBL623057,1,,1,,,,A,10516,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5160,50597,,Oral bioavailability in rat (mature male) (dose 30 mg/kg)
CHEMBL623058,1,,1,,,,A,10517,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6057,50597,,Oral bioavailability in rat
CHEMBL623059,1,,1,,,,A,10518,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6535,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o.)
CHEMBL623060,1,,1,,,,A,10519,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6535,50597,,Oral bioavailability in rat after administration of 10 mg/kg po
CHEMBL623061,1,,1,,,,A,10520,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4194,50597,,Oral bioavailability in rat
CHEMBL623062,1,,1,,,,A,10521,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6230,50597,,Oral bioavailability in rat
CHEMBL623063,1,,1,,,,A,10522,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6619,50597,,Oral bioavailability in rat
CHEMBL623064,1,,1,,,,A,10523,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17607,50597,,Oral bioavailability in rat
CHEMBL623065,1,,1,,,,A,10524,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4942,50597,,Oral bioavailability in ratrs
CHEMBL623066,1,,1,,,,A,10525,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4942,50597,,Oral bioavailability in rat
CHEMBL623067,1,,1,,,,A,10526,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6646,50597,,Oral bioavailability in rat
CHEMBL623068,1,,1,,,,A,10527,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5237,50597,,Oral bioavailability in rats was determined; High
CHEMBL623069,1,,1,,,,A,10528,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6646,50597,,Oral bioavailability in rat
CHEMBL623070,1,,1,,,,A,10529,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4449,50597,,Oral bioavailability in rat
CHEMBL623071,1,,1,,,,A,10530,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6057,50597,,Oral bioavailability was calculated in rat
CHEMBL623072,1,,1,,,,A,10531,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2552,50597,,Oral bioavailability
CHEMBL623073,1,,1,,,,A,10532,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5496,50597,,Oral bioavailability
CHEMBL623074,1,,1,,,,A,10533,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6484,50597,,Oral bioavailability
CHEMBL623075,1,,1,,,,A,10534,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6485,50597,,Oral bioavailability
CHEMBL623076,1,,1,,,,A,10535,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6616,50597,,Oral bioavailability after i.v. administration
CHEMBL623077,1,,1,,,,A,10536,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4969,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.)
CHEMBL623078,1,,1,,,,A,10537,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5862,50597,,Oral bioavailability in rat (Sprague-Dawley)
CHEMBL623079,1,,1,,,,A,10538,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4514,50597,,Oral bioavailability in Sprague-Dawley rats
CHEMBL623080,1,,1,,,,A,10539,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4514,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.)
CHEMBL623081,1,,1,,,,A,10540,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4514,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg)
CHEMBL623082,1,,1,,,,A,10541,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5546,50597,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration
CHEMBL874400,1,,1,,,,A,10542,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6168,50597,,Oral bioavailability in fasted rat
CHEMBL623083,1,,1,,,,A,10543,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6168,50597,,Oral bioavailability in fed rat
CHEMBL623084,1,,1,,,,A,10544,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3624,50597,,Oral bioavailability in rat
CHEMBL623085,1,,1,,,,A,10545,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5213,50597,,Oral bioavailability in rat
CHEMBL623086,1,,1,,,,A,10546,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5496,50597,,Oral bioavailability in rat
CHEMBL623087,1,,1,,,,A,10547,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5553,50597,,Oral bioavailability in rat
CHEMBL623088,1,,1,,,,A,10548,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5833,50597,,Oral bioavailability in rat
CHEMBL623089,1,,1,,,,A,10549,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5836,50597,,Oral bioavailability in rat
CHEMBL623090,1,,1,,,,A,10550,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5865,50597,,Oral bioavailability in rat
CHEMBL623091,1,,1,,,,A,10551,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5960,50597,,Oral bioavailability in rat
CHEMBL623092,1,,1,,,,A,10552,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6249,50597,,Oral bioavailability in rat
CHEMBL623093,1,,1,,,,A,10553,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6448,50597,,Oral bioavailability in rat
CHEMBL874401,1,,1,,,,A,10554,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6453,50597,,Oral bioavailability in rat
CHEMBL623094,1,,1,,,,A,10555,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6640,50597,,Oral bioavailability in rat
CHEMBL623095,1,,1,,,,A,10556,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17607,50597,,Oral bioavailability in rat
CHEMBL623096,1,,1,,,,A,10557,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5939,50597,,Oral bioavailability in rat after peroral administration at 10 mg/kg
CHEMBL624913,1,,1,,,,A,10558,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5939,50597,,Oral bioavailability in rat after peroral administration at 5 mg/kg
CHEMBL624914,1,,1,,,,A,10559,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6281,50597,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.)
CHEMBL624915,1,,1,,,,A,10560,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5874,50597,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg
CHEMBL624916,1,,1,,,,A,10561,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5213,50597,,Oral bioavailability in rat; Not measured
CHEMBL624917,1,,1,,,,A,10562,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4964,50597,,Oral bioavailability in rat
CHEMBL625157,1,,1,,,,A,10563,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11020,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE
CHEMBL625158,1,,1,,,,A,10564,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,6251,50597,,In vitro metabolic potential in rat liver microsomes
CHEMBL625159,1,,1,,,,A,10565,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1568,50597,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats."
CHEMBL625160,1,,1,,,,A,10566,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3032,50597,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)"
CHEMBL625161,1,,1,,,,A,10567,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3748,50597,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats
CHEMBL625162,1,,1,,,,A,10568,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,401,50597,,Oral bioavailability in rat
CHEMBL625163,1,,1,,,,A,10569,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6512,50597,,Oral bioavailability in rat
CHEMBL625164,1,,1,,,,A,10570,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17617,50597,,Oral bioavailability in rats at 10 mg/kg
CHEMBL625165,1,,1,,,,A,10571,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6679,50597,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration
CHEMBL625166,1,,1,,,,A,10572,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6742,50597,,Oral bioavailability in rat
CHEMBL625167,1,,1,,,,A,10573,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,589,50597,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis
CHEMBL625168,1,,1,,,,A,10574,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,589,50597,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration
CHEMBL625169,1,,1,,,,A,10575,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3185,50597,,Plasma clearance of the compound
CHEMBL626264,1,,1,,,,A,10576,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17596,50597,,Plasma clearance at 10 mg/kg in rat upon intravenous administration
CHEMBL626265,1,,1,,,,A,10577,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2713,50597,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats
CHEMBL626266,1,,1,,,,A,10578,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12500,50597,,The compound was tested for plasma clearance in rat
CHEMBL626267,1,,1,,,,A,10579,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12500,50597,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg
CHEMBL626268,1,,1,,,,A,10580,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2713,50597,,Plasma concentration upon oral administration of 1 mg/Kg in rats
CHEMBL626269,1,,1,,,,A,10581,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,1446,50597,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551
CHEMBL626270,1,,1,,,,A,10582,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6227,50597,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis
CHEMBL626271,1,,1,,,,A,10583,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4709,50597,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat
CHEMBL626272,1,,1,,,,A,10584,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1"
CHEMBL626273,1,,1,,,,A,10585,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined"
CHEMBL875346,1,,1,,,,A,10586,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined"
CHEMBL626274,1,,1,,,,A,10587,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5510,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable"
CHEMBL626275,1,,1,,,,A,10588,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4514,50597,,Compound was tested for protein binding in rat plasma
CHEMBL624646,1,,1,,,,A,10589,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2713,50597,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. 
CHEMBL624647,1,,1,,,,A,10590,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2713,50597,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats
CHEMBL624648,1,,1,,,,A,10591,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,5340,50597,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate
CHEMBL624649,1,,1,,,,A,10592,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12058,50597,,Area under curve ratio was determined (po/iv) in rat
CHEMBL624650,1,,1,,,,A,10593,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11195,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration
CHEMBL624651,1,,1,,,,A,10594,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11195,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration
CHEMBL624652,1,,1,,,,A,10595,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11195,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration
CHEMBL624653,1,,1,,,,A,10596,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6495,50597,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg
CHEMBL624654,1,,1,,,,A,10597,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6078,50597,,Ratio of AUCbrain to AUCplasma
CHEMBL624655,1,,1,,,,A,10598,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5656,50597,,Ratio of brain to plasma
CHEMBL624656,1,,1,,,,A,10599,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated
CHEMBL624657,1,,1,,,,A,10600,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated
CHEMBL624658,1,,1,,,,A,10601,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated
CHEMBL624659,1,,1,,,,A,10602,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10130,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio
CHEMBL624660,1,,1,,,,A,10603,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10130,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio
CHEMBL624661,1,,1,,,,A,10604,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10130,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio
CHEMBL624662,1,,1,,,,A,10605,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5213,50597,,Steady state brain :blood ratio was determined
CHEMBL625199,1,,1,,,,A,10606,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats
CHEMBL625200,1,,1,,,,A,10607,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined
CHEMBL625201,1,,1,,,,A,10608,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats
CHEMBL625202,1,,1,,,,A,10609,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,4910,50597,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined
CHEMBL625203,1,,1,,,,A,10610,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2083,50597,,Percentage recovery after 3h incubation with rat hapatocytes was determined
CHEMBL625204,1,,1,,,,A,10611,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2082,50597,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour
CHEMBL625205,1,,1,,,,A,10612,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2082,50597,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour
CHEMBL625206,1,,1,,,,A,10613,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6351,50597,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats
CHEMBL625207,0,,1,,,,A,10614,Autocuration,BAO_0000019,,U,,,,,,,14583,22224,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation."
CHEMBL625208,0,,1,,,,A,10615,Autocuration,BAO_0000019,,U,,,,,,,14583,22224,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.
CHEMBL625209,1,495.0,1,,,,A,10616,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,Caco-2,,,4608,50587,,In vivo absorption in Caco-2 cell line monolayers was determined
CHEMBL625210,0,,1,,,,P,10617,Autocuration,BAO_0000100,,U,,,,,,,13668,22229,,Calculated partition coefficient (clogP)
CHEMBL625211,1,,1,,,,A,10618,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5669,50597,,Area under curve was determine after peroral administration at 10 mpk in Rat
CHEMBL625212,1,,1,,,,A,10619,Intermediate,BAO_0000218,,N,Macaca mulatta,,9544.0,,,,5669,50797,,Area under curve was determine after peroral administration at 10 mpk in Rhesus
CHEMBL625213,1,,1,,,,A,10620,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5669,50597,,Area under curve was determine after peroral administration at 160 mpk in Rat
CHEMBL625214,1,,1,,,,A,10621,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5669,50597,,Area under curve was determine after peroral administration at 20 mpk in Rat
CHEMBL874542,1,,1,,,,A,10622,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,5669,50597,,Area under curve was determine after peroral administration at 50 mpk in Rat
CHEMBL625215,0,,1,,,,P,10623,Autocuration,BAO_0000100,,U,,,,,,,6472,22229,,Calculated partition coefficient (clogP) (AlogP)
CHEMBL625216,0,,1,,,,A,10624,Autocuration,BAO_0000019,,U,,,,,,,15106,22224,,Activated partial thromboplastin time measured
CHEMBL625217,0,,1,,,,P,10625,Autocuration,BAO_0000100,,U,,,,,,,15207,22224,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4)
CHEMBL625218,0,,1,,,,P,10626,Autocuration,BAO_0000100,,U,,,,,,,15207,22224,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL)
CHEMBL622864,1,,1,,,,A,10627,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,13941,50588,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog
CHEMBL622865,1,,1,,,,A,10628,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,13941,50597,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.
CHEMBL622866,1,,1,,,,A,10629,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,13941,50597,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.
CHEMBL622867,1,,1,,,,A,10630,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,13941,50588,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog
CHEMBL876808,1,,1,,,,A,10631,Intermediate,BAO_0000218,1969.0,N,Cavia porcellus,Plasma,10141.0,,,,15240,50512,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.
CHEMBL627725,0,,1,,,,A,10632,Autocuration,BAO_0000019,955.0,U,,Brain,,,,,10655,22224,,AUC in brain
CHEMBL627726,0,,1,,,,A,10633,Autocuration,BAO_0000019,1977.0,U,,Serum,,,,,10655,22224,,AUC in serum
CHEMBL627727,0,,1,,,,A,10634,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,6504,22224,,AUC was determined
CHEMBL627728,0,,1,,,,A,10635,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,10615,22224,,AUC of the compound.
CHEMBL627729,0,,1,,,,A,10636,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,10353,22224,,AUC value (0-4 hr)
CHEMBL627730,0,,1,,,,A,10637,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,14907,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,"
CHEMBL627731,0,,1,,,,A,10638,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,14907,22224,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg
CHEMBL627732,0,,1,,,,A,10639,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,14907,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,"
CHEMBL627733,0,,1,,,,A,10640,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,14907,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,"
CHEMBL627734,1,,1,,,,A,10641,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,16359,50597,,AUC(area under curve) was determined after intravenous administration in rats
CHEMBL627735,1,,1,,,,A,10642,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,16359,50597,,AUC(area under curve) was determined after oral administration in rats
CHEMBL627736,1,,1,,,,A,10643,Intermediate,BAO_0000218,1969.0,N,Cavia porcellus,Plasma,10141.0,,,,15240,50512,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.
CHEMBL876809,1,,1,,,,A,10644,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,15240,50597,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.
CHEMBL627737,0,,1,,,,A,10645,Autocuration,BAO_0000019,,U,,,,,,,15469,22224,,Area Under Curve after oral dosing of 100 uM/Kg
CHEMBL627738,0,,1,,,,A,10646,Autocuration,BAO_0000019,,U,,,,,,,15469,22224,,Area Under Curve after oral dosing of 30 uM/Kg
CHEMBL627739,0,,1,,,,A,10647,Autocuration,BAO_0000019,,U,,,,,,,13520,22224,,Area Under Curve was measured by ploting the graph between concentration verses time
CHEMBL626143,1,,1,,,,A,10648,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,17025,50588,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally
CHEMBL626144,0,,1,,,,A,10649,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,17025,22224,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally
CHEMBL626145,1,,1,,,,A,10650,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,17025,50592,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally
CHEMBL626146,1,,1,,,,A,10651,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17025,50597,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally
CHEMBL626147,1,,1,,,,A,10652,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,12032,50597,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time
CHEMBL626148,0,,1,,,,A,10653,Autocuration,BAO_0000019,,U,,,,,,,10291,22224,,Area under curve (AUC) was determined
CHEMBL626149,0,,1,,,,A,10654,Autocuration,BAO_0000218,,U,,,,,,,5767,22224,,Area under curve (AUC) following ip administration at 1 mg/kg
CHEMBL626150,0,,1,,,,A,10655,Autocuration,BAO_0000019,,U,,,,,,,1434,22224,,Area under curve (AUC) was determined; ND is Not determined
CHEMBL626151,1,,1,,,,A,10656,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14925,50588,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound
CHEMBL626152,1,,1,,,,A,10657,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14925,50588,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound
CHEMBL626153,1,,1,,,,A,10658,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14925,50588,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound
CHEMBL626154,0,,1,,,,A,10659,Autocuration,BAO_0000019,,U,,,,,,,1434,22224,,Area under curve (AUR) was determined
CHEMBL626155,0,,1,,,,A,10660,Autocuration,BAO_0000019,,U,,,,,,,11883,22224,,Area under curve at 1 uM/dg administered intravenously
CHEMBL626156,0,,1,,,,A,10661,Autocuration,BAO_0000019,,U,,,,,,,11883,22224,,Area under curve at 10 uM/dg administered perorally
CHEMBL626157,0,,1,,,,A,10662,Autocuration,BAO_0000019,,U,,,,,,,11883,22224,,Area under curve at 2 uM/dg administered intravenously
CHEMBL626158,0,,1,,,,A,10663,Autocuration,BAO_0000019,,U,,,,,,,11883,22224,,Area under curve at 20 uM/dg administered perorally
CHEMBL626159,1,,1,,,,A,10664,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,15233,50588,,Area under curve at a peroral dose of 3 mg/kg in dog
CHEMBL626160,1,,1,,,,A,10665,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15233,50597,,Area under curve at a peroral dose of 3 mg/kg in rat
CHEMBL626161,1,,1,,,,A,10666,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,15233,50588,,Area under curve at an iv dose of 1 mg/kg in dog
CHEMBL626162,1,,1,,,,A,10667,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15233,50597,,Area under curve at an iv dose of 1 mg/kg in rat
CHEMBL626163,0,,1,,,,A,10668,Autocuration,BAO_0000019,,U,,,,,,,12978,22224,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.
CHEMBL626164,0,,1,,,,A,10669,Autocuration,BAO_0000019,,U,,,,,,,12978,22224,,Area under curve gives the effective duration for the angiotensin II antagonist effect.
CHEMBL626165,1,,1,,,,A,10670,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,11355,50594,,Area under curve measured as conc vs time after intravenous administration to mice.
CHEMBL626166,1,,1,,,,A,10671,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,11355,50594,,Area under curve measured as conc vs time after peroral administration to mice.
CHEMBL626167,1,,1,,,,A,10672,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12923,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog
CHEMBL626168,1,,1,,,,A,10673,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12923,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog
CHEMBL877463,1,,1,,,,A,10674,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12923,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog
CHEMBL626169,1,,1,,,,A,10675,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12923,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog
CHEMBL626170,1,,1,,,,A,10676,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ
CHEMBL626171,1,,1,,,,A,10677,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ
CHEMBL626172,1,,1,,,,A,10678,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ
CHEMBL626173,1,,1,,,,A,10679,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ
CHEMBL626174,1,,1,,,,A,10680,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ
CHEMBL626175,1,,1,,,,A,10681,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ
CHEMBL626176,1,,1,,,,A,10682,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ
CHEMBL626177,1,,1,,,,A,10683,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ
CHEMBL622499,1,,1,,,,A,10684,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ
CHEMBL622500,1,,1,,,,A,10685,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ
CHEMBL622501,1,,1,,,,A,10686,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ
CHEMBL622502,1,,1,,,,A,10687,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ
CHEMBL622503,1,,1,,,,A,10688,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ
CHEMBL877614,1,,1,,,,A,10689,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ
CHEMBL624839,1,,1,,,,A,10690,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ
CHEMBL624840,1,,1,,,,A,10691,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ
CHEMBL624841,1,,1,,,,A,10692,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ
CHEMBL624842,1,,1,,,,A,10693,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ
CHEMBL624843,1,,1,,,,A,10694,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ
CHEMBL624844,1,,1,,,,A,10695,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ
CHEMBL624845,1,,1,,,,A,10696,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ
CHEMBL621904,1,,1,,,,A,10697,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,17738,50597,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ
CHEMBL621905,1,,1,,,,A,10698,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration
CHEMBL874382,1,,1,,,,A,10699,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration
CHEMBL621906,1,,1,,,,A,10700,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration
CHEMBL621907,1,,1,,,,A,10701,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration
CHEMBL622096,1,,1,,,,A,10702,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration
CHEMBL622097,1,,1,,,,A,10703,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration
CHEMBL622098,1,,1,,,,A,10704,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration
CHEMBL622099,1,,1,,,,A,10705,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration
CHEMBL622100,1,,1,,,,A,10706,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration
CHEMBL622101,1,,1,,,,A,10707,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration
CHEMBL622102,1,,1,,,,A,10708,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration
CHEMBL622103,1,,1,,,,A,10709,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration
CHEMBL622104,1,,1,,,,A,10710,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration
CHEMBL622105,1,,1,,,,A,10711,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration
CHEMBL622106,1,,1,,,,A,10712,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration
CHEMBL622107,1,,1,,,,A,10713,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration
CHEMBL622108,1,,1,,,,A,10714,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration
CHEMBL622109,1,,1,,,,A,10715,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration
CHEMBL622110,1,,1,,,,A,10716,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration
CHEMBL622111,1,,1,,,,A,10717,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration
CHEMBL874383,1,,1,,,,A,10718,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration
CHEMBL622112,1,,1,,,,A,10719,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration
CHEMBL622113,1,,1,,,,A,10720,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration
CHEMBL622114,1,,1,,,,A,10721,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration
CHEMBL622115,1,,1,,,,A,10722,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration
CHEMBL622116,1,,1,,,,A,10723,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,11195,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration
CHEMBL622117,1,,1,,,,A,10724,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6193,50597,,Oral bioavailability in rat
CHEMBL622118,1,,1,,,,A,10725,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6803,50597,,Oral bioavailability in rat
CHEMBL622119,1,,1,,,,A,10726,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6647,50597,,Oral bioavailability in rats at 6 mg/kg
CHEMBL622120,1,,1,,,,A,10727,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6647,50597,,Oral bioavailability in rat (dose 6 mg/kg)
CHEMBL622121,1,,1,,,,A,10728,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6647,50597,,Oral bioavailability in rats at 6 mg/kg dose; Not tested
CHEMBL622122,1,,1,,,,A,10729,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6640,50597,,Oral bioavailability in rat
CHEMBL622123,1,,1,,,,A,10730,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6641,50597,,Oral bioavailability in rat
CHEMBL622124,1,,1,,,,A,10731,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6641,50597,,Oral bioavailability in rat
CHEMBL622125,1,,1,,,,A,10732,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6642,50597,,Bioavailability in rat
CHEMBL622126,1,,1,,,,A,10733,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5472,50597,,Oral bioavailability
CHEMBL620455,1,,1,,,,A,10734,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6141,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg)
CHEMBL620456,1,,1,,,,A,10735,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4390,50597,,Oral bioavailability in rat
CHEMBL620457,1,,1,,,,A,10736,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5472,50597,,Oral bioavailability in rat
CHEMBL620458,1,,1,,,,A,10737,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5472,50597,,Oral bioavailability was evaluated; Not tested
CHEMBL620459,1,,1,,,,A,10738,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5438,50597,,Oral bioavailability
CHEMBL620460,1,,1,,,,A,10739,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4883,50597,,Oral bioavailability in rat by oral dosing
CHEMBL620461,1,,1,,,,A,10740,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1908,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o.)
CHEMBL620462,1,,1,,,,A,10741,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4853,50597,,Oral bioavailability in rat (Sprague-Dawley)
CHEMBL620463,1,,1,,,,A,10742,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4853,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.)
CHEMBL620464,1,,1,,,,A,10743,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4853,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.)
CHEMBL620465,1,,1,,,,A,10744,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4853,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg)
CHEMBL620466,1,,1,,,,A,10745,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4853,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.)
CHEMBL620467,1,,1,,,,A,10746,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4853,50597,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg
CHEMBL620468,1,,1,,,,A,10747,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4853,50597,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg
CHEMBL620469,1,,1,,,,A,10748,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12873,50597,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form
CHEMBL620470,1,,1,,,,A,10749,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12873,50597,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form
CHEMBL620471,1,,1,,,,A,10750,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3169,50597,,Oral bioavailability in rat
CHEMBL620472,1,,1,,,,A,10751,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6305,50597,,Oral bioavailability in rat
CHEMBL620473,1,,1,,,,A,10752,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4762,50597,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat
CHEMBL620474,1,,1,,,,A,10753,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17847,50597,,Oral bioavailability in rat
CHEMBL620475,1,,1,,,,A,10754,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6211,50597,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg)
CHEMBL620476,1,,1,,,,A,10755,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6011,50597,,Oral bioavailability in rat
CHEMBL620477,1,,1,,,,A,10756,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6317,50597,,Oral bioavailability in rat
CHEMBL620478,1,,1,,,,A,10757,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6644,50597,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose
CHEMBL618768,1,,1,,,,A,10758,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6644,50597,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose
CHEMBL618769,1,,1,,,,A,10759,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6644,50597,,Oral bioavailability in rat after oral administration at 13 mg/kg dose
CHEMBL618770,1,,1,,,,A,10760,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6644,50597,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose
CHEMBL618771,1,,1,,,,A,10761,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6113,50597,,Oral bioavailability (dose 20 mg/kg p.o.)
CHEMBL618772,1,,1,,,,A,10762,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5937,50597,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg
CHEMBL618773,1,,1,,,,A,10763,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5711,50597,,Oral bioavailability in rat at 10 mg/kg of the compound
CHEMBL875842,1,,1,,,,A,10764,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11
CHEMBL618774,1,,1,,,,A,10765,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Bioavailability in rat (dose 3 mg/kg i.v.)
CHEMBL618775,1,,1,,,,A,10766,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11
CHEMBL618776,1,,1,,,,A,10767,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17717,50597,,Oral bioavailability in rat (dose 60 mg/kg p.o.)
CHEMBL618777,1,,1,,,,A,10768,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4722,50597,,Percent bioavailability (F) in rats after iv administration
CHEMBL618778,1,,1,,,,A,10769,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4722,50597,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg
CHEMBL618779,1,,1,,,,A,10770,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4353,50597,,Bioavailability in rat (dose 5 uM/kg p.o.)
CHEMBL618780,1,,1,,,,A,10771,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15662,50597,,Oral bioavailability
CHEMBL618781,1,,1,,,,A,10772,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4756,50597,,Bioavailability in rat (dose 2 mg/kg p.o.)
CHEMBL618782,1,,1,,,,A,10773,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,4756,50597,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats
CHEMBL618783,1,,1,,,,A,10774,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3436,50597,,Oral bioavailability in rat (dose 20 mg/kg)
CHEMBL618784,1,,1,,,,A,10775,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17800,50597,,Oral bioavailability in rat
CHEMBL618785,1,,1,,,,A,10776,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15762,50597,,Percent oral bioavailability evaluated in rat
CHEMBL618786,1,,1,,,,A,10777,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5089,50597,,Oral bioavailability in rat
CHEMBL618787,1,,1,,,,A,10778,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5089,50597,,Percent oral bioavailability in rat; Not determined
CHEMBL618788,1,,1,,,,A,10779,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3185,50597,,Oral bioavailability in rat
CHEMBL618789,1,,1,,,,A,10780,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5145,50597,,Bioavailability in rat
CHEMBL618790,1,,1,,,,A,10781,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3457,50597,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution)
CHEMBL618791,1,,1,,,,A,10782,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3457,50597,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension)
CHEMBL875843,1,,1,,,,A,10783,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5983,50597,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg
CHEMBL618792,1,,1,,,,A,10784,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5739,50597,,Oral bioavailability in rat (dose 20 mg/kg p.o.)
CHEMBL623395,1,,1,,,,A,10785,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,3579,50597,,Cmax at a dose of 30 mg/kg in rat
CHEMBL623396,0,,1,,,,A,10786,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,17788,22224,,Cmax in monkeys at a dose of 1 mg/kg
CHEMBL623397,1,,1,,,,A,10787,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14956,50597,,Cmax in rat
CHEMBL623398,1,,1,,,,A,10788,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17788,50597,,Cmax in rats at a dose of 1 mg/kg
CHEMBL623399,1,,1,,,,A,10789,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,9750,50594,,Cmax was measured in mice after an oral dose of 50 mg/kg.
CHEMBL623400,0,,1,,,,A,10790,Autocuration,BAO_0000218,,U,,,,,In vivo,,12767,22224,,"Cmax value at a dose of 12.7 uM/kg, po"
CHEMBL623401,0,,1,,,,A,10791,Autocuration,BAO_0000218,,U,,,,,In vivo,,12767,22224,,"Cmax value at a dose of 6.3 uM/kg, iv"
CHEMBL623402,0,,1,,,,A,10792,Autocuration,BAO_0000218,,U,,,,,In vivo,,12767,22224,,"Cmax value at a dose of 7.1 uM/kg, iv"
CHEMBL623403,0,,1,,,,A,10793,Autocuration,BAO_0000218,,U,,,,,In vivo,,12703,22224,,Cmax value of compound was determined after 1 hr
CHEMBL623404,0,,1,,,,A,10794,Autocuration,BAO_0000218,,U,,,,,In vivo,,15778,22224,,Cmax value of the compound
CHEMBL625997,1,,1,,,,A,10795,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12818,50597,,Cmax value administered intraintestinal in rats.
CHEMBL625998,1,,1,,,,A,10796,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14964,50597,,Cmax value administered perorally was determined in rat; Not determined
CHEMBL625999,0,,1,,,,A,10797,Autocuration,BAO_0000218,,U,,,,,In vivo,,15808,22224,,Cmax value at the dose of 2.3 mg/kg
CHEMBL626000,0,,1,,,,A,10798,Autocuration,BAO_0000218,,U,,,,,In vivo,,15808,22224,,Cmax value at the dose of 5 mg/kg
CHEMBL626001,0,,1,,,,A,10799,Autocuration,BAO_0000218,,U,,,,,In vivo,,15778,22224,,Cmax value in the period of 8 hr after dosing. 
CHEMBL626002,0,,1,,,,A,10800,Autocuration,BAO_0000218,,U,,,,,In vivo,,3715,22224,,Cmax value at a oral dose of 20 mg/kg; Not tested
CHEMBL626003,0,,1,,,,A,10801,Autocuration,BAO_0000218,,U,,,,,In vivo,,3715,22224,,Cmax value at a oral dose of 20 mg/kg
CHEMBL626004,1,,1,,,,A,10802,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,1446,50597,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500
CHEMBL626005,1,,1,,,,A,10803,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,In vivo,,15240,50512,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.
CHEMBL626006,1,,1,,,,A,10804,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15240,50597,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.
CHEMBL626007,1,,1,,,,A,10805,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14810,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported
CHEMBL626008,1,,1,,,,A,10806,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,14239,50594,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice
CHEMBL626009,1,,1,,,,A,10807,Intermediate,BAO_0000218,2107.0,N,Canis lupus familiaris,Liver,9615.0,,In vivo,,12555,50588,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid
CHEMBL626010,1,,1,,,,A,10808,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,10754,50588,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.
CHEMBL626011,1,,1,,,,A,10809,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,10754,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice
CHEMBL626012,1,,1,,,,A,10810,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,10754,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice
CHEMBL626013,1,,1,,,,A,10811,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,10754,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice
CHEMBL626014,1,,1,,,,A,10812,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,10754,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice
CHEMBL877496,1,,1,,,,A,10813,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,10754,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.
CHEMBL626015,1,,1,,,,F,10814,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14600,50588,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs
CHEMBL626016,1,,1,,,,F,10815,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14600,50588,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs
CHEMBL626017,1,,1,,,,F,10816,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14600,50588,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs
CHEMBL626018,1,,1,,,,A,10817,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,13543,50588,,Bioavailability as maximal plasma concentration in dogs
CHEMBL626692,1,,1,,,,A,10818,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,13543,50588,,Bioavailability as maximal plasma concentration in dogs
CHEMBL626693,1,,1,,,,A,10819,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,13543,50597,,Bioavailability as maximal plasma concentration in rats
CHEMBL626694,0,,1,,,,A,10820,Autocuration,BAO_0000218,1969.0,U,Rattus norvegicus,Plasma,10116.0,,In vivo,,13543,22224,,Bioavailability as maximal plasma concentration in rats
CHEMBL626695,1,,1,,,,A,10821,Intermediate,BAO_0000218,178.0,N,Canis lupus familiaris,Blood,9615.0,,In vivo,,14600,50588,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration
CHEMBL626696,1,,1,,,,A,10822,Intermediate,BAO_0000218,178.0,N,Canis lupus familiaris,Blood,9615.0,,In vivo,,14600,50588,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration
CHEMBL626697,1,,1,,,,A,10823,Intermediate,BAO_0000218,178.0,N,Canis lupus familiaris,Blood,9615.0,,In vivo,,14600,50588,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration
CHEMBL626859,1,,1,,,,A,10824,Intermediate,BAO_0000218,178.0,N,Canis lupus familiaris,Blood,9615.0,,In vivo,,14600,50588,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable
CHEMBL626860,1,,1,,,,A,10825,Intermediate,BAO_0000218,178.0,N,Canis lupus familiaris,Blood,9615.0,,In vivo,,14600,50588,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration
CHEMBL626861,1,,1,,,,A,10826,Intermediate,BAO_0000218,178.0,N,Canis lupus familiaris,Blood,9615.0,,In vivo,,14600,50588,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration
CHEMBL626296,1,,1,,,,A,10827,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14681,50597,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose
CHEMBL626297,0,,1,,,,A,10828,Autocuration,BAO_0000218,,U,,,,,In vivo,,15905,22224,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg
CHEMBL626298,0,,1,,,,A,10829,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,15905,22224,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.
CHEMBL626299,1,,1,,,,A,10830,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,13304,50597,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated"
CHEMBL626300,1,,1,,,,A,10831,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15137,50597,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.
CHEMBL626301,1,,1,,,,A,10832,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15137,50597,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.
CHEMBL626962,1,,1,,,,A,10833,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15137,50597,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.
CHEMBL626963,1,,1,,,,A,10834,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15137,50597,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.
CHEMBL626964,1,,1,,,,A,10835,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15137,50597,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.
CHEMBL626965,1,,1,,,,A,10836,Intermediate,BAO_0000218,1969.0,N,Macaca fascicularis,Plasma,9541.0,,In vivo,,14839,100710,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys
CHEMBL626966,1,,1,,,,A,10837,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,14839,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose
CHEMBL626967,1,,1,,,,A,10838,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,14839,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose
CHEMBL626968,1,,1,,,,A,10839,Intermediate,BAO_0000218,1969.0,N,Macaca fascicularis,Plasma,9541.0,,In vivo,,14839,100710,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys
CHEMBL626969,1,,1,,,,A,10840,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24
CHEMBL627126,1,,1,,,,A,10841,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58
CHEMBL631276,1,,1,,,,A,10842,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28
CHEMBL631277,1,,1,,,,A,10843,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62
CHEMBL631278,1,,1,,,,A,10844,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84
CHEMBL874457,1,,1,,,,A,10845,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03
CHEMBL631279,1,,1,,,,A,10846,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46
CHEMBL631280,1,,1,,,,A,10847,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42
CHEMBL631281,1,,1,,,,A,10848,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82
CHEMBL631968,1,,1,,,,A,10849,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46
CHEMBL631969,1,,1,,,,A,10850,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96
CHEMBL631970,1,,1,,,,A,10851,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29
CHEMBL631971,1,,1,,,,A,10852,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74
CHEMBL631972,1,,1,,,,A,10853,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85
CHEMBL630435,1,,1,,,,A,10854,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86
CHEMBL630436,1,,1,,,,A,10855,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23
CHEMBL630437,1,,1,,,,A,10856,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23
CHEMBL630438,1,,1,,,,A,10857,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29
CHEMBL630439,1,,1,,,,A,10858,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8418,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75
CHEMBL630440,1,,1,,,,A,10859,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82
CHEMBL630441,1,,1,,,,A,10860,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12
CHEMBL630442,1,,1,,,,A,10861,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92
CHEMBL625234,1,,1,,,,A,10862,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04
CHEMBL625235,1,,1,,,,A,10863,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03
CHEMBL625236,1,,1,,,,A,10864,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4
CHEMBL625237,1,,1,,,,A,10865,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83
CHEMBL626125,1,,1,,,,A,10866,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73
CHEMBL626126,1,,1,,,,A,10867,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11
CHEMBL626127,1,,1,,,,A,10868,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43
CHEMBL626128,1,,1,,,,A,10869,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74
CHEMBL626129,1,,1,,,,A,10870,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13
CHEMBL626130,1,,1,,,,A,10871,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64
CHEMBL626131,1,,1,,,,A,10872,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07
CHEMBL626132,1,,1,,,,A,10873,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19
CHEMBL626752,1,,1,,,,A,10874,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48
CHEMBL626753,1,,1,,,,A,10875,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72
CHEMBL626754,1,,1,,,,A,10876,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57
CHEMBL626755,1,,1,,,,A,10877,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8418,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24
CHEMBL626756,1,,1,,,,A,10878,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78
CHEMBL626757,1,,1,,,,A,10879,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92
CHEMBL626758,1,,1,,,,A,10880,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18
CHEMBL626759,1,,1,,,,A,10881,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74
CHEMBL626760,1,,1,,,,A,10882,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81
CHEMBL626394,1,,1,,,,A,10883,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr)
CHEMBL626395,1,,1,,,,A,10884,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration
CHEMBL626396,1,,1,,,,A,10885,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr)
CHEMBL626397,1,,1,,,,A,10886,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr)
CHEMBL626398,1,,1,,,,A,10887,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr )
CHEMBL626399,1,,1,,,,A,10888,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr)
CHEMBL874653,1,,1,,,,A,10889,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration
CHEMBL626400,1,,1,,,,A,10890,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr)
CHEMBL626401,1,,1,,,,A,10891,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr)
CHEMBL626402,1,,1,,,,A,10892,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL626403,1,,1,,,,A,10893,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr )
CHEMBL626404,1,,1,,,,A,10894,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr)
CHEMBL626405,1,,1,,,,A,10895,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration
CHEMBL625529,1,,1,,,,A,10896,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr)
CHEMBL625530,1,,1,,,,A,10897,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr)
CHEMBL625531,1,,1,,,,A,10898,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL625532,1,,1,,,,A,10899,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr )
CHEMBL625533,1,,1,,,,A,10900,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr)
CHEMBL875474,1,,1,,,,A,10901,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration
CHEMBL625534,1,,1,,,,A,10902,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr)
CHEMBL625535,1,,1,,,,A,10903,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr)
CHEMBL625536,1,,1,,,,A,10904,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL625537,1,,1,,,,A,10905,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr )
CHEMBL625538,1,,1,,,,A,10906,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr)
CHEMBL625539,1,,1,,,,A,10907,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration
CHEMBL625540,1,,1,,,,A,10908,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr)
CHEMBL625541,1,,1,,,,A,10909,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr)
CHEMBL625542,1,,1,,,,A,10910,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL625543,1,,1,,,,A,10911,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr )
CHEMBL625544,1,,1,,,,A,10912,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr)
CHEMBL625545,1,,1,,,,A,10913,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration
CHEMBL625546,1,,1,,,,A,10914,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr)
CHEMBL625547,1,,1,,,,A,10915,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration
CHEMBL625548,1,,1,,,,A,10916,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr)
CHEMBL625549,1,,1,,,,A,10917,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr)
CHEMBL625550,1,,1,,,,A,10918,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr)
CHEMBL625551,1,,1,,,,A,10919,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr)
CHEMBL875475,1,,1,,,,A,10920,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr)
CHEMBL625552,1,,1,,,,A,10921,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr)
CHEMBL625553,1,,1,,,,A,10922,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr)
CHEMBL625554,1,,1,,,,A,10923,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr)
CHEMBL625555,1,,1,,,,A,10924,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr )
CHEMBL625556,1,,1,,,,A,10925,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr)
CHEMBL624986,1,,1,,,,A,10926,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration
CHEMBL624987,1,,1,,,,A,10927,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr)
CHEMBL624988,1,,1,,,,A,10928,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr)
CHEMBL624989,1,,1,,,,A,10929,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14
CHEMBL624990,1,,1,,,,A,10930,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4
CHEMBL874391,1,,1,,,,A,10931,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7
CHEMBL624991,1,,1,,,,A,10932,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4
CHEMBL624992,1,,1,,,,A,10933,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0
CHEMBL624993,1,,1,,,,A,10934,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31
CHEMBL624994,1,,1,,,,A,10935,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19
CHEMBL624995,1,,1,,,,A,10936,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6
CHEMBL624996,1,,1,,,,A,10937,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25
CHEMBL624997,1,,1,,,,A,10938,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3
CHEMBL624998,1,,1,,,,A,10939,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16
CHEMBL624999,1,,1,,,,A,10940,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2
CHEMBL882955,1,,1,,,,A,10941,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26
CHEMBL625000,1,,1,,,,A,10942,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49
CHEMBL625001,1,,1,,,,A,10943,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8
CHEMBL625089,1,,1,,,,A,10944,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18
CHEMBL625090,1,,1,,,,A,10945,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23
CHEMBL625091,1,,1,,,,A,10946,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range
CHEMBL625092,1,,1,,,,A,10947,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11
CHEMBL625093,1,,1,,,,A,10948,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7
CHEMBL625094,1,,1,,,,A,10949,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19
CHEMBL625095,1,,1,,,,A,10950,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47
CHEMBL625096,1,,1,,,,A,10951,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,2249,50588,,Compound was evaluated for its bioavailability in the dogs
CHEMBL625097,1,,1,,,,A,10952,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2249,50597,,Compound was evaluated for its bioavailability in the rats
CHEMBL882956,0,,1,,,,A,10953,Autocuration,BAO_0000218,,U,,,,,In vivo,,17515,22224,,Compound was evaluated for oral bioavailability
CHEMBL625098,1,,1,,,,A,10954,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14541,50597,,Compound was evaluated for percentage of Oral bioavailability in rats
CHEMBL625099,0,,1,,,,A,10955,Autocuration,BAO_0000218,,U,Cavia porcellus,,10141.0,,In vivo,,12797,22224,,Bioavailability in guinea pig
CHEMBL625100,1,,1,,,,A,10956,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12797,50597,,Compound was evaluated for the oral bioavailability in rat
CHEMBL625101,1,,1,,,,A,10957,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,12797,50588,,Compound was evaluated for the oral bioavailability in dog
CHEMBL874396,1,,1,,,,A,10958,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12797,50597,,Compound was evaluated for the oral bioavailability in rat
CHEMBL625102,0,,1,,,,F,10959,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,11727,22224,,Bioavailability in dog (dosed i.v.)
CHEMBL625103,1,,1,,,,A,10960,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13249,50588,,Compound was tested for in vivo bioavailability in dog
CHEMBL625104,1,,1,,,,A,10961,Intermediate,BAO_0000218,,N,Cricetinae,,10026.0,,In vivo,,13249,100712,,Compound was tested for in vivo bioavailability in hamsters
CHEMBL625105,0,,1,,,,A,10962,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,13249,22224,,Compound was tested for in vivo bioavailability in monkey
CHEMBL625106,1,,1,,,,A,10963,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13249,50597,,Compound was tested for in vivo bioavailability in rat
CHEMBL625107,0,,1,,,,A,10964,Autocuration,BAO_0000218,,U,Mus musculus,,10090.0,,In vivo,,9552,22224,,Oral bioavailability in mouse
CHEMBL625108,1,,1,,,,A,10965,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,9552,50594,,Compound was tested for percent of oral bioavailability in mice; 56-74
CHEMBL625109,0,,1,,,,A,10966,Autocuration,BAO_0000218,,U,Mus musculus,,10090.0,,In vivo,,14839,22224,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg)
CHEMBL625110,0,,1,,,,A,10967,Autocuration,BAO_0000218,,U,Macaca fascicularis,,9541.0,,In vivo,,14839,22224,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.)
CHEMBL625111,0,,1,,,,A,10968,Autocuration,BAO_0000218,,U,Macaca fascicularis,,9541.0,,In vivo,,14839,22224,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.)
CHEMBL625112,1,,1,,,,A,10969,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14839,50594,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.)
CHEMBL875334,1,,1,,,,A,10970,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14839,50594,,Oral bioavailability in nude mice
CHEMBL628617,0,,1,,,,A,10971,Autocuration,BAO_0000218,,U,Primates,,9443.0,,In vivo,,11219,22224,,Bioavailability in monkey (i.d. dosing)
CHEMBL628618,0,,1,,,,A,10972,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,9552,22224,,Bioavailability in rat
CHEMBL628619,0,,1,,,,A,10973,Autocuration,BAO_0000218,,U,,,,,In vivo,,11732,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%
CHEMBL628620,0,,1,,,,A,10974,Autocuration,BAO_0000218,,U,,,,,In vivo,,11732,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%
CHEMBL628621,1,,1,,,,A,10975,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined"
CHEMBL628622,1,,1,,,,A,10976,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined"
CHEMBL628623,1,,1,,,,A,10977,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,14839,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined"
CHEMBL628624,1,,1,,,,A,10978,Intermediate,BAO_0000218,1969.0,N,Macaca fascicularis,Plasma,9541.0,,In vivo,,14839,100710,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose
CHEMBL628625,1,,1,,,,A,10979,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,14839,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose
CHEMBL628626,1,,1,,,,A,10980,Intermediate,BAO_0000218,1969.0,N,Macaca fascicularis,Plasma,9541.0,,In vivo,,14839,100710,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose
CHEMBL627041,1,,1,,,,A,10981,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,14839,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose
CHEMBL627042,1,,1,,,,A,10982,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,14839,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose
CHEMBL627043,1,,1,,,,A,10983,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,14839,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose
CHEMBL627044,0,,1,,,,A,10984,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,13932,22224,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg
CHEMBL627045,1,,1,,,,A,10985,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,11637,50594,,Cmax in mouse plasma
CHEMBL627046,0,,1,,,,A,10986,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,11637,22224,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.
CHEMBL627047,1,,1,,,,A,10987,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,13960,50597,,Maximal plasma concentration in rat
CHEMBL627048,1,,1,,,,A,10988,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15905,50597,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat
CHEMBL627049,1,,1,,,,A,10989,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat
CHEMBL627050,1,,1,,,,A,10990,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat
CHEMBL627051,1,,1,,,,A,10991,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat
CHEMBL627052,1,,1,,,,A,10992,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat
CHEMBL627053,1,,1,,,,A,10993,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat
CHEMBL627054,1,,1,,,,A,10994,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat
CHEMBL627055,1,,1,,,,A,10995,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,15011,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg
CHEMBL627056,1,,1,,,,A,10996,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,15011,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg
CHEMBL627057,1,,1,,,,A,10997,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,15011,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample)
CHEMBL627058,1,,1,,,,A,10998,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,15011,50594,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg
CHEMBL626211,1,,1,,,,A,10999,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,15011,50594,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg
CHEMBL626212,0,,1,,,,A,11000,Autocuration,BAO_0000218,,U,,,,,In vivo,,10291,22224,,Maximum Concentration of the compound.
CHEMBL626213,1,,1,,,,A,11001,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14599,50588,,Maximum Concentration was measured after iv administration into Beagle dog
CHEMBL626214,1,,1,,,,A,11002,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14599,50588,,Maximum Concentration was measured after iv administration into Beagle dog.
CHEMBL626215,1,,1,,,,A,11003,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14599,50588,,Maximum Concentration was measured after po administration into Beagle dog
CHEMBL626216,1,,1,,,,A,11004,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14599,50588,,Maximum Concentration was measured after po administration into Beagle dog.
CHEMBL626217,0,,1,,,,A,11005,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,12767,22224,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously
CHEMBL626218,0,,1,,,,A,11006,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,12767,22224,,Maximum blood level reached after an iv dose of 12.2 uM/kg
CHEMBL626219,0,,1,,,,A,11007,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,12767,22224,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route
CHEMBL626220,0,,1,,,,A,11008,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,12767,22224,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route
CHEMBL626221,0,,1,,,,A,11009,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,12767,22224,,Maximum blood level reached after an oral dose of 5.0 mg/kg
CHEMBL626222,0,,1,,,,A,11010,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,12767,22224,,Maximum blood level reached at dose of 10.6 uM/kg orally
CHEMBL626223,1,,1,,,,A,11011,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,In vivo,,14706,50512,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration
CHEMBL626224,1,,1,,,,A,11012,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,In vivo,,14706,50512,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration
CHEMBL626225,1,,1,,,,A,11013,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14793,50597,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg
CHEMBL626226,1,,1,,,,A,11014,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14793,50597,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg
CHEMBL626227,1,,1,,,,A,11015,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14793,50597,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg
CHEMBL626228,1,,1,,,,A,11016,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14793,50597,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg
CHEMBL626229,1,,1,,,,A,11017,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14793,50597,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg
CHEMBL626921,1,,1,,,,A,11018,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14793,50597,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg
CHEMBL876793,1,,1,,,,A,11019,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14793,50597,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg
CHEMBL625309,1,,1,,,,A,11020,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14793,50597,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg
CHEMBL625310,1,,1,,,,A,11021,Intermediate,BAO_0000218,,N,Bacillus subtilis,,1423.0,,In vivo,,10524,50278,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg)
CHEMBL625311,0,,1,,,,A,11022,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,11871,22224,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg
CHEMBL625312,1,,1,,,,A,11023,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,11871,50597,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg
CHEMBL625313,0,,1,,,,A,11024,Autocuration,BAO_0000218,,U,,,,,In vivo,,3437,22224,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally
CHEMBL625314,1,,1,,,,A,11025,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,12038,50594,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg
CHEMBL625315,1,,1,,,,A,11026,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12038,50597,,Maximum concentration in male rats after iv administration of 20 mg/kg
CHEMBL625316,1,,1,,,,A,11027,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29
CHEMBL625317,1,,1,,,,A,11028,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08
CHEMBL625318,1,,1,,,,A,11029,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89
CHEMBL625319,1,,1,,,,A,11030,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66
CHEMBL625320,1,,1,,,,A,11031,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71
CHEMBL625321,1,,1,,,,A,11032,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22
CHEMBL625322,1,,1,,,,A,11033,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45
CHEMBL876801,1,,1,,,,A,11034,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31
CHEMBL625323,1,,1,,,,A,11035,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44
CHEMBL625324,1,,1,,,,A,11036,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17
CHEMBL625325,1,,1,,,,A,11037,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44
CHEMBL625326,1,,1,,,,A,11038,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57
CHEMBL625327,1,,1,,,,A,11039,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14
CHEMBL625328,1,,1,,,,A,11040,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8418,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74
CHEMBL625329,1,,1,,,,A,11041,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5
CHEMBL625330,1,,1,,,,A,11042,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77
CHEMBL627774,1,,1,,,,A,11043,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54
CHEMBL627775,1,,1,,,,A,11044,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86
CHEMBL627949,1,,1,,,,A,11045,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86
CHEMBL627950,1,,1,,,,A,11046,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13
CHEMBL627951,1,,1,,,,A,11047,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89
CHEMBL627952,1,,1,,,,A,11048,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7
CHEMBL627953,1,,1,,,,A,11049,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66
CHEMBL627954,1,,1,,,,A,11050,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74
CHEMBL627955,1,,1,,,,A,11051,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08
CHEMBL627956,1,,1,,,,A,11052,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56
CHEMBL876802,1,,1,,,,A,11053,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07
CHEMBL627957,1,,1,,,,A,11054,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91
CHEMBL627958,1,,1,,,,A,11055,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86
CHEMBL627959,1,,1,,,,A,11056,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79
CHEMBL627960,1,,1,,,,A,11057,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36
CHEMBL627961,1,,1,,,,A,11058,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44
CHEMBL627962,1,,1,,,,A,11059,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8418,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65
CHEMBL627963,1,,1,,,,A,11060,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg
CHEMBL624759,1,,1,,,,A,11061,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL624760,1,,1,,,,A,11062,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg
CHEMBL624761,1,,1,,,,A,11063,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL877607,1,,1,,,,A,11064,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL624762,1,,1,,,,A,11065,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg
CHEMBL624763,1,,1,,,,A,11066,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL624764,1,,1,,,,A,11067,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg
CHEMBL624765,1,,1,,,,A,11068,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL624766,1,,1,,,,A,11069,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL624767,1,,1,,,,A,11070,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr)
CHEMBL624768,1,,1,,,,A,11071,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration
CHEMBL624769,1,,1,,,,A,11072,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr)
CHEMBL624770,1,,1,,,,A,11073,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr)
CHEMBL624771,1,,1,,,,A,11074,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr )
CHEMBL624772,1,,1,,,,A,11075,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr)
CHEMBL624773,1,,1,,,,A,11076,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration
CHEMBL624774,1,,1,,,,A,11077,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr)
CHEMBL624775,1,,1,,,,A,11078,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr)
CHEMBL624776,1,,1,,,,A,11079,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL624777,1,,1,,,,A,11080,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr )
CHEMBL624778,1,,1,,,,A,11081,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr)
CHEMBL624779,1,,1,,,,A,11082,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration
CHEMBL624780,1,,1,,,,A,11083,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL624781,1,,1,,,,A,11084,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr )
CHEMBL877608,1,,1,,,,A,11085,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr)
CHEMBL624782,1,,1,,,,A,11086,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr)
CHEMBL624783,1,,1,,,,A,11087,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr)
CHEMBL624784,1,,1,,,,A,11088,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration
CHEMBL624785,1,,1,,,,A,11089,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr)
CHEMBL624786,1,,1,,,,A,11090,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr)
CHEMBL624787,1,,1,,,,A,11091,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr )
CHEMBL628676,1,,1,,,,A,11092,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr)
CHEMBL621842,1,,1,,,,A,11093,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration
CHEMBL621843,1,,1,,,,A,11094,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr)
CHEMBL623873,1,,1,,,,A,11095,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr)
CHEMBL623874,1,,1,,,,A,11096,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL623875,1,,1,,,,A,11097,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr )
CHEMBL623876,1,,1,,,,A,11098,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr)
CHEMBL623877,1,,1,,,,A,11099,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration
CHEMBL623878,1,,1,,,,A,11100,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr)
CHEMBL623879,1,,1,,,,A,11101,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration
CHEMBL623880,1,,1,,,,A,11102,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr)
CHEMBL623881,1,,1,,,,A,11103,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr)
CHEMBL623957,1,,1,,,,A,11104,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr)
CHEMBL623958,1,,1,,,,A,11105,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr)
CHEMBL623959,1,,1,,,,A,11106,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr)
CHEMBL623960,1,,1,,,,A,11107,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr)
CHEMBL623961,1,,1,,,,A,11108,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr)
CHEMBL623962,1,,1,,,,A,11109,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr)
CHEMBL624676,1,,1,,,,A,11110,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr )
CHEMBL624677,1,,1,,,,A,11111,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr)
CHEMBL624678,1,,1,,,,A,11112,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration
CHEMBL624679,1,,1,,,,A,11113,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr)
CHEMBL624680,1,,1,,,,A,11114,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr)
CHEMBL624849,0,,1,,,,A,11115,Autocuration,BAO_0000218,,U,,,,,In vivo,,11732,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%
CHEMBL624850,0,,1,,,,A,11116,Autocuration,BAO_0000218,,U,,,,,In vivo,,11732,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%
CHEMBL874399,0,,1,,,,A,11117,Autocuration,BAO_0000218,,U,,,,,In vivo,,11732,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%
CHEMBL624851,0,,1,,,,A,11118,Autocuration,BAO_0000218,,U,,,,,In vivo,,11732,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%
CHEMBL624852,0,,1,,,,A,11119,Autocuration,BAO_0000218,,U,,,,,In vivo,,11732,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%
CHEMBL624853,0,,1,,,,A,11120,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,13359,22224,,Oral bioavailability in rat (dose 10 mg/kg)
CHEMBL624854,0,,1,,,,A,11121,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,16618,22224,,Oral bioavailability in rat (Sprague-Dawley)
CHEMBL624855,0,,1,,,,A,11122,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,13960,22224,,Oral bioavailability in rat
CHEMBL624856,0,,1,,,,A,11123,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,13917,22224,,Oral bioavailability in rats was determined in vivo
CHEMBL882957,0,,1,,,,A,11124,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,14266,22224,,Oral bioavailability in dog
CHEMBL624857,0,,1,,,,A,11125,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,12359,22224,,Oral bioavailability of compound in monkey
CHEMBL622202,1,,1,,,,A,11126,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12359,50597,,Oral bioavailability of compound in rat
CHEMBL622203,0,,1,,,,A,11127,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,12359,22224,,Bioavailability in rat of PMEA prodrug
CHEMBL625522,1,,1,,,,A,11128,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12359,50597,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility
CHEMBL622868,0,,1,,,,A,11129,Autocuration,BAO_0000218,,U,Macaca mulatta,,9544.0,,In vivo,,10791,22224,,Serum conc at 3 hours following 25 mg/kg dose
CHEMBL622869,0,,1,,,,A,11130,Autocuration,BAO_0000218,1088.0,U,Macaca mulatta,Urine,9544.0,,In vivo,,10791,22224,,Urine conc 0-5 hours following 25 mg/kg dose
CHEMBL622870,0,,1,,,,A,11131,Autocuration,BAO_0000218,1088.0,U,Macaca mulatta,Urine,9544.0,,In vivo,,10791,22224,,Urine conc 0-24 hours following 25 mg/kg dose
CHEMBL622871,0,,1,,,,A,11132,Autocuration,BAO_0000218,,U,Chlorocebus aethiops,,9534.0,,In vivo,,138,22224,,Oral bioavailability in African green monkeys; 20-25
CHEMBL620560,1,,1,,,,A,11133,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,14521,100710,,Oral bioavailability in cynomolgus monkey.
CHEMBL620561,0,,1,,,,A,11134,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,13953,22224,,Oral bioavailability in dog
CHEMBL620562,1,,1,,,,A,11135,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,12836,50588,,Oral bioavailability in dog at 10 mg/kg oral dose
CHEMBL620563,1,,1,,,,A,11136,Intermediate,BAO_0000218,,N,Cricetinae,,10026.0,,In vivo,,12836,100712,,Oral bioavailability in hamster at 10 mg/kg oral dose
CHEMBL620564,1,,1,,,,A,11137,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12836,50597,,Oral bioavailability in rat at 10 mg/kg oral dose
CHEMBL872265,0,,1,,,,A,11138,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,14521,22224,,Oral bioavailability in rat
CHEMBL620565,0,,1,,,,A,11139,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,13953,22224,,Oral bioavailability in rat
CHEMBL620566,0,,1,,,,A,11140,Autocuration,BAO_0000218,,U,Eutheria,,9347.0,,In vivo,,6799,22224,,Oral bioavailability
CHEMBL620567,0,,1,,,,A,11141,Autocuration,BAO_0000218,,U,,,,,In vivo,,11311,22224,,Oral bioavailability was determined; range 49-102%
CHEMBL620568,1,,1,,,,A,11142,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,4013,50588,,Oral bioavailability was determined in dogs
CHEMBL620569,0,,1,,,,A,11143,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,4013,22224,,Oral bioavailability in rat
CHEMBL620570,0,,1,,,,A,11144,Autocuration,BAO_0000218,,U,Eutheria,,9347.0,,In vivo,,17591,22224,,Oral bioavailability
CHEMBL620571,0,,1,,,,A,11145,Autocuration,BAO_0000218,,U,,,,,In vivo,,17591,22224,,Oral bioavailability was determined; Not orally available
CHEMBL620572,1,,1,,,,A,11146,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,15011,50594,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample)
CHEMBL620573,0,,1,,,,A,11147,Autocuration,BAO_0000218,,U,Mus musculus,,10090.0,,In vivo,,15011,22224,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg)
CHEMBL620574,0,,1,,,,A,11148,Autocuration,BAO_0000218,,U,Mus musculus,,10090.0,,In vivo,,15011,22224,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg
CHEMBL620575,0,,1,,,,A,11149,Autocuration,BAO_0000218,,U,Macaca mulatta,,9544.0,,In vivo,,9552,22224,,Oral bioavailability in Rhesus monkey
CHEMBL620576,0,,1,,,,A,11150,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,9552,22224,,Oral bioavailability in dog (female mongrel)
CHEMBL875846,0,,1,,,,A,11151,Autocuration,BAO_0000218,,U,,,,,In vivo,,3639,22224,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested
CHEMBL620577,0,,1,,,,A,11152,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,13397,22224,,Oral bioavailability in dog
CHEMBL620578,0,,1,,,,A,11153,Autocuration,BAO_0000218,,U,,,,,In vivo,,3031,22224,,Percentage Bioavailability was evaluated.
CHEMBL620579,0,,1,,,,A,11154,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,12818,22224,,Bioavailability in rat administered i.d.
CHEMBL621248,0,,1,,,,A,11155,Autocuration,BAO_0000218,,U,Eutheria,,9347.0,,In vivo,,4847,22224,,Bioavailability
CHEMBL625390,0,,1,,,,A,11156,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,12421,22224,,Bioavailability in dog (male Beagle) i.v. administration
CHEMBL625391,0,,1,,,,A,11157,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,11966,22224,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)"
CHEMBL872266,0,,1,,,,A,11158,Autocuration,BAO_0000218,,U,Primates,,9443.0,,In vivo,,11218,22224,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.)
CHEMBL625392,0,,1,,,,A,11159,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,13129,22224,,Oral bioavailability in rat (Sprague-Dawley) (male)
CHEMBL625393,1,,1,,,,A,11160,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12350,50597,,The oral bioavailability was measured on rats after oral administration
CHEMBL625394,1,,1,,,,A,11161,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,2231,50597,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg
CHEMBL625395,1,,1,,,,A,11162,Intermediate,BAO_0000218,,N,Macaca mulatta,,9544.0,,In vivo,,2231,50797,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg
CHEMBL625396,0,,1,,,,A,11163,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,12187,22224,,Bioavailability in rat (dose 10 mg/kg i.d.)
CHEMBL625397,0,,1,,,,A,11164,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,12421,22224,,Bioavailability in dog (male Beagle) i.v. administration
CHEMBL625398,1,,1,,,,A,11165,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL625399,1,,1,,,,A,11166,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL626074,1,,1,,,,A,11167,Intermediate,BAO_0000218,2037.0,N,Mus musculus,Cerebellum,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL626075,1,,1,,,,A,11168,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL626076,1,,1,,,,A,11169,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2231,50597,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg
CHEMBL626077,1,,1,,,,A,11170,Intermediate,BAO_0000218,1969.0,N,Macaca mulatta,Plasma,9544.0,,In vivo,,2231,50797,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg
CHEMBL626078,1,,1,,,,A,11171,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12178,50597,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose)
CHEMBL625846,0,,1,,,,A,11172,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,12178,22224,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose)
CHEMBL625847,0,,1,,,,A,11173,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,12178,22224,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose)
CHEMBL625848,1,,1,,,,A,11174,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15633,50597,,Maximum concentration observed in rats at an oral dose of 50 mg/kg
CHEMBL625849,1,,1,,,,A,11175,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14258,50597,,Maximum concentration of compound in plasma administered orally to rats
CHEMBL626023,1,,1,,,,A,11176,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14224,50588,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs"
CHEMBL626024,1,,1,,,,A,11177,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14224,50588,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs"
CHEMBL626025,1,,1,,,,A,11178,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14224,50588,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs"
CHEMBL626026,0,,1,,,,A,11179,Autocuration,BAO_0000218,,U,,,,,In vivo,,5566,22224,,Maximum concentration after 10 mg/kg by oral administration
CHEMBL626027,0,,1,,,,A,11180,Autocuration,BAO_0000218,,U,,,,,In vivo,,16935,22224,,Maximum concentration at a dose of 1.5 mg/kg
CHEMBL626028,0,,1,,,,A,11181,Autocuration,BAO_0000218,,U,,,,,In vivo,,16935,22224,,Maximum concentration at a dose of 2.0 mg/kg
CHEMBL626029,1,,1,,,,A,11182,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14224,50588,,Maximum concentration in dog plasma
CHEMBL626030,0,,1,,,,A,11183,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,12536,22224,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally
CHEMBL626031,0,,1,,,,A,11184,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,12536,22224,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously
CHEMBL626032,0,,1,,,,A,11185,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,12536,22224,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously
CHEMBL626033,0,,1,,,,A,11186,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,12536,22224,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally
CHEMBL626034,0,,1,,,,A,11187,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,12536,22224,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously
CHEMBL626035,1,,1,,,,A,11188,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,9994,50588,,Maximum concentration in plasma after oral administration in dog (25 mg/kg)
CHEMBL626036,0,,1,,,,A,11189,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,1434,22224,,Maximum concentration in plasma at Tmax
CHEMBL626037,1,,1,,,,A,11190,Expert,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,12836,50588,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose
CHEMBL626038,1,,1,,,,A,11191,Intermediate,BAO_0000218,1969.0,N,Cricetinae,Plasma,10026.0,,In vivo,,12836,100712,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose
CHEMBL626039,1,,1,,,,A,11192,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12836,50597,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose
CHEMBL626040,1,,1,,,,A,11193,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12545,50597,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg
CHEMBL626041,1,,1,,,,A,11194,Intermediate,BAO_0000218,1969.0,N,Oryctolagus cuniculus,Plasma,9986.0,,In vivo,,13856,50592,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg
CHEMBL626042,0,,1,,,,A,11195,Autocuration,BAO_0000218,,U,,,,,In vivo,,3550,22224,,Maximum concentration was calculated
CHEMBL626043,0,,1,,,,A,11196,Autocuration,BAO_0000218,,U,,,,,In vivo,,2632,22224,,Maximum concentration was calculated.
CHEMBL626044,0,,1,,,,A,11197,Autocuration,BAO_0000218,,U,,,,,In vivo,,5566,22224,,Maximum concentration at a peroral dose of 10 mg/kg
CHEMBL626045,0,,1,,,,A,11198,Autocuration,BAO_0000218,,U,,,,,In vivo,,11883,22224,,Maximum concentration of the drug at 10 uM/dg administered perorally
CHEMBL626046,0,,1,,,,A,11199,Autocuration,BAO_0000218,,U,,,,,In vivo,,11883,22224,,Maximum concentration of the drug at 2 uM/dg administered intravenously
CHEMBL626047,1,,1,,,,A,11200,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14122,50588,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose."
CHEMBL626048,1,,1,,,,A,11201,Intermediate,BAO_0000218,1969.0,N,Cricetinae,Plasma,10026.0,,In vivo,,14122,100712,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose."
CHEMBL626049,1,,1,,,,A,11202,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14122,50597,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose."
CHEMBL626050,1,,1,,,,A,11203,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12542,50597,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose
CHEMBL874541,1,,1,,,,A,11204,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,12542,50588,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose
CHEMBL622826,1,,1,,,,A,11205,Intermediate,BAO_0000218,1969.0,N,Cricetinae,Plasma,10026.0,,In vivo,,12542,100712,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose
CHEMBL622827,1,,1,,,,A,11206,Intermediate,BAO_0000218,1969.0,N,Cricetinae,Plasma,10026.0,,In vivo,,12542,100712,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose
CHEMBL622828,1,,1,,,,A,11207,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12542,50597,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose
CHEMBL622829,1,,1,,,,A,11208,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14080,50597,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing
CHEMBL876806,1,,1,,,,A,11209,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,11911,50597,,Maximum concentration reached following intravenous administration in male rat
CHEMBL622830,1,,1,,,,A,11210,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13204,50588,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog
CHEMBL622831,1,,1,,,,A,11211,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13204,50597,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats
CHEMBL626794,1,,1,,,,A,11212,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14346,50588,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs
CHEMBL626795,1,,1,,,,A,11213,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14346,50597,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats
CHEMBL626796,1,,1,,,,A,11214,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14346,50597,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats
CHEMBL626797,1,,1,,,,A,11215,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14346,50597,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats
CHEMBL626798,1,,1,,,,A,11216,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14127,50597,,Maximum drug concentration is determined after oral dosing in rats.
CHEMBL626799,1,,1,,,,A,11217,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14339,50588,,Maximum observed concentration in oral (5 mg/kg) fasted dogs
CHEMBL626800,1,,1,,,,A,11218,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14339,50588,,Maximum observed concentration in oral (5 mg/kg) fed dogs
CHEMBL626801,0,,1,,,,A,11219,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,13494,22224,,Maximum plasma concentration
CHEMBL876816,1,,1,,,,A,11220,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14925,50597,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug
CHEMBL626802,1,,1,,,,A,11221,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14474,50597,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats
CHEMBL626803,1,,1,,,,A,11222,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14474,50588,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog
CHEMBL626804,0,,1,,,,A,11223,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,13917,22224,,Maximum plasma concentration following oral administration of 30 umol/kg
CHEMBL626805,1,,1,,,,A,11224,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose
CHEMBL626309,1,,1,,,,A,11225,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg
CHEMBL626310,1,,1,,,,A,11226,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg
CHEMBL626311,1,,1,,,,A,11227,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL626312,1,,1,,,,A,11228,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL626313,1,,1,,,,A,11229,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL626314,1,,1,,,,A,11230,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg
CHEMBL626315,1,,1,,,,A,11231,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg
CHEMBL626316,1,,1,,,,A,11232,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL626317,1,,1,,,,A,11233,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,9796,50597,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg
CHEMBL626318,1,,1,,,,A,11234,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-)
CHEMBL626319,1,,1,,,,A,11235,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+)
CHEMBL626320,1,,1,,,,A,11236,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-)
CHEMBL875053,1,,1,,,,A,11237,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+)
CHEMBL626321,1,,1,,,,A,11238,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-)
CHEMBL626322,1,,1,,,,A,11239,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+)
CHEMBL626323,1,,1,,,,A,11240,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-)
CHEMBL626324,1,,1,,,,A,11241,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+)
CHEMBL626325,1,,1,,,,A,11242,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-)
CHEMBL626326,1,,1,,,,A,11243,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+)
CHEMBL626327,1,,1,,,,A,11244,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+)
CHEMBL626328,1,,1,,,,A,11245,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8363,50597,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-)
CHEMBL626329,1,,1,,,,A,11246,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8684,50597,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm"
CHEMBL626330,1,,1,,,,A,11247,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8684,50597,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm"
CHEMBL626331,1,,1,,,,A,11248,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8684,50597,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm"
CHEMBL626332,1,,1,,,,A,11249,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8684,50597,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm"
CHEMBL626333,1,,1,,,,A,11250,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8684,50597,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm"
CHEMBL626334,1,,1,,,,A,11251,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8684,50597,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm"
CHEMBL626335,1,,1,,,,A,11252,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8684,50597,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm"
CHEMBL624798,1,,1,,,,A,11253,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8684,50597,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm"
CHEMBL624799,1,,1,,,,A,11254,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,8684,50597,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm"
CHEMBL624800,1,,1,,,,A,11255,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,8684,50597,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm"
CHEMBL624801,1,,1,,,,A,11256,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,8684,50597,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm"
CHEMBL624802,1,,1,,,,A,11257,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,8684,50597,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm"
CHEMBL624803,1,,1,,,,A,11258,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,8684,50597,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm"
CHEMBL624804,1,,1,,,,A,11259,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,8684,50597,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm"
CHEMBL624805,1,,1,,,,A,11260,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,8684,50597,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm"
CHEMBL624806,1,,1,,,,A,11261,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,8684,50597,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm"
CHEMBL624807,1,,1,,,,A,11262,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm"
CHEMBL624808,1,,1,,,,A,11263,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm"
CHEMBL624809,1,,1,,,,A,11264,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm"
CHEMBL624810,1,,1,,,,A,11265,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm"
CHEMBL877618,1,,1,,,,A,11266,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm"
CHEMBL624811,1,,1,,,,A,11267,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm"
CHEMBL624812,1,,1,,,,A,11268,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm"
CHEMBL624813,1,,1,,,,A,11269,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm"
CHEMBL624814,1,,1,,,,A,11270,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm"
CHEMBL624815,1,,1,,,,A,11271,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm"
CHEMBL624816,1,,1,,,,A,11272,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm"
CHEMBL624817,1,,1,,,,A,11273,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm"
CHEMBL624818,1,,1,,,,A,11274,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr)
CHEMBL624819,1,,1,,,,A,11275,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration
CHEMBL624820,1,,1,,,,A,11276,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr)
CHEMBL624821,1,,1,,,,A,11277,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr)
CHEMBL624822,1,,1,,,,A,11278,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr )
CHEMBL624823,1,,1,,,,A,11279,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr)
CHEMBL624824,1,,1,,,,A,11280,Intermediate,BAO_0000218,,N,Escherichia coli,,562.0,,,,15599,50212,,Observed diffusion coefficient in organic solvent for Escherichia coli
CHEMBL624825,1,,1,,,,A,11281,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,9614,50597,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer"
CHEMBL624826,1,,1,,,,A,11282,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,9614,50597,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g"
CHEMBL876817,1,,1,,,,A,11283,Intermediate,BAO_0000218,2081.0,N,Rattus norvegicus,Cardiac atrium,10116.0,,,,9614,50597,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer"
CHEMBL624827,1,,1,,,,A,11284,Intermediate,BAO_0000218,2081.0,N,Rattus norvegicus,Cardiac atrium,10116.0,,,,9614,50597,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g"
CHEMBL624828,1,,1,,,,A,11285,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9614,50597,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer"
CHEMBL624829,1,,1,,,,A,11286,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9614,50597,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g"
CHEMBL624830,1,,1,,,,A,11287,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9614,50597,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer"
CHEMBL624831,1,,1,,,,A,11288,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9614,50597,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g"
CHEMBL624832,1,,1,,,,A,11289,Intermediate,BAO_0000218,2081.0,N,Rattus norvegicus,Cardiac atrium,10116.0,,,,9614,50597,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer"
CHEMBL624833,1,,1,,,,A,11290,Intermediate,BAO_0000218,2081.0,N,Rattus norvegicus,Cardiac atrium,10116.0,,,,9614,50597,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g"
CHEMBL624834,1,,1,,,,A,11291,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9614,50597,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g"
CHEMBL624835,1,,1,,,,A,11292,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9614,50597,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer"
CHEMBL624836,1,,1,,,,A,11293,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,9614,50597,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer"
CHEMBL624837,1,,1,,,,A,11294,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,9614,50597,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g"
CHEMBL624838,1,,1,,,,A,11295,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration
CHEMBL622188,1,,1,,,,A,11296,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration
CHEMBL622189,1,,1,,,,A,11297,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration
CHEMBL622190,1,,1,,,,A,11298,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at
CHEMBL625170,1,,1,,,,A,11299,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration
CHEMBL625171,1,,1,,,,A,11300,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration
CHEMBL625172,1,,1,,,,A,11301,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration
CHEMBL625173,1,,1,,,,A,11302,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration
CHEMBL625174,1,,1,,,,A,11303,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration
CHEMBL625175,1,,1,,,,A,11304,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration
CHEMBL625176,1,,1,,,,A,11305,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at
CHEMBL625177,1,,1,,,,A,11306,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration
CHEMBL625178,1,,1,,,,A,11307,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration
CHEMBL625179,1,,1,,,,A,11308,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at
CHEMBL625180,1,,1,,,,A,11309,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,9071,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration
CHEMBL625181,0,,1,,,,A,11310,Autocuration,BAO_0000218,,U,,,,,,,10677,22224,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration"
CHEMBL625182,1,,1,,,,A,11311,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,9750,50594,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.
CHEMBL625183,1,,1,,,,A,11312,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ
CHEMBL875848,1,,1,,,,A,11313,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ
CHEMBL622260,1,,1,,,,A,11314,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ
CHEMBL622261,1,,1,,,,A,11315,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ
CHEMBL622262,1,,1,,,,A,11316,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ
CHEMBL622263,1,,1,,,,A,11317,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ
CHEMBL622418,1,,1,,,,A,11318,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ
CHEMBL622419,1,,1,,,,A,11319,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ
CHEMBL623388,1,,1,,,,A,11320,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL623389,1,,1,,,,A,11321,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL623390,1,,1,,,,A,11322,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL623391,1,,1,,,,A,11323,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL623392,1,,1,,,,A,11324,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL623393,1,,1,,,,A,11325,Intermediate,BAO_0000218,2037.0,N,Mus musculus,Cerebellum,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL623394,1,,1,,,,A,11326,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL618885,1,,1,,,,A,11327,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL618886,1,,1,,,,A,11328,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL618887,1,,1,,,,A,11329,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL619535,1,,1,,,,A,11330,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL619536,1,,1,,,,A,11331,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL619537,1,,1,,,,A,11332,Intermediate,BAO_0000218,2037.0,N,Mus musculus,Cerebellum,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL619705,1,,1,,,,A,11333,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL619706,1,,1,,,,A,11334,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL619707,1,,1,,,,A,11335,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL619708,1,,1,,,,A,11336,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL625219,1,,1,,,,A,11337,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL625220,1,,1,,,,A,11338,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL625221,1,,1,,,,A,11339,Intermediate,BAO_0000218,2037.0,N,Mus musculus,Cerebellum,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL625222,1,,1,,,,A,11340,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL625223,1,,1,,,,A,11341,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL625224,1,,1,,,,A,11342,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL625225,1,,1,,,,A,11343,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13256,50594,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse)
CHEMBL625226,1,,1,,,,A,11344,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat blood after 24 hours of iv administration
CHEMBL625227,1,,1,,,,A,11345,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue
CHEMBL625228,1,,1,,,,A,11346,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat blood after 30 minutes of iv administration
CHEMBL875354,1,,1,,,,A,11347,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue
CHEMBL625229,1,,1,,,,A,11348,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat blood after 5 minutes of iv administration
CHEMBL625230,1,,1,,,,A,11349,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue
CHEMBL625231,1,,1,,,,A,11350,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat heart after 24 hours of iv administration
CHEMBL625900,1,,1,,,,A,11351,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue
CHEMBL625901,1,,1,,,,A,11352,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat heart after 30 minutes of iv administration
CHEMBL625902,1,,1,,,,A,11353,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue
CHEMBL625903,1,,1,,,,A,11354,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat heart after 5 minutes of iv administration
CHEMBL625904,1,,1,,,,A,11355,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue
CHEMBL625905,1,,1,,,,A,11356,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat liver after 24 hours of iv administration
CHEMBL627861,1,,1,,,,A,11357,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue
CHEMBL627862,1,,1,,,,A,11358,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat liver after 30 minutes of iv administration
CHEMBL627863,1,,1,,,,A,11359,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue
CHEMBL627769,1,,1,,,,A,11360,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat liver after 30 minutes of iv administration
CHEMBL627770,1,,1,,,,A,11361,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,13249,50588,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered
CHEMBL627771,1,,1,,,,A,11362,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,13622,100710,,Cmax in cynomolgus monkey (PO dose)
CHEMBL627772,1,,1,,,,A,11363,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13622,50597,,Cmax in rat (PO dose)
CHEMBL627773,1,,1,,,,A,11364,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13622,50597,,Cmax in rat (PO dose)
CHEMBL621922,1,,1,,,,A,11365,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,13494,50597,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg
CHEMBL621923,1,,1,,,,A,11366,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12170,50597,,Cmax in rat plasma after oral dose (10 mg/kg)
CHEMBL621924,0,,1,,,,A,11367,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,12170,22224,,Cmax in plasma after oral dose (10 mg/kg)
CHEMBL621925,1,,1,,,,A,11368,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,17025,50588,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally
CHEMBL621926,0,,1,,,,A,11369,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,In vivo,,17025,22224,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally
CHEMBL621927,1,,1,,,,A,11370,Intermediate,BAO_0000218,1969.0,N,Oryctolagus cuniculus,Plasma,9986.0,,In vivo,,17025,50592,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally
CHEMBL621928,1,,1,,,,A,11371,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17025,50597,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally
CHEMBL621929,1,,1,,,,A,11372,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14187,50597,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.
CHEMBL621930,1,,1,,,,A,11373,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,14816,50594,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice
CHEMBL621931,1,,1,,,,A,11374,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17820,50597,,Maximum plasma concentration after oral dosing in rat
CHEMBL621932,0,,1,,,,A,11375,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally
CHEMBL621933,0,,1,,,,A,11376,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally
CHEMBL621934,1,,1,,,,A,11377,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14691,50588,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration
CHEMBL621935,1,,1,,,,A,11378,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14691,50588,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration
CHEMBL621936,1,,1,,,,A,11379,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,13375,50597,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg
CHEMBL621937,0,,1,,,,A,11380,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,6236,22224,,Maximum plasma concentration was determined
CHEMBL621938,0,,1,,,,A,11381,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally
CHEMBL621939,0,,1,,,,A,11382,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally
CHEMBL621940,0,,1,,,,A,11383,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally
CHEMBL621941,0,,1,,,,A,11384,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally
CHEMBL621942,0,,1,,,,A,11385,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally
CHEMBL626178,0,,1,,,,A,11386,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally
CHEMBL626179,0,,1,,,,A,11387,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally
CHEMBL626180,0,,1,,,,A,11388,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14380,22224,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally
CHEMBL626181,1,,1,,,,A,11389,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,13622,50597,,Plasma Cmax in rat (PO dose)
CHEMBL626182,1,,1,,,,A,11390,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15372,50597,,Maximum serum concentration after po dose of 5.22 mg/kg in rats
CHEMBL626183,1,,1,,,,A,11391,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15372,50597,,Maximum serum concentration after po dose of 5.46 mg/kg in rats
CHEMBL626184,1,,1,,,,A,11392,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15372,50597,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats
CHEMBL626185,1,,1,,,,A,11393,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15372,50597,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats
CHEMBL626186,1,,1,,,,A,11394,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14925,50588,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.
CHEMBL877589,1,,1,,,,A,11395,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14925,50588,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.
CHEMBL626187,0,,1,,,,A,11396,Autocuration,BAO_0000218,,U,,,,,In vivo,,11883,22224,,Maximum concentration of the drug at 1 uM/dg administered intravenously
CHEMBL626188,0,,1,,,,A,11397,Autocuration,BAO_0000218,,U,,,,,In vivo,,11883,22224,,Maximum concentration of the drug at 20 uM/dg administered perorally
CHEMBL626189,0,,1,,,,A,11398,Autocuration,BAO_0000218,,U,,,,,In vivo,,13391,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg
CHEMBL626855,0,,1,,,,A,11399,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,13391,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM
CHEMBL623781,0,,1,,,,A,11400,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,13391,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM
CHEMBL623782,0,,1,,,,A,11401,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,13391,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM
CHEMBL623783,1,,1,,,,A,11402,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16360,50597,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat
CHEMBL623784,1,,1,,,,A,11403,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,3673,50588,,Cmax in dog plasma after 1mg/kg oral dose
CHEMBL623785,1,,1,,,,A,11404,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14431,50588,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose
CHEMBL623786,1,,1,,,,A,11405,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14431,50597,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose
CHEMBL623787,1,,1,,,,A,11406,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14964,50597,,Oral maximum concentration in rat
CHEMBL623788,1,,1,,,,A,11407,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14964,50597,,Oral maximum concentration in rat
CHEMBL623789,1,,1,,,,A,11408,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,14209,50594,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.
CHEMBL623790,1,,1,,,,A,11409,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,11355,50594,,Peak concentration in blood after intravenous administration to mice
CHEMBL623791,1,,1,,,,A,11410,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,11355,50594,,Peak concentration in blood after peroral administration to mice
CHEMBL623792,1,,1,,,,A,11411,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,11966,50597,,Peak concentration in rat plasma was determined
CHEMBL623793,0,,1,,,,A,11412,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,In vivo,,8918,22224,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg
CHEMBL623794,1,,1,,,,A,11413,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,8918,50594,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg
CHEMBL623795,1,,1,,,,A,11414,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,8918,50597,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg
CHEMBL623796,1,,1,,,,A,11415,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm"
CHEMBL623797,1,,1,,,,A,11416,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm"
CHEMBL623798,1,,1,,,,A,11417,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm"
CHEMBL623799,1,,1,,,,A,11418,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm"
CHEMBL624490,1,,1,,,,A,11419,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,,,8684,50597,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm"
CHEMBL624491,1,,1,,,,A,11420,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,,,8684,50597,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm"
CHEMBL624492,1,,1,,,,A,11421,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,,,8684,50597,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm"
CHEMBL624493,1,,1,,,,A,11422,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,,,8684,50597,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm"
CHEMBL877595,1,,1,,,,A,11423,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,,,8684,50597,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm"
CHEMBL624494,1,,1,,,,A,11424,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,,,8684,50597,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm"
CHEMBL624495,1,,1,,,,A,11425,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,,,8684,50597,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm"
CHEMBL624681,1,,1,,,,A,11426,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,,,8684,50597,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm"
CHEMBL624682,1,,1,,,,A,11427,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm"
CHEMBL624683,1,,1,,,,A,11428,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm"
CHEMBL624684,1,,1,,,,A,11429,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm"
CHEMBL624685,1,,1,,,,A,11430,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm"
CHEMBL624686,1,,1,,,,A,11431,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm"
CHEMBL624687,1,,1,,,,A,11432,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm"
CHEMBL624688,1,,1,,,,A,11433,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm"
CHEMBL627161,1,,1,,,,A,11434,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm"
CHEMBL622127,1,,1,,,,A,11435,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm"
CHEMBL622128,1,,1,,,,A,11436,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm"
CHEMBL874384,1,,1,,,,A,11437,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm"
CHEMBL624898,1,,1,,,,A,11438,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm"
CHEMBL624899,1,,1,,,,A,11439,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm"
CHEMBL624900,1,,1,,,,A,11440,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm"
CHEMBL624901,1,,1,,,,A,11441,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm"
CHEMBL624902,1,,1,,,,A,11442,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm"
CHEMBL624903,1,,1,,,,A,11443,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm"
CHEMBL624904,1,,1,,,,A,11444,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm"
CHEMBL624905,1,,1,,,,A,11445,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm"
CHEMBL624906,1,,1,,,,A,11446,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm"
CHEMBL624907,1,,1,,,,A,11447,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm"
CHEMBL624908,1,,1,,,,A,11448,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm"
CHEMBL624909,1,,1,,,,A,11449,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm"
CHEMBL624910,1,,1,,,,A,11450,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm"
CHEMBL624911,1,,1,,,,A,11451,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,8684,50597,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm"
CHEMBL874388,1,,1,,,,A,11452,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,8684,50597,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm"
CHEMBL624912,1,,1,,,,A,11453,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,8684,50597,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm"
CHEMBL622930,1,,1,,,,A,11454,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,8684,50597,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm"
CHEMBL623121,1,,1,,,,A,11455,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,8684,50597,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm"
CHEMBL623122,1,,1,,,,A,11456,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,8684,50597,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm"
CHEMBL623123,1,,1,,,,A,11457,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,8684,50597,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm"
CHEMBL623124,1,,1,,,,A,11458,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,8684,50597,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm"
CHEMBL623125,1,,1,,,,A,11459,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm"
CHEMBL623126,1,,1,,,,A,11460,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm"
CHEMBL623127,1,,1,,,,A,11461,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm"
CHEMBL623128,1,,1,,,,A,11462,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm"
CHEMBL623129,1,,1,,,,A,11463,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm"
CHEMBL623130,1,,1,,,,A,11464,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm"
CHEMBL623131,1,,1,,,,A,11465,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm"
CHEMBL623132,1,,1,,,,A,11466,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm"
CHEMBL623133,1,,1,,,,A,11467,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ
CHEMBL623134,1,,1,,,,A,11468,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ
CHEMBL874389,1,,1,,,,A,11469,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ
CHEMBL623135,1,,1,,,,A,11470,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ
CHEMBL623136,1,,1,,,,A,11471,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ
CHEMBL623137,1,,1,,,,A,11472,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ
CHEMBL623138,1,,1,,,,A,11473,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ
CHEMBL623139,1,,1,,,,A,11474,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ
CHEMBL623140,1,,1,,,,A,11475,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ
CHEMBL623141,1,,1,,,,A,11476,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ
CHEMBL623142,1,,1,,,,A,11477,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ
CHEMBL623143,1,,1,,,,A,11478,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ
CHEMBL623144,1,,1,,,,A,11479,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,14571,50594,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.
CHEMBL623405,1,,1,,,,A,11480,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,14571,50597,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.
CHEMBL624074,1,,1,,,,A,11481,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ
CHEMBL624075,1,,1,,,,A,11482,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ
CHEMBL624076,1,,1,,,,A,11483,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ
CHEMBL624077,1,,1,,,,A,11484,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ
CHEMBL624078,1,,1,,,,A,11485,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ
CHEMBL624079,1,,1,,,,A,11486,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ
CHEMBL624261,1,,1,,,,A,11487,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ
CHEMBL624262,1,,1,,,,A,11488,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ
CHEMBL624263,1,,1,,,,A,11489,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ
CHEMBL624264,1,,1,,,,A,11490,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ
CHEMBL624265,1,,1,,,,A,11491,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ
CHEMBL624266,1,,1,,,,A,11492,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ
CHEMBL624267,1,,1,,,,A,11493,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ
CHEMBL624268,1,,1,,,,A,11494,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ
CHEMBL875227,1,,1,,,,A,11495,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ
CHEMBL624269,1,,1,,,,A,11496,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ
CHEMBL624270,1,,1,,,,A,11497,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ
CHEMBL624271,1,,1,,,,A,11498,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ
CHEMBL624272,1,,1,,,,A,11499,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ
CHEMBL624273,1,,1,,,,A,11500,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8319,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ
CHEMBL624274,1,,1,,,,A,11501,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12064,50597,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg
CHEMBL624275,1,,1,,,,A,11502,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12064,50597,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg
CHEMBL624276,1,,1,,,,A,11503,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12064,50597,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg
CHEMBL624277,1,,1,,,,A,11504,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12038,50597,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg
CHEMBL624278,0,,1,,,,A,11505,Autocuration,BAO_0000019,,U,,,,,,,14314,22224,,% dose converted to 2-amino-5-chlorophenyl sulfate
CHEMBL624279,0,,1,,,,A,11506,Autocuration,BAO_0000019,,U,,,,,,,14314,22224,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41)
CHEMBL624280,1,,1,,,,A,11507,Intermediate,BAO_0000218,1988.0,N,Rattus norvegicus,Feces,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr"
CHEMBL624281,1,,1,,,,A,11508,Intermediate,BAO_0000218,1988.0,N,Rattus norvegicus,Feces,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr"
CHEMBL622933,1,,1,,,,A,11509,Intermediate,BAO_0000218,1988.0,N,Rattus norvegicus,Feces,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr"
CHEMBL622934,1,,1,,,,A,11510,Intermediate,BAO_0000218,1988.0,N,Rattus norvegicus,Feces,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr"
CHEMBL622935,1,,1,,,,A,11511,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue
CHEMBL622936,1,,1,,,,A,11512,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat liver after 5 minutes of iv administration
CHEMBL875228,1,,1,,,,A,11513,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue
CHEMBL622937,1,,1,,,,A,11514,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat lung after 24 hours of iv administration
CHEMBL622938,1,,1,,,,A,11515,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue
CHEMBL619736,1,,1,,,,A,11516,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat lung after 30 minutes of iv administration
CHEMBL625117,1,,1,,,,A,11517,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue
CHEMBL625118,1,,1,,,,A,11518,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat lung after 5 minutes of iv administration
CHEMBL625119,1,,1,,,,A,11519,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,8829,50597,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue
CHEMBL625120,1,,1,,,,A,11520,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,14972,50597,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue"
CHEMBL625121,1,,1,,,,A,11521,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14972,50597,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue"
CHEMBL625122,1,,1,,,,A,11522,Intermediate,BAO_0000218,10000006.0,N,Rattus norvegicus,Thalamus,10116.0,,In vivo,,14972,50597,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue"
CHEMBL622204,1,,1,,,,A,11523,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL877503,1,,1,,,,A,11524,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL627127,1,,1,,,,A,11525,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL627128,0,,1,,,,A,11526,Autocuration,BAO_0000218,10000000.0,U,,Hippocampus,,,In vivo,,14608,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL627129,0,,1,,,,A,11527,Autocuration,BAO_0000218,10000000.0,U,,Hippocampus,,,In vivo,,14608,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL627130,0,,1,,,,A,11528,Autocuration,BAO_0000218,10000000.0,U,,Hippocampus,,,In vivo,,14608,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL627131,1,,1,,,,A,11529,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL627132,1,,1,,,,A,11530,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL627133,1,,1,,,,A,11531,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL627134,1,,1,,,,A,11532,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL627135,1,,1,,,,A,11533,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL627136,1,,1,,,,A,11534,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL628435,1,,1,,,,A,11535,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL628436,1,,1,,,,A,11536,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL628437,1,,1,,,,A,11537,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL628438,1,,1,,,,A,11538,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL628439,1,,1,,,,A,11539,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL628440,1,,1,,,,A,11540,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL628441,1,,1,,,,A,11541,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL628442,1,,1,,,,A,11542,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL628443,1,,1,,,,A,11543,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL628444,1,,1,,,,A,11544,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL628445,1,,1,,,,A,11545,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL877504,1,,1,,,,A,11546,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL628446,1,,1,,,,A,11547,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL626874,1,,1,,,,A,11548,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL626875,1,,1,,,,A,11549,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL626876,1,,1,,,,A,11550,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL626877,1,,1,,,,A,11551,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL626878,1,,1,,,,A,11552,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL626879,1,,1,,,,A,11553,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL626880,0,,1,,,,A,11554,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,In vivo,,8918,22224,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg
CHEMBL626881,1,,1,,,,A,11555,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,8918,50594,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg
CHEMBL626882,1,,1,,,,A,11556,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,8918,50597,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg
CHEMBL626883,1,,1,,,,A,11557,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14470,50588,,Peak plasma concentration was measured in dogs
CHEMBL626884,1,,1,,,,A,11558,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14393,50597,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats
CHEMBL626885,1,,1,,,,A,11559,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14886,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg
CHEMBL626886,1,,1,,,,A,11560,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14886,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg
CHEMBL626887,1,,1,,,,A,11561,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14886,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg
CHEMBL626888,1,,1,,,,A,11562,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14393,50597,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats
CHEMBL626889,1,,1,,,,A,11563,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13465,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog
CHEMBL626761,0,,1,,,,A,11564,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,13465,22224,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey
CHEMBL626762,1,,1,,,,A,11565,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13465,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog
CHEMBL626763,1,,1,,,,A,11566,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13465,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog
CHEMBL626764,1,,1,,,,A,11567,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13465,50597,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat
CHEMBL626765,1,,1,,,,A,11568,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13465,50597,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat
CHEMBL626766,1,,1,,,,A,11569,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13465,50588,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog
CHEMBL626767,1,,1,,,,A,11570,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13465,50597,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat
CHEMBL626768,1,,1,,,,A,11571,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13465,50597,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels
CHEMBL626769,1,,1,,,,A,11572,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13465,50588,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog
CHEMBL874463,1,,1,,,,A,11573,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13465,50588,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog
CHEMBL626770,0,,1,,,,A,11574,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,13465,22224,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey
CHEMBL626771,0,,1,,,,A,11575,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,13465,22224,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels
CHEMBL626772,1,,1,,,,A,11576,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13465,50597,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat
CHEMBL626773,1,,1,,,,A,11577,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,14731,100710,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. 
CHEMBL626774,1,,1,,,,A,11578,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14731,50594,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. 
CHEMBL626775,1,,1,,,,A,11579,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13376,50588,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg
CHEMBL626776,1,,1,,,,A,11580,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13376,50588,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg
CHEMBL626777,1,,1,,,,A,11581,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14443,50597,,Maximum concentration (Cmax) in rat when administered orally
CHEMBL626778,0,,1,,,,A,11582,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,In vivo,,13465,22224,,Maximal concentration in monkey plasma after 25 mg/kg oral dose
CHEMBL626779,0,,1,,,,A,11583,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,16359,22224,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)"
CHEMBL626780,0,,1,,,,A,11584,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,16359,22224,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)"
CHEMBL626781,0,,1,,,,A,11585,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,15618,22224,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose
CHEMBL632164,1,,1,,,,A,11586,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14554,50597,,Pharmacokinetic profile Cmax was evaluated in rats
CHEMBL632165,1,,1,,,,A,11587,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,11537,50588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg)
CHEMBL632166,1,,1,,,,A,11588,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,11537,50594,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg)
CHEMBL632167,1,,1,,,,A,11589,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,11537,50588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg)
CHEMBL632168,1,,1,,,,A,11590,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,11537,50594,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg)
CHEMBL632169,0,,1,,,,A,11591,Autocuration,BAO_0000218,1969.0,U,Rattus norvegicus,Plasma,10116.0,,In vivo,,2021,22224,,Cmax in rat plasma
CHEMBL632170,1,,1,,,,A,11592,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,5932,50588,,Cmax in dog plasma after 30mg/kg oral dose
CHEMBL632171,1,,1,,,,A,11593,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5932,50597,,Cmax in rat plasma after 30mg/kg oral dose
CHEMBL632172,1,,1,,,,A,11594,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,17320,50597,,Plasma level in rats at 30 mg/kg
CHEMBL632173,1,,1,,,,A,11595,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,15831,50594,,Tested for maximum plasma concentration in mice
CHEMBL632174,1,,1,,,,A,11596,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15078,50597,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL632175,1,,1,,,,A,11597,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14941,50597,,The Cmax values in female wistar rats.
CHEMBL632176,1,,1,,,,A,11598,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,15343,50588,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose
CHEMBL632177,1,,1,,,,A,11599,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15343,50597,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose
CHEMBL632178,1,,1,,,,A,11600,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14856,50597,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.
CHEMBL632179,1,,1,,,,A,11601,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13129,50597,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.
CHEMBL632180,1,,1,,,,A,11602,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13098,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.
CHEMBL632181,1,,1,,,,A,11603,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13098,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.
CHEMBL632182,1,,1,,,,A,11604,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13098,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.
CHEMBL632183,0,,1,,,,A,11605,Autocuration,BAO_0000218,178.0,U,Mus musculus,Blood,10090.0,,In vivo,,15478,22224,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.
CHEMBL632184,1,,1,,,,A,11606,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,15341,50588,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.
CHEMBL874470,1,,1,,,,A,11607,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15341,50597,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.
CHEMBL631302,1,,1,,,,A,11608,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm"
CHEMBL631303,1,,1,,,,A,11609,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm"
CHEMBL631304,1,,1,,,,A,11610,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm"
CHEMBL631305,1,,1,,,,A,11611,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm"
CHEMBL631306,1,,1,,,,A,11612,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm"
CHEMBL631307,1,,1,,,,A,11613,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm"
CHEMBL631308,1,,1,,,,A,11614,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm"
CHEMBL625557,1,,1,,,,A,11615,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8684,50597,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm"
CHEMBL625558,1,,1,,,,A,11616,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,8684,50597,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm"
CHEMBL625559,1,,1,,,,A,11617,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,8684,50597,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm"
CHEMBL625560,1,,1,,,,A,11618,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,8684,50597,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm"
CHEMBL625561,1,,1,,,,A,11619,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,8684,50597,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm"
CHEMBL625562,1,,1,,,,A,11620,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,8684,50597,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm"
CHEMBL875320,1,,1,,,,A,11621,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,8684,50597,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm"
CHEMBL625563,1,,1,,,,A,11622,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,8684,50597,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm"
CHEMBL625564,1,,1,,,,A,11623,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,8684,50597,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm"
CHEMBL625565,1,,1,,,,A,11624,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8684,50597,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm"
CHEMBL625566,1,,1,,,,A,11625,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8684,50597,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm"
CHEMBL625567,1,,1,,,,A,11626,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8684,50597,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm"
CHEMBL625568,1,,1,,,,A,11627,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8684,50597,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm"
CHEMBL628217,1,,1,,,,A,11628,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8684,50597,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm"
CHEMBL628218,1,,1,,,,A,11629,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8684,50597,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm"
CHEMBL628219,1,,1,,,,A,11630,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8684,50597,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm"
CHEMBL628220,1,,1,,,,A,11631,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8684,50597,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm"
CHEMBL628221,0,,1,,,,A,11632,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the blood after 120 min of intravenous administration
CHEMBL628222,0,,1,,,,A,11633,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the blood after 15 min of intravenous administration
CHEMBL628223,0,,1,,,,A,11634,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the blood after 30 min of intravenous administration
CHEMBL628224,0,,1,,,,A,11635,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the blood after 5 min of intravenous administration
CHEMBL628225,0,,1,,,,A,11636,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the blood after 60 min of intravenous administration
CHEMBL628226,0,,1,,,,A,11637,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the blood after 90 min of intravenous administration
CHEMBL628227,0,,1,,,,A,11638,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the bone after 120 min of intravenous administration
CHEMBL875481,0,,1,,,,A,11639,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the bone after 15 min of intravenous administration
CHEMBL628228,0,,1,,,,A,11640,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the bone after 30 min of intravenous administration
CHEMBL628229,0,,1,,,,A,11641,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the bone after 5 min of intravenous administration
CHEMBL628230,0,,1,,,,A,11642,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the bone after 60 min of intravenous administration
CHEMBL628231,0,,1,,,,A,11643,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the bone after 90 min of intravenous administration
CHEMBL628232,0,,1,,,,A,11644,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the heart after 120 min of intravenous administration
CHEMBL628233,0,,1,,,,A,11645,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the heart after 15 min of intravenous administration
CHEMBL628234,0,,1,,,,A,11646,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the heart after 30 min of intravenous administration
CHEMBL628235,0,,1,,,,A,11647,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the heart after 5 min of intravenous administration
CHEMBL628236,0,,1,,,,A,11648,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the heart after 60 min of intravenous administration
CHEMBL628237,0,,1,,,,A,11649,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the heart after 90 min of intravenous administration
CHEMBL628238,0,,1,,,,A,11650,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the kidneys after 120 min of intravenous administration
CHEMBL628239,0,,1,,,,A,11651,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the kidneys after 15 min of intravenous administration
CHEMBL628240,0,,1,,,,A,11652,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the kidneys after 30 min of intravenous administration
CHEMBL628241,0,,1,,,,A,11653,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the kidneys after 5 min of intravenous administration
CHEMBL628242,0,,1,,,,A,11654,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the kidneys after 60 min of intravenous administration
CHEMBL875482,0,,1,,,,A,11655,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the kidneys after 90 min of intravenous administration
CHEMBL628243,0,,1,,,,A,11656,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the liver after 120 min of intravenous administration
CHEMBL628244,0,,1,,,,A,11657,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the liver after 15 min of intravenous administration
CHEMBL628245,0,,1,,,,A,11658,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the liver after 30 min of intravenous administration
CHEMBL628246,0,,1,,,,A,11659,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the liver after 5 min of intravenous administration
CHEMBL628247,0,,1,,,,A,11660,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the liver after 60 min of intravenous administration
CHEMBL628248,0,,1,,,,A,11661,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the liver after 90 min of intravenous administration
CHEMBL628249,0,,1,,,,A,11662,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the lung after 120 min of intravenous administration
CHEMBL625452,1,,1,,,,A,11663,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)"
CHEMBL625453,1,,1,,,,A,11664,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)"
CHEMBL625454,1,,1,,,,A,11665,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)"
CHEMBL623844,1,,1,,,,A,11666,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14839,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)"
CHEMBL623845,1,,1,,,,A,11667,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12178,50597,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat
CHEMBL623846,1,,1,,,,A,11668,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12178,50597,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat
CHEMBL623847,0,,1,,,,A,11669,Autocuration,BAO_0000218,,U,,,,,,,12178,22224,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP
CHEMBL623848,1,,1,,,,A,11670,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,12186,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay
CHEMBL623849,1,,1,,,,A,11671,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,12186,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay
CHEMBL623850,1,,1,,,,A,11672,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,12186,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay
CHEMBL623851,1,,1,,,,A,11673,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,12186,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay
CHEMBL623852,0,,1,,,,A,11674,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,12187,22224,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey
CHEMBL624551,1,,1,,,,A,11675,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,12187,50506,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret
CHEMBL624552,1,,1,,,,A,11676,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,12187,50506,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay"
CHEMBL624553,0,,1,,,,A,11677,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,12187,22224,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey
CHEMBL624554,0,,1,,,,A,11678,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,12187,22224,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay
CHEMBL624555,1,,1,,,,A,11679,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12187,50597,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat
CHEMBL624741,1,,1,,,,A,11680,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12187,50597,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay"
CHEMBL624742,1,,1,,,,A,11681,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14122,50588,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma"
CHEMBL624743,1,,1,,,,A,11682,Intermediate,BAO_0000218,,N,Cricetinae,,10026.0,,,,14122,100712,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma"
CHEMBL877606,1,,1,,,,A,11683,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14122,50597,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma"
CHEMBL624744,0,,1,,,,A,11684,Autocuration,BAO_0000218,,U,,,,,,,13391,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg
CHEMBL624745,0,,1,,,,A,11685,Autocuration,BAO_0000218,178.0,U,,Blood,,,,,13391,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM
CHEMBL624746,0,,1,,,,A,11686,Autocuration,BAO_0000218,178.0,U,,Blood,,,,,13391,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM
CHEMBL624747,0,,1,,,,A,11687,Autocuration,BAO_0000218,178.0,U,,Blood,,,,,13391,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM
CHEMBL624748,0,,1,,,,A,11688,Autocuration,BAO_0000019,,U,,,,,,,16360,22224,,Oral absorption expressed as Area under curve was determined
CHEMBL622504,1,,1,,,,A,11689,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,3673,50588,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs
CHEMBL622505,1,,1,,,,A,11690,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14122,50588,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma"
CHEMBL622506,1,,1,,,,A,11691,Intermediate,BAO_0000218,,N,Cricetinae,,10026.0,,,,14122,100712,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma"
CHEMBL622507,1,,1,,,,A,11692,Intermediate,BAO_0000218,,N,Cricetinae,,10026.0,,,,14122,100712,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma"
CHEMBL622508,1,,1,,,,A,11693,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14122,50597,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma"
CHEMBL622509,0,,1,,,,A,11694,Autocuration,BAO_0000019,,U,,,,,,,13889,22224,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound
CHEMBL622510,1,,1,,,,A,11695,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14393,50597,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats
CHEMBL622511,1,,1,,,,A,11696,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17279,50597,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer)
CHEMBL622512,1,,1,,,,A,11697,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14548,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration
CHEMBL622513,1,,1,,,,A,11698,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14548,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration
CHEMBL622514,1,,1,,,,A,11699,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14548,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration
CHEMBL622515,1,,1,,,,A,11700,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14548,50588,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration
CHEMBL622516,1,,1,,,,A,11701,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14548,50588,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration
CHEMBL622517,1,,1,,,,A,11702,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14548,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration
CHEMBL622518,1,,1,,,,A,11703,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14548,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration
CHEMBL622519,1,,1,,,,A,11704,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14548,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration
CHEMBL622520,1,,1,,,,A,11705,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL622521,1,,1,,,,A,11706,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL625113,1,,1,,,,A,11707,Intermediate,BAO_0000218,14.0,N,Mus musculus,Zone of skin,10090.0,,In vivo,,14608,50594,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL625114,1,,1,,,,A,11708,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL874397,1,,1,,,,A,11709,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL625115,1,,1,,,,A,11710,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL625116,1,,1,,,,A,11711,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL623932,1,,1,,,,A,11712,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL623933,1,,1,,,,A,11713,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL623934,1,,1,,,,A,11714,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL623935,1,,1,,,,A,11715,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL623936,1,,1,,,,A,11716,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min
CHEMBL623937,1,,1,,,,A,11717,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min
CHEMBL623938,1,,1,,,,A,11718,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,14608,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min
CHEMBL623939,1,,1,,,,A,11719,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day
CHEMBL623940,1,,1,,,,A,11720,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g
CHEMBL623941,1,,1,,,,A,11721,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g
CHEMBL627216,1,,1,,,,A,11722,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL623942,1,,1,,,,A,11723,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL618793,1,,1,,,,A,11724,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,15383,50594,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day
CHEMBL618794,1,,1,,,,A,11725,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,15383,50594,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL618795,1,,1,,,,A,11726,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,15383,50594,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL618796,1,,1,,,,A,11727,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL618797,1,,1,,,,A,11728,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL618798,1,,1,,,,A,11729,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,,,15383,50594,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day
CHEMBL618799,1,,1,,,,A,11730,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,,,15383,50594,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day
CHEMBL618800,1,,1,,,,A,11731,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,,,15383,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g
CHEMBL618801,1,,1,,,,A,11732,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,,,15383,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g
CHEMBL618802,1,,1,,,,A,11733,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,,,15383,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL618803,1,,1,,,,A,11734,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,,,15383,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL618804,1,,1,,,,A,11735,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,,,15383,50594,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day
CHEMBL618805,1,,1,,,,A,11736,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,,,15383,50594,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day
CHEMBL618806,1,,1,,,,A,11737,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,,,15383,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g
CHEMBL618807,1,,1,,,,A,11738,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,,,15383,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g
CHEMBL618808,1,,1,,,,A,11739,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,,,15383,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL618809,1,,1,,,,A,11740,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,,,15383,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL618810,1,,1,,,,A,11741,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,,,15383,50594,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day
CHEMBL618811,1,,1,,,,A,11742,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,,,15383,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g
CHEMBL875844,1,,1,,,,A,11743,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,,,15383,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g
CHEMBL618812,1,,1,,,,A,11744,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,,,15383,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL618813,1,,1,,,,A,11745,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,,,15383,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL618814,1,,1,,,,A,11746,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day
CHEMBL618815,1,,1,,,,A,11747,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL618816,1,,1,,,,A,11748,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL618817,1,,1,,,,A,11749,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL620544,1,,1,,,,A,11750,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL626230,1,,1,,,,A,11751,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15341,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.
CHEMBL626231,1,,1,,,,A,11752,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15341,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.
CHEMBL626232,1,,1,,,,A,11753,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15341,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.
CHEMBL626233,1,,1,,,,A,11754,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14906,50588,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.
CHEMBL626234,1,,1,,,,A,11755,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14906,50597,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat
CHEMBL875341,1,,1,,,,A,11756,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14906,50597,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.
CHEMBL626235,1,,1,,,,A,11757,Intermediate,BAO_0000218,1969.0,N,Homo sapiens,Plasma,9606.0,,In vivo,,14215,50587,,The maximum plasma concentration (100 mg/kg) administered orally in human
CHEMBL626236,0,,1,,,,A,11758,Autocuration,BAO_0000218,1969.0,U,Callithrix,Plasma,9481.0,,In vivo,,14215,22224,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset
CHEMBL626237,0,,1,,,,A,11759,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,In vivo,,14215,22224,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey
CHEMBL626238,1,,1,,,,A,11760,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14215,50588,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog
CHEMBL622412,1,,1,,,,A,11761,Intermediate,BAO_0000218,1969.0,N,Homo sapiens,Plasma,9606.0,,In vivo,,14215,50587,,The maximum plasma concentration (200 mg/kg) administered orally in human
CHEMBL623114,1,,1,,,,A,11762,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14215,50597,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat
CHEMBL623115,0,,1,,,,A,11763,Autocuration,BAO_0000218,1969.0,U,Callithrix,Plasma,9481.0,,In vivo,,14215,22224,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset
CHEMBL623116,0,,1,,,,A,11764,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,In vivo,,14215,22224,,The maximum plasma concentration (25 mg/kg) administered orally in monkey
CHEMBL623117,0,,1,,,,A,11765,Autocuration,BAO_0000218,1969.0,U,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14215,22224,,The maximum plasma concentration (30 mg/kg) administered orally in dog
CHEMBL623118,1,,1,,,,A,11766,Intermediate,BAO_0000218,1969.0,N,Homo sapiens,Plasma,9606.0,,In vivo,,14215,50587,,The maximum plasma concentration (400 mg/kg) administered orally in human
CHEMBL623119,1,,1,,,,A,11767,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14215,50597,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat
CHEMBL623120,1,,1,,,,A,11768,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14215,50597,,The maximum plasma concentration (50 mg/kg) administered orally in rat
CHEMBL623286,1,,1,,,,A,11769,Intermediate,BAO_0000218,1969.0,N,Homo sapiens,Plasma,9606.0,,In vivo,,14215,50587,,The maximum plasma concentration (800 mg/kg) administered orally in human
CHEMBL623287,1,,1,,,,A,11770,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14067,50597,,The maximum plasma concentration was measured on rats
CHEMBL623288,1,,1,,,,A,11771,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12350,50597,,The maximum plasma concentration was measured on rats after oral administration
CHEMBL623289,1,,1,,,,A,11772,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14813,50597,,Plasma drug Cmax in rat (PO dose)
CHEMBL623290,0,,1,,,,A,11773,Autocuration,BAO_0000218,,U,,,,,In vivo,,12536,22224,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously
CHEMBL623291,1,,1,,,,A,11774,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14169,50588,,maximum Plasma concentration in Dog was determined after Peroral administration
CHEMBL623292,1,,1,,,,A,11775,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14169,50597,,maximum Plasma concentration in Rats was determined after Peroral administration
CHEMBL623293,1,,1,,,,A,11776,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,15604,50588,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog
CHEMBL623294,0,,1,,,,A,11777,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,In vivo,,15604,22224,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey
CHEMBL623295,1,,1,,,,A,11778,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15604,50597,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat
CHEMBL623296,1,,1,,,,A,11779,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14387,50594,,maximum concentration was measured when administered through oral route in mice
CHEMBL875349,1,,1,,,,A,11780,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15115,50594,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1
CHEMBL623297,0,,1,,,,A,11781,Autocuration,BAO_0000019,,U,Simiiformes,,314293.0,,,,15115,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1
CHEMBL623298,0,,1,,,,A,11782,Autocuration,BAO_0000019,,U,Simiiformes,,314293.0,,,,15115,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6
CHEMBL623299,0,,1,,,,A,11783,Autocuration,BAO_0000019,,U,Simiiformes,,314293.0,,,,15115,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3
CHEMBL623300,1,,1,,,,A,11784,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,16359,50597,,Pharmacokinetic parameter was evaluated in rats
CHEMBL623301,1,,1,,,,A,11785,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12829,50594,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle
CHEMBL623302,1,,1,,,,A,11786,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12829,50594,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle
CHEMBL623303,1,,1,,,,A,11787,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12829,50594,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle
CHEMBL623304,1,,1,,,,A,11788,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12829,50594,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle
CHEMBL623305,1,,1,,,,A,11789,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12829,50594,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle
CHEMBL623306,1,,1,,,,A,11790,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,15137,50597,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.
CHEMBL623307,1,,1,,,,A,11791,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,15137,50597,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.
CHEMBL623308,1,,1,,,,A,11792,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,15137,50597,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.
CHEMBL623309,1,,1,,,,A,11793,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,,,15137,50594,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.
CHEMBL623310,1,,1,,,,A,11794,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13509,50594,,Plasma Concentration after 120 min of oral administration to mice
CHEMBL623311,1,,1,,,,A,11795,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13509,50594,,Plasma Concentration after 30 min of oral administration to mice
CHEMBL623312,1,,1,,,,A,11796,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,13509,100710,,Plasma Concentration after 60 min of oral administration to mice
CHEMBL875350,1,,1,,,,A,11797,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13509,50594,,Plasma Concentration after 60 min of oral administration to mice; Not determined
CHEMBL628635,1,,1,,,,A,11798,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13509,50594,,Plasma Concentration after 90 min of oral administration to mice
CHEMBL628636,1,,1,,,,A,11799,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12064,50597,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg
CHEMBL628637,1,,1,,,,A,11800,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12064,50597,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg
CHEMBL628058,1,,1,,,,A,11801,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12064,50597,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg
CHEMBL628059,1,,1,,,,A,11802,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10677,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time
CHEMBL628060,1,,1,,,,A,11803,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10677,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time
CHEMBL628061,0,,1,,,,A,11804,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the lung after 15 min of intravenous administration
CHEMBL628062,0,,1,,,,A,11805,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the lung after 30 min of intravenous administration
CHEMBL628063,0,,1,,,,A,11806,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the lung after 5 min of intravenous administration
CHEMBL628064,0,,1,,,,A,11807,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the lung after 60 min of intravenous administration
CHEMBL628065,0,,1,,,,A,11808,Autocuration,BAO_0000019,,U,,,,,,,8926,22224,,Distribution in the lung after 90 min of intravenous administration
CHEMBL628066,0,,1,,,,A,11809,Autocuration,BAO_0000019,2385.0,U,,Muscle tissue,,,,,8926,22224,,Distribution in the muscle after 120 min of intravenous administration
CHEMBL628067,0,,1,,,,A,11810,Autocuration,BAO_0000019,2385.0,U,,Muscle tissue,,,,,8926,22224,,Distribution in the muscle after 15 min of intravenous administration
CHEMBL874646,1,,1,,,,A,11811,Intermediate,BAO_0000218,2385.0,N,Mus musculus,Muscle tissue,10090.0,,,,8926,50594,,Distribution in the muscle after 30 min of intravenous administration
CHEMBL628068,0,,1,,,,A,11812,Autocuration,BAO_0000019,2385.0,U,,Muscle tissue,,,,,8926,22224,,Distribution in the muscle after 5 min of intravenous administration
CHEMBL628069,0,,1,,,,A,11813,Autocuration,BAO_0000019,2385.0,U,,Muscle tissue,,,,,8926,22224,,Distribution in the muscle after 60 min of intravenous administration
CHEMBL628070,0,,1,,,,A,11814,Autocuration,BAO_0000019,2385.0,U,,Muscle tissue,,,,,8926,22224,,Distribution in the muscle after 90 min of intravenous administration
CHEMBL628071,0,,1,,,,A,11815,Autocuration,BAO_0000019,2106.0,U,,Spleen,,,,,8926,22224,,Distribution in the spleen after 120 min of intravenous administration
CHEMBL628072,0,,1,,,,A,11816,Autocuration,BAO_0000019,2106.0,U,,Spleen,,,,,8926,22224,,Distribution in the spleen after 15 min of intravenous administration
CHEMBL628073,0,,1,,,,A,11817,Autocuration,BAO_0000019,2106.0,U,,Spleen,,,,,8926,22224,,Distribution in the spleen after 30 min of intravenous administration
CHEMBL628074,0,,1,,,,A,11818,Autocuration,BAO_0000019,2106.0,U,,Spleen,,,,,8926,22224,,Distribution in the spleen after 5 min of intravenous administration
CHEMBL628075,0,,1,,,,A,11819,Autocuration,BAO_0000019,2106.0,U,,Spleen,,,,,8926,22224,,Distribution in the spleen after 60 min of intravenous administration
CHEMBL628076,0,,1,,,,A,11820,Autocuration,BAO_0000019,2106.0,U,,Spleen,,,,,8926,22224,,Distribution in the spleen after 90 min of intravenous administration
CHEMBL628077,1,,1,,,,A,11821,Intermediate,BAO_0000218,1235.0,N,Rattus norvegicus,Adrenal cortex,10116.0,,,,7570,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats
CHEMBL628078,1,,1,,,,A,11822,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7570,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats
CHEMBL628079,1,,1,,,,A,11823,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7570,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats
CHEMBL628080,1,,1,,,,A,11824,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,,,7570,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats
CHEMBL628081,1,,1,,,,A,11825,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,7570,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats
CHEMBL628082,1,,1,,,,A,11826,Intermediate,BAO_0000218,1235.0,N,Rattus norvegicus,Adrenal cortex,10116.0,,,,7570,50597,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats
CHEMBL874647,1,,1,,,,A,11827,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7570,50597,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats
CHEMBL626406,1,,1,,,,A,11828,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7570,50597,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats
CHEMBL626407,1,,1,,,,A,11829,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,,,7570,50597,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats
CHEMBL626408,1,,1,,,,A,11830,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,7570,50597,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats
CHEMBL626409,1,,1,,,,A,11831,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09"
CHEMBL626410,1,,1,,,,A,11832,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13"
CHEMBL626411,1,,1,,,,A,11833,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24"
CHEMBL626412,1,,1,,,,A,11834,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24"
CHEMBL626413,1,,1,,,,A,11835,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32"
CHEMBL626414,1,,1,,,,A,11836,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32"
CHEMBL626415,1,,1,,,,A,11837,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14"
CHEMBL626416,1,,1,,,,A,11838,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34"
CHEMBL627062,1,,1,,,,A,11839,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33"
CHEMBL627063,1,,1,,,,A,11840,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46"
CHEMBL627064,1,,1,,,,A,11841,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45"
CHEMBL627227,1,,1,,,,A,11842,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52"
CHEMBL627228,1,,1,,,,A,11843,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09"
CHEMBL627229,1,,1,,,,A,11844,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14"
CHEMBL625792,1,,1,,,,A,11845,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15"
CHEMBL625793,1,,1,,,,A,11846,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20"
CHEMBL625794,1,,1,,,,A,11847,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23"
CHEMBL625795,1,,1,,,,A,11848,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21"
CHEMBL625796,1,,1,,,,A,11849,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13792,50594,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.
CHEMBL625797,1,,1,,,,A,11850,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,13376,50588,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg
CHEMBL625798,1,,1,,,,A,11851,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,13376,50588,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg
CHEMBL875613,0,,1,,,,A,11852,Autocuration,BAO_0000218,,U,,,,,,,14380,22224,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally
CHEMBL625799,0,,1,,,,A,11853,Autocuration,BAO_0000218,,U,,,,,,,14380,22224,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally
CHEMBL625800,0,,1,,,,A,11854,Autocuration,BAO_0000218,,U,,,,,,,14380,22224,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally
CHEMBL625801,0,,1,,,,A,11855,Autocuration,BAO_0000218,,U,,,,,,,14380,22224,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally
CHEMBL625802,0,,1,,,,A,11856,Autocuration,BAO_0000218,,U,,,,,,,14380,22224,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally
CHEMBL625803,0,,1,,,,A,11857,Autocuration,BAO_0000218,,U,,,,,,,14380,22224,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally
CHEMBL625804,0,,1,,,,A,11858,Autocuration,BAO_0000019,,U,,,,,,,14380,22224,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution
CHEMBL622530,0,,1,,,,A,11859,Autocuration,BAO_0000218,,U,,,,,,,14380,22224,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally
CHEMBL622531,1,,1,,,,A,11860,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected
CHEMBL622532,1,,1,,,,A,11861,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h)
CHEMBL623176,1,,1,,,,A,11862,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h)
CHEMBL623177,1,,1,,,,A,11863,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h)
CHEMBL623178,1,,1,,,,A,11864,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h)
CHEMBL623179,1,,1,,,,A,11865,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected
CHEMBL623180,1,,1,,,,A,11866,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h)
CHEMBL623181,1,,1,,,,A,11867,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h)
CHEMBL624131,1,,1,,,,A,11868,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h)
CHEMBL624132,1,,1,,,,A,11869,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h)
CHEMBL624133,1,,1,,,,A,11870,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h)
CHEMBL624846,1,,1,,,,A,11871,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).
CHEMBL624847,1,,1,,,,A,11872,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h)
CHEMBL624848,1,,1,,,,A,11873,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h)
CHEMBL625012,1,,1,,,,A,11874,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h)
CHEMBL625013,1,,1,,,,A,11875,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h)
CHEMBL625014,1,,1,,,,A,11876,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected
CHEMBL625015,1,,1,,,,A,11877,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h)
CHEMBL625016,1,,1,,,,A,11878,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h)
CHEMBL625017,1,,1,,,,A,11879,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected
CHEMBL625018,1,,1,,,,A,11880,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h)
CHEMBL625019,1,,1,,,,A,11881,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h)
CHEMBL625020,1,,1,,,,A,11882,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h)
CHEMBL625021,1,,1,,,,A,11883,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.
CHEMBL625022,1,,1,,,,A,11884,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14393,50597,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats
CHEMBL625023,1,,1,,,,A,11885,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14731,50594,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. 
CHEMBL625024,1,,1,,,,A,11886,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14731,100710,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration
CHEMBL627626,1,,1,,,,A,11887,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,14731,100710,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. 
CHEMBL627627,0,,1,,,,A,11888,Autocuration,BAO_0000218,955.0,U,,Brain,,,,,13758,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain
CHEMBL627628,0,,1,,,,A,11889,Autocuration,BAO_0000218,1977.0,U,,Serum,,,,,13758,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum
CHEMBL627629,0,,1,,,,A,11890,Autocuration,BAO_0000218,955.0,U,,Brain,,,,,13758,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain
CHEMBL627630,0,,1,,,,A,11891,Autocuration,BAO_0000218,1977.0,U,,Serum,,,,,13758,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum
CHEMBL627631,0,,1,,,,A,11892,Autocuration,BAO_0000019,,U,,,,,,,16359,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35)
CHEMBL629515,0,,1,,,,A,11893,Autocuration,BAO_0000218,,U,,,,,,,16359,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3)
CHEMBL629516,1,,1,,,,A,11894,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,,,15383,50594,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day
CHEMBL629517,1,,1,,,,A,11895,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,,,15383,50594,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL629518,1,,1,,,,A,11896,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,,,15383,50594,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL877499,1,,1,,,,A,11897,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day
CHEMBL629519,1,,1,,,,A,11898,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g
CHEMBL629520,1,,1,,,,A,11899,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g
CHEMBL629521,1,,1,,,,A,11900,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,15383,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g
CHEMBL629522,1,,1,,,,A,11901,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B)
CHEMBL629523,1,,1,,,,A,11902,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L)
CHEMBL629524,1,,1,,,,A,11903,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M)
CHEMBL629525,1,,1,,,,A,11904,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B)
CHEMBL629526,1,,1,,,,A,11905,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B)
CHEMBL629527,1,,1,,,,A,11906,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L)
CHEMBL629528,1,,1,,,,A,11907,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M)
CHEMBL629529,1,,1,,,,A,11908,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B)
CHEMBL629530,1,,1,,,,A,11909,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B)
CHEMBL629531,1,,1,,,,A,11910,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L)
CHEMBL628656,1,,1,,,,A,11911,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M)
CHEMBL628657,1,,1,,,,A,11912,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14439,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B)
CHEMBL628658,1,,1,,,,A,11913,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL628659,1,,1,,,,A,11914,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL877500,1,,1,,,,A,11915,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g"
CHEMBL628660,1,,1,,,,A,11916,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL628661,1,,1,,,,A,11917,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL628662,1,,1,,,,A,11918,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL628663,1,,1,,,,A,11919,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g"
CHEMBL628664,1,,1,,,,A,11920,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g"
CHEMBL628665,1,,1,,,,A,11921,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13751,50597,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL628666,1,,1,,,,A,11922,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13751,50597,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g"
CHEMBL628667,1,,1,,,,A,11923,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13751,50597,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL628668,1,,1,,,,A,11924,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13751,50597,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL628669,1,,1,,,,A,11925,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13751,50597,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL628670,1,,1,,,,A,11926,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13751,50597,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g"
CHEMBL628671,1,,1,,,,A,11927,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13751,50597,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g"
CHEMBL628672,1,,1,,,,A,11928,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,13751,50597,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL630300,1,,1,,,,A,11929,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,13751,50597,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL629787,1,,1,,,,A,11930,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,13751,50597,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL629788,1,,1,,,,A,11931,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,13751,50597,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL629789,1,,1,,,,A,11932,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13751,50597,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL629790,1,,1,,,,A,11933,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13751,50597,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g"
CHEMBL629791,1,,1,,,,A,11934,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13751,50597,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL629792,1,,1,,,,A,11935,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13751,50597,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL629793,1,,1,,,,A,11936,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13751,50597,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL629794,1,,1,,,,A,11937,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13751,50597,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g"
CHEMBL874459,1,,1,,,,A,11938,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10677,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time
CHEMBL629795,1,,1,,,,A,11939,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10677,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time
CHEMBL629796,1,,1,,,,A,11940,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10677,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time
CHEMBL629797,1,,1,,,,A,11941,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10677,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time
CHEMBL629798,1,,1,,,,A,11942,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10677,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time
CHEMBL629799,1,,1,,,,A,11943,Intermediate,BAO_0000218,2369.0,N,Rattus norvegicus,Adrenal gland,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL629800,1,,1,,,,A,11944,Intermediate,BAO_0000218,2369.0,N,Rattus norvegicus,Adrenal gland,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL629801,1,,1,,,,A,11945,Intermediate,BAO_0000218,2369.0,N,Rattus norvegicus,Adrenal gland,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL629802,1,,1,,,,A,11946,Intermediate,BAO_0000218,2369.0,N,Rattus norvegicus,Adrenal gland,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour
CHEMBL629803,1,,1,,,,A,11947,Intermediate,BAO_0000218,2369.0,N,Rattus norvegicus,Adrenal gland,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL629804,1,,1,,,,A,11948,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL629805,1,,1,,,,A,11949,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL629806,1,,1,,,,A,11950,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram
CHEMBL629807,1,,1,,,,A,11951,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL629808,1,,1,,,,A,11952,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL629809,1,,1,,,,A,11953,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL629810,1,,1,,,,A,11954,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL629811,1,,1,,,,A,11955,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram
CHEMBL629812,1,,1,,,,A,11956,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL629813,1,,1,,,,A,11957,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram
CHEMBL874460,1,,1,,,,A,11958,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL629814,1,,1,,,,A,11959,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL629815,1,,1,,,,A,11960,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL629816,1,,1,,,,A,11961,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL629817,1,,1,,,,A,11962,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL626643,1,,1,,,,A,11963,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL626644,1,,1,,,,A,11964,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL626806,1,,1,,,,A,11965,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL626807,1,,1,,,,A,11966,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL627261,1,,1,,,,A,11967,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL627262,1,,1,,,,A,11968,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL627263,1,,1,,,,A,11969,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL627264,1,,1,,,,A,11970,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL627265,1,,1,,,,A,11971,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL627266,1,,1,,,,A,11972,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL627267,1,,1,,,,A,11973,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL627268,1,,1,,,,A,11974,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL627269,1,,1,,,,A,11975,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL627270,1,,1,,,,A,11976,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL627271,1,,1,,,,A,11977,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44"
CHEMBL627946,1,,1,,,,A,11978,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43"
CHEMBL875472,1,,1,,,,A,11979,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96"
CHEMBL627947,1,,1,,,,A,11980,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69"
CHEMBL627948,1,,1,,,,A,11981,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31"
CHEMBL628113,1,,1,,,,A,11982,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70"
CHEMBL628114,1,,1,,,,A,11983,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97"
CHEMBL628115,1,,1,,,,A,11984,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46"
CHEMBL628116,1,,1,,,,A,11985,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52"
CHEMBL628117,1,,1,,,,A,11986,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62"
CHEMBL628118,1,,1,,,,A,11987,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86"
CHEMBL628119,1,,1,,,,A,11988,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74"
CHEMBL628120,1,,1,,,,A,11989,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57"
CHEMBL628121,1,,1,,,,A,11990,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58"
CHEMBL628122,1,,1,,,,A,11991,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32"
CHEMBL627297,1,,1,,,,A,11992,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70"
CHEMBL627298,1,,1,,,,A,11993,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92"
CHEMBL627299,1,,1,,,,A,11994,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44"
CHEMBL627300,1,,1,,,,A,11995,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31"
CHEMBL627301,1,,1,,,,A,11996,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4"
CHEMBL627302,1,,1,,,,A,11997,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41"
CHEMBL627303,1,,1,,,,A,11998,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2"
CHEMBL627304,1,,1,,,,A,11999,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95"
CHEMBL627305,1,,1,,,,A,12000,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72"
CHEMBL627306,1,,1,,,,A,12001,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56"
CHEMBL623982,1,,1,,,,A,12002,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9"
CHEMBL623983,1,,1,,,,A,12003,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6"
CHEMBL623984,1,,1,,,,A,12004,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1"
CHEMBL623985,1,,1,,,,A,12005,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72"
CHEMBL623986,1,,1,,,,A,12006,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9"
CHEMBL623987,1,,1,,,,A,12007,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25"
CHEMBL623988,1,,1,,,,A,12008,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68"
CHEMBL623989,1,,1,,,,A,12009,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81"
CHEMBL622215,1,,1,,,,A,12010,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60"
CHEMBL622216,1,,1,,,,A,12011,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57"
CHEMBL877481,1,,1,,,,A,12012,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41"
CHEMBL622217,0,,1,,,,A,12013,Autocuration,BAO_0000218,,U,,,,,,,16359,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8)
CHEMBL622218,1,,1,,,,A,12014,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13701,50594,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h)
CHEMBL622219,1,,1,,,,A,12015,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14554,50597,,Pharmacokinetic profile AUC was evaluated in rats
CHEMBL622220,0,,1,,,,A,12016,Autocuration,BAO_0000019,,U,,,,,,,6241,22224,,Pharmacokinetic property (Area under curve)
CHEMBL622221,1,,1,,,,A,12017,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,11537,50588,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg)."
CHEMBL622222,1,,1,,,,A,12018,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,11537,50594,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg)."
CHEMBL622223,1,,1,,,,A,12019,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,11537,50588,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg)."
CHEMBL622224,1,,1,,,,A,12020,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,11537,50594,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg)."
CHEMBL622225,0,,1,,,,A,12021,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Plasma concentration (AUC) was determined
CHEMBL622226,0,,1,,,,A,12022,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Plasma concentration (AUC) was determined; Not detectable
CHEMBL624154,1,,1,,,,A,12023,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,,,9562,50512,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC)
CHEMBL624155,1,,1,,,,A,12024,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10363,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg
CHEMBL624156,1,,1,,,,A,12025,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10363,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant
CHEMBL624157,1,,1,,,,A,12026,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10363,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg
CHEMBL624158,1,,1,,,,A,12027,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10363,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg
CHEMBL624159,1,,1,,,,A,12028,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12504,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1
CHEMBL624160,1,,1,,,,A,12029,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12504,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2
CHEMBL624161,1,,1,,,,A,12030,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12504,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3
CHEMBL624162,1,,1,,,,A,12031,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12504,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4
CHEMBL624163,1,,1,,,,A,12032,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,13317,50588,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.
CHEMBL624164,1,,1,,,,A,12033,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL624165,1,,1,,,,A,12034,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14941,50597,,The AUC(0-infinity) values in female wistar rats.
CHEMBL624166,1,,1,,,,A,12035,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL624167,1,,1,,,,A,12036,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice"
CHEMBL624168,1,,1,,,,A,12037,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14941,50597,,The AUC(0-t)values in female wistar rats.
CHEMBL624169,1,,1,,,,A,12038,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14067,50597,,The Area under the concentration time curve of compound was measured on rats
CHEMBL624170,1,,1,,,,A,12039,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,14215,50587,,The area under curve (100 mg/kg) administered orally in humans
CHEMBL624171,0,,1,,,,A,12040,Autocuration,BAO_0000218,,U,Callithrix,,9481.0,,,,14215,22224,,The area under curve (12.5 mg/kg) administered intravenously in marmoset
CHEMBL624172,0,,1,,,,A,12041,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,14215,22224,,The area under curve (12.5 mg/kg) administered intravenously in monkey
CHEMBL624173,1,,1,,,,A,12042,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14215,50588,,The area under curve (15 mg/kg) administered intravenously in dog
CHEMBL877488,1,,1,,,,A,12043,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,14215,50587,,The area under curve (200 mg/kg) administered orally in humans
CHEMBL624174,1,,1,,,,A,12044,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14215,50597,,The area under curve (25 mg/kg) administered intravenously in rat
CHEMBL624175,0,,1,,,,A,12045,Autocuration,BAO_0000218,,U,Callithrix,,9481.0,,,,14215,22224,,The area under curve (25 mg/kg) administered orally in marmoset
CHEMBL624176,0,,1,,,,A,12046,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,14215,22224,,The area under curve (25 mg/kg) administered orally in monkey
CHEMBL624177,1,,1,,,,A,12047,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,14215,50588,,The area under curve (30 mg/kg) administered orally in dog
CHEMBL624178,1,,1,,,,A,12048,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,14215,50587,,The area under curve (400 mg/kg) administered orally in humans
CHEMBL624179,1,,1,,,,A,12049,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14215,50597,,The area under curve (50 mg/kg) administered orally in fasted rat
CHEMBL627689,1,,1,,,,A,12050,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14215,50597,,The area under curve (50 mg/kg) administered orally in rat
CHEMBL627690,1,,1,,,,A,12051,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,14215,50587,,The area under curve (800 mg/kg) administered orally in humans
CHEMBL627691,0,,1,,,,A,12052,Autocuration,BAO_0000019,,U,,,,,,,11324,22224,,The compound was evaluated for area under the curve
CHEMBL627692,0,,1,,,,A,12053,Autocuration,BAO_0000019,,U,Callithrix,,9481.0,,,,11324,22224,,The compound was evaluated for area under the curve in marmosets
CHEMBL627693,0,,1,,,,A,12054,Autocuration,BAO_0000019,,U,Callithrix,,9481.0,,,,11324,22224,,The compound was evaluated for area under the curve in marmosets
CHEMBL627694,1,,1,,,,A,12055,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13875,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat
CHEMBL627695,1,,1,,,,A,12056,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13875,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat
CHEMBL627696,0,,1,,,,A,12057,Autocuration,BAO_0000218,,U,,,,,,,13875,22224,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po)
CHEMBL627697,1,,1,,,,A,12058,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13875,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat
CHEMBL627698,1,,1,,,,A,12059,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13875,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat
CHEMBL627699,1,,1,,,,A,12060,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13875,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat
CHEMBL627700,1,,1,,,,A,12061,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13807,50597,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat
CHEMBL627701,1,,1,,,,A,12062,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14127,50597,,Total drug exposure is determined after oral dosing in rats.
CHEMBL627702,0,,1,,,,A,12063,Autocuration,BAO_0000218,,U,,,,,,,15116,22224,,Total drug exposure (5 mg/kg) when administered intravenously
CHEMBL627703,0,,1,,,,A,12064,Autocuration,BAO_0000218,,U,,,,,,,15116,22224,,Total drug exposure (5 mg/kg) when administered orally
CHEMBL626873,0,,1,,,,A,12065,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,15604,22224,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey
CHEMBL629583,1,,1,,,,A,12066,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15604,50597,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat
CHEMBL629584,1,,1,,,,A,12067,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,15604,50588,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog
CHEMBL629585,1,,1,,,,A,12068,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,15604,50588,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog
CHEMBL629586,1,,1,,,,A,12069,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13751,50597,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g"
CHEMBL629587,1,,1,,,,A,12070,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13751,50597,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL629588,1,,1,,,,A,12071,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL629589,1,,1,,,,A,12072,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g"
CHEMBL629590,1,,1,,,,A,12073,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL629591,1,,1,,,,A,12074,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL629592,1,,1,,,,A,12075,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL629593,1,,1,,,,A,12076,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g"
CHEMBL629594,1,,1,,,,A,12077,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g"
CHEMBL629595,1,,1,,,,A,12078,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13751,50597,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL630290,1,,1,,,,A,12079,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13751,50597,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g"
CHEMBL627137,1,,1,,,,A,12080,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13751,50597,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL627138,1,,1,,,,A,12081,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13751,50597,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL627139,1,,1,,,,A,12082,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13751,50597,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL627140,1,,1,,,,A,12083,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13751,50597,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g"
CHEMBL627141,1,,1,,,,A,12084,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13751,50597,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g"
CHEMBL627142,1,,1,,,,A,12085,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13751,50597,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL627143,1,,1,,,,A,12086,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13751,50597,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g"
CHEMBL874449,1,,1,,,,A,12087,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13751,50597,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL627144,1,,1,,,,A,12088,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13751,50597,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL627145,1,,1,,,,A,12089,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13751,50597,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL627146,1,,1,,,,A,12090,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13751,50597,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g"
CHEMBL627147,1,,1,,,,A,12091,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13751,50597,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g"
CHEMBL627148,1,,1,,,,A,12092,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13751,50597,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL627149,1,,1,,,,A,12093,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13751,50597,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL632160,1,,1,,,,A,12094,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13751,50597,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g"
CHEMBL632161,1,,1,,,,A,12095,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13751,50597,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL632162,1,,1,,,,A,12096,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13751,50597,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL632163,1,,1,,,,A,12097,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13751,50597,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL874469,1,,1,,,,A,12098,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13751,50597,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g"
CHEMBL627182,1,,1,,,,A,12099,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13751,50597,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g"
CHEMBL627183,1,,1,,,,A,12100,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13751,50597,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g"
CHEMBL627184,1,,1,,,,A,12101,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13751,50597,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g"
CHEMBL627185,1,,1,,,,A,12102,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13751,50597,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL627186,1,,1,,,,A,12103,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13751,50597,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL627187,1,,1,,,,A,12104,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13751,50597,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL627188,1,,1,,,,A,12105,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13751,50597,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g"
CHEMBL627189,1,,1,,,,A,12106,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13751,50597,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g"
CHEMBL627190,1,,1,,,,A,12107,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13751,50597,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL627191,1,,1,,,,A,12108,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13751,50597,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g"
CHEMBL627192,1,,1,,,,A,12109,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13751,50597,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g"
CHEMBL627193,1,,1,,,,A,12110,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13751,50597,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g"
CHEMBL874590,1,,1,,,,A,12111,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram
CHEMBL627194,1,,1,,,,A,12112,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL627195,1,,1,,,,A,12113,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL627196,1,,1,,,,A,12114,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL627197,1,,1,,,,A,12115,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL627198,1,,1,,,,A,12116,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL627199,1,,1,,,,A,12117,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour
CHEMBL627200,1,,1,,,,A,12118,Intermediate,BAO_0000218,992.0,N,Rattus norvegicus,Female gonad,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL627201,1,,1,,,,A,12119,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL627202,1,,1,,,,A,12120,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL627203,1,,1,,,,A,12121,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL627204,1,,1,,,,A,12122,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL627205,1,,1,,,,A,12123,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL627206,1,,1,,,,A,12124,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL627207,1,,1,,,,A,12125,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL627208,1,,1,,,,A,12126,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL627209,1,,1,,,,A,12127,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL627210,1,,1,,,,A,12128,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL627211,1,,1,,,,A,12129,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL627212,1,,1,,,,A,12130,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL627213,1,,1,,,,A,12131,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram
CHEMBL626599,1,,1,,,,A,12132,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram
CHEMBL626600,1,,1,,,,A,12133,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram
CHEMBL626601,1,,1,,,,A,12134,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,In vivo,,10911,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram
CHEMBL627484,0,,1,,,,A,12135,Autocuration,BAO_0000019,,U,,,,,,,8081,22224,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound
CHEMBL627485,1,,1,,,,A,12136,Intermediate,BAO_0000218,1969.0,N,Macaca fascicularis,Plasma,9541.0,,,,17248,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg)
CHEMBL628147,1,,1,,,,A,12137,Intermediate,BAO_0000218,1969.0,N,Macaca fascicularis,Plasma,9541.0,,,,17248,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable
CHEMBL628148,1,,1,,,,A,12138,Intermediate,BAO_0000218,1969.0,N,Macaca fascicularis,Plasma,9541.0,,,,17248,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined
CHEMBL628149,1,,1,,,,A,12139,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,17248,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg)
CHEMBL628150,1,,1,,,,A,12140,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,17248,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1
CHEMBL628318,1,,1,,,,A,12141,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,17248,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2
CHEMBL628319,1,,1,,,,A,12142,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,17248,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable
CHEMBL875609,1,,1,,,,A,12143,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,15592,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )"
CHEMBL628320,0,,1,,,,A,12144,Autocuration,BAO_0000019,,U,,,,,,,7040,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10
CHEMBL628321,0,,1,,,,A,12145,Autocuration,BAO_0000019,,U,,,,,,,7040,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5
CHEMBL628322,0,,1,,,,A,12146,Autocuration,BAO_0000019,,U,,,,,,,7040,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8
CHEMBL628323,0,,1,,,,A,12147,Autocuration,BAO_0000019,,U,,,,,,,7040,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2
CHEMBL628324,0,,1,,,,A,12148,Autocuration,BAO_0000019,,U,,,,,,,7040,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6
CHEMBL628325,0,,1,,,,A,12149,Autocuration,BAO_0000019,,U,,,,,,,7040,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2
CHEMBL628326,0,,1,,,,A,12150,Autocuration,BAO_0000019,,U,,,,,,,7040,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6
CHEMBL628327,1,,1,,,,A,12151,Intermediate,BAO_0000218,1236.0,N,Canis lupus familiaris,Adrenal medulla,9615.0,,,,9614,50588,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously"
CHEMBL628328,1,,1,,,,A,12152,Intermediate,BAO_0000218,1236.0,N,Canis lupus familiaris,Adrenal medulla,9615.0,,,,9614,50588,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously"
CHEMBL628329,1,,1,,,,A,12153,Intermediate,BAO_0000218,178.0,N,Canis lupus familiaris,Blood,9615.0,,,,9614,50588,,"Concentration of compound in blood of dog 1, after administering intravenously"
CHEMBL628330,1,,1,,,,A,12154,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29"
CHEMBL628331,1,,1,,,,A,12155,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30"
CHEMBL628332,1,,1,,,,A,12156,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71"
CHEMBL628333,1,,1,,,,A,12157,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72"
CHEMBL628334,1,,1,,,,A,12158,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23"
CHEMBL628335,1,,1,,,,A,12159,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12"
CHEMBL628336,1,,1,,,,A,12160,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20"
CHEMBL628337,1,,1,,,,A,12161,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56"
CHEMBL628338,1,,1,,,,A,12162,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70"
CHEMBL875610,1,,1,,,,A,12163,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45"
CHEMBL628339,1,,1,,,,A,12164,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56"
CHEMBL628340,1,,1,,,,A,12165,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30"
CHEMBL628341,1,,1,,,,A,12166,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19"
CHEMBL622214,1,,1,,,,A,12167,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19"
CHEMBL623167,1,,1,,,,A,12168,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30"
CHEMBL623168,1,,1,,,,A,12169,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54"
CHEMBL623169,1,,1,,,,A,12170,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19"
CHEMBL623170,1,,1,,,,A,12171,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31"
CHEMBL627224,1,,1,,,,A,12172,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47"
CHEMBL875634,1,,1,,,,A,12173,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21"
CHEMBL627225,1,,1,,,,A,12174,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74"
CHEMBL627226,1,,1,,,,A,12175,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23"
CHEMBL626083,1,,1,,,,A,12176,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30"
CHEMBL626084,1,,1,,,,A,12177,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39"
CHEMBL626085,1,,1,,,,A,12178,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66"
CHEMBL626086,1,,1,,,,A,12179,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49"
CHEMBL626087,1,,1,,,,A,12180,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35"
CHEMBL626088,1,,1,,,,A,12181,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44"
CHEMBL626089,1,,1,,,,A,12182,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52"
CHEMBL626090,1,,1,,,,A,12183,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17"
CHEMBL626091,1,,1,,,,A,12184,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33"
CHEMBL626092,1,,1,,,,A,12185,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13"
CHEMBL626093,1,,1,,,,A,12186,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11"
CHEMBL626094,1,,1,,,,A,12187,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36"
CHEMBL626095,1,,1,,,,A,12188,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54"
CHEMBL626096,1,,1,,,,A,12189,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26"
CHEMBL626097,0,,1,,,,A,12190,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,15604,22224,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey
CHEMBL626098,1,,1,,,,A,12191,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15604,50597,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat
CHEMBL626099,0,,1,,,,A,12192,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,,,1806,22224,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv
CHEMBL626100,0,,1,,,,A,12193,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,,,1806,22224,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv
CHEMBL626101,1,,1,,,,A,12194,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,17237,50588,,AUC 0-inf in dog
CHEMBL626102,1,,1,,,,A,12195,Intermediate,BAO_0000218,1969.0,N,Cavia porcellus,Plasma,10141.0,,,,17237,50512,,AUC 0-inf in guinea pig
CHEMBL626103,1,,1,,,,A,12196,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,,,17237,50588,,AUC 0-t in dog
CHEMBL628391,1,,1,,,,A,12197,Intermediate,BAO_0000218,1969.0,N,Cavia porcellus,Plasma,10141.0,,,,17237,50512,,AUC 0-t in guinea pig
CHEMBL628392,1,,1,,,,A,12198,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15194,50597,,The compound was tested for brain to plasma partition in rat
CHEMBL628393,1,,1,,,,A,12199,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15194,50597,,The compound was tested for brain to plasma partition in rat.
CHEMBL628394,0,,1,,,,A,12200,Autocuration,BAO_0000019,178.0,U,,Blood,,,,,8787,22224,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure
CHEMBL628395,1,,1,,,,A,12201,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,17025,50588,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.
CHEMBL628396,0,,1,,,,A,12202,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,17025,22224,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.
CHEMBL628397,1,,1,,,,A,12203,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,17025,50592,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.
CHEMBL628398,1,,1,,,,A,12204,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17025,50597,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.
CHEMBL628399,1,,1,,,,A,12205,Intermediate,BAO_0000218,,N,Macaca mulatta,,9544.0,,,,4236,50797,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey
CHEMBL628400,1,,1,,,,A,12206,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,15343,50588,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose
CHEMBL874907,1,,1,,,,A,12207,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15343,50597,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose
CHEMBL628401,0,,1,,,,A,12208,Autocuration,BAO_0000019,,U,,,,,,,17720,22224,,Area under curve of the compound was determined
CHEMBL628402,0,,1,,,,A,12209,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,,,17788,22224,,AUC in monkeys at a dose of 1 mg/kg
CHEMBL628403,1,,1,,,,A,12210,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,17788,50597,,AUC in rats at a dose of 1 mg/kg
CHEMBL628404,0,,1,,,,A,12211,Autocuration,BAO_0000019,,U,,,,,,,8778,22224,,Compound was evaluated for the overall absorbance loss at pH of 2
CHEMBL628405,0,,1,,,,A,12212,Autocuration,BAO_0000019,,U,,,,,,,8778,22224,,Compound was evaluated for the overall absorbance loss at pH of 4
CHEMBL628406,0,,1,,,,A,12213,Autocuration,BAO_0000019,,U,,,,,,,8778,22224,,Compound was evaluated for the overall absorbance loss at pH of 7
CHEMBL628407,1,,1,,,,A,12214,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,2249,50597,,Compound was evaluated for its absorption in the rats
CHEMBL628408,1,,1,,,,A,12215,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8881,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug
CHEMBL629171,1,,1,,,,A,12216,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8881,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.
CHEMBL629172,1,,1,,,,A,12217,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8881,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug
CHEMBL629173,1,,1,,,,A,12218,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8881,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid
CHEMBL629174,1,,1,,,,A,12219,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum
CHEMBL629175,1,,1,,,,A,12220,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 10-17
CHEMBL629176,1,,1,,,,A,12221,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 10-18
CHEMBL629177,1,,1,,,,A,12222,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 10-19
CHEMBL629178,1,,1,,,,A,12223,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 12-15
CHEMBL631869,1,,1,,,,A,12224,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 13-19
CHEMBL631870,1,,1,,,,A,12225,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 14-17
CHEMBL631871,1,,1,,,,A,12226,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 15-18
CHEMBL631872,1,,1,,,,A,12227,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 2-5
CHEMBL875775,0,,1,,,,A,12228,Autocuration,BAO_0000221,2116.0,U,,Ileum,,,,,15286,22224,,In vitro percent permeability into rat ileum; Range is 23-42
CHEMBL631873,1,,1,,,,A,12229,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 28-36
CHEMBL631874,1,,1,,,,A,12230,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 29-35
CHEMBL631875,1,,1,,,,A,12231,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 46-66
CHEMBL631876,1,,1,,,,A,12232,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 50-68
CHEMBL631877,1,,1,,,,A,12233,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; Range is 78-81
CHEMBL631878,1,,1,,,,A,12234,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer
CHEMBL631879,1,,1,,,,A,12235,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; nd indicates not detected
CHEMBL631880,1,,1,,,,A,12236,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; nt indicates not detected
CHEMBL631881,1,,1,,,,A,12237,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15286,50597,,In vitro percent permeability into rat ileum; nt indicates not tested
CHEMBL631882,1,,1,,,,A,12238,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13770,50597,,Compound was tested for oral absorption in bile-duct cannulated rats
CHEMBL630749,1,,1,,,,A,12239,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13770,50597,,Compound was tested for oral absorption in bile-duct cannulated rats.
CHEMBL630750,1,,1,,,,A,12240,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,5202,50587,,Oral absorption using Caco-2 cell monolayers.
CHEMBL630253,1,,1,,,,A,12241,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,14920,50587,,Percent of the drug absorbed after administration to humans was determined
CHEMBL630254,1,,1,,,,A,12242,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.
CHEMBL630255,1,,1,,,,A,12243,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.
CHEMBL630256,1,,1,,,,A,12244,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.
CHEMBL875781,1,,1,,,,A,12245,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13751,50597,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g"
CHEMBL630257,1,,1,,,,A,12246,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13751,50597,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g"
CHEMBL630258,1,,1,,,,A,12247,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13751,50597,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g"
CHEMBL630259,1,,1,,,,A,12248,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15807,50597,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue"
CHEMBL630260,1,,1,,,,A,12249,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,,,15807,50597,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue"
CHEMBL630261,1,,1,,,,A,12250,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,,,15807,50597,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue"
CHEMBL630262,1,,1,,,,A,12251,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported
CHEMBL630263,1,,1,,,,A,12252,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time
CHEMBL630264,1,,1,,,,A,12253,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time
CHEMBL630265,1,,1,,,,A,12254,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time
CHEMBL630266,1,,1,,,,A,12255,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time
CHEMBL630267,1,,1,,,,A,12256,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time
CHEMBL630268,1,,1,,,,A,12257,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time
CHEMBL630269,1,,1,,,,A,12258,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time
CHEMBL630270,1,,1,,,,A,12259,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time
CHEMBL630141,1,,1,,,,A,12260,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time
CHEMBL630142,1,,1,,,,A,12261,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time
CHEMBL630143,1,,1,,,,A,12262,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time
CHEMBL630144,1,,1,,,,A,12263,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time
CHEMBL630145,1,,1,,,,A,12264,Intermediate,BAO_0000218,2367.0,N,Rattus norvegicus,Prostate gland,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time
CHEMBL630146,1,,1,,,,A,12265,Intermediate,BAO_0000218,2367.0,N,Rattus norvegicus,Prostate gland,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time
CHEMBL630147,1,,1,,,,A,12266,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood
CHEMBL630148,1,,1,,,,A,12267,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time
CHEMBL630149,1,,1,,,,A,12268,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time
CHEMBL630150,1,,1,,,,A,12269,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time
CHEMBL630151,1,,1,,,,A,12270,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time
CHEMBL632031,1,,1,,,,A,12271,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time
CHEMBL632032,1,,1,,,,A,12272,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time
CHEMBL632033,1,,1,,,,A,12273,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time
CHEMBL632034,1,,1,,,,A,12274,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time
CHEMBL632035,1,,1,,,,A,12275,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time
CHEMBL632036,1,,1,,,,A,12276,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time
CHEMBL632037,1,,1,,,,A,12277,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,14950,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time
CHEMBL632038,1,,1,,,,A,12278,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes
CHEMBL632039,1,,1,,,,A,12279,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes
CHEMBL632040,1,,1,,,,A,12280,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes
CHEMBL632041,1,,1,,,,A,12281,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes
CHEMBL632042,1,,1,,,,A,12282,Intermediate,BAO_0000218,178.0,N,Canis lupus familiaris,Blood,9615.0,,,,9614,50588,,"Concentration of compound in blood of dog 2, after administering intravenously"
CHEMBL632043,1,,1,,,,A,12283,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,9614,50588,,"Concentration of compound in left ventricle of dog 1, after administering intravenously"
CHEMBL632044,1,,1,,,,A,12284,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,9614,50588,,"Concentration of compound in left ventricle of dog 2, after administering intravenously"
CHEMBL632045,1,,1,,,,A,12285,Intermediate,BAO_0000218,2107.0,N,Canis lupus familiaris,Liver,9615.0,,,,9614,50588,,"Concentration of compound in liver of dog 1, after administering intravenously"
CHEMBL632046,1,,1,,,,A,12286,Intermediate,BAO_0000218,2107.0,N,Canis lupus familiaris,Liver,9615.0,,,,9614,50588,,"Concentration of compound in liver of dog 2, after administering intravenously"
CHEMBL632047,1,,1,,,,A,12287,Intermediate,BAO_0000218,2048.0,N,Canis lupus familiaris,Lung,9615.0,,,,9614,50588,,"Concentration of compound in lung of dog 1, after administering intravenously"
CHEMBL632048,1,,1,,,,A,12288,Intermediate,BAO_0000218,2048.0,N,Canis lupus familiaris,Lung,9615.0,,,,9614,50588,,"Concentration of compound in lung of dog 2, after administering intravenously"
CHEMBL632049,1,,1,,,,A,12289,Intermediate,BAO_0000218,2385.0,N,Canis lupus familiaris,Muscle tissue,9615.0,,,,9614,50588,,"Concentration of compound in muscle of dog 1, after administering intravenously"
CHEMBL876418,1,,1,,,,A,12290,Intermediate,BAO_0000218,2385.0,N,Canis lupus familiaris,Muscle tissue,9615.0,,,,9614,50588,,"Concentration of compound in muscle of dog 2, after administering intravenously"
CHEMBL632050,1,,1,,,,A,12291,Intermediate,BAO_0000218,2106.0,N,Canis lupus familiaris,Spleen,9615.0,,,,9614,50588,,"Concentration of compound in spleen of dog 1,after administering intravenously"
CHEMBL632051,1,,1,,,,A,12292,Intermediate,BAO_0000218,2106.0,N,Canis lupus familiaris,Spleen,9615.0,,,,9614,50588,,"Concentration of compound in spleen of dog 2, after administering intravenously"
CHEMBL632052,0,,1,,,,F,12293,Autocuration,BAO_0000218,,U,,,,,,,10353,22224,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).
CHEMBL632053,0,,1,,,,F,12294,Autocuration,BAO_0000218,,U,,,,,,,10353,22224,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).
CHEMBL632054,0,,1,,,,A,12295,Autocuration,BAO_0000218,,U,,,,,,,10353,22224,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).
CHEMBL632055,0,,1,,,,F,12296,Autocuration,BAO_0000218,,U,,,,,,,10353,22224,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).
CHEMBL631181,0,,1,,,,F,12297,Autocuration,BAO_0000218,,U,,,,,,,10353,22224,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).
CHEMBL631182,0,,1,,,,A,12298,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr
CHEMBL631183,0,,1,,,,A,12299,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr
CHEMBL631184,0,,1,,,,A,12300,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr
CHEMBL629774,0,,1,,,,A,12301,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr
CHEMBL629775,0,,1,,,,A,12302,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr
CHEMBL876549,0,,1,,,,A,12303,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr
CHEMBL628172,0,,1,,,,A,12304,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr
CHEMBL628173,0,,1,,,,A,12305,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr
CHEMBL628174,0,,1,,,,A,12306,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr
CHEMBL628175,0,,1,,,,A,12307,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr
CHEMBL628176,0,,1,,,,A,12308,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr
CHEMBL628177,0,,1,,,,A,12309,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr
CHEMBL628178,0,,1,,,,A,12310,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr
CHEMBL628179,0,,1,,,,A,12311,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr
CHEMBL628180,0,,1,,,,A,12312,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced
CHEMBL628181,0,,1,,,,A,12313,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr
CHEMBL628182,0,,1,,,,A,12314,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr
CHEMBL628183,0,,1,,,,A,12315,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr
CHEMBL628184,0,,1,,,,A,12316,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined
CHEMBL628185,0,,1,,,,A,12317,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr
CHEMBL875617,0,,1,,,,A,12318,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr
CHEMBL628186,0,,1,,,,A,12319,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined
CHEMBL628187,0,,1,,,,A,12320,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr
CHEMBL628188,0,,1,,,,A,12321,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr
CHEMBL628189,0,,1,,,,A,12322,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr
CHEMBL628190,0,,1,,,,A,12323,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined
CHEMBL628191,0,,1,,,,A,12324,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr
CHEMBL626513,0,,1,,,,A,12325,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined
CHEMBL626514,1,,1,,,,A,12326,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24"
CHEMBL626515,1,,1,,,,A,12327,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40"
CHEMBL626516,1,,1,,,,A,12328,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44"
CHEMBL626517,1,,1,,,,A,12329,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42"
CHEMBL626518,1,,1,,,,A,12330,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60"
CHEMBL626519,1,,1,,,,A,12331,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7"
CHEMBL626520,1,,1,,,,A,12332,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18"
CHEMBL626521,1,,1,,,,A,12333,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32"
CHEMBL626522,1,,1,,,,A,12334,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25"
CHEMBL626523,1,,1,,,,A,12335,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49"
CHEMBL626524,1,,1,,,,A,12336,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36"
CHEMBL626688,1,,1,,,,A,12337,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8"
CHEMBL626689,1,,1,,,,A,12338,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42"
CHEMBL626690,1,,1,,,,A,12339,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53"
CHEMBL626691,1,,1,,,,A,12340,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43"
CHEMBL627319,1,,1,,,,A,12341,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53"
CHEMBL624052,1,,1,,,,A,12342,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12"
CHEMBL624053,1,,1,,,,A,12343,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8608,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102"
CHEMBL624054,1,,1,,,,A,12344,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8085,50597,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL624055,1,,1,,,,A,12345,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8085,50597,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL624056,1,,1,,,,A,12346,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8085,50597,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL624057,1,,1,,,,A,12347,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8085,50597,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL622281,1,,1,,,,A,12348,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8085,50597,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL622282,1,,1,,,,A,12349,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8085,50597,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL622283,1,,1,,,,A,12350,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8085,50597,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL622284,1,,1,,,,A,12351,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8085,50597,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL622285,1,,1,,,,A,12352,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8085,50597,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL622286,1,,1,,,,A,12353,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,8085,50597,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats
CHEMBL622287,0,,1,,,,P,12354,Autocuration,BAO_0000100,,U,,,,,,,7657,22224,,Distribution coefficient (D %) between octanol and buffer of pH 7.4
CHEMBL622288,1,,1,,,,A,12355,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8935,50594,,Partition coefficient (logD7.4)
CHEMBL622289,1,,1,,,,A,12356,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13792,50594,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection"
CHEMBL622290,1,,1,,,,A,12357,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,13792,50594,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection"
CHEMBL622291,1,,1,,,,A,12358,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13792,50594,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection
CHEMBL622292,1,,1,,,,A,12359,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,13792,50594,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection
CHEMBL622293,1,,1,,,,A,12360,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13792,50594,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection"
CHEMBL622294,1,,1,,,,A,12361,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,13792,50594,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection"
CHEMBL622295,1,,1,,,,A,12362,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13792,50594,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection
CHEMBL622296,1,,1,,,,A,12363,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,,,13792,50597,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection
CHEMBL874409,1,,1,,,,A,12364,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.
CHEMBL622297,1,,1,,,,A,12365,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.
CHEMBL622298,1,,1,,,,A,12366,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.
CHEMBL622299,1,,1,,,,A,12367,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.
CHEMBL622300,1,,1,,,,A,12368,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.
CHEMBL622301,1,,1,,,,A,12369,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.
CHEMBL622302,1,,1,,,,A,12370,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.
CHEMBL622303,1,,1,,,,A,12371,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.
CHEMBL622304,1,,1,,,,A,12372,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.
CHEMBL622305,1,,1,,,,A,12373,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined
CHEMBL622306,1,,1,,,,A,12374,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.
CHEMBL626864,1,,1,,,,A,12375,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined
CHEMBL626865,1,,1,,,,A,12376,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.
CHEMBL626866,1,,1,,,,A,12377,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined
CHEMBL626867,1,,1,,,,A,12378,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.
CHEMBL626868,1,,1,,,,A,12379,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.
CHEMBL626869,1,,1,,,,A,12380,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined
CHEMBL626870,1,,1,,,,A,12381,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.
CHEMBL626871,1,,1,,,,A,12382,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined
CHEMBL626872,1,,1,,,,A,12383,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.
CHEMBL632185,1,,1,,,,A,12384,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.
CHEMBL632186,1,,1,,,,A,12385,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,14103,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined
CHEMBL629310,0,,1,,,,A,12386,Autocuration,BAO_0000019,,U,,,,,,,12904,22224,,Amount of acetic acid produced by the compound
CHEMBL629311,0,,1,,,,A,12387,Autocuration,BAO_0000019,,U,,,,,,,12904,22224,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined
CHEMBL629312,1,,1,,,,A,12388,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9663,50597,,Log of (Cbrain/Cblood) in rats
CHEMBL629313,0,,1,,,,A,12389,Autocuration,BAO_0000221,,U,,,,,,,7652,22224,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng)
CHEMBL629314,0,,1,,,,A,12390,Autocuration,BAO_0000221,,U,,,,,,,7652,22224,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng)
CHEMBL629315,0,,1,,,,A,12391,Autocuration,BAO_0000221,,U,,,,,,,7652,22224,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng)
CHEMBL629316,0,,1,,,,B,12392,Autocuration,BAO_0000219,,U,,,,,,,7652,22224,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng)
CHEMBL629317,0,,1,,,,A,12393,Autocuration,BAO_0000221,,U,,,,,,,7652,22224,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng)
CHEMBL629318,0,,1,,,,A,12394,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng)
CHEMBL877497,0,,1,,,,A,12395,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng)
CHEMBL629319,0,,1,,,,A,12396,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng)
CHEMBL629320,0,,1,,,,A,12397,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng)
CHEMBL629496,0,,1,,,,A,12398,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng)
CHEMBL629497,0,,1,,,,A,12399,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng)
CHEMBL629498,0,,1,,,,A,12400,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng)
CHEMBL629499,0,,1,,,,A,12401,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng)
CHEMBL629500,0,,1,,,,A,12402,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng)
CHEMBL629501,0,,1,,,,A,12403,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng)
CHEMBL629502,0,,1,,,,A,12404,Autocuration,BAO_0000019,,U,,,,,,,7652,22224,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng)
CHEMBL629503,0,,1,,,,F,12405,Autocuration,BAO_0000218,,U,,,,,In vivo,,8267,22224,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs
CHEMBL629504,1,,1,,,,A,12406,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8267,50588,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs
CHEMBL629505,0,,1,,,,A,12407,Autocuration,BAO_0000019,,U,,,,,,,14479,22224,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.
CHEMBL629506,0,,1,,,,A,12408,Autocuration,BAO_0000019,,U,,,,,,,17515,22224,,Compound was evaluated for total body clearance
CHEMBL629507,0,,1,,,,A,12409,Autocuration,BAO_0000019,,U,,,,,,,17515,22224,,Compound was evaluated for volume of distribution at steady state
CHEMBL877498,0,,1,,,,A,12410,Autocuration,BAO_0000019,,U,,,,,,,8142,22224,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.
CHEMBL629508,0,,1,,,,A,12411,Autocuration,BAO_0000019,,U,,,,,,,14849,22224,,Percentage of the diamine which is monoprotonated at pH 7.4
CHEMBL629509,0,,1,,,,A,12412,Autocuration,BAO_0000019,,U,,,,,,,7653,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells
CHEMBL629510,1,,1,,,,A,12413,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes
CHEMBL629511,1,,1,,,,A,12414,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes
CHEMBL629512,1,,1,,,,A,12415,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes
CHEMBL629513,1,,1,,,,A,12416,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes
CHEMBL629514,1,,1,,,,A,12417,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes
CHEMBL628447,1,,1,,,,A,12418,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes
CHEMBL628448,1,,1,,,,A,12419,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes
CHEMBL628449,1,,1,,,,A,12420,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes
CHEMBL631119,1,,1,,,,A,12421,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes
CHEMBL631120,1,,1,,,,A,12422,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes
CHEMBL631121,1,,1,,,,A,12423,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes
CHEMBL874458,1,,1,,,,A,12424,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min
CHEMBL631122,1,,1,,,,A,12425,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes
CHEMBL631123,1,,1,,,,A,12426,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes
CHEMBL631124,1,,1,,,,A,12427,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes
CHEMBL631125,1,,1,,,,A,12428,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes
CHEMBL631290,1,,1,,,,A,12429,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes
CHEMBL631291,1,,1,,,,A,12430,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes
CHEMBL631292,1,,1,,,,A,12431,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes
CHEMBL631293,1,,1,,,,A,12432,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes
CHEMBL631294,1,,1,,,,A,12433,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes
CHEMBL631295,1,,1,,,,A,12434,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes
CHEMBL631296,1,,1,,,,A,12435,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes
CHEMBL631297,1,,1,,,,A,12436,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8631,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes
CHEMBL631298,0,,1,,,,A,12437,Autocuration,BAO_0000218,,U,,,,,,,10263,22224,,Maximum biodistribution (Bmax) was determined.
CHEMBL631299,1,,1,,,,A,12438,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12364,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice
CHEMBL631300,1,,1,,,,A,12439,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12364,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice
CHEMBL631301,1,,1,,,,A,12440,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12364,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice
CHEMBL630291,1,,1,,,,A,12441,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12364,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice
CHEMBL630292,0,,1,,,,A,12442,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally
CHEMBL630293,0,,1,,,,A,12443,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously
CHEMBL630294,0,,1,,,,A,12444,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally
CHEMBL630295,0,,1,,,,A,12445,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally
CHEMBL630296,0,,1,,,,A,12446,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously
CHEMBL626782,0,,1,,,,A,12447,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally
CHEMBL626783,0,,1,,,,A,12448,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally
CHEMBL626784,0,,1,,,,A,12449,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally
CHEMBL626785,0,,1,,,,A,12450,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously
CHEMBL626786,0,,1,,,,A,12451,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally
CHEMBL626787,0,,1,,,,A,12452,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr
CHEMBL626788,0,,1,,,,A,12453,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined
CHEMBL625927,0,,1,,,,A,12454,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr
CHEMBL625928,1,,1,,,,A,12455,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL625929,1,,1,,,,A,12456,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected
CHEMBL625930,1,,1,,,,A,12457,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.
CHEMBL625931,1,,1,,,,A,12458,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount."
CHEMBL627230,1,,1,,,,A,12459,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.
CHEMBL627231,1,,1,,,,A,12460,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627232,1,,1,,,,A,12461,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected
CHEMBL627233,1,,1,,,,A,12462,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.
CHEMBL875470,1,,1,,,,A,12463,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627234,1,,1,,,,A,12464,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627235,1,,1,,,,A,12465,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627236,1,,1,,,,A,12466,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627237,1,,1,,,,A,12467,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627238,1,,1,,,,A,12468,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627239,1,,1,,,,A,12469,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627240,1,,1,,,,A,12470,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627241,1,,1,,,,A,12471,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627242,1,,1,,,,A,12472,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627243,1,,1,,,,A,12473,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected
CHEMBL627244,1,,1,,,,A,12474,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected
CHEMBL627245,1,,1,,,,A,12475,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627246,1,,1,,,,A,12476,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627247,1,,1,,,,A,12477,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627248,1,,1,,,,A,12478,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627249,1,,1,,,,A,12479,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL625569,1,,1,,,,A,12480,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL625570,1,,1,,,,A,12481,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL625571,1,,1,,,,A,12482,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL625572,1,,1,,,,A,12483,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected
CHEMBL625573,1,,1,,,,A,12484,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected
CHEMBL625574,1,,1,,,,A,12485,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg
CHEMBL626245,1,,1,,,,A,12486,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected
CHEMBL626246,1,,1,,,,A,12487,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL626247,0,,1,,,,A,12488,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr
CHEMBL626248,0,,1,,,,A,12489,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr
CHEMBL626249,0,,1,,,,A,12490,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr
CHEMBL626420,0,,1,,,,A,12491,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr
CHEMBL626421,0,,1,,,,A,12492,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr
CHEMBL626422,0,,1,,,,A,12493,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr
CHEMBL626423,0,,1,,,,A,12494,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr
CHEMBL626424,0,,1,,,,A,12495,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr
CHEMBL626425,1,,1,,,,A,12496,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12023,50588,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously
CHEMBL875476,1,,1,,,,A,12497,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12023,50597,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously
CHEMBL626426,1,,1,,,,A,12498,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,12023,100710,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously
CHEMBL626427,0,,1,,,,P,12499,Autocuration,BAO_0000100,,U,,,,,,,10580,22224,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol
CHEMBL626428,0,,1,,,,P,12500,Autocuration,BAO_0000100,,U,,,,,,,10580,22224,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol
CHEMBL626429,0,,1,,,,A,12501,Autocuration,BAO_0000019,,U,,,,,,,16032,22224,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg
CHEMBL625025,0,,1,,,,A,12502,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,16032,22224,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg
CHEMBL625026,1,,1,,,,A,12503,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-
CHEMBL625027,1,,1,,,,A,12504,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-
CHEMBL874410,1,,1,,,,A,12505,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-
CHEMBL625028,1,,1,,,,A,12506,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-
CHEMBL625029,1,,1,,,,A,12507,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-
CHEMBL625030,1,,1,,,,A,12508,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-
CHEMBL625031,1,,1,,,,A,12509,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-
CHEMBL625032,1,,1,,,,A,12510,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-
CHEMBL625033,1,,1,,,,A,12511,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-
CHEMBL625034,1,,1,,,,A,12512,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-
CHEMBL624872,1,,1,,,,A,12513,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-
CHEMBL624873,1,,1,,,,A,12514,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-
CHEMBL624874,1,,1,,,,A,12515,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-
CHEMBL624875,1,,1,,,,A,12516,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-
CHEMBL624876,1,,1,,,,A,12517,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-
CHEMBL624877,1,,1,,,,A,12518,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-
CHEMBL624878,1,,1,,,,A,12519,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-
CHEMBL624879,1,,1,,,,A,12520,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-
CHEMBL624880,1,,1,,,,A,12521,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-
CHEMBL624881,1,,1,,,,A,12522,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-
CHEMBL624882,1,,1,,,,A,12523,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-"
CHEMBL624883,1,,1,,,,A,12524,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-
CHEMBL624884,1,,1,,,,A,12525,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-
CHEMBL624885,1,,1,,,,A,12526,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-
CHEMBL624886,1,,1,,,,A,12527,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-
CHEMBL624887,1,,1,,,,A,12528,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-
CHEMBL624888,1,,1,,,,A,12529,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-
CHEMBL624889,1,,1,,,,A,12530,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-
CHEMBL624890,1,,1,,,,A,12531,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-
CHEMBL621964,1,,1,,,,A,12532,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-
CHEMBL621965,1,,1,,,,A,12533,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-
CHEMBL621966,1,,1,,,,A,12534,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-
CHEMBL621967,1,,1,,,,A,12535,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-
CHEMBL622164,1,,1,,,,A,12536,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-
CHEMBL623097,0,,1,,,,A,12537,Autocuration,BAO_0000019,,U,,,,,,,7653,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids)
CHEMBL623098,0,,1,,,,A,12538,Autocuration,BAO_0000019,,U,,,,,,,7653,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein)
CHEMBL623099,0,,1,,,,A,12539,Autocuration,BAO_0000019,,U,,,,,,,7653,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble
CHEMBL623100,0,,1,,,,A,12540,Autocuration,BAO_0000019,,U,,,,,,,7653,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake
CHEMBL628673,1,,1,,,,A,12541,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9104,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed"
CHEMBL628674,1,,1,,,,A,12542,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9104,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable."
CHEMBL628675,1,,1,,,,A,12543,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9104,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test."
CHEMBL627644,1,,1,,,,A,12544,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9104,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size"
CHEMBL627645,1,,1,,,,A,12545,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9104,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%."
CHEMBL627646,1,,1,,,,A,12546,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9104,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size"
CHEMBL627647,1,,1,,,,A,12547,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9104,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size"
CHEMBL627648,1,,1,,,,A,12548,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9104,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy."
CHEMBL627649,1,,1,,,,A,12549,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12902,50597,,Free level in rat plasma
CHEMBL628313,0,,1,,,,A,12550,Autocuration,BAO_0000019,,U,,,,,,,6614,22224,,Level reaching in blood plasma of rat or human was determined
CHEMBL628314,1,,1,,,,A,12551,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9663,50597,,Log (Cbrain/Cblood) in rats
CHEMBL628315,0,,1,,,,A,12552,Autocuration,BAO_0000019,,U,,,,,,,17658,22224,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity
CHEMBL628316,0,,1,,,,A,12553,Autocuration,BAO_0000019,,U,,,,,,,17658,22224,,Mean percentage of compound transport through membrane; expressed as membrane transport
CHEMBL628317,0,,1,,,,A,12554,Autocuration,BAO_0000218,,U,,,,,,,14314,22224,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound
CHEMBL628473,0,,1,,,,A,12555,Autocuration,BAO_0000019,,U,,,,,,,7385,22224,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5
CHEMBL628474,0,,1,,,,A,12556,Autocuration,BAO_0000019,,U,,,,,,,7385,22224,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined"
CHEMBL628475,0,,1,,,,A,12557,Autocuration,BAO_0000019,,U,,,,,,,7385,22224,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5
CHEMBL628476,0,,1,,,,A,12558,Autocuration,BAO_0000019,,U,,,,,,,1329,22224,,Net water uptake by a carrier mediated transport (%cm) mechanism
CHEMBL628477,0,,1,,,,A,12559,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,12187,22224,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey
CHEMBL628478,1,,1,,,,A,12560,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,12187,50506,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret
CHEMBL628479,1,,1,,,,A,12561,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,12187,50506,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay"
CHEMBL628480,0,,1,,,,A,12562,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,12187,22224,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey
CHEMBL628481,0,,1,,,,A,12563,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,12187,22224,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay"
CHEMBL628482,1,,1,,,,A,12564,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12187,50597,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat
CHEMBL628483,1,,1,,,,A,12565,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12187,50597,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay"
CHEMBL628484,1,,1,,,,A,12566,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9278,50597,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data."
CHEMBL628485,1,,1,,,,A,12567,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9278,50597,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)"
CHEMBL628486,1,,1,,,,A,12568,Intermediate,BAO_0000218,1969.0,N,Macaca fascicularis,Plasma,9541.0,,,,9278,100710,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)"
CHEMBL628487,1,,1,,,,A,12569,Intermediate,BAO_0000218,1969.0,N,Homo sapiens,Plasma,9606.0,,,,9278,50587,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human"
CHEMBL628488,1,,1,,,,A,12570,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9278,50597,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data."
CHEMBL628489,1,,1,,,,A,12571,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9278,50597,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)"
CHEMBL628490,1,,1,,,,A,12572,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,9278,50597,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)"
CHEMBL628491,1,,1,,,,A,12573,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,12186,100710,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay
CHEMBL877507,1,,1,,,,A,12574,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,,,12186,100710,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay
CHEMBL628492,0,,1,,,,A,12575,Autocuration,BAO_0000218,,U,,,,,,,12186,22224,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay
CHEMBL628493,0,,1,,,,A,12576,Autocuration,BAO_0000019,,U,Simiiformes,,314293.0,,,,12041,22224,,% metabolized in monkey S-9 after 2 hours (10 ug/mL)
CHEMBL628494,0,,1,,,,A,12577,Autocuration,BAO_0000019,,U,Simiiformes,,314293.0,,,,12041,22224,,% metabolized in monkey S-9 after 2 hours (1 ug/ml)
CHEMBL628495,0,,1,,,,A,12578,Autocuration,BAO_0000019,,U,Simiiformes,,314293.0,,,,12041,22224,,% metabolized in monkey S-9 after 2 hours (10 ug/ml)
CHEMBL628496,1,,1,,,,A,12579,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,6737,50587,,Permeability in Caco-2 assay at 10E-6
CHEMBL628497,0,,1,,,,A,12580,Autocuration,BAO_0000218,955.0,U,,Brain,,,,,13758,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain
CHEMBL628498,0,,1,,,,A,12581,Autocuration,BAO_0000218,955.0,U,,Brain,,,,,13758,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain
CHEMBL628499,0,,1,,,,A,12582,Autocuration,BAO_0000019,,U,,,,,,,5676,22224,,Plasma protein binding was determined
CHEMBL627656,0,,1,,,,A,12583,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally
CHEMBL627657,0,,1,,,,A,12584,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally
CHEMBL626808,0,,1,,,,A,12585,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously
CHEMBL626809,0,,1,,,,A,12586,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally
CHEMBL626810,0,,1,,,,A,12587,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally
CHEMBL626811,0,,1,,,,A,12588,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally
CHEMBL874465,0,,1,,,,A,12589,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously
CHEMBL626812,0,,1,,,,A,12590,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally
CHEMBL626813,0,,1,,,,A,12591,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally
CHEMBL626814,0,,1,,,,A,12592,Autocuration,BAO_0000218,,U,,,,,,,14793,22224,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally
CHEMBL626815,0,,1,,,,A,12593,Autocuration,BAO_0000019,,U,,,,,,,14000,22224,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.
CHEMBL628566,0,,1,,,,A,12594,Autocuration,BAO_0000019,,U,,,,,,,5948,22224,,Partition coefficient (logP)
CHEMBL628567,0,,1,,,,P,12595,Autocuration,BAO_0000100,,U,,,,,,,13824,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4)
CHEMBL628568,0,,1,,,,P,12596,Autocuration,BAO_0000100,,U,,,,,,,10778,22229,,Calculated partition coefficient (clogP)
CHEMBL628569,1,,1,,,,A,12597,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,17237,50588,,C max in dog
CHEMBL628570,1,,1,,,,A,12598,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,In vivo,,17237,50512,,C max in guinea pig
CHEMBL628571,0,,1,,,,A,12599,Autocuration,BAO_0000218,,U,,,,,In vivo,,2809,22224,,C max value was evaluated
CHEMBL628572,0,,1,,,,A,12600,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Cmax value after oral dose of 0.1 mg//kg
CHEMBL628573,0,,1,,,,A,12601,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Cmax value after oral dose of 0.3 mg/kg
CHEMBL628574,0,,1,,,,A,12602,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Cmax value after oral dose of 1 mg/kg
CHEMBL628575,0,,1,,,,A,12603,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Cmax value after oral dose of 10 mg/kg
CHEMBL628576,0,,1,,,,A,12604,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Cmax value after oral dose of 23.4 mg/kg
CHEMBL628577,0,,1,,,,A,12605,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Cmax value after oral dose of 3 mg/kg
CHEMBL628578,0,,1,,,,A,12606,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Cmax value after oral dose of 3.87 mg/kg
CHEMBL874466,1,,1,,,,A,12607,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,12768,50588,,Cmax value in female Beagle dogs
CHEMBL628579,1,,1,,,,A,12608,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12768,50597,,Cmax value in male rats
CHEMBL628580,1,,1,,,,A,12609,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,12780,50597,,Cmax value in rat plasma when administered 20 mg/kg perorally
CHEMBL628581,1,,1,,,,A,12610,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,15592,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid
CHEMBL628582,1,,1,,,,A,12611,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,15592,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid
CHEMBL628583,1,,1,,,,A,12612,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,17025,50588,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.
CHEMBL625782,0,,1,,,,A,12613,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,17025,22224,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.
CHEMBL625783,1,,1,,,,A,12614,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,17025,50592,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.
CHEMBL625784,1,,1,,,,A,12615,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,17025,50597,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.
CHEMBL625785,1,,1,,,,A,12616,Intermediate,BAO_0000218,1969.0,N,Macaca mulatta,Plasma,9544.0,,,,4236,50797,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey
CHEMBL625786,1,,1,,,,A,12617,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15791,50597,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg
CHEMBL874467,0,,1,,,,A,12618,Autocuration,BAO_0000019,,U,,,,,,,11149,22224,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate
CHEMBL625787,1,,1,,,,A,12619,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,15592,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )"
CHEMBL625964,1,,1,,,,A,12620,Intermediate,BAO_0000218,,N,Human immunodeficiency virus,,12721.0,,,,15778,50677,,cytotoxicity against HIV protease enzyme.
CHEMBL625965,1,,1,,,,A,12621,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose
CHEMBL625966,1,,1,,,,A,12622,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12745,50594,,Apparent clearance in mice after oral administration of 100 mg/kg of dose
CHEMBL625967,1,,1,,,,A,12623,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,13941,50588,,The plasma clearance in dog.
CHEMBL625968,1,,1,,,,A,12624,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,13941,50597,,The plasma clearance in rat.
CHEMBL625969,1,,1,,,,A,12625,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,16449,50597,,Clearance from plasma in male Sprague-Dawley rats
CHEMBL625970,1,,1,,,,A,12626,Intermediate,BAO_0000218,1969.0,N,Macaca fascicularis,Plasma,9541.0,,In vivo,,16449,100710,,Clearance from plasma in male cynomolgus monkeys
CHEMBL625971,1,,1,,,,A,12627,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14224,50588,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma"
CHEMBL625972,1,,1,,,,A,12628,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14224,50588,,Clearance of compound in dog plasma
CHEMBL625973,1,,1,,,,A,12629,Intermediate,BAO_0000218,1969.0,N,Homo sapiens,Plasma,9606.0,,In vivo,,14224,50587,,Clearance of compound in human plasma
CHEMBL625974,1,,1,,,,A,12630,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14317,50588,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.
CHEMBL625975,1,,1,,,,A,12631,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14317,50588,,Clearance of compound when administered intravenously as an individual dose to a single dog.
CHEMBL625976,1,,1,,,,A,12632,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14224,50588,,"Clearance (10 mg/kg, intravenously) in dog plasma"
CHEMBL625977,1,,1,,,,A,12633,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,17237,50588,,Clearance value in dog
CHEMBL625978,1,,1,,,,A,12634,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,In vivo,,17237,50512,,Clearance value in guinea pig
CHEMBL874468,1,,1,,,,A,12635,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14187,50597,,Clearance values in rats after iv administration.
CHEMBL625421,0,,1,,,,A,12636,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,4806,22224,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk
CHEMBL625422,1,,1,,,,A,12637,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,In vivo,,15025,50592,,In vivo clearance (5 mg/kg) was determined in rabbits
CHEMBL625423,1,,1,,,,A,12638,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13197,50597,,Plasma Clearance rate was determined for the compound in rats
CHEMBL625424,0,,1,,,,A,12639,Autocuration,BAO_0000218,,U,Saimiri,,9520.0,,In vivo,,13197,22224,,Plasma Clearance rate was determined for the compound in squirrel monkeys
CHEMBL625425,1,,1,,,,A,12640,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13960,50597,,Plasma clearance in rat
CHEMBL625426,0,,1,,,,A,12641,Autocuration,BAO_0000218,,U,,,,,In vivo,,17820,22224,,Plasma clearance of the compound
CHEMBL625427,1,,1,,,,A,12642,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,In vivo,,14706,50512,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration
CHEMBL625428,1,,1,,,,A,12643,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,In vivo,,14706,50512,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration
CHEMBL625429,0,,1,,,,A,12644,Autocuration,BAO_0000218,,U,,,,,In vivo,,6504,22224,,Plasma clearance was determined
CHEMBL625430,1,,1,,,,A,12645,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14925,50588,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.
CHEMBL625431,1,,1,,,,A,12646,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13197,50597,,Plasma clearance rate was determined for the compound in rats
CHEMBL627307,0,,1,,,,A,12647,Autocuration,BAO_0000218,,U,Saimiri,,9520.0,,In vivo,,13197,22224,,Plasma clearance rate was determined for the compound in squirrel monkeys
CHEMBL627308,0,,1,,,,A,12648,Autocuration,BAO_0000218,,U,,,,,In vivo,,3437,22224,,Slow clearance (CL) was determined
CHEMBL627309,0,,1,,,,A,12649,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr
CHEMBL627310,0,,1,,,,A,12650,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced
CHEMBL627311,0,,1,,,,A,12651,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr
CHEMBL627312,0,,1,,,,A,12652,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr
CHEMBL627313,0,,1,,,,A,12653,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr
CHEMBL627314,0,,1,,,,A,12654,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr
CHEMBL627315,0,,1,,,,A,12655,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr
CHEMBL627316,0,,1,,,,A,12656,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr
CHEMBL627317,0,,1,,,,A,12657,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr
CHEMBL627318,0,,1,,,,A,12658,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr
CHEMBL627999,0,,1,,,,A,12659,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr
CHEMBL628000,0,,1,,,,A,12660,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr
CHEMBL628001,0,,1,,,,A,12661,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr
CHEMBL628002,0,,1,,,,A,12662,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr
CHEMBL625610,0,,1,,,,A,12663,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr
CHEMBL625611,0,,1,,,,A,12664,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr
CHEMBL625612,0,,1,,,,A,12665,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr
CHEMBL625613,0,,1,,,,A,12666,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr
CHEMBL875479,0,,1,,,,A,12667,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr
CHEMBL625614,0,,1,,,,A,12668,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr
CHEMBL625615,0,,1,,,,A,12669,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr
CHEMBL626302,0,,1,,,,A,12670,Autocuration,BAO_0000218,,U,,,,,,,9196,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr
CHEMBL626303,1,,1,,,,A,12671,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627420,1,,1,,,,A,12672,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8374,50597,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound
CHEMBL627421,1,,1,,,,A,12673,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM
CHEMBL625695,1,,1,,,,A,12674,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM
CHEMBL625696,1,,1,,,,A,12675,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM
CHEMBL875606,1,,1,,,,A,12676,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,10009,50594,,Distribution of compound in mice brain was measured after 1 hr
CHEMBL625697,1,,1,,,,A,12677,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,10009,50594,,Distribution of compound in mice brain was measured after 24 hr r
CHEMBL625698,1,,1,,,,A,12678,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,10009,50594,,Distribution of compound in mice brain was measured after 2 hr
CHEMBL625699,1,,1,,,,A,12679,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,10009,50594,,Distribution of compound in mice brain was measured after 3 hr
CHEMBL625700,1,,1,,,,A,12680,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,10009,50594,,Distribution of compound in mice brain was measured after 6 hr
CHEMBL625701,1,,1,,,,A,12681,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10009,50594,,Distribution of compound in mice liver was measured after 1 hr
CHEMBL625702,1,,1,,,,A,12682,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10009,50594,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected
CHEMBL625703,1,,1,,,,A,12683,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10009,50594,,Distribution of compound in mice liver was measured after 2 hr
CHEMBL625704,1,,1,,,,A,12684,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10009,50594,,Distribution of compound in mice liver was measured after 3 hr
CHEMBL625705,1,,1,,,,A,12685,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10009,50594,,Distribution of compound in mice liver was measured after 6 hr
CHEMBL625706,1,,1,,,,A,12686,Intermediate,BAO_0000218,1236.0,N,Canis lupus familiaris,Adrenal medulla,9615.0,,,,8170,50588,,Distribution in dog adrenal medulla 30 min after administration.
CHEMBL625707,1,,1,,,,A,12687,Intermediate,BAO_0000218,1236.0,N,Canis lupus familiaris,Adrenal medulla,9615.0,,,,8170,50588,,Distribution in dog adrenal medulla 72 hours after administration.
CHEMBL625708,1,,1,,,,A,12688,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog Ovary 24 hours after administration.
CHEMBL625709,1,,1,,,,A,12689,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog Ovary 72 hours after administration.
CHEMBL624180,1,,1,,,,A,12690,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog adipose 24 hours after administration.
CHEMBL624181,1,,1,,,,A,12691,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog adipose 72 hours after administration.
CHEMBL624182,1,,1,,,,A,12692,Intermediate,BAO_0000218,1235.0,N,Canis lupus familiaris,Adrenal cortex,9615.0,,,,8170,50588,,Distribution in female dog adrenal cortex 72 hours after administration.
CHEMBL624183,1,,1,,,,A,12693,Intermediate,BAO_0000218,1235.0,N,Canis lupus familiaris,Adrenal cortex,9615.0,,,,8170,50588,,Distribution in female dog adrenal cortex 72 hours after administration.
CHEMBL624184,1,,1,,,,A,12694,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-
CHEMBL877489,1,,1,,,,A,12695,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-
CHEMBL624185,1,,1,,,,A,12696,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-
CHEMBL624186,1,,1,,,,A,12697,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-
CHEMBL624187,1,,1,,,,A,12698,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-
CHEMBL624188,1,,1,,,,A,12699,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-
CHEMBL624189,1,,1,,,,A,12700,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-
CHEMBL624190,1,,1,,,,A,12701,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-
CHEMBL624191,1,,1,,,,A,12702,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-
CHEMBL624192,1,,1,,,,A,12703,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-
CHEMBL624193,1,,1,,,,A,12704,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-
CHEMBL624194,1,,1,,,,A,12705,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-
CHEMBL624891,1,,1,,,,A,12706,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-
CHEMBL624892,1,,1,,,,A,12707,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-
CHEMBL624893,1,,1,,,,A,12708,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-
CHEMBL627632,1,,1,,,,A,12709,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-
CHEMBL627633,1,,1,,,,A,12710,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-
CHEMBL627634,1,,1,,,,A,12711,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-
CHEMBL627635,1,,1,,,,A,12712,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-
CHEMBL627636,1,,1,,,,A,12713,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-
CHEMBL626816,1,,1,,,,A,12714,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-
CHEMBL626817,1,,1,,,,A,12715,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-
CHEMBL626818,1,,1,,,,A,12716,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-
CHEMBL626819,1,,1,,,,A,12717,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-
CHEMBL626820,1,,1,,,,A,12718,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-
CHEMBL626821,1,,1,,,,A,12719,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-
CHEMBL626822,1,,1,,,,A,12720,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-
CHEMBL626823,1,,1,,,,A,12721,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-
CHEMBL626824,1,,1,,,,A,12722,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-
CHEMBL626825,1,,1,,,,A,12723,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-
CHEMBL626826,1,,1,,,,A,12724,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-
CHEMBL626827,1,,1,,,,A,12725,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-
CHEMBL626828,1,,1,,,,A,12726,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-
CHEMBL626829,1,,1,,,,A,12727,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-
CHEMBL626830,1,,1,,,,A,12728,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-
CHEMBL627150,1,,1,,,,A,12729,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-
CHEMBL627151,1,,1,,,,A,12730,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-
CHEMBL627152,1,,1,,,,A,12731,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-
CHEMBL627153,1,,1,,,,A,12732,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-
CHEMBL627154,0,,1,,,,A,12733,Autocuration,BAO_0000019,,U,,,,,,,12904,22224,,Rate of acetate production by the compound was determined
CHEMBL627155,0,,1,,,,A,12734,Autocuration,BAO_0000019,,U,,,,,,,12904,22224,,Rate of acetate production by the compound was determined; Not determined
CHEMBL627156,0,,1,,,,A,12735,Autocuration,BAO_0000019,,U,,,,,,,3730,22224,,Rate of hydrolysis of nitrocefin by compound was evaluated in water
CHEMBL627157,0,,1,,,,A,12736,Autocuration,BAO_0000019,,U,,,,,,,3627,22224,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent
CHEMBL627158,1,,1,,,,A,12737,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,13799,50592,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration
CHEMBL627159,1,,1,,,,A,12738,Intermediate,BAO_0000218,1969.0,N,Oryctolagus cuniculus,Plasma,9986.0,,,,13799,50592,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration
CHEMBL627160,1,,1,,,,A,12739,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13799,50594,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration
CHEMBL628540,1,,1,,,,A,12740,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13799,50597,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration
CHEMBL628541,1,,1,,,,A,12741,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,13799,50597,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration
CHEMBL628542,1,,1,,,,A,12742,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,13799,50597,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration
CHEMBL628543,0,,1,,,,P,12743,Autocuration,BAO_0000100,,U,,,,,,,6629,22229,,Solubility after at a pH 1.2
CHEMBL628544,0,,1,,,,P,12744,Autocuration,BAO_0000100,,U,,,,,,,6629,22229,,Solubility after at pH 1.2
CHEMBL628545,0,,1,,,,P,12745,Autocuration,BAO_0000100,,U,,,,,,,6629,22229,,Solubility after injection of water
CHEMBL628546,0,,1,,,,A,12746,Autocuration,BAO_0000019,,U,,,,,,,14000,22224,,Statistical significance of IC 50 values; Expressed as R value
CHEMBL874455,0,,1,,,,A,12747,Autocuration,BAO_0000019,,U,,,,,,,8267,22224,,Systemic availability with respect to methyldopa was determined
CHEMBL628547,1,,1,,,,A,12748,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13799,50597,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration
CHEMBL628548,1,,1,,,,A,12749,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,13799,50597,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration
CHEMBL628549,1,,1,,,,A,12750,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated"
CHEMBL628550,1,,1,,,,A,12751,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated"
CHEMBL628551,1,,1,,,,A,12752,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours"
CHEMBL628552,1,,1,,,,A,12753,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr"
CHEMBL628553,1,,1,,,,A,12754,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr"
CHEMBL628554,1,,1,,,,A,12755,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr"
CHEMBL628555,1,,1,,,,A,12756,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h"
CHEMBL628556,1,,1,,,,A,12757,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h"
CHEMBL628557,1,,1,,,,A,12758,Intermediate,BAO_0000218,2113.0,N,Oryctolagus cuniculus,Kidney,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated"
CHEMBL628558,1,,1,,,,A,12759,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated"
CHEMBL628559,1,,1,,,,A,12760,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at"
CHEMBL628560,1,,1,,,,A,12761,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated"
CHEMBL874456,1,,1,,,,A,12762,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours"
CHEMBL628561,1,,1,,,,A,12763,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr"
CHEMBL628562,1,,1,,,,A,12764,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours"
CHEMBL628563,1,,1,,,,A,12765,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr"
CHEMBL628564,1,,1,,,,A,12766,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at"
CHEMBL628565,1,,1,,,,A,12767,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h"
CHEMBL631248,1,,1,,,,A,12768,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h"
CHEMBL631249,1,,1,,,,A,12769,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours"
CHEMBL627214,1,,1,,,,A,12770,Intermediate,BAO_0000218,2113.0,N,Oryctolagus cuniculus,Kidney,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated"
CHEMBL874591,1,,1,,,,A,12771,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated"
CHEMBL627215,1,,1,,,,A,12772,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated"
CHEMBL625471,1,,1,,,,A,12773,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated
CHEMBL625472,1,,1,,,,A,12774,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,7132,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1
CHEMBL625473,1,,1,,,,A,12775,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,7132,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis
CHEMBL625474,1,,1,,,,A,12776,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13317,50588,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.
CHEMBL625475,1,,1,,,,A,12777,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,15341,50588,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.
CHEMBL625476,1,,1,,,,A,12778,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15341,50597,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.
CHEMBL625477,1,,1,,,,A,12779,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15341,50597,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.
CHEMBL625478,1,,1,,,,A,12780,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15341,50597,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.
CHEMBL625479,1,,1,,,,A,12781,Intermediate,BAO_0000218,,N,Rattus norvegicus,esophageal tunica muscularis mucosae,10116.0,,In vitro,,12801,50597,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose
CHEMBL625480,1,,1,,,,A,12782,Intermediate,BAO_0000218,,N,Rattus norvegicus,esophageal tunica muscularis mucosae,10116.0,,In vitro,,12801,50597,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose
CHEMBL625481,1,,1,,,,A,12783,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14856,50597,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.
CHEMBL625482,1,,1,,,,A,12784,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat
CHEMBL625483,1,,1,,,,A,12785,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat
CHEMBL625484,1,,1,,,,A,12786,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat
CHEMBL625485,1,,1,,,,A,12787,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14062,50597,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat
CHEMBL625486,1,,1,,,,A,12788,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14346,50588,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs
CHEMBL625487,1,,1,,,,A,12789,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14346,50597,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats
CHEMBL625488,1,,1,,,,A,12790,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14346,50597,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats
CHEMBL625489,1,,1,,,,A,12791,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14346,50597,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats
CHEMBL625490,1,,1,,,,A,12792,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14346,50597,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats
CHEMBL625491,1,,1,,,,A,12793,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14346,50588,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs
CHEMBL625492,1,,1,,,,A,12794,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14346,50597,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats
CHEMBL625493,1,,1,,,,A,12795,Intermediate,BAO_0000218,1969.0,N,Homo sapiens,Plasma,9606.0,,In vivo,,15711,50587,,plasma clearance in human
CHEMBL625494,1,,1,,,,A,12796,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14886,50597,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg
CHEMBL625495,1,,1,,,,A,12797,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14886,50597,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg
CHEMBL625496,1,,1,,,,A,12798,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14886,50597,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg
CHEMBL625497,0,,1,,,,P,12799,Autocuration,BAO_0000100,,U,,,,,,,4115,22229,,1-Octanol/water partition coefficient measured at 7.4
CHEMBL625498,0,,1,,,,P,12800,Autocuration,BAO_0000100,,U,,,,,,,13733,22229,,Calculated partition coefficient (clogP)
CHEMBL625499,0,,1,,,,A,12801,Autocuration,BAO_0000019,,U,,,,,,,12102,22224,,Partition coefficient (logP)
CHEMBL625500,0,,1,,,,P,12802,Autocuration,BAO_0000100,,U,,,,,,,12676,22229,,Calculated partition coefficient (clogP)
CHEMBL625501,0,,1,,,,P,12803,Autocuration,BAO_0000100,,U,,,,,,,13733,22229,,Calculated partition coefficient (clogP)
CHEMBL625502,0,,1,,,,P,12804,Autocuration,BAO_0000100,,U,,,,,,,13740,22229,,Calculated partition coefficient (clogP)
CHEMBL625503,0,,1,,,,P,12805,Autocuration,BAO_0000100,,U,,,,,,,12766,22229,,Calculated partition coefficient (clogP) (relative to BAY K 8644)
CHEMBL625504,0,,1,,,,P,12806,Autocuration,BAO_0000100,,U,,,,,,,2764,22229,,Calculated partition coefficient (clogP)
CHEMBL625505,0,,1,,,,P,12807,Autocuration,BAO_0000100,,U,,,,,,,12355,22229,,Calculated partition coefficient (clogP)
CHEMBL625506,0,,1,,,,P,12808,Autocuration,BAO_0000100,,U,,,,,,,11314,22229,,Calculated partition coefficient of the compound
CHEMBL625507,0,,1,,,,A,12809,Autocuration,BAO_0000019,,U,,,,,,,12706,22224,,Partition coefficient (logP)
CHEMBL625508,0,,1,,,,P,12810,Autocuration,BAO_0000100,,U,,,,,,,12645,22229,,Calculated partition coefficient (clogP)
CHEMBL625509,0,,1,,,,P,12811,Autocuration,BAO_0000100,,U,,,,,,,13668,22229,,Calculated partition coefficient (clogP)
CHEMBL625510,0,,1,,,,P,12812,Autocuration,BAO_0000100,,U,,,,,,,12819,22229,,Calculated partition coefficient (clogP)
CHEMBL883125,0,,1,,,,P,12813,Autocuration,BAO_0000100,,U,,,,,,,13668,22229,,Calculated partition coefficient (clogP)
CHEMBL625511,0,,1,,,,P,12814,Autocuration,BAO_0000100,,U,,,,,,,13017,22229,,Calculated partition coefficient (clogP)
CHEMBL874650,0,,1,,,,A,12815,Autocuration,BAO_0000019,,U,,,,,,,2448,22224,,Partition coefficient of the compound
CHEMBL625512,0,,1,,,,A,12816,Autocuration,BAO_0000019,,U,,,,,,,11526,22224,,Partition coefficient of the compound
CHEMBL625513,0,,1,,,,A,12817,Autocuration,BAO_0000019,,U,,,,,,,12426,22224,,Partition coefficient of compound was determined
CHEMBL625514,0,,1,,,,A,12818,Autocuration,BAO_0000019,,U,,,,,,,2448,22224,,Partition coefficient was determined
CHEMBL625515,0,,1,,,,P,12819,Autocuration,BAO_0000100,,U,,,,,,,12001,22229,,Calculated partition coefficient (clogP)
CHEMBL625516,0,,1,,,,P,12820,Autocuration,BAO_0000100,,U,,,,,,,12426,22229,,partition coefficient of compound was determined
CHEMBL625517,1,,1,,,,A,12821,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13204,50588,,The total body administered intravenously in dog
CHEMBL625518,1,,1,,,,A,12822,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13204,50597,,The total body administered intravenously in rats
CHEMBL625519,1,,1,,,,A,12823,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13889,50594,,Time taken for the administration to female NIH mice weighing 25-30 g.
CHEMBL625520,0,,1,,,,A,12824,Autocuration,BAO_0000019,,U,,,,,,,13889,22224,,Time taken for the administration
CHEMBL874651,1,,1,,,,A,12825,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,17025,50588,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.
CHEMBL625521,0,,1,,,,A,12826,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,17025,22224,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.
CHEMBL623171,1,,1,,,,A,12827,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,In vivo,,17025,50592,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.
CHEMBL623853,1,,1,,,,A,12828,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,17025,50597,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.
CHEMBL623854,0,,1,,,,A,12829,Autocuration,BAO_0000019,,U,,,,,,,15067,22224,,Plasma clearance for the compound was determined.
CHEMBL874405,0,,1,,,,P,12830,Autocuration,BAO_0000100,,U,,,,,,,3091,22224,,CLog P value of the compound
CHEMBL623855,0,,1,,,,P,12831,Autocuration,BAO_0000100,,U,,,,,,,15592,22229,,Calculated partition coefficient (clogP)
CHEMBL623856,0,,1,,,,P,12832,Autocuration,BAO_0000100,,U,,,,,,,14738,22229,,Calculated partition coefficient (clogP)
CHEMBL623857,0,,1,,,,P,12833,Autocuration,BAO_0000100,,U,,,,,,,14738,22224,,ClogP value of the compound; nd ='no data'
CHEMBL623858,0,,1,,,,P,12834,Autocuration,BAO_0000100,,U,,,,,,,14738,22224,,ClogP value of the compound; nd ='not determined'
CHEMBL623859,0,,1,,,,P,12835,Autocuration,BAO_0000100,,U,,,,,,,6076,22224,,CLog P was determined
CHEMBL839829,0,,1,,,,P,12836,Autocuration,BAO_0000100,,U,,,,,,,17840,22229,,Calculated partition coefficient (clogP)
CHEMBL623860,0,,1,,,,A,12837,Autocuration,BAO_0000019,,U,,,,,,,13589,22224,,CLogP was calculated
CHEMBL623861,0,,1,,,,A,12838,Autocuration,BAO_0000019,,U,,,,,,,17655,22224,,CLogP value was determined
CHEMBL623862,0,,1,,,,A,12839,Autocuration,BAO_0000019,,U,,,,,,,5867,22224,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.
CHEMBL874406,0,,1,,,,P,12840,Autocuration,BAO_0000100,,U,,,,,,,5867,22229,,Calculated partition coefficient (clogP)
CHEMBL623863,0,,1,,,,P,12841,Autocuration,BAO_0000100,,U,,,,,,,10783,22229,,Calculated partition coefficient (clogP)
CHEMBL624021,0,,1,,,,P,12842,Autocuration,BAO_0000100,,U,,,,,,,14849,22229,,Calculated partition coefficient (clogP)
CHEMBL624022,1,,1,,,,A,12843,Intermediate,BAO_0000218,1236.0,N,Canis lupus familiaris,Adrenal medulla,9615.0,,,,8170,50588,,Distribution in female dog adrenal medulla 24 hours after administration.
CHEMBL624023,1,,1,,,,A,12844,Intermediate,BAO_0000218,1236.0,N,Canis lupus familiaris,Adrenal medulla,9615.0,,,,8170,50588,,Distribution in female dog adrenal medulla 72 hours after administration.
CHEMBL624024,1,,1,,,,A,12845,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog bile 24 hours after administration.
CHEMBL624025,1,,1,,,,A,12846,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog bile 72 hr after administration.
CHEMBL624026,1,,1,,,,A,12847,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog blood 24 hours after administration.
CHEMBL624027,1,,1,,,,A,12848,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog blood 72 hours after administration.
CHEMBL624028,1,,1,,,,A,12849,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog heart 24 hours after administration.
CHEMBL624029,1,,1,,,,A,12850,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog heart 72 hours after administration.
CHEMBL624030,1,,1,,,,A,12851,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog kidney 24 hours after administration.
CHEMBL624031,1,,1,,,,A,12852,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog kidney 72 hours after administration.
CHEMBL624032,1,,1,,,,A,12853,Intermediate,BAO_0000218,160.0,N,Canis lupus familiaris,Intestine,9615.0,,,,8170,50588,,Distribution in female dog large intestine 24 hours after administration.
CHEMBL874407,1,,1,,,,A,12854,Intermediate,BAO_0000218,160.0,N,Canis lupus familiaris,Intestine,9615.0,,,,8170,50588,,Distribution in female dog large intestine 72 hours after administration.
CHEMBL624033,1,,1,,,,A,12855,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog liver 24 hours after administration.
CHEMBL624034,1,,1,,,,A,12856,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog liver 72 hours after administration.
CHEMBL624035,1,,1,,,,A,12857,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog lung 24 hours after administration.
CHEMBL624036,1,,1,,,,A,12858,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog lung 72 hours after administration.
CHEMBL624037,1,,1,,,,A,12859,Intermediate,BAO_0000218,2385.0,N,Canis lupus familiaris,Muscle tissue,9615.0,,,,8170,50588,,Distribution in female dog muscle 24 hours after administration.
CHEMBL624038,1,,1,,,,A,12860,Intermediate,BAO_0000218,2385.0,N,Canis lupus familiaris,Muscle tissue,9615.0,,,,8170,50588,,Distribution in female dog muscle 72 hours after administration.
CHEMBL624039,1,,1,,,,A,12861,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog pancreas 24 hours after administration.
CHEMBL624040,1,,1,,,,A,12862,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8170,50588,,Distribution in female dog pancreas 72 hours after administration.
CHEMBL624041,1,,1,,,,A,12863,Intermediate,BAO_0000218,160.0,N,Canis lupus familiaris,Intestine,9615.0,,,,8170,50588,,Distribution in female dog small intestine 24 hours after administration.
CHEMBL624042,1,,1,,,,A,12864,Intermediate,BAO_0000218,160.0,N,Canis lupus familiaris,Intestine,9615.0,,,,8170,50588,,Distribution in female dog small intestine 72 hours after administration.
CHEMBL624043,1,,1,,,,A,12865,Intermediate,BAO_0000218,2106.0,N,Canis lupus familiaris,Spleen,9615.0,,,,8170,50588,,Distribution in female dog spleen 24 hours after administration.
CHEMBL624044,1,,1,,,,A,12866,Intermediate,BAO_0000218,2106.0,N,Canis lupus familiaris,Spleen,9615.0,,,,8170,50588,,Distribution in female dog spleen 72 hours after administration.
CHEMBL624045,1,,1,,,,A,12867,Intermediate,BAO_0000218,945.0,N,Canis lupus familiaris,Stomach,9615.0,,,,8170,50588,,Distribution in female dog stomach 24 hours after administration.
CHEMBL624046,1,,1,,,,A,12868,Intermediate,BAO_0000218,945.0,N,Canis lupus familiaris,Stomach,9615.0,,,,8170,50588,,Distribution in female dog stomach 72 hours after administration.
CHEMBL624047,1,,1,,,,A,12869,Intermediate,BAO_0000218,2046.0,N,Canis lupus familiaris,Thyroid gland,9615.0,,,,8170,50588,,Distribution in female dog thyroid 24 hours after administration.
CHEMBL624048,1,,1,,,,A,12870,Intermediate,BAO_0000218,2046.0,N,Canis lupus familiaris,Thyroid gland,9615.0,,,,8170,50588,,Distribution in female dog thyroid 72 hours after administration.
CHEMBL874408,1,,1,,,,A,12871,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8170,50588,,Distribution in female dog urine 24 hours after administration.
CHEMBL624049,1,,1,,,,A,12872,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8170,50588,,Distribution in female dog urine 72 hr after administration.
CHEMBL624050,0,,1,,,,A,12873,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,,,14283,22224,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg
CHEMBL624051,0,,1,,,,A,12874,Autocuration,BAO_0000019,,U,,,,,,,5623,22224,,Plasma concentration at 7 hr after intravenous dosing
CHEMBL623278,1,,1,,,,A,12875,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats
CHEMBL623279,1,,1,,,,A,12876,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats
CHEMBL623280,1,,1,,,,A,12877,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration of 3 mg/kg iv after 1 hr in rats
CHEMBL623963,1,,1,,,,A,12878,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration of 3 mg/kg iv after 2 hr in rats
CHEMBL623964,1,,1,,,,A,12879,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration of 3 mg/kg iv after 4 hr in rats
CHEMBL623965,1,,1,,,,A,12880,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration of 3 mg/kg iv after 6 hr in rats
CHEMBL623966,1,,1,,,,A,12881,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats
CHEMBL874415,1,,1,,,,A,12882,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h
CHEMBL623967,1,,1,,,,A,12883,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr
CHEMBL623968,1,,1,,,,A,12884,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr
CHEMBL623969,1,,1,,,,A,12885,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr
CHEMBL628409,1,,1,,,,A,12886,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr
CHEMBL628410,1,,1,,,,A,12887,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr
CHEMBL628411,1,,1,,,,A,12888,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr
CHEMBL628412,1,,1,,,,A,12889,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13477,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr
CHEMBL628413,0,,1,,,,A,12890,Autocuration,BAO_0000019,,U,,,,,,,12553,22224,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts
CHEMBL628414,0,,1,,,,A,12891,Autocuration,BAO_0000019,1969.0,U,,Plasma,,,,,14548,22224,,The concentration in plasmat; Not determined
CHEMBL628415,1,,1,,,,A,12892,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14393,50597,,Tissue level at 10 mg/kg/po in wistar rats in blood
CHEMBL628416,1,,1,,,,A,12893,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14393,50597,,Tissue level at 10 mg/kg/po in wistar rats in brown fat
CHEMBL628417,1,,1,,,,A,12894,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14393,50597,,Tissue level at 10 mg/kg/po in wistar rats in heart
CHEMBL874908,1,,1,,,,A,12895,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,14393,50597,,Tissue level at 10 mg/kg/po in wistar rats in liver
CHEMBL628418,1,,1,,,,A,12896,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14393,50597,,Tissue level at 10 mg/kg/po in wistar rats in plasma
CHEMBL628419,1,,1,,,,A,12897,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,14393,50597,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle
CHEMBL628420,1,,1,,,,A,12898,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14393,50597,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat
CHEMBL628421,0,,1,,,,A,12899,Autocuration,BAO_0000019,,U,,,,,,,1629,22224,,Water solubility at 37 degree C.
CHEMBL626726,0,,1,,,,P,12900,Autocuration,BAO_0000100,,U,,,,,,,8194,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr
CHEMBL626727,0,,1,,,,P,12901,Autocuration,BAO_0000100,,U,,,,,,,8194,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr
CHEMBL626728,1,,1,,,,A,12902,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-
CHEMBL626729,1,,1,,,,A,12903,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-
CHEMBL626730,1,,1,,,,A,12904,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-
CHEMBL626731,1,,1,,,,A,12905,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-
CHEMBL626732,1,,1,,,,A,12906,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-
CHEMBL626733,1,,1,,,,A,12907,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-
CHEMBL626734,1,,1,,,,A,12908,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-
CHEMBL626735,1,,1,,,,A,12909,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-
CHEMBL874909,1,,1,,,,A,12910,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-
CHEMBL626736,1,,1,,,,A,12911,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-
CHEMBL626737,1,,1,,,,A,12912,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-
CHEMBL630999,1,,1,,,,A,12913,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-
CHEMBL631000,1,,1,,,,A,12914,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-
CHEMBL631001,1,,1,,,,A,12915,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-
CHEMBL631002,1,,1,,,,A,12916,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-
CHEMBL631003,1,,1,,,,A,12917,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-
CHEMBL631004,1,,1,,,,A,12918,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-
CHEMBL631005,1,,1,,,,A,12919,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-
CHEMBL631006,1,,1,,,,A,12920,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-
CHEMBL631007,1,,1,,,,A,12921,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-
CHEMBL631008,1,,1,,,,A,12922,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-
CHEMBL631009,1,,1,,,,A,12923,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-
CHEMBL631010,1,,1,,,,A,12924,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-
CHEMBL631011,1,,1,,,,A,12925,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-
CHEMBL631012,1,,1,,,,A,12926,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-
CHEMBL630271,1,,1,,,,A,12927,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-
CHEMBL630272,1,,1,,,,A,12928,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-
CHEMBL630273,1,,1,,,,A,12929,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-
CHEMBL630274,1,,1,,,,A,12930,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-
CHEMBL630275,1,,1,,,,A,12931,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,,,8594,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-
CHEMBL875782,1,,1,,,,A,12932,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-
CHEMBL630276,1,,1,,,,A,12933,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-
CHEMBL630277,1,,1,,,,A,12934,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-
CHEMBL630278,1,,1,,,,A,12935,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-
CHEMBL630279,1,,1,,,,A,12936,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8594,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-
CHEMBL630280,0,,1,,,,A,12937,Autocuration,BAO_0000019,,U,,,,,,,8151,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg
CHEMBL630281,0,,1,,,,A,12938,Autocuration,BAO_0000019,,U,,,,,,,8151,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg
CHEMBL630282,1,,1,,,,A,12939,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,7132,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis
CHEMBL630283,1,,1,,,,A,12940,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,7132,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2
CHEMBL630284,0,,1,,,,A,12941,Autocuration,BAO_0000019,,U,,,,,,,5797,22224,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug)
CHEMBL630285,0,,1,,,,A,12942,Autocuration,BAO_0000019,,U,,,,,,,7849,22224,,Alkylating activity was determined
CHEMBL630286,0,,1,,,,A,12943,Autocuration,BAO_0000251,,U,,,,,,,14220,22224,Microsomes,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM)
CHEMBL630069,1,,1,,,,A,12944,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,8650,50592,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours"
CHEMBL630070,1,,1,,,,A,12945,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,8650,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour"
CHEMBL630071,1,,1,,,,A,12946,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,8650,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour"
CHEMBL630072,1,,1,,,,A,12947,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,8650,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours"
CHEMBL875110,1,,1,,,,A,12948,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,8650,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour"
CHEMBL630073,1,,1,,,,A,12949,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7116,50597,,Compound was tested for antidiuretic activity in rats
CHEMBL630074,0,,1,,,,A,12950,Autocuration,BAO_0000019,,U,,,,,,,14131,22224,,Compound was tested for inactivation kinetic values
CHEMBL630075,0,,1,,,,A,12951,Autocuration,BAO_0000218,,U,,,,,In vivo,,7415,22224,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route
CHEMBL630076,0,,1,,,,A,12952,Autocuration,BAO_0000019,,U,,,,,,,13178,22224,,Dissociation rate calculated from the first-order equation using the t1/2 value
CHEMBL630077,0,,1,,,,P,12953,Autocuration,BAO_0000100,,U,,,,,,,8815,22229,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water
CHEMBL630078,0,,1,,,,P,12954,Autocuration,BAO_0000100,,U,,,,,,,1450,22229,,Aqueous solubility was measured
CHEMBL630079,0,,1,,,,P,12955,Autocuration,BAO_0000100,,U,,,,,,,1450,22229,,Aqueous solubility was measured at a pH 4
CHEMBL630080,0,,1,,,,P,12956,Autocuration,BAO_0000100,,U,,,,,,,1450,22229,,Aqueous solubility (pH 7)
CHEMBL630081,0,,1,,,,P,12957,Autocuration,BAO_0000100,,U,,,,,,,1450,22229,,Aqueous solubility was measured at a pH 9
CHEMBL630082,0,,1,,,,A,12958,Autocuration,BAO_0000019,,U,,,,,,,12711,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents"
CHEMBL630083,0,,1,,,,A,12959,Autocuration,BAO_0000019,,U,,,,,,,12711,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents."
CHEMBL630084,0,,1,,,,A,12960,Autocuration,BAO_0000019,,U,,,,,,,12711,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents."
CHEMBL629198,0,,1,,,,P,12961,Autocuration,BAO_0000100,,U,,,,,,,15032,22229,,Aqueous solubility of the compound
CHEMBL629199,0,,1,,,,P,12962,Autocuration,BAO_0000100,,U,,,,,,,9964,22229,,Aqueous solubility at 37 degree Celsius at pH 7.38
CHEMBL629200,0,,1,,,,P,12963,Autocuration,BAO_0000100,,U,,,,,,,14962,22229,,Aqueous solubility in pH 7.4 phosphate buffer
CHEMBL629201,1,,1,,,,A,12964,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12487,50588,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog
CHEMBL629202,1,,1,,,,A,12965,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,12487,50588,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog
CHEMBL875111,1,,1,,,,A,12966,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,10026,50587,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius
CHEMBL629203,1,,1,,,,A,12967,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,10026,50587,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius
CHEMBL629204,1,,1,,,,A,12968,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,10026,50587,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius
CHEMBL629205,1,,1,,,,A,12969,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,10026,50587,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius
CHEMBL629206,1,,1,,,,A,12970,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,10026,50587,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius
CHEMBL631185,0,,1,,,,A,12971,Autocuration,BAO_0000019,,U,,,,,,,10026,22224,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius
CHEMBL631186,1,,1,,,,A,12972,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7415,50597,,Compound was evaluated for the average bile flow rat in rats
CHEMBL631187,1,,1,,,,A,12973,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,17025,50592,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg"
CHEMBL631188,1,,1,,,,A,12974,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,,,17025,50592,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg"
CHEMBL876419,0,,1,,,,A,12975,Autocuration,BAO_0000019,,U,,,,,,,10184,22224,,Average half life period was determined
CHEMBL631189,0,,1,,,,A,12976,Autocuration,BAO_0000019,,U,,,,,,,10184,22224,,Average half life period was determined
CHEMBL631190,1,,1,,,,A,12977,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.
CHEMBL631191,1,,1,,,,A,12978,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.
CHEMBL631192,1,,1,,,,A,12979,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.
CHEMBL632400,1,,1,,,,A,12980,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.
CHEMBL630564,1,,1,,,,A,12981,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.
CHEMBL630565,1,,1,,,,A,12982,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.
CHEMBL630566,1,,1,,,,A,12983,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.
CHEMBL631229,1,,1,,,,A,12984,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.
CHEMBL631230,1,,1,,,,A,12985,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.
CHEMBL876428,0,,1,,,,P,12986,Autocuration,BAO_0000100,,U,,,,,,,6030,22229,,Calculated partition coefficient (clogP)
CHEMBL631231,0,,1,,,,P,12987,Autocuration,BAO_0000100,,U,,,,,,,6147,22229,,Calculated partition coefficient (clogP)
CHEMBL631232,0,,1,,,,P,12988,Autocuration,BAO_0000100,,U,,,,,,,14556,22229,,Calculated partition coefficient (clogP) (MacLogP)
CHEMBL631233,0,,1,,,,A,12989,Autocuration,BAO_0000019,,U,,,,,,,768,22224,,Hydrophilicity was determined
CHEMBL631234,0,,1,,,,P,12990,Autocuration,BAO_0000100,,U,,,,,,,14452,22229,,Calculated partition coefficient (clogP)
CHEMBL883126,0,,1,,,,A,12991,Autocuration,BAO_0000019,,U,,,,,,,5237,22224,,Increased absorption was determined
CHEMBL631235,0,,1,,,,P,12992,Autocuration,BAO_0000100,,U,,,,,,,14378,22224,,Lipophilicity value was evaluated
CHEMBL631236,0,,1,,,,P,12993,Autocuration,BAO_0000100,,U,,,,,,,14418,22224,,Log P value of the compound.
CHEMBL631237,0,,1,,,,A,12994,Autocuration,BAO_0000019,,U,,,,,,,5249,22224,,Partition coefficient of compound was determined
CHEMBL631238,0,,1,,,,P,12995,Autocuration,BAO_0000100,,U,,,,,,,14621,22229,,Calculated partition coefficient (clogP)
CHEMBL876429,0,,1,,,,P,12996,Autocuration,BAO_0000100,,U,,,,,,,12542,22229,,Calculated partition coefficient (clogP)
CHEMBL631414,0,,1,,,,A,12997,Autocuration,BAO_0000019,,U,,,,,,,12542,22224,,Partition coefficient was measured by medchem software; Not calculated
CHEMBL631415,0,,1,,,,P,12998,Autocuration,BAO_0000100,,U,,,,,,,12542,22224,,Partition coefficient was measured by octanol-water using standard shake-flask method
CHEMBL631416,0,,1,,,,P,12999,Autocuration,BAO_0000100,,U,,,,,,,15462,22229,,Calculated partition coefficient (clogP)
CHEMBL631417,0,,1,,,,A,13000,Autocuration,BAO_0000019,,U,,,,,,,14884,22224,,Partition coefficient (logP)
CHEMBL631418,0,,1,,,,P,13001,Autocuration,BAO_0000100,,U,,,,,,,16526,22229,,Calculated partition coefficient (clogP)
CHEMBL631419,0,,1,,,,P,13002,Autocuration,BAO_0000100,,U,,,,,,,13693,22229,,The Octanol/Water partition coefficient CLogP
CHEMBL631420,0,,1,,,,A,13003,Autocuration,BAO_0000019,,U,,,,,,,13693,22224,,The pharmacokinetic parameter C Log p was reported
CHEMBL631421,0,,1,,,,P,13004,Autocuration,BAO_0000100,,U,,,,,,,13779,22229,,Calculated partition coefficient (clogP)
CHEMBL631422,0,,1,,,,P,13005,Autocuration,BAO_0000100,,U,,,,,,,14772,22229,,Calculated partition coefficient (clogP)
CHEMBL631423,0,,1,,,,P,13006,Autocuration,BAO_0000100,,U,,,,,,,14393,22229,,Calculated partition coefficient (clogP)
CHEMBL876430,1,,1,,,,A,13007,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14793,50597,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg
CHEMBL631424,1,,1,,,,A,13008,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14793,50597,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg
CHEMBL631425,1,,1,,,,A,13009,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,13744,50588,,Compound was administered intravenously in dog to evaluate plasma clearance values
CHEMBL631426,0,,1,,,,A,13010,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,In vivo,,13744,22224,,Compound was administered intravenously in monkey to evaluate plasma clearance values
CHEMBL631427,1,,1,,,,A,13011,Intermediate,BAO_0000218,1969.0,N,Mus musculus,Plasma,10090.0,,In vivo,,13744,50594,,Compound was administered intravenously in mouse to evaluate plasma clearance values
CHEMBL631428,1,,1,,,,A,13012,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,13207,50588,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg
CHEMBL631429,1,,1,,,,A,13013,Intermediate,BAO_0000218,2107.0,N,Macaca mulatta,Liver,9544.0,,In vitro,,5669,50797,Microsomes,Intrinsic clearance in Rhesus liver microsome
CHEMBL631430,1,,1,,,,A,13014,Intermediate,BAO_0000218,2107.0,N,Canis lupus familiaris,Liver,9615.0,,In vitro,,5669,50588,Microsomes,Intrinsic clearance in dog liver microsome
CHEMBL631431,1,,1,,,,A,13015,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vitro,,5669,50597,Microsomes,Intrinsic clearance in rat liver microsome
CHEMBL631432,1,,1,,,,A,13016,Intermediate,BAO_0000218,1969.0,N,Macaca mulatta,Plasma,9544.0,,In vivo,,4853,50797,,Low plasma clearance was calculated in rhesus monkey
CHEMBL631433,1,,1,,,,A,13017,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,16452,50588,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.
CHEMBL631434,0,,1,,,,A,13018,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Plasma clearance after intravenous dose of 0.3 mg/kg
CHEMBL631435,0,,1,,,,A,13019,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Plasma clearance after intravenous dose of 1 mg/kg
CHEMBL631436,0,,1,,,,A,13020,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Plasma clearance after intravenous dose of 3 mg/kg
CHEMBL631437,0,,1,,,,A,13021,Autocuration,BAO_0000218,,U,,,,,In vivo,,11954,22224,,Plasma clearance after intravenous dose of 3.87 mg/kg
CHEMBL631438,1,,1,,,,A,13022,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5669,50597,,Plasma clearance after peroral administration at 10 mpk in Rat
CHEMBL876431,1,,1,,,,A,13023,Intermediate,BAO_0000218,,N,Macaca mulatta,,9544.0,,In vivo,,5669,50797,,Plasma clearance after peroral administration at 10 mpk in Rhesus
CHEMBL631439,1,,1,,,,A,13024,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,5669,50588,,Plasma clearance after peroral administration at 10 mpk in dog
CHEMBL631440,1,,1,,,,A,13025,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13662,50597,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat
CHEMBL631441,0,,1,,,,A,13026,Autocuration,BAO_0000019,,U,,,,,,,8272,22224,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC)
CHEMBL631442,0,,1,,,,A,13027,Autocuration,BAO_0000019,,U,,,,,,,13410,22224,,Critical Micellar concentration was determined
CHEMBL626525,0,,1,,,,A,13028,Autocuration,BAO_0000019,,U,,,,,,,13410,22224,,Critical Micellar concentration of the compound. was determined
CHEMBL627168,0,,1,,,,A,13029,Autocuration,BAO_0000019,,U,,,,,,,12628,22224,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration
CHEMBL875618,0,,1,,,,A,13030,Autocuration,BAO_0000019,,U,,,,,,,9675,22224,,Critical micellar concentration was measured in water by the dye solubilization method
CHEMBL626612,0,,1,,,,B,13031,Autocuration,BAO_0000019,,U,,,,,,,12628,22224,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC
CHEMBL626613,0,,1,,,,A,13032,Autocuration,BAO_0000019,,U,,,,,,,12766,22224,,CMR value (relative to BAY K 8644)
CHEMBL626614,0,,1,,,,A,13033,Autocuration,BAO_0000019,,U,,,,,,,7849,22224,,Carbamoylating activity was determined
CHEMBL626615,0,,1,,,,A,13034,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,,,12187,22224,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey
CHEMBL626616,0,,1,,,,A,13035,Autocuration,BAO_0000019,,U,,,,,,,2040,22224,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.
CHEMBL626617,0,,1,,,,A,13036,Autocuration,BAO_0000019,,U,,,,,,,2040,22224,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.
CHEMBL626618,1,,1,,,,A,13037,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,14180,50588,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound
CHEMBL626619,1,,1,,,,A,13038,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14180,50597,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound
CHEMBL626620,1,,1,,,,A,13039,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14474,50588,,"Clearance rate at 0.46 mg/kg, iv, in dogs"
CHEMBL626621,1,,1,,,,A,13040,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14474,50597,,"Clearance rate at 5.5 mg/kg, iv, in rat"
CHEMBL626622,1,,1,,,,A,13041,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,14548,100710,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration
CHEMBL626623,1,,1,,,,A,13042,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,14548,100710,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration
CHEMBL626624,1,,1,,,,A,13043,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,14548,50588,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration
CHEMBL626625,1,,1,,,,A,13044,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14548,50597,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration
CHEMBL626626,1,,1,,,,A,13045,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,Ex vivo,,6125,50597,,Clearance rate constant using isolated perfused rat liver (IPRL) assay
CHEMBL626627,0,,1,,,,A,13046,Autocuration,BAO_0000218,,U,,,,,In vivo,,6874,22224,,Tested for the total clearance of the compound
CHEMBL626628,1,,1,,,,A,13047,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,15343,50588,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose
CHEMBL626629,0,,1,,,,A,13048,Autocuration,BAO_0000218,,U,,,,,In vivo,,6236,22224,,Total body clearance was determined
CHEMBL626630,1,,1,,,,A,13049,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg
CHEMBL626631,1,,1,,,,A,13050,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg
CHEMBL626632,0,,1,,,,P,13051,Autocuration,BAO_0000100,,U,,,,,,,8194,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr
CHEMBL626633,0,,1,,,,P,13052,Autocuration,BAO_0000100,,U,,,,,,,8194,22229,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr
CHEMBL626634,0,,1,,,,P,13053,Autocuration,BAO_0000100,,U,,,,,,,8194,22229,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr
CHEMBL626635,0,,1,,,,P,13054,Autocuration,BAO_0000100,,U,,,,,,,8194,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr
CHEMBL626636,0,,1,,,,P,13055,Autocuration,BAO_0000100,,U,,,,,,,8194,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr
CHEMBL626637,0,,1,,,,P,13056,Autocuration,BAO_0000100,,U,,,,,,,8194,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr
CHEMBL626638,1,,1,,,,A,13057,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day)
CHEMBL626639,1,,1,,,,A,13058,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day
CHEMBL626640,1,,1,,,,A,13059,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day
CHEMBL626641,1,,1,,,,A,13060,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day
CHEMBL627272,1,,1,,,,A,13061,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day
CHEMBL627273,1,,1,,,,A,13062,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day
CHEMBL627441,1,,1,,,,A,13063,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day)
CHEMBL628355,1,,1,,,,A,13064,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day)
CHEMBL628356,1,,1,,,,A,13065,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day)
CHEMBL628357,1,,1,,,,A,13066,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day)
CHEMBL628358,1,,1,,,,A,13067,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day)
CHEMBL622307,1,,1,,,,A,13068,Intermediate,BAO_0000218,,N,Pneumocystis carinii,,4754.0,,,,13273,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day)
CHEMBL622527,0,,1,,,,A,13069,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0
CHEMBL622528,0,,1,,,,A,13070,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable
CHEMBL622529,0,,1,,,,A,13071,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4
CHEMBL622992,0,,1,,,,A,13072,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable
CHEMBL622993,0,,1,,,,A,13073,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Conversion rate by hydrolysis of compound in plasma after 6 hr. 
CHEMBL622994,0,,1,,,,A,13074,Autocuration,BAO_0000019,,U,,,,,,,13118,22224,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable
CHEMBL622995,1,,1,,,,A,13075,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10633,50597,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate"
CHEMBL622996,1,,1,,,,A,13076,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10633,50597,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood."
CHEMBL622997,1,,1,,,,A,13077,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10633,50597,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate"
CHEMBL622998,1,,1,,,,A,13078,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10633,50597,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate"
CHEMBL622999,0,,1,,,,A,13079,Autocuration,BAO_0000218,,U,,,,,,,5767,22224,,Cp max following ip administration at 1 mg/kg
CHEMBL623000,0,,1,,,,A,13080,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,3302,22224,,Maximum concentration in plasma was reported at 0.5 hour
CHEMBL623001,0,,1,,,,A,13081,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,3302,22224,,Maximum concentration in plasma was reported at 2 hour
CHEMBL623002,1,,1,,,,A,13082,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12467,50594,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells
CHEMBL623003,0,,1,,,,P,13083,Autocuration,BAO_0000100,,U,,,,,,,11778,22229,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8)
CHEMBL623004,0,,1,,,,A,13084,Autocuration,BAO_0000019,,U,,,,,,,4321,22224,,Steady state concentration was evaluated
CHEMBL623005,0,,1,,,,A,13085,Autocuration,BAO_0000019,,U,,,,,,,14884,22224,,Partition coefficient (logP)
CHEMBL623006,0,,1,,,,A,13086,Autocuration,BAO_0000019,,U,,,,,,,15234,22224,,Partition coefficient (logD7.4)
CHEMBL623007,1,,1,,,,A,13087,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,14198,50597,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats
CHEMBL623008,1,,1,,,,A,13088,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats
CHEMBL876654,1,,1,,,,A,13089,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats
CHEMBL623009,1,,1,,,,A,13090,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats
CHEMBL623010,1,,1,,,,A,13091,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats
CHEMBL623011,1,,1,,,,A,13092,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats
CHEMBL623012,1,,1,,,,A,13093,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats
CHEMBL623013,0,,1,,,,A,13094,Autocuration,BAO_0000019,,U,,,,,,,8151,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg
CHEMBL623014,0,,1,,,,A,13095,Autocuration,BAO_0000019,,U,,,,,,,8151,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg
CHEMBL623015,0,,1,,,,A,13096,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,8151,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg
CHEMBL623016,0,,1,,,,A,13097,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,8151,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg
CHEMBL624858,0,,1,,,,A,13098,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,8151,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg
CHEMBL624859,1,,1,,,,A,13099,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8151,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.
CHEMBL624860,1,,1,,,,A,13100,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8151,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg
CHEMBL624861,1,,1,,,,A,13101,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8151,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.
CHEMBL624862,1,,1,,,,A,13102,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8151,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg
CHEMBL624863,1,,1,,,,A,13103,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8151,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.
CHEMBL876655,1,,1,,,,A,13104,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8151,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.
CHEMBL624864,1,,1,,,,A,13105,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog
CHEMBL624865,1,,1,,,,A,13106,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99
CHEMBL624866,1,,1,,,,A,13107,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249
CHEMBL624867,1,,1,,,,F,13108,Expert,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg
CHEMBL624868,1,,1,,,,A,13109,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599
CHEMBL628450,1,,1,,,,A,13110,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799
CHEMBL628451,1,,1,,,,A,13111,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799
CHEMBL628452,1,,1,,,,A,13112,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899
CHEMBL628453,1,,1,,,,A,13113,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249
CHEMBL628454,1,,1,,,,A,13114,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg
CHEMBL628455,1,,1,,,,A,13115,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog
CHEMBL628456,1,,1,,,,A,13116,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99
CHEMBL628457,1,,1,,,,A,13117,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249
CHEMBL877505,1,,1,,,,A,13118,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299
CHEMBL628458,1,,1,,,,A,13119,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399
CHEMBL628459,1,,1,,,,A,13120,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599
CHEMBL628460,1,,1,,,,A,13121,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799
CHEMBL628461,1,,1,,,,A,13122,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899
CHEMBL628462,0,,1,,,,B,13123,Autocuration,BAO_0000218,,U,,,,,,,6996,22224,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg"
CHEMBL628463,1,,1,,,,A,13124,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat
CHEMBL625666,1,,1,,,,F,13125,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg"
CHEMBL625667,0,,1,,,,B,13126,Autocuration,BAO_0000218,,U,,,,,,,6996,22224,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat
CHEMBL625668,1,,1,,,,A,13127,Expert,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat
CHEMBL625669,1,,1,,,,A,13128,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat
CHEMBL625670,0,,1,,,,A,13129,Autocuration,BAO_0000019,,U,,,,,,,7114,22224,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry
CHEMBL625671,1,,1,,,,A,13130,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7114,50597,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat
CHEMBL625672,1,,1,,,,A,13131,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.
CHEMBL625673,1,,1,,,,A,13132,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously
CHEMBL625674,1,,1,,,,A,13133,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.
CHEMBL625675,1,,1,,,,A,13134,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously
CHEMBL627637,1,,1,,,,A,13135,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.
CHEMBL627638,1,,1,,,,A,13136,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.
CHEMBL627639,1,,1,,,,A,13137,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously
CHEMBL627640,1,,1,,,,A,13138,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.
CHEMBL627641,1,,1,,,,A,13139,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.
CHEMBL627642,1,,1,,,,A,13140,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.
CHEMBL877506,1,,1,,,,A,13141,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.
CHEMBL627275,1,,1,,,,A,13142,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8613,50594,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.
CHEMBL627643,1,,1,,,,A,13143,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,11219,50506,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets."
CHEMBL631246,1,,1,,,,A,13144,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,11219,50506,,"Average area under curve value dosed at 10 mg/kg, id in ferrets."
CHEMBL631247,1,,1,,,,A,13145,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,11219,50506,,"Average area under curve value dosed at 10 mg/kg, id in ferrets."
CHEMBL629532,1,,1,,,,A,13146,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,11219,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).
CHEMBL629533,1,,1,,,,A,13147,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,11219,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).
CHEMBL629534,1,,1,,,,A,13148,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,11219,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).
CHEMBL629535,1,,1,,,,A,13149,Intermediate,BAO_0000218,,N,Mustela putorius furo,,9669.0,,,,11219,50506,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.
CHEMBL625932,0,,1,,,,A,13150,Autocuration,BAO_0000019,,U,,,,,,,14837,22224,,Pharmacokinetic parameter :drug bound to plasma was reported
CHEMBL625933,0,,1,,,,A,13151,Autocuration,BAO_0000019,,U,,,,,,,14837,22224,,compound was evaluated for drug bound in plasma
CHEMBL625934,1,,1,,,,A,13152,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15343,50597,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose
CHEMBL625935,0,,1,,,,A,13153,Autocuration,BAO_0000218,,U,Eutheria,,9347.0,,,,13761,22224,,Bioavailability
CHEMBL625936,1,,1,,,,A,13154,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14810,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported
CHEMBL625937,1,,1,,,,A,13155,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14810,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested
CHEMBL625938,1,,1,,,,A,13156,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,13249,50588,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered
CHEMBL625939,1,,1,,,,A,13157,Intermediate,BAO_0000218,1970.0,N,Rattus norvegicus,Bile,10116.0,,,,9267,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.
CHEMBL625940,1,,1,,,,A,13158,Intermediate,BAO_0000218,1970.0,N,Rattus norvegicus,Bile,10116.0,,,,9267,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.
CHEMBL874464,1,,1,,,,A,13159,Intermediate,BAO_0000218,1970.0,N,Rattus norvegicus,Bile,10116.0,,,,9267,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.
CHEMBL625941,1,,1,,,,A,13160,Intermediate,BAO_0000218,1970.0,N,Rattus norvegicus,Bile,10116.0,,,,9267,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.
CHEMBL625942,1,,1,,,,A,13161,Intermediate,BAO_0000218,1970.0,N,Rattus norvegicus,Bile,10116.0,,,,9267,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.
CHEMBL625943,1,,1,,,,A,13162,Intermediate,BAO_0000218,1970.0,N,Rattus norvegicus,Bile,10116.0,,,,9267,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.
CHEMBL625944,1,,1,,,,A,13163,Intermediate,BAO_0000218,1977.0,N,Homo sapiens,Serum,9606.0,,,,15549,50587,,In vitro protein binding in human serum at 5 ug/ml
CHEMBL625945,0,,1,,,,A,13164,Autocuration,BAO_0000019,,U,,,,,,,10929,22224,,Serum protein binding ability was measured
CHEMBL625946,0,,1,,,,A,13165,Autocuration,BAO_0000019,,U,,,,,,,15444,22224,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.)
CHEMBL625947,0,,1,,,,A,13166,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,12860,22224,,Oral bioavailability in dog
CHEMBL625948,1,,1,,,,A,13167,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12170,50597,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.
CHEMBL625949,0,,1,,,,A,13168,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,Absolute oral bioavailability at an iv dose of 14 mg/kg
CHEMBL625950,0,,1,,,,A,13169,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg
CHEMBL625951,0,,1,,,,A,13170,Autocuration,BAO_0000218,,U,Eutheria,,9347.0,,In vivo,,15173,22224,,Oral bioavailability (dose 15 mg/kg i.v.)
CHEMBL625952,0,,1,,,,A,13171,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.
CHEMBL625953,0,,1,,,,A,13172,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally
CHEMBL625954,0,,1,,,,A,13173,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.
CHEMBL882959,0,,1,,,,A,13174,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.
CHEMBL625955,1,,1,,,,A,13175,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,11767,50588,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen
CHEMBL625956,0,,1,,,,A,13176,Autocuration,BAO_0000218,,U,Mustela putorius furo,,9669.0,,In vivo,,11219,22224,,Bioavailability in ferret
CHEMBL625957,1,,1,,,,A,13177,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,12186,100710,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay
CHEMBL625958,1,,1,,,,A,13178,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg
CHEMBL625959,1,,1,,,,A,13179,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg
CHEMBL626642,1,,1,,,,A,13180,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg
CHEMBL631330,1,,1,,,,A,13181,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg
CHEMBL631331,1,,1,,,,A,13182,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg
CHEMBL631332,1,,1,,,,A,13183,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined
CHEMBL631333,1,,1,,,,A,13184,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg
CHEMBL632018,1,,1,,,,A,13185,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg
CHEMBL632019,1,,1,,,,A,13186,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg
CHEMBL632020,1,,1,,,,A,13187,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg
CHEMBL632021,1,,1,,,,A,13188,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg
CHEMBL632022,1,,1,,,,A,13189,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg
CHEMBL632023,1,,1,,,,A,13190,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg
CHEMBL632024,1,,1,,,,A,13191,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg
CHEMBL874472,1,,1,,,,A,13192,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg
CHEMBL632025,1,,1,,,,A,13193,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg
CHEMBL632026,1,,1,,,,A,13194,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg
CHEMBL632027,1,,1,,,,A,13195,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg
CHEMBL632028,1,,1,,,,A,13196,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg
CHEMBL626430,1,,1,,,,A,13197,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg
CHEMBL626431,1,,1,,,,A,13198,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg
CHEMBL626432,1,,1,,,,A,13199,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg
CHEMBL626433,1,,1,,,,A,13200,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg
CHEMBL626434,1,,1,,,,A,13201,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg
CHEMBL627280,1,,1,,,,A,13202,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg
CHEMBL627281,1,,1,,,,A,13203,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg
CHEMBL627282,1,,1,,,,A,13204,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg
CHEMBL627283,0,,1,,,,A,13205,Autocuration,BAO_0000019,,U,,,,,,,7199,22224,,Total body clearance was measured at given dose
CHEMBL627284,0,,1,,,,A,13206,Autocuration,BAO_0000218,,U,,,,,,,7199,22224,,Total body clearance was measured at given dose.
CHEMBL627285,1,,1,,,,A,13207,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7095,50597,,Metabolic clearance from the body in rat
CHEMBL627286,0,,1,,,,A,13208,Autocuration,BAO_0000218,,U,,,,,In vivo,,7095,22224,,Renal clearance from the body
CHEMBL875477,1,,1,,,,A,13209,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,7095,50597,,Renal clearance from the body in rat
CHEMBL627287,1,,1,,,,A,13210,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12528,50597,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat
CHEMBL627288,1,,1,,,,A,13211,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,12528,50588,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog
CHEMBL627289,1,,1,,,,A,13212,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7095,50597,,Total clearance from the body in rat
CHEMBL627290,1,,1,,,,A,13213,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14223,50597,,Clearance into cortex from rat plasma or PBS
CHEMBL627291,0,,1,,,,A,13214,Autocuration,BAO_0000218,,U,,,,,In vivo,,13569,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg
CHEMBL627292,0,,1,,,,A,13215,Autocuration,BAO_0000218,,U,,,,,In vivo,,13569,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg
CHEMBL627293,0,,1,,,,A,13216,Autocuration,BAO_0000218,,U,,,,,In vivo,,13569,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg
CHEMBL627294,0,,1,,,,A,13217,Autocuration,BAO_0000218,,U,,,,,In vivo,,13569,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg
CHEMBL875478,0,,1,,,,A,13218,Autocuration,BAO_0000218,,U,,,,,In vivo,,13569,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg
CHEMBL627295,0,,1,,,,A,13219,Autocuration,BAO_0000218,,U,,,,,In vivo,,13979,22224,,Clearance was determined
CHEMBL627296,1,,1,,,,A,13220,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14315,50594,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously
CHEMBL626119,1,,1,,,,A,13221,Intermediate,BAO_0000218,,N,Oryctolagus cuniculus,,9986.0,,In vivo,,14315,50592,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously
CHEMBL626120,1,,1,,,,A,13222,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14315,50597,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously
CHEMBL626121,1,,1,,,,A,13223,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12174,50597,,Clearance in rat after iv dose (100 ug/kg)
CHEMBL626122,0,,1,,,,A,13224,Autocuration,BAO_0000218,,U,Cavia porcellus,,10141.0,,In vivo,,12797,22224,,Clearance in guinea pig
CHEMBL626123,1,,1,,,,A,13225,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12797,50597,,Compound was evaluated for clearance in rat
CHEMBL623456,1,,1,,,,A,13226,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,12797,50588,,Compound was evaluated for the clearance in dog
CHEMBL623457,1,,1,,,,A,13227,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12797,50597,,Compound was evaluated for the clearance in rat
CHEMBL623458,1,,1,,,,A,13228,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,11500,50597,,Compound was tested in vivo for clearance after iv administration in the rat
CHEMBL623459,0,,1,,,,A,13229,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,IV clearance determined at an iv dose of 14 mg/kg
CHEMBL875484,0,,1,,,,A,13230,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,IV clearance determined at an iv dose of 15.2 mg/kg
CHEMBL623460,0,,1,,,,A,13231,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,IV clearance determined at an iv dose of 15 mg/kg
CHEMBL623461,0,,1,,,,A,13232,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,IV clearance determined at an peroral dose of 30 mg/kg.
CHEMBL623462,0,,1,,,,A,13233,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,IV clearance determined at an peroral dose of 30.2 mg/kg.
CHEMBL627386,0,,1,,,,A,13234,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,IV clearance determined at an peroral dose of 30.3 mg/kg.
CHEMBL627387,1,,1,,,,A,13235,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats
CHEMBL627388,1,,1,,,,A,13236,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats
CHEMBL627389,1,,1,,,,A,13237,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats
CHEMBL627390,1,,1,,,,A,13238,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats
CHEMBL627391,1,,1,,,,A,13239,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats
CHEMBL627392,1,,1,,,,A,13240,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats
CHEMBL627393,1,,1,,,,A,13241,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats
CHEMBL627394,1,,1,,,,A,13242,Intermediate,BAO_0000218,3126.0,N,Rattus norvegicus,Trachea,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats
CHEMBL627395,1,,1,,,,A,13243,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats
CHEMBL875485,1,,1,,,,A,13244,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats
CHEMBL627396,1,,1,,,,A,13245,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats
CHEMBL627397,1,,1,,,,A,13246,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats
CHEMBL627398,1,,1,,,,A,13247,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats
CHEMBL627399,1,,1,,,,A,13248,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats
CHEMBL627400,1,,1,,,,A,13249,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats
CHEMBL627401,1,,1,,,,A,13250,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats
CHEMBL627402,1,,1,,,,A,13251,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats
CHEMBL627403,1,,1,,,,A,13252,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats
CHEMBL627404,1,,1,,,,A,13253,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats
CHEMBL623101,1,,1,,,,A,13254,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats
CHEMBL877480,1,,1,,,,A,13255,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats
CHEMBL623102,1,,1,,,,A,13256,Intermediate,BAO_0000218,3126.0,N,Rattus norvegicus,Trachea,10116.0,,In vivo,,14198,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats
CHEMBL623103,1,,1,,,,A,13257,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats
CHEMBL623104,1,,1,,,,A,13258,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats
CHEMBL623105,1,,1,,,,A,13259,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats
CHEMBL623106,1,,1,,,,A,13260,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats
CHEMBL623107,1,,1,,,,A,13261,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats
CHEMBL623108,1,,1,,,,A,13262,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats
CHEMBL623109,1,,1,,,,A,13263,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats
CHEMBL623110,1,,1,,,,A,13264,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats
CHEMBL623111,1,,1,,,,A,13265,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats
CHEMBL625060,1,,1,,,,A,13266,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats
CHEMBL625061,1,,1,,,,A,13267,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats
CHEMBL625062,1,,1,,,,A,13268,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats
CHEMBL625063,1,,1,,,,A,13269,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats
CHEMBL625064,1,,1,,,,A,13270,Intermediate,BAO_0000218,3126.0,N,Rattus norvegicus,Trachea,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats
CHEMBL625065,1,,1,,,,A,13271,Intermediate,BAO_0000218,10000001.0,N,Rattus norvegicus,Bone,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats
CHEMBL625066,1,,1,,,,A,13272,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats
CHEMBL625067,1,,1,,,,A,13273,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats
CHEMBL625068,1,,1,,,,A,13274,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats
CHEMBL622159,1,,1,,,,A,13275,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats
CHEMBL622160,1,,1,,,,A,13276,Intermediate,BAO_0000218,160.0,N,Rattus norvegicus,Intestine,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats
CHEMBL622161,1,,1,,,,A,13277,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats
CHEMBL622162,1,,1,,,,A,13278,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats
CHEMBL622163,1,,1,,,,A,13279,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats
CHEMBL622313,1,,1,,,,A,13280,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats
CHEMBL622314,1,,1,,,,A,13281,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats
CHEMBL622315,1,,1,,,,A,13282,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats
CHEMBL622316,1,,1,,,,A,13283,Intermediate,BAO_0000218,3126.0,N,Rattus norvegicus,Trachea,10116.0,,In vivo,,14198,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats
CHEMBL877486,1,,1,,,,A,13284,Intermediate,BAO_0000218,,N,Escherichia coli,,562.0,,,,15599,50212,,Normal diffusion coefficient in water for Escherichia coli
CHEMBL622317,0,,1,,,,A,13285,Autocuration,BAO_0000019,,U,,,,,,,8204,22224,,Average max percent decrease in RVR (renal vascular resistance) was determined
CHEMBL622318,0,,1,,,,A,13286,Autocuration,BAO_0000019,,U,,,,,,,8204,22224,,Average max percent decrease in RVR (renal vascular resistance) was determined.
CHEMBL622319,0,,1,,,,A,13287,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time
CHEMBL622320,0,,1,,,,A,13288,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time
CHEMBL622321,0,,1,,,,A,13289,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time
CHEMBL622322,0,,1,,,,A,13290,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time
CHEMBL622323,0,,1,,,,A,13291,Autocuration,BAO_0000019,,U,,,,,,,7114,22224,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry
CHEMBL622324,1,,1,,,,A,13292,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7114,50597,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat
CHEMBL622325,1,,1,,,,A,13293,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po"
CHEMBL622326,1,,1,,,,A,13294,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po"
CHEMBL877487,1,,1,,,,A,13295,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po"
CHEMBL622327,1,,1,,,,A,13296,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po"
CHEMBL622328,1,,1,,,,A,13297,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po"
CHEMBL622329,1,,1,,,,A,13298,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po"
CHEMBL622330,1,,1,,,,A,13299,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po"
CHEMBL622331,1,,1,,,,A,13300,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po"
CHEMBL622332,1,,1,,,,A,13301,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po"
CHEMBL622333,1,,1,,,,A,13302,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po"
CHEMBL627658,0,,1,,,,A,13303,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po"
CHEMBL630428,0,,1,,,,A,13304,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po"
CHEMBL630429,0,,1,,,,A,13305,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po"
CHEMBL630430,0,,1,,,,A,13306,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po"
CHEMBL630431,0,,1,,,,A,13307,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po"
CHEMBL630432,1,,1,,,,A,13308,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po"
CHEMBL630433,1,,1,,,,A,13309,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po"
CHEMBL630434,1,,1,,,,A,13310,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po"
CHEMBL629372,1,,1,,,,A,13311,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po"
CHEMBL629553,1,,1,,,,A,13312,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po"
CHEMBL629554,1,,1,,,,A,13313,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po"
CHEMBL874447,1,,1,,,,A,13314,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po"
CHEMBL629555,1,,1,,,,A,13315,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po"
CHEMBL629556,1,,1,,,,A,13316,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po"
CHEMBL629557,1,,1,,,,A,13317,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po"
CHEMBL629558,1,,1,,,,A,13318,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po"
CHEMBL629559,1,,1,,,,A,13319,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po"
CHEMBL629560,1,,1,,,,A,13320,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po"
CHEMBL629561,1,,1,,,,A,13321,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po"
CHEMBL629562,1,,1,,,,A,13322,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po"
CHEMBL629563,1,,1,,,,A,13323,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po"
CHEMBL629564,1,,1,,,,A,13324,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po"
CHEMBL629565,1,,1,,,,A,13325,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po"
CHEMBL629566,1,,1,,,,A,13326,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po"
CHEMBL629567,1,,1,,,,A,13327,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po"
CHEMBL629568,1,,1,,,,A,13328,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po"
CHEMBL629569,1,,1,,,,A,13329,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po"
CHEMBL629570,1,,1,,,,A,13330,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po"
CHEMBL629571,0,,1,,,,A,13331,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po"
CHEMBL629572,0,,1,,,,A,13332,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,12170,22224,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.
CHEMBL629573,0,,1,,,,A,13333,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,12170,22224,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.
CHEMBL629574,0,,1,,,,A,13334,Autocuration,BAO_0000218,,U,Eutheria,,9347.0,,In vivo,,4985,22224,,Bioavailability (dose 20 mg/kg)
CHEMBL629575,0,,1,,,,A,13335,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,15145,22224,,Bioavailability in dog
CHEMBL874448,0,,1,,,,A,13336,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,14080,22224,,Bioavailability in rat (Sprague-Dawley) (male)
CHEMBL629576,0,,1,,,,A,13337,Autocuration,BAO_0000218,,U,Primates,,9443.0,,In vivo,,11219,22224,,Bioavailability in monkey (dose 10 mg/kg i.d.)
CHEMBL629577,0,,1,,,,A,13338,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,15145,22224,,Bioavailability in rat
CHEMBL629578,0,,1,,,,A,13339,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,15145,22224,,Bioavailability in rat
CHEMBL629579,0,,1,,,,A,13340,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,1202,22224,,Bioavailability in dog (dose 3.0 mg/kg p.o.)
CHEMBL882958,0,,1,,,,A,13341,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,1202,22224,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr
CHEMBL629580,1,,1,,,,A,13342,Intermediate,BAO_0000218,,N,Pan troglodytes,,9598.0,,In vivo,,1202,50505,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp
CHEMBL629581,0,,1,,,,A,13343,Autocuration,BAO_0000218,,U,Eutheria,,9347.0,,In vivo,,4026,22224,,Bioavailability
CHEMBL629582,0,,1,,,,A,13344,Autocuration,BAO_0000218,,U,Saimiri,,9520.0,,In vivo,,1492,22224,,Bioavailability in squirrel monkey
CHEMBL628522,1,,1,,,,A,13345,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,12793,50588,,Bioavailability was evaluated in dog
CHEMBL625432,1,,1,,,,A,13346,Intermediate,BAO_0000218,,N,Cricetinae,,10026.0,,In vivo,,12793,100712,,Bioavailability was evaluated in hamster
CHEMBL625433,0,,1,,,,A,13347,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,12793,22224,,Bioavailability in rat
CHEMBL625434,1,,1,,,,A,13348,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14793,50597,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg
CHEMBL625435,1,,1,,,,A,13349,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,14793,50597,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>
CHEMBL625436,0,,1,,,,A,13350,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,14793,22224,,Bioavailability in rat (dose 10 mg/kg p.o.)
CHEMBL874588,1,,1,,,,A,13351,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,14731,100710,,Bioavailability was measured in cynomolgus monkeys.
CHEMBL625437,1,,1,,,,A,13352,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14731,50594,,Bioavailability was measured in nude mice.
CHEMBL625438,0,,1,,,,A,13353,Autocuration,BAO_0000218,,U,Mustela putorius furo,,9669.0,,In vivo,,12187,22224,,Bioavailability in ferret (dose 10 mg/kg i.d.)
CHEMBL625439,0,,1,,,,A,13354,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,12187,22224,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose)
CHEMBL625440,0,,1,,,,A,13355,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,12187,22224,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay"
CHEMBL625441,0,,1,,,,A,13356,Autocuration,BAO_0000218,,U,Simiiformes,,314293.0,,In vivo,,12187,22224,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose)
CHEMBL625442,0,,1,,,,A,13357,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,12187,22224,,Bioavailability in rat (dose 10 mg/kg i.d.)
CHEMBL625443,1,,1,,,,A,13358,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12187,50597,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay"
CHEMBL625444,0,,1,,,,A,13359,Autocuration,BAO_0000218,,U,,,,,In vivo,,17431,22224,,Bioavailability was determined; extremely poor
CHEMBL625445,1,,1,,,,A,13360,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,13318,50594,,% bioavailability in mice after oral administration of prodrug
CHEMBL625446,1,,1,,,,A,13361,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5
CHEMBL882960,1,,1,,,,A,13362,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6
CHEMBL625447,1,,1,,,,A,13363,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14
CHEMBL625448,1,,1,,,,A,13364,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12
CHEMBL625449,1,,1,,,,A,13365,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11
CHEMBL874589,1,,1,,,,A,13366,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high)
CHEMBL625450,1,,1,,,,A,13367,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9
CHEMBL625451,1,,1,,,,A,13368,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28
CHEMBL626584,1,,1,,,,A,13369,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29
CHEMBL626585,1,,1,,,,A,13370,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30
CHEMBL626586,1,,1,,,,A,13371,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18
CHEMBL626587,1,,1,,,,A,13372,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35
CHEMBL626588,1,,1,,,,A,13373,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50
CHEMBL626589,1,,1,,,,A,13374,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29
CHEMBL626590,1,,1,,,,A,13375,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56
CHEMBL626591,1,,1,,,,A,13376,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33
CHEMBL627181,1,,1,,,,A,13377,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13
CHEMBL628083,1,,1,,,,A,13378,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47
CHEMBL628084,0,,1,,,,A,13379,Autocuration,BAO_0000218,,U,,,,,In vivo,,15173,22224,,IV clearance determined at an peroral dose of 15 mg/kg.
CHEMBL628085,1,,1,,,,F,13380,Expert,BAO_0000218,,N,Hymenolepis nana,,102285.0,,In vivo,,7732,50064,,Mouse oral clearance was measured against Hymenolepiasis nana.
CHEMBL628086,1,,1,,,,F,13381,Expert,BAO_0000218,,N,Heligmosomoides polygyrus,,6339.0,,In vivo,,7732,50545,,Mouse oral clearance was measured against Nematospiroides dubius
CHEMBL628087,0,,1,,,,F,13382,Autocuration,BAO_0000218,,U,,,,,In vivo,,7732,22224,,Mouse oral clearance was measured against N. dubius; NT is Not Tested
CHEMBL628088,1,,1,,,,A,13383,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,7732,50594,,Mouse oral clearance was measured against N. nana; NT is Not Tested
CHEMBL628089,0,,1,,,,B,13384,Autocuration,BAO_0000218,,U,,,,,In vivo,,7732,22224,,Mouse oral clearance was measured against N. nana; NT is Not Tested
CHEMBL628090,0,,1,,,,A,13385,Autocuration,BAO_0000218,,U,,,,,In vivo,,8328,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation
CHEMBL628091,0,,1,,,,A,13386,Autocuration,BAO_0000218,,U,,,,,In vivo,,8328,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation
CHEMBL628092,0,,1,,,,A,13387,Autocuration,BAO_0000218,,U,,,,,In vivo,,8328,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation
CHEMBL628093,0,,1,,,,A,13388,Autocuration,BAO_0000218,,U,,,,,In vivo,,8328,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation
CHEMBL875607,0,,1,,,,A,13389,Autocuration,BAO_0000218,,U,,,,,In vivo,,8328,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation
CHEMBL625710,0,,1,,,,A,13390,Autocuration,BAO_0000218,,U,,,,,In vivo,,8328,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation
CHEMBL625711,0,,1,,,,A,13391,Autocuration,BAO_0000218,,U,,,,,In vivo,,8328,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation
CHEMBL625712,0,,1,,,,A,13392,Autocuration,BAO_0000218,,U,,,,,In vivo,,8328,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation
CHEMBL625713,0,,1,,,,A,13393,Autocuration,BAO_0000218,,U,,,,,In vivo,,8328,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation
CHEMBL625714,1,,1,,,,A,13394,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,13376,50588,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg
CHEMBL625715,1,,1,,,,A,13395,Intermediate,BAO_0000218,,N,Macaca mulatta,,9544.0,,In vivo,,13477,50797,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey
CHEMBL625716,1,,1,,,,A,13396,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13477,50597,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat
CHEMBL625717,1,,1,,,,A,13397,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13477,50597,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat
CHEMBL625718,1,,1,,,,A,13398,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13313,50597,,Plasma clearance was determined for the compound in rats
CHEMBL625719,1,,1,,,,A,13399,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12504,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1
CHEMBL625720,1,,1,,,,A,13400,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12504,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2
CHEMBL625721,1,,1,,,,A,13401,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12504,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3
CHEMBL625722,1,,1,,,,A,13402,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12504,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4
CHEMBL625723,1,,1,,,,A,13403,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13129,50597,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.
CHEMBL625724,1,,1,,,,A,13404,Intermediate,BAO_0000218,,N,Heligmosomoides polygyrus,,6339.0,,In vivo,,7732,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.
CHEMBL625725,1,,1,,,,A,13405,Intermediate,BAO_0000218,,N,Heligmosomoides polygyrus,,6339.0,,In vivo,,7732,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.
CHEMBL625726,1,,1,,,,A,13406,Intermediate,BAO_0000218,,N,Heligmosomoides polygyrus,,6339.0,,In vivo,,7732,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.
CHEMBL875608,1,,1,,,,A,13407,Intermediate,BAO_0000218,,N,Heligmosomoides polygyrus,,6339.0,,In vivo,,7732,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.
CHEMBL625727,1,,1,,,,A,13408,Intermediate,BAO_0000218,,N,Heligmosomoides polygyrus,,6339.0,,In vivo,,7732,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.
CHEMBL625728,0,,1,,,,A,13409,Autocuration,BAO_0000218,1088.0,U,Rattus norvegicus,Urine,10116.0,,In vivo,,9278,22224,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.
CHEMBL625729,0,,1,,,,A,13410,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,9278,22224,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage
CHEMBL625730,0,,1,,,,A,13411,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,9278,22224,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.
CHEMBL625731,0,,1,,,,A,13412,Autocuration,BAO_0000218,1088.0,U,Rattus norvegicus,Urine,10116.0,,In vivo,,9278,22224,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage
CHEMBL626417,0,,1,,,,A,13413,Autocuration,BAO_0000218,1088.0,U,Rattus norvegicus,Urine,10116.0,,In vivo,,9278,22224,,Urinary clearance was determined in rat at 25 mg/kg os dosage
CHEMBL626418,1,,1,,,,A,13414,Intermediate,BAO_0000218,1088.0,N,Homo sapiens,Urine,9606.0,,In vivo,,9278,50587,,Urinary clearance was determined at 100 mg/kg oral dosage in human
CHEMBL626419,1,,1,,,,A,13415,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,In vivo,,9278,50588,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.
CHEMBL626592,1,,1,,,,A,13416,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,5932,50588,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose
CHEMBL626593,1,,1,,,,A,13417,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,5932,50597,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose
CHEMBL626594,1,,1,,,,A,13418,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5182,50597,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat
CHEMBL625035,1,,1,,,,A,13419,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,10499,50588,,Clearance rate in dogs
CHEMBL625036,0,,1,,,,A,13420,Autocuration,BAO_0000019,,U,,,,,In vitro,,6051,22224,,Compound was measured for intrinsic clearance
CHEMBL625037,0,,1,,,,P,13421,Autocuration,BAO_0000100,,U,,,,,,,17508,22229,,Calculated partition coefficient (clogP)
CHEMBL625038,0,,1,,,,P,13422,Autocuration,BAO_0000100,,U,,,,,,,6228,22229,,Calculated partition coefficient (clogP)
CHEMBL625039,0,,1,,,,P,13423,Autocuration,BAO_0000100,,U,,,,,,,6231,22229,,Calculated partition coefficient (clogP)
CHEMBL625040,0,,1,,,,P,13424,Autocuration,BAO_0000100,,U,,,,,,,17740,22229,,Calculated partition coefficient (clogP)
CHEMBL625041,0,,1,,,,P,13425,Autocuration,BAO_0000100,,U,,,,,,,6495,22229,,Calculated partition coefficient (clogP)
CHEMBL625042,0,,1,,,,P,13426,Autocuration,BAO_0000100,,U,,,,,,,2171,22229,,Calculated partition coefficient (clogP)
CHEMBL874411,0,,1,,,,A,13427,Autocuration,BAO_0000019,,U,,,,,,,3255,22224,,Partition coefficient of the compound
CHEMBL625043,0,,1,,,,A,13428,Autocuration,BAO_0000019,,U,,,,,,,6821,22224,,Permeability
CHEMBL625044,0,,1,,,,P,13429,Autocuration,BAO_0000100,,U,,,,,,,2685,22229,,Calculated partition coefficient (clogP)
CHEMBL625045,0,,1,,,,A,13430,Autocuration,BAO_0000019,,U,,,,,,,17584,22224,,Partition coefficient (logD)
CHEMBL625046,0,,1,,,,P,13431,Autocuration,BAO_0000100,,U,,,,,,,13824,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4)
CHEMBL625047,0,,1,,,,P,13432,Autocuration,BAO_0000100,,U,,,,,,,13824,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4)
CHEMBL625048,0,,1,,,,P,13433,Autocuration,BAO_0000100,,U,,,,,,,16479,22229,,Calculated partition coefficient (clogP)
CHEMBL625049,0,,1,,,,P,13434,Autocuration,BAO_0000100,,U,,,,,,,11997,22229,,Calculated partition coefficient (clogP)
CHEMBL625050,0,,1,,,,P,13435,Autocuration,BAO_0000100,,U,,,,,,,2988,22229,,Calculated logarithm of partition coefficient (P) was determined
CHEMBL625051,0,,1,,,,P,13436,Autocuration,BAO_0000100,,U,,,,,,,931,22229,,Calculated partition coefficient (clogP)
CHEMBL874412,0,,1,,,,P,13437,Autocuration,BAO_0000100,,U,,,,,,,4381,22229,,Calculated partition coefficient (clogP)
CHEMBL625052,0,,1,,,,P,13438,Autocuration,BAO_0000100,,U,,,,,,,4397,22229,,Calculated partition coefficient (clogP)
CHEMBL625053,0,,1,,,,P,13439,Autocuration,BAO_0000100,,U,,,,,,,5889,22229,,Calculated partition coefficient (clogP)
CHEMBL623250,0,,1,,,,A,13440,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time
CHEMBL623251,0,,1,,,,A,13441,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time
CHEMBL623252,0,,1,,,,A,13442,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time
CHEMBL623253,0,,1,,,,A,13443,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time
CHEMBL623254,0,,1,,,,A,13444,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time
CHEMBL623255,0,,1,,,,A,13445,Autocuration,BAO_0000019,,U,,,,,,,6154,22224,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time
CHEMBL626831,0,,1,,,,A,13446,Autocuration,BAO_0000019,,U,,,,,,,6887,22224,,Percent degradation of compound at a pH of 1 over a 18 hr period
CHEMBL877494,0,,1,,,,A,13447,Autocuration,BAO_0000019,,U,,,,,,,6887,22224,,Percent degradation of compound at pH of 1 over an 18 hr period
CHEMBL626832,0,,1,,,,A,13448,Autocuration,BAO_0000019,,U,,,,,,,14116,22224,,Delta Logarithm of Partition Coefficient value was determined.
CHEMBL626833,0,,1,,,,A,13449,Autocuration,BAO_0000019,,U,,,,,,,11137,22224,,Delta logPoct-cyc
CHEMBL626834,0,,1,,,,P,13450,Autocuration,BAO_0000100,,U,,,,,,,7230,22224,,Lipophilicity estimated on reversed phase TLC
CHEMBL626835,0,,1,,,,A,13451,Autocuration,BAO_0000019,,U,,,,,,,15741,22224,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.
CHEMBL626836,0,,1,,,,A,13452,Autocuration,BAO_0000019,,U,,,,,,,9663,22224,,Delta logPoct-cyc
CHEMBL626837,0,,1,,,,P,13453,Autocuration,BAO_0000100,,U,,,,,,,9663,22229,,Change in logarithm of partition coefficient of the compound
CHEMBL626838,0,,1,,,,A,13454,Autocuration,BAO_0000019,,U,,,,,,,13807,22224,,Delta logD (pH 6.5)
CHEMBL626839,0,,1,,,,P,13455,Autocuration,BAO_0000100,,U,,,,,,,13807,22224,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane"
CHEMBL626840,0,,1,,,,A,13456,Autocuration,BAO_0000019,,U,,,,,,,17425,22224,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb
CHEMBL626841,0,,1,,,,A,13457,Autocuration,BAO_0000019,,U,,,,,,,12143,22224,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound)
CHEMBL626842,0,,1,,,,A,13458,Autocuration,BAO_0000219,,U,,,,,,,12608,22224,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells
CHEMBL626843,0,,1,,,,A,13459,Autocuration,BAO_0000219,,U,,,,,,,12608,22224,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells
CHEMBL626844,1,,1,,,,A,13460,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8649,50597,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D
CHEMBL877495,1,,1,,,,A,13461,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8649,50597,,Amount of deuterium retained was reported after normal workup in rats
CHEMBL626845,1,,1,,,,A,13462,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8649,50597,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats
CHEMBL626846,1,,1,,,,A,13463,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8649,50597,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D
CHEMBL626847,1,,1,,,,A,13464,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8649,50597,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup
CHEMBL628677,1,,1,,,,A,13465,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8649,50597,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup
CHEMBL628678,1,,1,,,,A,13466,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8649,50597,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup
CHEMBL628679,0,,1,,,,A,13467,Autocuration,BAO_0000019,,U,,,,,,,9659,22224,,Compound was subjected to electrochemical oxidation
CHEMBL628680,0,,1,,,,A,13468,Autocuration,BAO_0000019,,U,,,,,,,9659,22224,,Compound was subjected to photochemical oxidation
CHEMBL628681,0,,1,,,,A,13469,Autocuration,BAO_0000019,,U,,,,,,,9659,22224,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide
CHEMBL628682,0,,1,,,,A,13470,Autocuration,BAO_0000019,,U,,,,,,,9659,22224,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide
CHEMBL628683,0,,1,,,,A,13471,Autocuration,BAO_0000019,,U,,,,,,,9659,22224,,Oxidation of compound by methemoglobin in presence of hydroperoxide
CHEMBL628684,1,,1,,,,A,13472,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,9607,50597,,Percent diffusion through fuzzy rat skin after 48 h of incubation
CHEMBL877501,0,,1,,,,P,13473,Autocuration,BAO_0000100,,U,,,,,,,7057,22229,,Dissociation constant (pKa)
CHEMBL628685,0,,1,,,,P,13474,Autocuration,BAO_0000100,,U,,,,,,,7057,22224,,Dissociation constant value of the compound; ND means not determined.
CHEMBL628686,1,,1,,,,A,13475,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7911,50597,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent
CHEMBL628687,1,,1,,,,A,13476,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,7911,50597,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent
CHEMBL628688,1,,1,,,,A,13477,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7911,50597,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent
CHEMBL628689,1,,1,,,,A,13478,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7911,50597,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent
CHEMBL628690,1,,1,,,,A,13479,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7911,50597,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent
CHEMBL629363,1,,1,,,,A,13480,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,7911,50597,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent
CHEMBL629364,1,,1,,,,A,13481,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,7911,50597,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent
CHEMBL629365,1,,1,,,,A,13482,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,,,7911,50597,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent
CHEMBL629366,1,,1,,,,A,13483,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7911,50597,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent
CHEMBL629367,1,,1,,,,A,13484,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,7911,50597,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent
CHEMBL629368,1,,1,,,,A,13485,Intermediate,BAO_0000218,1988.0,N,Rattus norvegicus,Feces,10116.0,,,,7911,50597,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent
CHEMBL877502,1,,1,,,,A,13486,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,7911,50597,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent
CHEMBL629369,1,,1,,,,A,13487,Intermediate,BAO_0000218,2037.0,N,Mus musculus,Cerebellum,10090.0,,,,13792,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum
CHEMBL629370,1,,1,,,,A,13488,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,13792,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex
CHEMBL629371,0,,1,,,,A,13489,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po"
CHEMBL626276,0,,1,,,,A,13490,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po"
CHEMBL626277,0,,1,,,,A,13491,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po"
CHEMBL631250,0,,1,,,,A,13492,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po"
CHEMBL631251,1,,1,,,,A,13493,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po"
CHEMBL631252,1,,1,,,,A,13494,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po"
CHEMBL631253,1,,1,,,,A,13495,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po"
CHEMBL631254,1,,1,,,,A,13496,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po"
CHEMBL631255,1,,1,,,,A,13497,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po"
CHEMBL631256,1,,1,,,,A,13498,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po"
CHEMBL631257,1,,1,,,,A,13499,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po"
CHEMBL628009,1,,1,,,,A,13500,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po"
CHEMBL628010,1,,1,,,,A,13501,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po"
CHEMBL628011,1,,1,,,,A,13502,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po"
CHEMBL628012,1,,1,,,,A,13503,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po"
CHEMBL628013,1,,1,,,,A,13504,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po"
CHEMBL628014,1,,1,,,,A,13505,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po"
CHEMBL628015,1,,1,,,,A,13506,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po"
CHEMBL628016,1,,1,,,,A,13507,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po"
CHEMBL874461,1,,1,,,,A,13508,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po"
CHEMBL628017,1,,1,,,,A,13509,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po"
CHEMBL628018,1,,1,,,,A,13510,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po"
CHEMBL628019,1,,1,,,,A,13511,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po"
CHEMBL628020,1,,1,,,,A,13512,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po"
CHEMBL628021,1,,1,,,,A,13513,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po"
CHEMBL628022,1,,1,,,,A,13514,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po"
CHEMBL628023,1,,1,,,,A,13515,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,8133,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po"
CHEMBL628024,0,,1,,,,A,13516,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po"
CHEMBL628025,0,,1,,,,A,13517,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po"
CHEMBL628026,0,,1,,,,A,13518,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po"
CHEMBL628027,0,,1,,,,A,13519,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po"
CHEMBL628028,0,,1,,,,A,13520,Autocuration,BAO_0000218,1088.0,U,Simiiformes,Urine,314293.0,,,,8133,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po"
CHEMBL628029,1,,1,,,,A,13521,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po"
CHEMBL628030,1,,1,,,,A,13522,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po"
CHEMBL628031,1,,1,,,,A,13523,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po"
CHEMBL628032,1,,1,,,,A,13524,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po"
CHEMBL628033,1,,1,,,,A,13525,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po"
CHEMBL628034,1,,1,,,,A,13526,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po"
CHEMBL628035,1,,1,,,,A,13527,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po"
CHEMBL628036,1,,1,,,,A,13528,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po"
CHEMBL874462,1,,1,,,,A,13529,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po"
CHEMBL628037,1,,1,,,,A,13530,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38
CHEMBL628123,1,,1,,,,A,13531,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25
CHEMBL628124,1,,1,,,,A,13532,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15
CHEMBL628125,1,,1,,,,A,13533,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19
CHEMBL628126,1,,1,,,,A,13534,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4
CHEMBL628127,1,,1,,,,A,13535,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high)
CHEMBL628128,1,,1,,,,A,13536,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24
CHEMBL628129,1,,1,,,,A,13537,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1
CHEMBL628130,1,,1,,,,A,13538,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23
CHEMBL628131,1,,1,,,,A,13539,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3
CHEMBL628132,1,,1,,,,A,13540,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16
CHEMBL628133,1,,1,,,,A,13541,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14
CHEMBL628134,1,,1,,,,A,13542,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23
CHEMBL628135,1,,1,,,,A,13543,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14
CHEMBL628136,1,,1,,,,A,13544,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15
CHEMBL628137,1,,1,,,,A,13545,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44
CHEMBL628138,1,,1,,,,A,13546,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28
CHEMBL628139,1,,1,,,,A,13547,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28
CHEMBL628140,1,,1,,,,A,13548,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3
CHEMBL628141,1,,1,,,,A,13549,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32
CHEMBL628142,1,,1,,,,A,13550,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1
CHEMBL628143,1,,1,,,,A,13551,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12
CHEMBL628144,1,,1,,,,A,13552,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7
CHEMBL628145,1,,1,,,,A,13553,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6
CHEMBL628146,1,,1,,,,A,13554,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12
CHEMBL625355,1,,1,,,,A,13555,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27
CHEMBL625356,1,,1,,,,A,13556,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14
CHEMBL625357,1,,1,,,,A,13557,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16
CHEMBL625527,1,,1,,,,A,13558,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23
CHEMBL875473,1,,1,,,,A,13559,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high)
CHEMBL625528,1,,1,,,,A,13560,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22
CHEMBL626304,1,,1,,,,A,13561,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,9025,50597,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12
CHEMBL624138,1,,1,,,,A,13562,Intermediate,BAO_0000218,1637.0,N,Canis lupus familiaris,Artery,9615.0,,In vivo,,9025,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11
CHEMBL624139,0,,1,,,,P,13563,Autocuration,BAO_0000100,,U,,,,,,,6448,22229,,Calculated partition coefficient (clogP)
CHEMBL624140,0,,1,,,,P,13564,Autocuration,BAO_0000100,,U,,,,,,,17221,22229,,Calculated partition coefficient (clogP)
CHEMBL624141,0,,1,,,,P,13565,Autocuration,BAO_0000100,,U,,,,,,,6545,22229,,Calculated partition coefficient (clogP)
CHEMBL624142,0,,1,,,,P,13566,Autocuration,BAO_0000100,,U,,,,,,,577,22229,,Calculated partition coefficient (clogP)
CHEMBL624143,0,,1,,,,P,13567,Autocuration,BAO_0000100,,U,,,,,,,6285,22229,,Calculated partition coefficient (clogP)
CHEMBL624144,0,,1,,,,P,13568,Autocuration,BAO_0000100,,U,,,,,,,6500,22229,,Calculated partition coefficient (clogP)
CHEMBL624145,0,,1,,,,P,13569,Autocuration,BAO_0000100,,U,,,,,,,6716,22229,,Calculated partition coefficient (clogP)
CHEMBL624146,0,,1,,,,P,13570,Autocuration,BAO_0000100,,U,,,,,,,13658,22229,,Calculated partition coefficient (clogP)
CHEMBL624147,0,,1,,,,P,13571,Autocuration,BAO_0000100,,U,,,,,,,6549,22229,,Calculated partition coefficient (clogP)
CHEMBL883123,0,,1,,,,P,13572,Autocuration,BAO_0000100,,U,,,,,,,14685,22229,,Calculated partition coefficient (clogP) (MacLogP)
CHEMBL624148,0,,1,,,,A,13573,Autocuration,BAO_0000019,,U,,,,,,,6893,22224,,Partition coefficient (logP)
CHEMBL874416,0,,1,,,,A,13574,Autocuration,BAO_0000019,,U,,,,,,,3687,22224,,Kinetic parameter was determined
CHEMBL624149,0,,1,,,,P,13575,Autocuration,BAO_0000100,,U,,,,,,,4207,22229,,Calculated partition coefficient (clogP)
CHEMBL624150,0,,1,,,,P,13576,Autocuration,BAO_0000100,,U,,,,,,,4626,22229,,Calculated partition coefficient (clogP)
CHEMBL624151,0,,1,,,,P,13577,Autocuration,BAO_0000100,,U,,,,,,,1021,22224,,Lipophilicity was determined
CHEMBL624152,0,,1,,,,P,13578,Autocuration,BAO_0000100,,U,,,,,,,3777,22224,,Lipophilicity was determined
CHEMBL622139,0,,1,,,,P,13579,Autocuration,BAO_0000100,,U,,,,,,,17533,22224,,Lipophilicity was determined
CHEMBL622140,0,,1,,,,P,13580,Autocuration,BAO_0000100,,U,,,,,,,6524,22229,,Calculated partition coefficient (clogP)
CHEMBL622141,0,,1,,,,P,13581,Autocuration,BAO_0000100,,U,,,,,,,17533,22224,,Lipophilicity was determined
CHEMBL622142,0,,1,,,,P,13582,Autocuration,BAO_0000100,,U,,,,,,,6480,22224,,Lipophilicity in octanol-water
CHEMBL622143,0,,1,,,,P,13583,Autocuration,BAO_0000100,,U,,,,,,,17606,22229,,Calculated partition coefficient (clogP)
CHEMBL622144,0,,1,,,,P,13584,Autocuration,BAO_0000100,,U,,,,,,,6863,22229,,Octanol-water partition coefficient was determined
CHEMBL877473,0,,1,,,,A,13585,Autocuration,BAO_0000019,,U,,,,,,,1356,22224,,Partition coefficient (logP)
CHEMBL622145,0,,1,,,,P,13586,Autocuration,BAO_0000100,,U,,,,,,,3326,22229,,Calculated partition coefficient (clogP)
CHEMBL622146,0,,1,,,,A,13587,Autocuration,BAO_0000019,,U,,,,,,,1356,22224,,Partition coefficient was determined; ND means not determined
CHEMBL622147,0,,1,,,,P,13588,Autocuration,BAO_0000100,,U,,,,,,,12984,22229,,Calculated partition coefficient (clogP)
CHEMBL622148,0,,1,,,,A,13589,Autocuration,BAO_0000019,,U,,,,,,,17363,22224,,Partition coefficient of the compound
CHEMBL883124,0,,1,,,,A,13590,Autocuration,BAO_0000019,,U,,,,,,,6827,22224,,Permeability was determined
CHEMBL622149,0,,1,,,,P,13591,Autocuration,BAO_0000100,,U,,,,,,,261,22229,,The compound was evaluated for the partition coefficient
CHEMBL622150,0,,1,,,,A,13592,Autocuration,BAO_0000019,,U,,,,,,,2685,22224,,Partition coefficient (logP)
CHEMBL622151,0,,1,,,,P,13593,Autocuration,BAO_0000100,,U,,,,,,,414,22224,,The lipophilicity was reported
CHEMBL622152,0,,1,,,,P,13594,Autocuration,BAO_0000100,,U,,,,,,,15769,22229,,logarithm of the octanol-water partition coefficient for the compound
CHEMBL622153,0,,1,,,,A,13595,Autocuration,BAO_0000019,,U,,,,,,,17248,22224,,Clogp value was determined
CHEMBL877474,0,,1,,,,A,13596,Autocuration,BAO_0000218,,U,,,,,In vivo,,16935,22224,,Clp at a dose of 1.5 mg/kg
CHEMBL622154,0,,1,,,,A,13597,Autocuration,BAO_0000218,,U,,,,,In vivo,,16935,22224,,Clp at a dose of 2.0 mg/kg
CHEMBL622155,0,,1,,,,A,13598,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14832,22224,,"Clp, plasma clearance at a dose of 10 mg/kg"
CHEMBL622156,0,,1,,,,A,13599,Autocuration,BAO_0000218,1969.0,U,,Plasma,,,In vivo,,14832,22224,,"Clp, plasma clearance at a dose of 50 mg/kg"
CHEMBL622157,1,,1,,,,A,13600,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2399,50597,,Compound was tested for plasma clearance in rat
CHEMBL622158,1,,1,,,,A,13601,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,2399,50597,,Compound was tested for plasma clearance in rat; Not determined
CHEMBL622807,1,,1,,,,A,13602,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,6227,50597,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg
CHEMBL622808,1,,1,,,,A,13603,Intermediate,BAO_0000218,,N,Macaca mulatta,,9544.0,,In vivo,,6227,50797,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg
CHEMBL622809,0,,1,,,,A,13604,Autocuration,BAO_0000218,,U,,,,,In vivo,,5623,22224,,Plasma clearance by iv administration at a dose 0.003 ug/mL
CHEMBL622810,0,,1,,,,A,13605,Autocuration,BAO_0000218,,U,,,,,In vivo,,4854,22224,,Plasma clearance determined
CHEMBL876653,1,,1,,,,A,13606,Intermediate,BAO_0000218,,N,Cricetinae,,10026.0,,In vivo,,4493,100712,,Plasma clearance after iv administration at 3 mg/kg in hamster
CHEMBL622811,1,,1,,,,A,13607,Intermediate,BAO_0000218,,N,Cricetinae,,10026.0,,In vivo,,4493,100712,,Plasma clearance after iv administration at 4 mg/kg in hamster
CHEMBL622986,1,,1,,,,A,13608,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14956,50597,,Rate of clearance in rat was determined
CHEMBL622987,1,,1,,,,A,13609,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15372,50597,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats
CHEMBL622988,1,,1,,,,A,13610,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15372,50597,,Total plasma clearance after iv dose of 5.10 mg/kg in rats
CHEMBL622989,1,,1,,,,A,13611,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15372,50597,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats
CHEMBL622990,1,,1,,,,A,13612,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15372,50597,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats
CHEMBL622991,0,,1,,,,A,13613,Autocuration,BAO_0000218,1969.0,U,Simiiformes,Plasma,314293.0,,In vivo,,15604,22224,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey
CHEMBL622227,1,,1,,,,A,13614,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,In vivo,,15604,50597,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat
CHEMBL622228,1,,1,,,,A,13615,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,15604,50588,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog
CHEMBL622229,1,,1,,,,A,13616,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14964,50597,,Clpl value in rat
CHEMBL622230,1,,1,,,,A,13617,Intermediate,BAO_0000218,,N,Cavia porcellus,,10141.0,,In vivo,,15240,50512,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.
CHEMBL622231,1,,1,,,,A,13618,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16449,50597,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats
CHEMBL622232,1,,1,,,,A,13619,Intermediate,BAO_0000218,,N,Macaca fascicularis,,9541.0,,In vivo,,16449,100710,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys
CHEMBL622233,0,,1,,,,A,13620,Autocuration,BAO_0000218,,U,,,,,In vivo,,12902,22224,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).
CHEMBL622234,0,,1,,,,A,13621,Autocuration,BAO_0000218,,U,,,,,In vivo,,12902,22224,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).
CHEMBL622235,0,,1,,,,A,13622,Autocuration,BAO_0000218,,U,,,,,In vivo,,12902,22224,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).
CHEMBL622236,0,,1,,,,A,13623,Autocuration,BAO_0000218,,U,,,,,In vivo,,12902,22224,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).
CHEMBL622237,0,,1,,,,A,13624,Autocuration,BAO_0000218,,U,,,,,In vivo,,12902,22224,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).
CHEMBL877482,0,,1,,,,A,13625,Autocuration,BAO_0000218,,U,,,,,In vivo,,12902,22224,,Cmax in minutes at a po dose of 10.0(pmol/g/h).
CHEMBL622238,0,,1,,,,A,13626,Autocuration,BAO_0000218,,U,,,,,In vivo,,12902,22224,,Cmax in minutes at a po dose of 20.0(pmol/g/h).
CHEMBL622239,0,,1,,,,A,13627,Autocuration,BAO_0000218,,U,,,,,In vivo,,12902,22224,,Cmax in minutes at a po dose of 40.0(pmol/g/h).
CHEMBL622240,0,,1,,,,A,13628,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,11149,22224,,Cmax was calculated as maximum concentration reached in the blood
CHEMBL622241,0,,1,,,,A,13629,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,11149,22224,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate
CHEMBL631013,1,,1,,,,A,13630,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5669,50597,,Cmax was determine after peroral administration at 10 mpk in Rat
CHEMBL631014,1,,1,,,,A,13631,Intermediate,BAO_0000218,,N,Macaca mulatta,,9544.0,,In vivo,,5669,50797,,Cmax was determine after peroral administration at 10 mpk in Rhesus
CHEMBL631015,1,,1,,,,A,13632,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,In vivo,,5669,50588,,Cmax was determine after peroral administration at 10 mpk in dog
CHEMBL631016,1,,1,,,,A,13633,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5669,50597,,Cmax was determine after peroral administration at 160 mpk in Rat
CHEMBL631017,1,,1,,,,A,13634,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5669,50597,,Cmax was determine after peroral administration at 20 mpk in Rat
CHEMBL631018,1,,1,,,,A,13635,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,5669,50597,,Cmax was determine after peroral administration at 50 mpk in Rat
CHEMBL631019,0,,1,,,,A,13636,Autocuration,BAO_0000218,,U,,,,,In vivo,,4236,22224,,Cmax was determined
CHEMBL875761,1,,1,,,,A,13637,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,13792,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus
CHEMBL631020,1,,1,,,,A,13638,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,13792,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus
CHEMBL631669,1,,1,,,,A,13639,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,13792,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla
CHEMBL631670,1,,1,,,,A,13640,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,13792,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain
CHEMBL631671,1,,1,,,,A,13641,Intermediate,BAO_0000218,2435.0,N,Mus musculus,Striatum,10090.0,,,,13792,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum
CHEMBL631672,1,,1,,,,A,13642,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4
CHEMBL631673,1,,1,,,,A,13643,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12
CHEMBL631856,1,,1,,,,A,13644,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37
CHEMBL631857,1,,1,,,,A,13645,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03
CHEMBL631858,1,,1,,,,A,13646,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06
CHEMBL631859,1,,1,,,,A,13647,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4
CHEMBL631860,1,,1,,,,A,13648,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85
CHEMBL631861,1,,1,,,,A,13649,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83
CHEMBL631862,1,,1,,,,A,13650,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84
CHEMBL631863,1,,1,,,,A,13651,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46
CHEMBL631864,1,,1,,,,A,13652,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5
CHEMBL631865,1,,1,,,,A,13653,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48
CHEMBL631866,1,,1,,,,A,13654,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17
CHEMBL629360,1,,1,,,,A,13655,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24
CHEMBL629361,1,,1,,,,A,13656,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37
CHEMBL629362,1,,1,,,,A,13657,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63
CHEMBL630740,1,,1,,,,A,13658,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32
CHEMBL630741,1,,1,,,,A,13659,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58
CHEMBL630742,1,,1,,,,A,13660,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,,,8418,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77
CHEMBL630743,1,,1,,,,A,13661,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25
CHEMBL630744,1,,1,,,,A,13662,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25
CHEMBL630745,1,,1,,,,A,13663,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03
CHEMBL630746,1,,1,,,,A,13664,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06
CHEMBL630747,1,,1,,,,A,13665,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5
CHEMBL630748,1,,1,,,,A,13666,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20
CHEMBL632056,1,,1,,,,A,13667,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26
CHEMBL632057,1,,1,,,,A,13668,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06
CHEMBL632058,1,,1,,,,A,13669,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36
CHEMBL632059,1,,1,,,,A,13670,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37
CHEMBL632060,1,,1,,,,A,13671,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17
CHEMBL632061,1,,1,,,,A,13672,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03
CHEMBL629207,1,,1,,,,A,13673,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07
CHEMBL629208,1,,1,,,,A,13674,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72
CHEMBL629209,1,,1,,,,A,13675,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19
CHEMBL629210,1,,1,,,,A,13676,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42
CHEMBL629211,1,,1,,,,A,13677,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03
CHEMBL629212,1,,1,,,,A,13678,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06
CHEMBL629213,1,,1,,,,A,13679,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8418,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06
CHEMBL629214,1,,1,,,,A,13680,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po"
CHEMBL629215,1,,1,,,,A,13681,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po"
CHEMBL635154,1,,1,,,,A,13682,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,8133,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po"
CHEMBL629216,1,,1,,,,A,13683,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr)
CHEMBL629217,1,,1,,,,A,13684,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration
CHEMBL629218,1,,1,,,,A,13685,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr)
CHEMBL629219,1,,1,,,,A,13686,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr)
CHEMBL629220,1,,1,,,,A,13687,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL629221,1,,1,,,,A,13688,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr )
CHEMBL631127,1,,1,,,,A,13689,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr)
CHEMBL631128,1,,1,,,,A,13690,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration
CHEMBL631129,1,,1,,,,A,13691,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr)
CHEMBL631130,1,,1,,,,A,13692,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr)
CHEMBL631131,1,,1,,,,A,13693,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL631132,1,,1,,,,A,13694,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr )
CHEMBL631133,1,,1,,,,A,13695,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr)
CHEMBL631134,1,,1,,,,A,13696,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration
CHEMBL875120,1,,1,,,,A,13697,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr)
CHEMBL631135,1,,1,,,,A,13698,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr)
CHEMBL631136,1,,1,,,,A,13699,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL631137,1,,1,,,,A,13700,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr )
CHEMBL631138,1,,1,,,,A,13701,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr)
CHEMBL631139,1,,1,,,,A,13702,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration
CHEMBL631140,1,,1,,,,A,13703,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr)
CHEMBL631141,1,,1,,,,A,13704,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr)
CHEMBL631142,1,,1,,,,A,13705,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr)
CHEMBL631143,1,,1,,,,A,13706,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr )
CHEMBL631144,1,,1,,,,A,13707,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6996,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr)
CHEMBL631145,1,,1,,,,A,13708,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration
CHEMBL631146,1,,1,,,,A,13709,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr)
CHEMBL631147,1,,1,,,,A,13710,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration
CHEMBL631148,1,,1,,,,A,13711,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr)
CHEMBL631149,1,,1,,,,A,13712,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr)
CHEMBL631150,1,,1,,,,A,13713,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr)
CHEMBL631151,1,,1,,,,A,13714,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr)
CHEMBL631152,1,,1,,,,A,13715,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr)
CHEMBL631443,1,,1,,,,A,13716,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr)
CHEMBL631444,1,,1,,,,A,13717,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr)
CHEMBL631445,1,,1,,,,A,13718,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr)
CHEMBL631446,1,,1,,,,A,13719,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr )
CHEMBL631447,1,,1,,,,A,13720,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr)
CHEMBL631448,1,,1,,,,A,13721,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr)
CHEMBL631449,1,,1,,,,A,13722,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration
CHEMBL631450,1,,1,,,,A,13723,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr)
CHEMBL629724,1,,1,,,,A,13724,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,6996,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr)
CHEMBL629725,1,,1,,,,A,13725,Intermediate,BAO_0000218,14.0,N,Mus musculus,Zone of skin,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL629726,1,,1,,,,A,13726,Intermediate,BAO_0000218,14.0,N,Mus musculus,Zone of skin,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL629727,1,,1,,,,A,13727,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630404,1,,1,,,,A,13728,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630405,1,,1,,,,A,13729,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630406,1,,1,,,,A,13730,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630407,1,,1,,,,A,13731,Intermediate,BAO_0000218,945.0,N,Mus musculus,Stomach,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630573,1,,1,,,,A,13732,Intermediate,BAO_0000218,945.0,N,Mus musculus,Stomach,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630574,1,,1,,,,A,13733,Intermediate,BAO_0000218,945.0,N,Mus musculus,Stomach,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630575,1,,1,,,,A,13734,Intermediate,BAO_0000218,945.0,N,Mus musculus,Stomach,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630576,1,,1,,,,A,13735,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630577,1,,1,,,,A,13736,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630578,1,,1,,,,A,13737,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630579,1,,1,,,,A,13738,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,9716,50594,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)"
CHEMBL630580,1,,1,,,,A,13739,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered)
CHEMBL630581,1,,1,,,,A,13740,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h
CHEMBL630582,1,,1,,,,A,13741,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered)
CHEMBL630583,1,,1,,,,A,13742,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h
CHEMBL630584,1,,1,,,,A,13743,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered)
CHEMBL630585,1,,1,,,,A,13744,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h
CHEMBL630586,1,,1,,,,A,13745,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered)
CHEMBL630587,1,,1,,,,A,13746,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h
CHEMBL630588,1,,1,,,,A,13747,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered)
CHEMBL630589,1,,1,,,,A,13748,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h
CHEMBL630590,1,,1,,,,A,13749,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,12192,50594,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered)
CHEMBL630591,0,,1,,,,A,13750,Autocuration,BAO_0000019,1988.0,U,,Feces,,,,,12192,22224,,Removal of 238-Plutonium(IV) in feces at 24 h
CHEMBL630592,0,,1,,,,A,13751,Autocuration,BAO_0000019,1988.0,U,,Feces,,,,,12192,22224,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered)
CHEMBL630593,0,,1,,,,A,13752,Autocuration,BAO_0000019,,U,,,,,,,12192,22224,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h
CHEMBL630594,0,,1,,,,A,13753,Autocuration,BAO_0000019,,U,,,,,,,12192,22224,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered)
CHEMBL630595,0,,1,,,,A,13754,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered)
CHEMBL630596,0,,1,,,,A,13755,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered)
CHEMBL630597,0,,1,,,,A,13756,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine after 0-24 h
CHEMBL630598,0,,1,,,,A,13757,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered)
CHEMBL630599,0,,1,,,,A,13758,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine after 0-4 h
CHEMBL630600,0,,1,,,,A,13759,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered)
CHEMBL630601,0,,1,,,,A,13760,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine after 4-24 h
CHEMBL630602,0,,1,,,,A,13761,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered)
CHEMBL630603,0,,1,,,,A,13762,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered)
CHEMBL630604,0,,1,,,,A,13763,Autocuration,BAO_0000019,1088.0,U,,Urine,,,,,12192,22224,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered)
CHEMBL624869,1,,1,,,,A,13764,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL624870,1,,1,,,,A,13765,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623189,1,,1,,,,A,13766,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL623190,1,,1,,,,A,13767,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623191,1,,1,,,,A,13768,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623192,1,,1,,,,A,13769,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623193,1,,1,,,,A,13770,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623194,1,,1,,,,A,13771,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL623195,1,,1,,,,A,13772,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623196,1,,1,,,,A,13773,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623197,1,,1,,,,A,13774,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol
CHEMBL623198,1,,1,,,,A,13775,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline
CHEMBL623199,1,,1,,,,A,13776,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol
CHEMBL623200,1,,1,,,,A,13777,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline
CHEMBL623201,1,,1,,,,A,13778,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline
CHEMBL623202,1,,1,,,,A,13779,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline
CHEMBL623203,1,,1,,,,A,13780,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline
CHEMBL623204,1,,1,,,,A,13781,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline
CHEMBL623205,1,,1,,,,A,13782,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol
CHEMBL623206,1,,1,,,,A,13783,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline
CHEMBL623207,1,,1,,,,A,13784,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol
CHEMBL623208,1,,1,,,,A,13785,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol
CHEMBL623209,1,,1,,,,A,13786,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline
CHEMBL623210,1,,1,,,,A,13787,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol
CHEMBL623211,1,,1,,,,A,13788,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline
CHEMBL623212,1,,1,,,,A,13789,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,,,11836,50597,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline
CHEMBL623213,0,,1,,,,A,13790,Autocuration,BAO_0000019,,U,,,,,,,12640,22224,,Tested in vitro for intrinsic activity relative to quinpirole
CHEMBL623214,0,,1,,,,A,13791,Autocuration,BAO_0000019,,U,,,,,,,14218,22224,,"Relative ion enhancement, determined in pulsed ultrafiltration"
CHEMBL623215,0,,1,,,,A,13792,Autocuration,BAO_0000019,,U,,,,,,,11296,22224,,% ionization at the pH 7.4 at 37 degree Centigrade
CHEMBL623216,0,,1,,,,A,13793,Autocuration,BAO_0000019,,U,,,,,,,10929,22224,,Percentage ionization was measured
CHEMBL623217,1,,1,,,,A,13794,Intermediate,BAO_0000218,,N,Bos taurus,,9913.0,,,,13841,50591,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.
CHEMBL623218,0,,1,,,,A,13795,Autocuration,BAO_0000019,,U,,,,,,,10431,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant
CHEMBL623913,0,,1,,,,A,13796,Autocuration,BAO_0000019,,U,,,,,,,10431,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant
CHEMBL623914,0,,1,,,,A,13797,Autocuration,BAO_0000019,,U,,,,,,,10431,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA
CHEMBL623915,0,,1,,,,P,13798,Autocuration,BAO_0000100,,U,,,,,,,8826,22229,,Compound was evaluated for the partition coefficient in octanol/water
CHEMBL624080,0,,1,,,,P,13799,Autocuration,BAO_0000100,,U,,,,,,,8826,22229,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4)
CHEMBL624081,0,,1,,,,A,13800,Autocuration,BAO_0000019,,U,,,,,,,9884,22224,,Equilibrium constant measured by the pulse radiolysis at pH 7
CHEMBL624082,1,,1,,,,A,13801,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,9827,50587,,In vitro hydrolytic rate constant determined in human blood
CHEMBL625054,1,,1,,,,A,13802,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,10009,50587,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma
CHEMBL877485,0,,1,,,,A,13803,Autocuration,BAO_0000019,,U,,,,,,,10009,22224,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide
CHEMBL625055,1,,1,,,,A,13804,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10009,50594,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate
CHEMBL625056,1,,1,,,,A,13805,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10009,50594,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate
CHEMBL625057,1,,1,,,,A,13806,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,10009,50587,,In vitro oxidation of compound in presence of human plasma
CHEMBL625058,0,,1,,,,A,13807,Autocuration,BAO_0000019,,U,,,,,,,10009,22224,,In vitro oxidation of compound in presence of hydrogen peroxide
CHEMBL625059,1,,1,,,,A,13808,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10009,50594,,In vitro oxidation of compound in presence of mouse brain homogenate
CHEMBL629536,1,,1,,,,A,13809,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,10009,50594,,In vitro oxidation of compound in presence of mouse liver homogenate
CHEMBL629537,1,,1,,,,A,13810,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg
CHEMBL629538,1,,1,,,,A,13811,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg
CHEMBL629539,1,,1,,,,A,13812,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg
CHEMBL874445,1,,1,,,,A,13813,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg
CHEMBL629540,1,,1,,,,A,13814,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg
CHEMBL629541,1,,1,,,,A,13815,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg
CHEMBL629542,1,,1,,,,A,13816,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg
CHEMBL630243,1,,1,,,,A,13817,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined
CHEMBL630244,1,,1,,,,A,13818,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg
CHEMBL630245,1,,1,,,,A,13819,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg
CHEMBL630246,1,,1,,,,A,13820,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg
CHEMBL630247,1,,1,,,,A,13821,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg
CHEMBL630248,1,,1,,,,A,13822,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg
CHEMBL630249,1,,1,,,,A,13823,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13100,50597,,Biodistribution in rat blood at 240 minutes after dose administration.
CHEMBL630250,1,,1,,,,A,13824,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13100,50597,,Biodistribution in rat blood at 30 minutes after dose administration.
CHEMBL630251,1,,1,,,,A,13825,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13100,50597,,Biodistribution in rat blood at 360 minutes after dose administration.
CHEMBL630252,1,,1,,,,A,13826,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13100,50597,,Biodistribution in rat blood at 3 hr after dose administration.
CHEMBL630408,1,,1,,,,A,13827,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13100,50597,,Biodistribution in rat blood at 60 minutes after dose administration.
CHEMBL630409,1,,1,,,,A,13828,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cerebellum at 120 minutes after dose administration.
CHEMBL874446,1,,1,,,,A,13829,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.
CHEMBL630410,1,,1,,,,A,13830,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cerebellum at 15 minutes after dose administration.
CHEMBL630411,1,,1,,,,A,13831,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cerebellum at 240 minutes after dose administration.
CHEMBL630412,1,,1,,,,A,13832,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cerebellum at 30 minutes after dose administration.
CHEMBL630413,1,,1,,,,A,13833,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cerebellum at 360 minutes after dose administration.
CHEMBL630414,1,,1,,,,A,13834,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cerebellum at 3 hr after dose administration.
CHEMBL630415,1,,1,,,,A,13835,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cerebellum at 60 minutes after dose administration.
CHEMBL630416,1,,1,,,,A,13836,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cortex at 120 minutes after dose administration.
CHEMBL630417,1,,1,,,,A,13837,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cortex at 1440 minutes after dose administration.
CHEMBL630418,1,,1,,,,A,13838,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cortex at 15 minutes after dose administration.
CHEMBL630419,1,,1,,,,A,13839,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cortex at 240 minutes after dose administration.
CHEMBL630420,1,,1,,,,A,13840,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cortex at 30 minutes after dose administration.
CHEMBL630421,1,,1,,,,A,13841,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cortex at 360 minutes after dose administration.
CHEMBL630422,1,,1,,,,A,13842,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cortex at 3 hr after dose administration.
CHEMBL630423,1,,1,,,,A,13843,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat cortex at 60 minutes after dose administration.
CHEMBL630424,1,,1,,,,A,13844,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13100,50597,,Biodistribution in rat heart at 120 minutes after dose administration.
CHEMBL630425,1,,1,,,,A,13845,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13100,50597,,Biodistribution in rat heart at 15 minutes after dose administration.
CHEMBL629462,1,,1,,,,A,13846,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13100,50597,,Biodistribution in rat heart at 240 minutes after dose administration.
CHEMBL630426,1,,1,,,,A,13847,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13100,50597,,Biodistribution in rat heart at 30 minutes after dose administration.
CHEMBL630427,1,,1,,,,A,13848,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13100,50597,,Biodistribution in rat heart at 360 minutes after dose administration.
CHEMBL625877,1,,1,,,,A,13849,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13100,50597,,Biodistribution in rat heart at 3 hr after dose administration.
CHEMBL625878,1,,1,,,,A,13850,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13100,50597,,Biodistribution in rat heart at 60 minutes after dose administration.
CHEMBL625879,1,,1,,,,A,13851,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,13100,50597,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.
CHEMBL625880,1,,1,,,,A,13852,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,13100,50597,,Biodistribution in rat hippocampus at 240 minutes after dose administration.
CHEMBL625881,1,,1,,,,A,13853,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,13100,50597,,Biodistribution in rat hippocampus at 30 minutes after dose administration.
CHEMBL625882,1,,1,,,,A,13854,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,13100,50597,,Biodistribution in rat hippocampus at 360 minutes after dose administration.
CHEMBL625883,1,,1,,,,A,13855,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,13100,50597,,Biodistribution in rat hippocampus at 15 minutes after dose administration.
CHEMBL625884,1,,1,,,,A,13856,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13100,50597,,Biodistribution in rat kidney at 120 minutes after dose administration.
CHEMBL625885,1,,1,,,,A,13857,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13100,50597,,Biodistribution in rat kidney at 1440 minutes after dose administration.
CHEMBL628649,1,,1,,,,A,13858,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13100,50597,,Biodistribution in rat kidney at 15 minutes after dose administration.
CHEMBL628650,1,,1,,,,A,13859,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13100,50597,,Biodistribution in rat kidney at 240 minutes after dose administration.
CHEMBL628651,1,,1,,,,A,13860,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13100,50597,,Biodistribution in rat kidney at 30 minutes after dose administration.
CHEMBL628652,1,,1,,,,A,13861,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13100,50597,,Biodistribution in rat kidney at 360 minutes after dose administration.
CHEMBL628653,1,,1,,,,A,13862,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13100,50597,,Biodistribution in rat kidney at 60 minutes after dose administration.
CHEMBL628654,1,,1,,,,A,13863,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13100,50597,,Biodistribution in rat liver at 120 minutes after dose administration.
CHEMBL628655,1,,1,,,,A,13864,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13100,50597,,Biodistribution in rat liver at 1440 minutes after dose administration.
CHEMBL625238,1,,1,,,,A,13865,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13100,50597,,Biodistribution in rat liver at 15 minutes after dose administration.
CHEMBL625239,1,,1,,,,A,13866,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13100,50597,,Biodistribution in rat liver at 240 minutes after dose administration.
CHEMBL625240,1,,1,,,,A,13867,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13100,50597,,Biodistribution in rat liver at 30 minutes after dose administration.
CHEMBL625241,1,,1,,,,A,13868,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13100,50597,,Biodistribution in rat liver at 360 minutes after dose administration.
CHEMBL625242,1,,1,,,,A,13869,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13100,50597,,Biodistribution in rat liver at 60 minutes after dose administration.
CHEMBL874587,1,,1,,,,A,13870,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13100,50597,,Biodistribution in rat lung at 120 minutes after dose administration.
CHEMBL625405,1,,1,,,,A,13871,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13100,50597,,Biodistribution in rat lung at 1440 minutes after dose administration.
CHEMBL625406,1,,1,,,,A,13872,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13100,50597,,Biodistribution in rat lung at 15 minutes after dose administration.
CHEMBL625407,1,,1,,,,A,13873,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13100,50597,,Biodistribution in rat lung at 240 minutes after dose administration.
CHEMBL625408,1,,1,,,,A,13874,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13100,50597,,Biodistribution in rat lung at 30 minutes after dose administration.
CHEMBL625409,1,,1,,,,A,13875,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13100,50597,,Biodistribution in rat lung at 360 minutes after dose administration.
CHEMBL625410,1,,1,,,,A,13876,Intermediate,BAO_0000218,1515.0,N,Rattus norvegicus,Thoracic aorta,10116.0,,,,12361,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer
CHEMBL625411,1,,1,,,,A,13877,Intermediate,BAO_0000218,1515.0,N,Rattus norvegicus,Thoracic aorta,10116.0,,,,12361,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine
CHEMBL625412,1,,1,,,,A,13878,Intermediate,BAO_0000218,1515.0,N,Rattus norvegicus,Thoracic aorta,10116.0,,,,12361,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil
CHEMBL625413,1,,1,,,,A,13879,Intermediate,BAO_0000218,1515.0,N,Rattus norvegicus,Thoracic aorta,10116.0,,,,12361,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR
CHEMBL625414,1,,1,,,,A,13880,Intermediate,BAO_0000218,1515.0,N,Rattus norvegicus,Thoracic aorta,10116.0,,,,12361,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips v
CHEMBL625415,1,,1,,,,A,13881,Intermediate,BAO_0000218,1515.0,N,Rattus norvegicus,Thoracic aorta,10116.0,,,,12361,50597,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips
CHEMBL625416,1,,1,,,,A,13882,Intermediate,BAO_0000218,1515.0,N,Rattus norvegicus,Thoracic aorta,10116.0,,,,12361,50597,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips
CHEMBL625417,1,,1,,,,A,13883,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12712,50597,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats
CHEMBL625418,1,,1,,,,A,13884,Intermediate,BAO_0000218,1988.0,N,Rattus norvegicus,Feces,10116.0,,,,7415,50597,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces
CHEMBL625419,1,,1,,,,A,13885,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,7415,50597,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine
CHEMBL625420,1,,1,,,,A,13886,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7415,50597,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg
CHEMBL626996,1,,1,,,,A,13887,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7415,50597,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg
CHEMBL626997,1,,1,,,,A,13888,Intermediate,BAO_0000218,1988.0,N,Rattus norvegicus,Feces,10116.0,,,,7415,50597,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces"
CHEMBL626998,1,,1,,,,A,13889,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,7415,50597,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine"
CHEMBL626999,1,,1,,,,A,13890,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7415,50597,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion"
CHEMBL627000,1,,1,,,,A,13891,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8050,50594,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h
CHEMBL627001,1,,1,,,,A,13892,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8050,50594,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h
CHEMBL627002,1,,1,,,,A,13893,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8050,50594,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h
CHEMBL627003,1,,1,,,,A,13894,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8050,50594,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h
CHEMBL627004,1,,1,,,,A,13895,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr
CHEMBL627005,1,,1,,,,A,13896,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr
CHEMBL874594,1,,1,,,,A,13897,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr
CHEMBL627006,1,,1,,,,A,13898,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr
CHEMBL627007,1,,1,,,,A,13899,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr
CHEMBL627884,1,,1,,,,A,13900,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr
CHEMBL627885,1,,1,,,,A,13901,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr
CHEMBL627886,1,,1,,,,A,13902,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr
CHEMBL627887,1,,1,,,,A,13903,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr
CHEMBL627888,1,,1,,,,A,13904,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr
CHEMBL628057,1,,1,,,,A,13905,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr
CHEMBL627405,1,,1,,,,A,13906,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,8050,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr
CHEMBL627406,1,,1,,,,A,13907,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug
CHEMBL627407,1,,1,,,,A,13908,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug
CHEMBL627408,1,,1,,,,A,13909,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug
CHEMBL627409,1,,1,,,,A,13910,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug
CHEMBL875486,1,,1,,,,A,13911,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug
CHEMBL627410,1,,1,,,,A,13912,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug
CHEMBL627411,1,,1,,,,A,13913,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug
CHEMBL627412,1,,1,,,,A,13914,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug
CHEMBL627413,1,,1,,,,A,13915,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug
CHEMBL627414,1,,1,,,,A,13916,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug
CHEMBL627415,1,,1,,,,A,13917,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug
CHEMBL627416,1,,1,,,,A,13918,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug
CHEMBL627417,1,,1,,,,A,13919,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug
CHEMBL627418,1,,1,,,,A,13920,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug
CHEMBL627419,1,,1,,,,A,13921,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug
CHEMBL627320,1,,1,,,,A,13922,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug
CHEMBL627321,1,,1,,,,A,13923,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug
CHEMBL627322,1,,1,,,,A,13924,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627323,1,,1,,,,A,13925,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627491,1,,1,,,,A,13926,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL627492,1,,1,,,,A,13927,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627493,1,,1,,,,A,13928,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627494,1,,1,,,,A,13929,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627495,1,,1,,,,A,13930,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627496,1,,1,,,,A,13931,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL627497,1,,1,,,,A,13932,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627498,1,,1,,,,A,13933,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627499,1,,1,,,,A,13934,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627500,1,,1,,,,A,13935,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL627501,1,,1,,,,A,13936,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL625616,1,,1,,,,A,13937,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL625617,1,,1,,,,A,13938,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL625618,1,,1,,,,A,13939,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL625619,1,,1,,,,A,13940,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL625620,1,,1,,,,A,13941,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL625621,1,,1,,,,A,13942,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL625622,1,,1,,,,A,13943,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL625788,1,,1,,,,A,13944,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL625789,1,,1,,,,A,13945,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL625790,1,,1,,,,A,13946,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL625791,1,,1,,,,A,13947,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL622334,1,,1,,,,A,13948,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL622335,1,,1,,,,A,13949,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,12017,50597,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL622336,1,,1,,,,A,13950,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,12017,50597,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL622337,1,,1,,,,A,13951,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,12017,50597,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL622338,1,,1,,,,A,13952,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,12017,50597,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL622339,1,,1,,,,A,13953,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,12017,50597,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL624153,1,,1,,,,A,13954,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL628430,1,,1,,,,A,13955,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL628431,1,,1,,,,A,13956,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL628432,1,,1,,,,A,13957,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL628433,1,,1,,,,A,13958,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL628434,1,,1,,,,A,13959,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol"
CHEMBL626789,1,,1,,,,A,13960,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol"
CHEMBL626790,1,,1,,,,A,13961,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)"
CHEMBL626791,1,,1,,,,A,13962,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol"
CHEMBL626792,1,,1,,,,A,13963,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol"
CHEMBL626793,1,,1,,,,A,13964,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol"
CHEMBL627436,1,,1,,,,A,13965,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg
CHEMBL627437,1,,1,,,,A,13966,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg
CHEMBL627438,1,,1,,,,A,13967,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg
CHEMBL627439,1,,1,,,,A,13968,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg
CHEMBL627440,1,,1,,,,A,13969,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg
CHEMBL627602,1,,1,,,,A,13970,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg
CHEMBL627603,1,,1,,,,A,13971,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg
CHEMBL627604,1,,1,,,,A,13972,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg
CHEMBL627605,1,,1,,,,A,13973,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg
CHEMBL627606,1,,1,,,,A,13974,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg
CHEMBL627607,1,,1,,,,A,13975,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg
CHEMBL627608,1,,1,,,,A,13976,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg
CHEMBL627609,1,,1,,,,A,13977,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg
CHEMBL627610,1,,1,,,,A,13978,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg
CHEMBL627611,1,,1,,,,A,13979,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg
CHEMBL627612,1,,1,,,,A,13980,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg
CHEMBL627613,0,,1,,,,P,13981,Autocuration,BAO_0000100,,U,,,,,,,8362,22229,,Octanol:water partition coefficient is evaluated
CHEMBL627614,0,,1,,,,P,13982,Autocuration,BAO_0000100,,U,,,,,,,8257,22224,,Partition coefficient in 1-octanol/water system
CHEMBL627615,0,,1,,,,P,13983,Autocuration,BAO_0000100,,U,,,,,,,8257,22224,,Partition coefficient in 1-octanol/water system measured using radio active compounds
CHEMBL627616,0,,1,,,,P,13984,Autocuration,BAO_0000100,,U,,,,,,,9468,22224,,Partition coefficient in octanol/water system was determined
CHEMBL627617,0,,1,,,,P,13985,Autocuration,BAO_0000100,,U,,,,,,,9468,22224,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.
CHEMBL627618,0,,1,,,,A,13986,Autocuration,BAO_0000019,,U,,,,,,,10568,22224,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade
CHEMBL627619,0,,1,,,,A,13987,Autocuration,BAO_0000019,,U,,,,,,,10568,22224,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade"
CHEMBL627620,0,,1,,,,A,13988,Autocuration,BAO_0000019,,U,,,,,,,15359,22224,,Pseudo-first-order rate constant of the compound
CHEMBL627621,0,,1,,,,A,13989,Autocuration,BAO_0000019,,U,,,,,,,15359,22224,,Pseudo-first-order rate constant with 1-min time point
CHEMBL627622,0,,1,,,,A,13990,Autocuration,BAO_0000019,,U,,,,,,,15359,22224,,Pseudo-first-order rate constant without 1-min time point
CHEMBL627623,0,,1,,,,A,13991,Autocuration,BAO_0000019,,U,,,,,,,10431,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA
CHEMBL627624,0,,1,,,,A,13992,Autocuration,BAO_0000019,,U,,,,,,,10431,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA
CHEMBL627625,0,,1,,,,A,13993,Autocuration,BAO_0000019,,U,,,,,,,10431,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA
CHEMBL628523,0,,1,,,,A,13994,Autocuration,BAO_0000019,,U,,,,,,,15704,22224,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade
CHEMBL628524,0,,1,,,,A,13995,Autocuration,BAO_0000019,,U,,,,,,,15287,22224,,The alkaline hydrolysis second order rate constant(K OH) of the compound
CHEMBL628525,0,,1,,,,A,13996,Autocuration,BAO_0000019,,U,,,,,,,7516,22224,,The efflux rate constant of the compound
CHEMBL625732,0,,1,,,,A,13997,Autocuration,BAO_0000019,,U,,,,,,,12973,22224,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine
CHEMBL625733,0,,1,,,,A,13998,Autocuration,BAO_0000019,,U,,,,,,,12973,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine
CHEMBL625734,0,,1,,,,F,13999,Autocuration,BAO_0000019,,U,,,,,,,12973,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine
CHEMBL625913,0,,1,,,,A,14000,Autocuration,BAO_0000019,,U,,,,,,,12973,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined
CHEMBL625914,0,,1,,,,A,14001,Autocuration,BAO_0000019,,U,,,,,,,8696,22224,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala
CHEMBL625915,0,,1,,,,A,14002,Autocuration,BAO_0000019,,U,,,,,,,15052,22224,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C
CHEMBL625916,0,,1,,,,A,14003,Autocuration,BAO_0000019,,U,,,,,,,15052,22224,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C
CHEMBL625917,0,,1,,,,A,14004,Autocuration,BAO_0000019,,U,,,,,,,10503,22224,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H)
CHEMBL625918,0,,1,,,,A,14005,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL625919,0,,1,,,,A,14006,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL625920,0,,1,,,,A,14007,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL874453,0,,1,,,,A,14008,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL625921,0,,1,,,,A,14009,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6"
CHEMBL625922,0,,1,,,,A,14010,Autocuration,BAO_0000019,,U,,,,,,,10503,22224,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay
CHEMBL625923,0,,1,,,,A,14011,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL625924,0,,1,,,,A,14012,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL625925,0,,1,,,,A,14013,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL625926,0,,1,,,,A,14014,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL627704,1,,1,,,,A,14015,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13100,50597,,Biodistribution in rat lung at 60 minutes after dose administration.
CHEMBL627705,1,,1,,,,A,14016,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.
CHEMBL627706,1,,1,,,,A,14017,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.
CHEMBL627707,1,,1,,,,A,14018,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.
CHEMBL627708,1,,1,,,,A,14019,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.
CHEMBL628361,1,,1,,,,A,14020,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.
CHEMBL628362,1,,1,,,,A,14021,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,13100,50597,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.
CHEMBL628363,1,,1,,,,A,14022,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat striatum at 120 minutes after dose administration.
CHEMBL628364,1,,1,,,,A,14023,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat striatum at 1440 minutes after dose administration.
CHEMBL628365,1,,1,,,,A,14024,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat striatum at 15 minutes after dose administration.
CHEMBL874454,1,,1,,,,A,14025,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat striatum at 240 minutes after dose administration.
CHEMBL628531,1,,1,,,,A,14026,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat striatum at 30 minutes after dose administration.
CHEMBL628532,1,,1,,,,A,14027,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat striatum at 360 minutes after dose administration.
CHEMBL628533,1,,1,,,,A,14028,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat striatum at 3 hr after dose administration.
CHEMBL628534,1,,1,,,,A,14029,Intermediate,BAO_0000218,2435.0,N,Rattus norvegicus,Striatum,10116.0,,In vivo,,13100,50597,,Biodistribution in rat striatum at 60 minutes after dose administration.
CHEMBL628535,1,,1,,,,A,14030,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,13100,50597,,Biodistribution in rat thyroid at 120 minutes after dose administration.
CHEMBL628536,1,,1,,,,A,14031,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,13100,50597,,Biodistribution in rat thyroid at 1440 minutes after dose administration.
CHEMBL628537,1,,1,,,,A,14032,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,13100,50597,,Biodistribution in rat thyroid at 15 minutes after dose administration.
CHEMBL628538,1,,1,,,,A,14033,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,13100,50597,,Biodistribution in rat thyroid at 240 minutes after dose administration.
CHEMBL628539,1,,1,,,,A,14034,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,13100,50597,,Biodistribution in rat thyroid at 30 minutes after dose administration.
CHEMBL630297,1,,1,,,,A,14035,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,13100,50597,,Biodistribution in rat thyroid at 360 minutes after dose administration.
CHEMBL630298,1,,1,,,,A,14036,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,13100,50597,,Biodistribution in rat thyroid at 60 minutes after dose administration.
CHEMBL630299,1,,1,,,,A,14037,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13100,50597,,Biodistribution in rest of brain of rat 120 minutes after dose administration.
CHEMBL628094,1,,1,,,,A,14038,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13100,50597,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.
CHEMBL628095,1,,1,,,,A,14039,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13100,50597,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.
CHEMBL874648,1,,1,,,,A,14040,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13100,50597,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.
CHEMBL628096,1,,1,,,,A,14041,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13100,50597,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.
CHEMBL628097,1,,1,,,,A,14042,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13100,50597,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.
CHEMBL628098,1,,1,,,,A,14043,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13100,50597,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.
CHEMBL628099,0,,1,,,,A,14044,Autocuration,BAO_0000019,,U,,,,,,,13331,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)"
CHEMBL628100,0,,1,,,,A,14045,Autocuration,BAO_0000019,,U,,,,,,,13331,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)"
CHEMBL628101,0,,1,,,,A,14046,Autocuration,BAO_0000019,,U,,,,,,,13331,22224,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!)
CHEMBL628102,0,,1,,,,A,14047,Autocuration,BAO_0000019,,U,,,,,,,13331,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)"
CHEMBL628103,0,,1,,,,A,14048,Autocuration,BAO_0000019,,U,,,,,,,13331,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)"
CHEMBL628104,0,,1,,,,A,14049,Autocuration,BAO_0000019,,U,,,,,,,13331,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)"
CHEMBL628105,0,,1,,,,A,14050,Autocuration,BAO_0000019,,U,,,,,,,13331,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)"
CHEMBL628106,0,,1,,,,A,14051,Autocuration,BAO_0000019,,U,,,,,,,13331,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)"
CHEMBL628107,1,,1,,,,A,14052,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,10086,50597,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally
CHEMBL628108,0,,1,,,,F,14053,Autocuration,BAO_0000218,1088.0,U,,Urine,,,,,10086,22224,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally
CHEMBL628109,1,,1,,,,A,14054,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,10086,50597,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally
CHEMBL625299,0,,1,,,,F,14055,Autocuration,BAO_0000218,1088.0,U,,Urine,,,,,10086,22224,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally
CHEMBL625300,1,,1,,,,A,14056,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,10086,50597,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally
CHEMBL625301,1,,1,,,,A,14057,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,10086,50597,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally
CHEMBL625302,1,,1,,,,A,14058,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,10086,50597,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally
CHEMBL874649,1,,1,,,,A,14059,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,10086,50597,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally
CHEMBL625303,1,,1,,,,A,14060,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13248,50597,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes
CHEMBL625463,1,,1,,,,A,14061,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13248,50597,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested
CHEMBL625464,1,,1,,,,A,14062,Intermediate,BAO_0000218,2107.0,N,Homo sapiens,Liver,9606.0,,,,14527,50587,,In vitro metabolism in human liver microsomes
CHEMBL625465,1,,1,,,,A,14063,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,3008,50587,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.
CHEMBL625466,1,,1,,,,A,14064,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug
CHEMBL625467,1,,1,,,,A,14065,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug
CHEMBL625468,1,,1,,,,A,14066,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug
CHEMBL625469,1,,1,,,,A,14067,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug
CHEMBL625470,1,,1,,,,A,14068,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug
CHEMBL632418,1,,1,,,,A,14069,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug
CHEMBL627250,1,,1,,,,A,14070,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug
CHEMBL627251,1,,1,,,,A,14071,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug
CHEMBL627252,1,,1,,,,A,14072,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug
CHEMBL627253,1,,1,,,,A,14073,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug
CHEMBL627254,1,,1,,,,A,14074,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug
CHEMBL875471,1,,1,,,,A,14075,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug
CHEMBL627255,1,,1,,,,A,14076,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug
CHEMBL627256,1,,1,,,,A,14077,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug
CHEMBL627257,1,,1,,,,A,14078,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug
CHEMBL627258,1,,1,,,,A,14079,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug
CHEMBL627259,1,,1,,,,A,14080,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug
CHEMBL627260,1,,1,,,,A,14081,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug
CHEMBL623256,1,,1,,,,A,14082,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug
CHEMBL874413,1,,1,,,,A,14083,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug
CHEMBL623257,1,,1,,,,A,14084,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug
CHEMBL623258,1,,1,,,,A,14085,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug
CHEMBL623259,1,,1,,,,A,14086,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug
CHEMBL623260,1,,1,,,,A,14087,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug
CHEMBL623261,1,,1,,,,A,14088,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug
CHEMBL623262,1,,1,,,,A,14089,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug
CHEMBL623263,1,,1,,,,A,14090,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug
CHEMBL623264,1,,1,,,,A,14091,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug
CHEMBL623265,1,,1,,,,A,14092,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug
CHEMBL623266,1,,1,,,,A,14093,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug
CHEMBL623267,1,,1,,,,A,14094,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug
CHEMBL623268,1,,1,,,,A,14095,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug
CHEMBL623269,1,,1,,,,A,14096,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug
CHEMBL623270,1,,1,,,,A,14097,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug
CHEMBL623271,1,,1,,,,A,14098,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug
CHEMBL623272,1,,1,,,,A,14099,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug
CHEMBL623273,1,,1,,,,A,14100,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug
CHEMBL623274,1,,1,,,,A,14101,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug
CHEMBL874414,1,,1,,,,A,14102,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug
CHEMBL623275,1,,1,,,,A,14103,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug
CHEMBL629150,1,,1,,,,A,14104,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug
CHEMBL623276,1,,1,,,,A,14105,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug
CHEMBL623277,1,,1,,,,A,14106,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug
CHEMBL623112,1,,1,,,,A,14107,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug
CHEMBL623113,1,,1,,,,A,14108,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug
CHEMBL623800,1,,1,,,,A,14109,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug
CHEMBL623801,1,,1,,,,A,14110,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug
CHEMBL623802,1,,1,,,,A,14111,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol"
CHEMBL623803,1,,1,,,,A,14112,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,In vivo,,12017,50597,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623970,1,,1,,,,A,14113,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,In vivo,,12017,50597,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623971,1,,1,,,,A,14114,Intermediate,BAO_0000218,995.0,N,Rattus norvegicus,Uterus,10116.0,,In vivo,,12017,50597,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL623972,1,,1,,,,A,14115,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals)
CHEMBL623973,1,,1,,,,A,14116,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals)
CHEMBL623974,1,,1,,,,A,14117,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals)
CHEMBL623975,1,,1,,,,A,14118,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals)
CHEMBL623976,1,,1,,,,A,14119,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals)
CHEMBL623977,1,,1,,,,A,14120,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals)
CHEMBL623978,1,,1,,,,A,14121,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals)
CHEMBL623979,1,,1,,,,A,14122,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals)
CHEMBL623980,1,,1,,,,A,14123,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals)
CHEMBL623981,1,,1,,,,A,14124,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals)
CHEMBL626278,1,,1,,,,A,14125,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals)
CHEMBL626279,1,,1,,,,A,14126,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,14045,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals)
CHEMBL626280,1,,1,,,,A,14127,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14045,50594,,Biodistribution in mice bladder plus excreted urine was determined
CHEMBL626281,1,,1,,,,A,14128,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse blood, 10 minutes post injection"
CHEMBL626282,1,,1,,,,A,14129,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse blood, 30 minutes post injection"
CHEMBL626283,1,,1,,,,A,14130,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse blood, 5 minutes post injection"
CHEMBL626284,1,,1,,,,A,14131,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse blood, 60 minutes post injection"
CHEMBL626285,1,,1,,,,A,14132,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse brain, 10 minutes post injection"
CHEMBL626286,1,,1,,,,A,14133,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse brain, 30 minutes post injection"
CHEMBL626287,1,,1,,,,A,14134,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse brain, 5 minutes post injection"
CHEMBL626288,1,,1,,,,A,14135,Intermediate,BAO_0000218,955.0,N,Mus musculus,Brain,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse brain, 60 minutes post injection"
CHEMBL626289,1,,1,,,,A,14136,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse heart, 10 minutes post injection"
CHEMBL626290,1,,1,,,,A,14137,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse heart, 30 minutes post injection"
CHEMBL626291,1,,1,,,,A,14138,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse heart, 5 minutes post injection"
CHEMBL839888,1,,1,,,,A,14139,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse heart, 60 minutes post injection"
CHEMBL626292,1,,1,,,,A,14140,Intermediate,BAO_0000218,160.0,N,Mus musculus,Intestine,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse intestine, 10 minutes post injection"
CHEMBL626293,1,,1,,,,A,14141,Intermediate,BAO_0000218,160.0,N,Mus musculus,Intestine,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse intestine, 30 minutes post injection"
CHEMBL626294,1,,1,,,,A,14142,Intermediate,BAO_0000218,160.0,N,Mus musculus,Intestine,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse intestine, 5 minutes post injection"
CHEMBL626295,1,,1,,,,A,14143,Intermediate,BAO_0000218,160.0,N,Mus musculus,Intestine,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse intestine, 60 minutes post injection"
CHEMBL627659,1,,1,,,,A,14144,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse liver, 10 minutes post injection"
CHEMBL627660,1,,1,,,,A,14145,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse liver, 30 minutes of post injection"
CHEMBL627661,1,,1,,,,A,14146,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse liver, 5 minutes post injection"
CHEMBL627662,1,,1,,,,A,14147,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,14045,50594,,Biodistribution in mice liver at 60 minutes of post injection
CHEMBL627663,1,,1,,,,A,14148,Intermediate,BAO_0000218,2048.0,N,Mus musculus,Lung,10090.0,,In vivo,,14045,50594,,Biodistribution in mice lungs at 10 min of post injection
CHEMBL627664,1,,1,,,,A,14149,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mouse lung, 30 minutes post injection"
CHEMBL627665,1,,1,,,,A,14150,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,14045,50594,,"Percentage biodistribution in mousee lung, 5 minutes post injection"
CHEMBL627666,1,,1,,,,A,14151,Intermediate,BAO_0000218,2048.0,N,Mus musculus,Lung,10090.0,,In vivo,,14045,50594,,Biodistribution in mice lungs at 60 min of post injection
CHEMBL627667,1,,1,,,,A,14152,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,,,14045,50594,,Percentage biodistribution in mouse spleen
CHEMBL627668,1,,1,,,,A,14153,Intermediate,BAO_0000218,945.0,N,Mus musculus,Stomach,10090.0,,,,14045,50594,,Percentage biodistribution in mouse stomach
CHEMBL627669,1,,1,,,,A,14154,Intermediate,BAO_0000218,1088.0,N,Mus musculus,Urine,10090.0,,,,11745,50594,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.
CHEMBL627670,0,,1,,,,A,14155,Autocuration,BAO_0000218,1255.0,U,,Urinary bladder,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder
CHEMBL627671,0,,1,,,,A,14156,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood
CHEMBL627672,0,,1,,,,A,14157,Autocuration,BAO_0000218,1474.0,U,,Bone element,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone
CHEMBL627673,0,,1,,,,A,14158,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat
CHEMBL627674,0,,1,,,,A,14159,Autocuration,BAO_0000218,2113.0,U,,Kidney,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney
CHEMBL627675,0,,1,,,,A,14160,Autocuration,BAO_0000218,2107.0,U,,Liver,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver
CHEMBL627676,0,,1,,,,A,14161,Autocuration,BAO_0000218,2048.0,U,,Lung,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung
CHEMBL627677,0,,1,,,,A,14162,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle
CHEMBL627678,0,,1,,,,A,14163,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6"
CHEMBL627679,1,,1,,,,A,14164,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,7095,50597,,Affinity for protein binding expressed as association constant in fresh rat serum
CHEMBL627680,0,,1,,,,A,14165,Autocuration,BAO_0000019,,U,,,,,,,12185,22224,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation
CHEMBL627681,0,,1,,,,A,14166,Autocuration,BAO_0000019,,U,,,,,,,12185,22224,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive
CHEMBL627682,0,,1,,,,A,14167,Autocuration,BAO_0000019,,U,,,,,,,12185,22224,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation
CHEMBL627683,0,,1,,,,A,14168,Autocuration,BAO_0000019,,U,,,,,,,12185,22224,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive
CHEMBL627684,0,,1,,,,A,14169,Autocuration,BAO_0000019,,U,,,,,,,12686,22224,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4
CHEMBL874441,0,,1,,,,A,14170,Autocuration,BAO_0000019,,U,,,,,,,12686,22224,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants"
CHEMBL627685,0,,1,,,,A,14171,Autocuration,BAO_0000019,,U,,,,,,,12686,22224,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h
CHEMBL627686,0,,1,,,,A,14172,Autocuration,BAO_0000019,,U,,,,,,,12686,22224,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants"
CHEMBL627687,0,,1,,,,A,14173,Autocuration,BAO_0000019,,U,,,,,,,8057,22224,,Apparent rate constant Koff for inactivation of dTMP synthase.
CHEMBL627688,0,,1,,,,A,14174,Autocuration,BAO_0000019,,U,,,,,,,15778,22224,,The irreversible inhibitor activity by second order rate equation.
CHEMBL628038,1,,1,,,,A,14175,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12375,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration
CHEMBL628039,1,,1,,,,A,14176,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12375,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration
CHEMBL628040,1,,1,,,,A,14177,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,12375,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration
CHEMBL628041,0,,1,,,,A,14178,Autocuration,BAO_0000019,,U,,,,,,,13588,22224,,Dissociation rate calculated from the first-order equation using t1/2 value
CHEMBL630226,0,,1,,,,A,14179,Autocuration,BAO_0000019,,U,,,,,,,15039,22224,,The compound was tested for Binding constant against DNA
CHEMBL628042,0,,1,,,,A,14180,Autocuration,BAO_0000019,,U,,,,,,,9500,22224,,First order rate constant for cyclization of the compound
CHEMBL625232,0,,1,,,,A,14181,Autocuration,BAO_0000019,,U,,,,,,,10014,22224,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius
CHEMBL625233,0,,1,,,,A,14182,Autocuration,BAO_0000019,,U,,,,,,,10014,22224,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius
CHEMBL625979,0,,1,,,,A,14183,Autocuration,BAO_0000019,,U,,,,,,,568,22224,,Hydrolysis rate constant was determined
CHEMBL625980,0,,1,,,,A,14184,Autocuration,BAO_0000019,,U,,,,,,,10026,22224,,Observed first order rate constant
CHEMBL625981,0,,1,,,,A,14185,Autocuration,BAO_0000019,,U,,,,,,,10281,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4
CHEMBL625982,0,,1,,,,A,14186,Autocuration,BAO_0000019,,U,,,,,,,10281,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4
CHEMBL625983,0,,1,,,,A,14187,Autocuration,BAO_0000019,,U,,,,,,,9680,22224,,Second-order rate constant for attack on PNPA at 25 degree Centigrade
CHEMBL625984,0,,1,,,,A,14188,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL625985,0,,1,,,,A,14189,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL625986,0,,1,,,,A,14190,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL625987,0,,1,,,,A,14191,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL625988,0,,1,,,,A,14192,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL625989,0,,1,,,,A,14193,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL625990,0,,1,,,,A,14194,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL625991,0,,1,,,,A,14195,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL625992,0,,1,,,,A,14196,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL625993,0,,1,,,,A,14197,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL631973,0,,1,,,,A,14198,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632143,0,,1,,,,A,14199,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632144,0,,1,,,,A,14200,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632145,0,,1,,,,A,14201,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632146,0,,1,,,,A,14202,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632147,0,,1,,,,A,14203,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632148,0,,1,,,,A,14204,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632149,0,,1,,,,A,14205,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632150,0,,1,,,,A,14206,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632151,0,,1,,,,A,14207,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL632152,1,,1,,,,A,14208,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,3008,50587,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected
CHEMBL632153,1,,1,,,,A,14209,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,4509,50587,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM
CHEMBL632154,1,,1,,,,A,14210,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,,,4509,50587,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM
CHEMBL632155,1,,1,,,,A,14211,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10
CHEMBL632156,1,,1,,,,A,14212,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10
CHEMBL632157,1,,1,,,,A,14213,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10
CHEMBL632158,1,,1,,,,A,14214,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10
CHEMBL632159,1,,1,,,,A,14215,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10
CHEMBL626305,1,,1,,,,A,14216,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10
CHEMBL626306,1,,1,,,,A,14217,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10
CHEMBL626307,1,,1,,,,A,14218,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10
CHEMBL626308,1,,1,,,,A,14219,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10
CHEMBL626479,1,,1,,,,A,14220,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10
CHEMBL626480,1,,1,,,,A,14221,Intermediate,BAO_0000218,,N,Human herpesvirus 1,,10298.0,,,,8613,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10
CHEMBL626481,0,,1,,,,P,14222,Autocuration,BAO_0000100,,U,,,,,,,6021,22229,,Calculated partition coefficient (clogP) (MlogP)
CHEMBL626482,0,,1,,,,A,14223,Autocuration,BAO_0000019,,U,,,,,,,9348,22224,,Equipotent potent ratio relative to carbachol (nicotinic activity)
CHEMBL626483,1,,1,,,,A,14224,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,15592,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available"
CHEMBL626484,1,,1,,,,A,14225,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,15592,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available"
CHEMBL626485,0,,1,,,,P,14226,Autocuration,BAO_0000100,,U,,,,,,,15592,22229,,Solubility at pH 7.4 in micro g/mL;NA denotes available
CHEMBL626486,0,,1,,,,P,14227,Autocuration,BAO_0000100,,U,,,,,,,15592,22229,,Solubility at pH 7.4 in micro g/mL;NA denotes not available
CHEMBL626487,0,,1,,,,P,14228,Autocuration,BAO_0000100,,U,,,,,,,15592,22229,,Solubility at pH 7.4 in ug/mL;NA denotes not available
CHEMBL626488,1,,1,,,,A,14229,Intermediate,BAO_0000218,1969.0,N,Canis lupus familiaris,Plasma,9615.0,,In vivo,,15592,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid
CHEMBL626489,1,,1,,,,A,14230,Intermediate,BAO_0000218,1977.0,N,Rattus norvegicus,Serum,10116.0,,,,7095,50597,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.
CHEMBL626490,0,,1,,,,A,14231,Autocuration,BAO_0000019,,U,,,,,,,16618,22224,,Area under the MAP curve measured over 5 min; ND means Not determined
CHEMBL626491,0,,1,,,,P,14232,Autocuration,BAO_0000100,,U,,,,,,,16835,22224,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.
CHEMBL626492,0,,1,,,,P,14233,Autocuration,BAO_0000100,,U,,,,,,,15284,22229,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined
CHEMBL626493,0,,1,,,,A,14234,Autocuration,BAO_0000019,,U,,,,,,,15750,22224,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition
CHEMBL626494,1,,1,,,,A,14235,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16618,50597,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested
CHEMBL626495,0,,1,,,,A,14236,Autocuration,BAO_0000218,,U,,,,,In vivo,,16618,22224,,Half life after oral tested
CHEMBL626496,1,,1,,,,A,14237,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,15812,50597,,Half life was determined in plasma of rat; NT indicates not tested
CHEMBL626497,1,,1,,,,A,14238,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,16618,50597,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested
CHEMBL626498,0,,1,,,,A,14239,Autocuration,BAO_0000218,,U,,,,,In vivo,,16618,22224,,Oral bioavailability after oral tested
CHEMBL626499,1,,1,,,,A,14240,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13098,50597,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F)
CHEMBL626500,1,,1,,,,A,14241,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13098,50597,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg)
CHEMBL626501,1,,1,,,,A,14242,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,15812,50597,,half life was determined in plasma of rat; NT indicates not tested
CHEMBL626502,1,,1,,,,A,14243,Intermediate,BAO_0000218,1969.0,N,Rattus norvegicus,Plasma,10116.0,,,,15812,50597,,half life was determined in plasma of rat; NT means not tested
CHEMBL626503,1,,1,,,,A,14244,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32
CHEMBL626504,1,,1,,,,A,14245,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); inactive
CHEMBL626505,1,,1,,,,A,14246,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43
CHEMBL626506,1,,1,,,,A,14247,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38
CHEMBL626507,1,,1,,,,A,14248,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23
CHEMBL626508,1,,1,,,,A,14249,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26
CHEMBL626509,1,,1,,,,A,14250,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35
CHEMBL875480,1,,1,,,,A,14251,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88
CHEMBL626510,1,,1,,,,A,14252,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29
CHEMBL626511,1,,1,,,,A,14253,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47
CHEMBL626512,1,,1,,,,A,14254,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49
CHEMBL628208,1,,1,,,,A,14255,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23
CHEMBL628209,1,,1,,,,A,14256,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22
CHEMBL628210,1,,1,,,,A,14257,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48
CHEMBL628211,1,,1,,,,A,14258,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49
CHEMBL628212,1,,1,,,,A,14259,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06
CHEMBL628213,1,,1,,,,A,14260,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65
CHEMBL628214,1,,1,,,,A,14261,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug
CHEMBL628215,1,,1,,,,A,14262,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug
CHEMBL628216,1,,1,,,,A,14263,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug
CHEMBL626595,1,,1,,,,A,14264,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug
CHEMBL626596,1,,1,,,,A,14265,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug
CHEMBL626597,1,,1,,,,A,14266,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug
CHEMBL626598,1,,1,,,,A,14267,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug
CHEMBL622242,1,,1,,,,A,14268,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug
CHEMBL622243,1,,1,,,,A,14269,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug
CHEMBL622244,1,,1,,,,A,14270,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug
CHEMBL622245,1,,1,,,,A,14271,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug
CHEMBL622246,1,,1,,,,A,14272,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug
CHEMBL622247,1,,1,,,,A,14273,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug
CHEMBL622248,1,,1,,,,A,14274,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug
CHEMBL877483,1,,1,,,,A,14275,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug
CHEMBL622249,1,,1,,,,A,14276,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug
CHEMBL622250,1,,1,,,,A,14277,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug
CHEMBL622251,1,,1,,,,A,14278,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug
CHEMBL622252,1,,1,,,,A,14279,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug
CHEMBL622253,1,,1,,,,A,14280,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug
CHEMBL622254,1,,1,,,,A,14281,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug
CHEMBL622255,1,,1,,,,A,14282,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug
CHEMBL622256,1,,1,,,,A,14283,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug
CHEMBL622257,1,,1,,,,A,14284,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug
CHEMBL622258,1,,1,,,,A,14285,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug
CHEMBL622259,1,,1,,,,A,14286,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug
CHEMBL622927,1,,1,,,,A,14287,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug
CHEMBL622928,1,,1,,,,A,14288,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug
CHEMBL622929,1,,1,,,,A,14289,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug
CHEMBL623182,1,,1,,,,A,14290,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug
CHEMBL623183,1,,1,,,,A,14291,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug
CHEMBL623184,1,,1,,,,A,14292,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug
CHEMBL623185,1,,1,,,,A,14293,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug
CHEMBL877484,1,,1,,,,A,14294,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug
CHEMBL627274,1,,1,,,,A,14295,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug
CHEMBL623186,1,,1,,,,A,14296,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug
CHEMBL623187,1,,1,,,,A,14297,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug
CHEMBL623188,1,,1,,,,A,14298,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug
CHEMBL628055,1,,1,,,,A,14299,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug
CHEMBL628056,1,,1,,,,A,14300,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug
CHEMBL628200,1,,1,,,,A,14301,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug
CHEMBL628201,1,,1,,,,A,14302,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug
CHEMBL628202,1,,1,,,,A,14303,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug
CHEMBL628203,1,,1,,,,A,14304,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug
CHEMBL628204,1,,1,,,,A,14305,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug
CHEMBL628205,1,,1,,,,A,14306,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug
CHEMBL628206,1,,1,,,,A,14307,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug
CHEMBL628207,0,,1,,,,A,14308,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)
CHEMBL627220,0,,1,,,,A,14309,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood
CHEMBL627221,0,,1,,,,A,14310,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle
CHEMBL627222,0,,1,,,,A,14311,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)
CHEMBL627223,0,,1,,,,A,14312,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood
CHEMBL632062,0,,1,,,,A,14313,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle
CHEMBL632063,0,,1,,,,A,14314,Autocuration,BAO_0000218,2106.0,U,,Spleen,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen
CHEMBL632064,0,,1,,,,A,14315,Autocuration,BAO_0000218,1255.0,U,,Urinary bladder,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder
CHEMBL632065,0,,1,,,,A,14316,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood
CHEMBL632066,0,,1,,,,A,14317,Autocuration,BAO_0000218,1474.0,U,,Bone element,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone
CHEMBL632067,0,,1,,,,A,14318,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat
CHEMBL629188,0,,1,,,,A,14319,Autocuration,BAO_0000218,2113.0,U,,Kidney,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney
CHEMBL629189,0,,1,,,,A,14320,Autocuration,BAO_0000218,2107.0,U,,Liver,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver
CHEMBL629190,0,,1,,,,A,14321,Autocuration,BAO_0000218,2048.0,U,,Lung,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung
CHEMBL629191,0,,1,,,,A,14322,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle
CHEMBL629192,0,,1,,,,A,14323,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)
CHEMBL629193,0,,1,,,,A,14324,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle
CHEMBL629194,0,,1,,,,A,14325,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)
CHEMBL629195,0,,1,,,,A,14326,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood
CHEMBL629373,0,,1,,,,A,14327,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle
CHEMBL629374,0,,1,,,,A,14328,Autocuration,BAO_0000218,2106.0,U,,Spleen,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen
CHEMBL629375,0,,1,,,,A,14329,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood
CHEMBL629376,0,,1,,,,A,14330,Autocuration,BAO_0000218,1255.0,U,,Urinary bladder,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder
CHEMBL629377,0,,1,,,,A,14331,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood
CHEMBL629378,0,,1,,,,A,14332,Autocuration,BAO_0000218,1474.0,U,,Bone element,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone
CHEMBL629379,0,,1,,,,A,14333,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat
CHEMBL629151,0,,1,,,,A,14334,Autocuration,BAO_0000218,2113.0,U,,Kidney,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney
CHEMBL629152,0,,1,,,,A,14335,Autocuration,BAO_0000218,2107.0,U,,Liver,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver
CHEMBL629153,0,,1,,,,A,14336,Autocuration,BAO_0000218,2048.0,U,,Lung,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung
CHEMBL629154,0,,1,,,,A,14337,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle
CHEMBL629155,0,,1,,,,A,14338,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)
CHEMBL629156,0,,1,,,,A,14339,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood
CHEMBL629157,0,,1,,,,A,14340,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle
CHEMBL629158,0,,1,,,,A,14341,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)
CHEMBL629159,0,,1,,,,A,14342,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood
CHEMBL629160,0,,1,,,,A,14343,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle
CHEMBL629161,0,,1,,,,A,14344,Autocuration,BAO_0000218,2106.0,U,,Spleen,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen
CHEMBL629162,0,,1,,,,A,14345,Autocuration,BAO_0000218,1255.0,U,,Urinary bladder,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder
CHEMBL629163,0,,1,,,,A,14346,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood
CHEMBL629164,0,,1,,,,A,14347,Autocuration,BAO_0000218,1474.0,U,,Bone element,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone
CHEMBL629165,0,,1,,,,A,14348,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat
CHEMBL629166,0,,1,,,,A,14349,Autocuration,BAO_0000218,2107.0,U,,Liver,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver
CHEMBL629167,0,,1,,,,A,14350,Autocuration,BAO_0000218,2048.0,U,,Lung,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung
CHEMBL629168,0,,1,,,,A,14351,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle
CHEMBL629169,0,,1,,,,A,14352,Autocuration,BAO_0000019,,U,,,,,,,2193,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM
CHEMBL629170,0,,1,,,,A,14353,Autocuration,BAO_0000019,,U,,,,,,,2193,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration
CHEMBL631153,0,,1,,,,A,14354,Autocuration,BAO_0000019,,U,,,,,,,2193,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM
CHEMBL875121,0,,1,,,,A,14355,Autocuration,BAO_0000019,,U,,,,,,,2193,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed
CHEMBL631154,0,,1,,,,A,14356,Autocuration,BAO_0000019,,U,,,,,,,2193,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM
CHEMBL631155,0,,1,,,,A,14357,Autocuration,BAO_0000019,,U,,,,,,,2193,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed
CHEMBL631156,0,,1,,,,A,14358,Autocuration,BAO_0000019,,U,,,,,,,568,22224,,Hydrolysis rate constant was determined
CHEMBL631157,0,,1,,,,A,14359,Autocuration,BAO_0000019,,U,,,,,,,9680,22224,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade"
CHEMBL631158,0,,1,,,,A,14360,Autocuration,BAO_0000019,,U,,,,,,,9680,22224,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade"
CHEMBL631159,0,,1,,,,A,14361,Autocuration,BAO_0000019,,U,,,,,,,9680,22224,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade"
CHEMBL631160,0,,1,,,,A,14362,Autocuration,BAO_0000019,,U,,,,,,,10026,22224,,Observed second order rate constant
CHEMBL631161,0,,1,,,,A,14363,Autocuration,BAO_0000019,,U,,,,,,,10281,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4
CHEMBL631162,0,,1,,,,A,14364,Autocuration,BAO_0000019,,U,,,,,,,10014,22224,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius
CHEMBL630313,0,,1,,,,A,14365,Autocuration,BAO_0000019,,U,,,,,,,10014,22224,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius
CHEMBL630314,0,,1,,,,A,14366,Autocuration,BAO_0000019,,U,,,,,,,9680,22224,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade"
CHEMBL630315,0,,1,,,,A,14367,Autocuration,BAO_0000019,,U,,,,,,,9680,22224,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade"
CHEMBL630316,0,,1,,,,A,14368,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630986,0,,1,,,,A,14369,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630987,0,,1,,,,A,14370,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630988,0,,1,,,,A,14371,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630989,0,,1,,,,A,14372,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630990,0,,1,,,,A,14373,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630991,0,,1,,,,A,14374,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630992,0,,1,,,,A,14375,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630993,0,,1,,,,A,14376,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630994,0,,1,,,,A,14377,Autocuration,BAO_0000019,,U,,,,,,,13028,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS
CHEMBL630995,1,,1,,,,A,14378,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,10014,50597,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex
CHEMBL629252,0,,1,,,,A,14379,Autocuration,BAO_0000019,,U,,,,,,,9962,22224,,Association constant for compound at 31 degree C was determined
CHEMBL629253,0,,1,,,,A,14380,Autocuration,BAO_0000019,,U,,,,,,,12029,22224,,Calculated antagonist equilibrium dissociation constant of the compound
CHEMBL629944,0,,1,,,,A,14381,Autocuration,BAO_0000019,,U,,,,,,,12029,22224,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed
CHEMBL629945,1,,1,,,,A,14382,Intermediate,BAO_0000218,3126.0,N,Cavia porcellus,Trachea,10141.0,,,,10583,50512,,Dissociation constants vs LTE4 on guinea pig trachea
CHEMBL629946,0,,1,,,,A,14383,Autocuration,BAO_0000019,,U,,,,,,,568,22224,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8"
CHEMBL629947,0,,1,,,,A,14384,Autocuration,BAO_0000019,,U,,,,,,,568,22224,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5"
CHEMBL629948,0,,1,,,,A,14385,Autocuration,BAO_0000019,,U,,,,,,,568,22224,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5"
CHEMBL856024,0,,1,,,,A,14386,Autocuration,BAO_0000019,,U,,,,,,,568,22224,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5"
CHEMBL629949,0,,1,,,,A,14387,Autocuration,BAO_0000019,,U,,,,,,,7493,22224,,Affinity constant KD value was derived from TMP
CHEMBL629950,0,,1,,,,A,14388,Autocuration,BAO_0000019,,U,,,,,,,8371,22224,,Apparent dissociation (binding) rate constant was evaluated
CHEMBL630127,0,,1,,,,P,14389,Autocuration,BAO_0000100,,U,,,,,,,13114,22224,,Dissociation constant (KD) of the compound
CHEMBL630128,0,,1,,,,P,14390,Autocuration,BAO_0000100,,U,,,,,,,15515,22224,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy
CHEMBL630129,0,,1,,,,P,14391,Autocuration,BAO_0000100,,U,,,,,,,522,22224,,Dissociation constant from ESR titration experiments
CHEMBL630130,0,,1,,,,,14392,Autocuration,BAO_0000019,,U,,,,,,,13888,22224,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant)
CHEMBL875234,0,,1,,,,P,14393,Autocuration,BAO_0000100,,U,,,,,,,2616,22224,,Dissociation constant was evaluated.
CHEMBL630131,0,,1,,,,P,14394,Autocuration,BAO_0000100,,U,,,,,,,3798,22224,,Dissociation constant was reported
CHEMBL630132,1,,1,,,,A,14395,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,8731,50597,,Dissociation constant was determined in rat pituitary cells.
CHEMBL630133,0,,1,,,,A,14396,Autocuration,BAO_0000019,,U,,,,,,,11892,22224,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound
CHEMBL630134,0,,1,,,,A,14397,Autocuration,BAO_0000019,,U,,,,,,,11892,22224,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound
CHEMBL630135,0,,1,,,,A,14398,Autocuration,BAO_0000019,,U,,,,,,,2582,22224,,Equilibrium dissociation constant of the compound
CHEMBL630136,0,,1,,,,A,14399,Autocuration,BAO_0000019,,U,,,,,,,11892,22224,,Equilibrium dissociation constant was determined
CHEMBL630137,0,,1,,,,A,14400,Autocuration,BAO_0000019,,U,,,,,,,13396,22224,,Kinetic constant KD was evaluated
CHEMBL630138,0,,1,,,,A,14401,Autocuration,BAO_0000019,,U,,,,,,,603,22224,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3
CHEMBL630139,0,,1,,,,A,14402,Autocuration,BAO_0000019,,U,,,,,,,15673,22224,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4
CHEMBL630140,0,,1,,,,A,14403,Autocuration,BAO_0000019,,U,,,,,,,10368,22224,,Rate constant for hydrolysis in aqueous acetone.
CHEMBL875235,0,,1,,,,A,14404,Autocuration,BAO_0000019,,U,,,,,,,14228,22224,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex
CHEMBL876439,1,,1,,,,A,14405,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86
CHEMBL630605,1,,1,,,,A,14406,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68
CHEMBL630606,1,,1,,,,A,14407,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55
CHEMBL630607,1,,1,,,,A,14408,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95
CHEMBL630608,1,,1,,,,A,14409,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79
CHEMBL630609,1,,1,,,,A,14410,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66
CHEMBL630610,1,,1,,,,A,14411,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02
CHEMBL630611,1,,1,,,,A,14412,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37
CHEMBL629552,1,,1,,,,A,14413,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36
CHEMBL629733,1,,1,,,,A,14414,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg
CHEMBL629734,1,,1,,,,A,14415,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg
CHEMBL629735,1,,1,,,,A,14416,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg
CHEMBL629736,1,,1,,,,A,14417,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg
CHEMBL629737,1,,1,,,,A,14418,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg
CHEMBL629738,1,,1,,,,A,14419,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg
CHEMBL629739,1,,1,,,,A,14420,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg
CHEMBL629740,1,,1,,,,A,14421,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined
CHEMBL629741,1,,1,,,,A,14422,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg
CHEMBL629742,1,,1,,,,A,14423,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg
CHEMBL629743,1,,1,,,,A,14424,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg
CHEMBL629744,1,,1,,,,A,14425,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg
CHEMBL629745,1,,1,,,,A,14426,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg
CHEMBL629746,1,,1,,,,A,14427,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg
CHEMBL629747,1,,1,,,,A,14428,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg
CHEMBL629748,1,,1,,,,A,14429,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg
CHEMBL629749,1,,1,,,,A,14430,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg
CHEMBL629750,1,,1,,,,A,14431,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg
CHEMBL629751,1,,1,,,,A,14432,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg
CHEMBL629752,1,,1,,,,A,14433,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg
CHEMBL629753,1,,1,,,,A,14434,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg
CHEMBL629754,1,,1,,,,A,14435,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg
CHEMBL629755,1,,1,,,,A,14436,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg
CHEMBL629756,1,,1,,,,A,14437,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg
CHEMBL629757,1,,1,,,,A,14438,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg
CHEMBL629758,1,,1,,,,A,14439,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg
CHEMBL629759,1,,1,,,,A,14440,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg
CHEMBL629760,1,,1,,,,A,14441,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg
CHEMBL876443,1,,1,,,,A,14442,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11510,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg
CHEMBL629761,1,,1,,,,A,14443,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8310,50588,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr
CHEMBL629762,1,,1,,,,A,14444,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8310,50588,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr
CHEMBL629763,1,,1,,,,A,14445,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally
CHEMBL629764,1,,1,,,,A,14446,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally
CHEMBL629765,1,,1,,,,A,14447,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally
CHEMBL629766,1,,1,,,,A,14448,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally
CHEMBL629767,1,,1,,,,A,14449,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally
CHEMBL629768,1,,1,,,,A,14450,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8310,50588,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr
CHEMBL629769,1,,1,,,,A,14451,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally
CHEMBL629770,1,,1,,,,A,14452,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8310,50588,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr
CHEMBL629771,1,,1,,,,A,14453,Intermediate,BAO_0000218,,N,Canis lupus familiaris,,9615.0,,,,8310,50588,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally
CHEMBL629772,1,,1,,,,A,14454,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally
CHEMBL629773,1,,1,,,,A,14455,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally
CHEMBL625455,1,,1,,,,A,14456,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally
CHEMBL625456,1,,1,,,,A,14457,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally
CHEMBL625457,1,,1,,,,A,14458,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,8310,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally
CHEMBL625458,1,,1,,,,A,14459,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug
CHEMBL625459,1,,1,,,,A,14460,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug
CHEMBL875483,1,,1,,,,A,14461,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug
CHEMBL634779,1,,1,,,,A,14462,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug
CHEMBL625460,1,,1,,,,A,14463,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug
CHEMBL626117,1,,1,,,,A,14464,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug
CHEMBL626118,1,,1,,,,A,14465,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug
CHEMBL628342,1,,1,,,,A,14466,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug
CHEMBL628343,1,,1,,,,A,14467,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug
CHEMBL628344,1,,1,,,,A,14468,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug
CHEMBL628345,1,,1,,,,A,14469,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug
CHEMBL628346,1,,1,,,,A,14470,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug
CHEMBL628347,1,,1,,,,A,14471,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug
CHEMBL628348,1,,1,,,,A,14472,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug
CHEMBL628349,1,,1,,,,A,14473,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug
CHEMBL875611,1,,1,,,,A,14474,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug
CHEMBL628350,1,,1,,,,A,14475,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug
CHEMBL628351,1,,1,,,,A,14476,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug
CHEMBL628352,1,,1,,,,A,14477,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug
CHEMBL628353,1,,1,,,,A,14478,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug
CHEMBL628354,1,,1,,,,A,14479,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug
CHEMBL626667,1,,1,,,,A,14480,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug
CHEMBL626668,1,,1,,,,A,14481,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug
CHEMBL626669,1,,1,,,,A,14482,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug
CHEMBL626670,1,,1,,,,A,14483,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug
CHEMBL626671,1,,1,,,,A,14484,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug
CHEMBL626672,1,,1,,,,A,14485,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug
CHEMBL626673,1,,1,,,,A,14486,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug
CHEMBL626674,1,,1,,,,A,14487,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug
CHEMBL626675,1,,1,,,,A,14488,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug
CHEMBL626676,1,,1,,,,A,14489,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug
CHEMBL626677,1,,1,,,,A,14490,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug
CHEMBL626678,1,,1,,,,A,14491,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug
CHEMBL626679,1,,1,,,,A,14492,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug
CHEMBL875612,1,,1,,,,A,14493,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug
CHEMBL626680,1,,1,,,,A,14494,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug
CHEMBL626681,1,,1,,,,A,14495,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug
CHEMBL626682,1,,1,,,,A,14496,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug
CHEMBL626683,1,,1,,,,A,14497,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug
CHEMBL626684,1,,1,,,,A,14498,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug
CHEMBL626685,1,,1,,,,A,14499,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug
CHEMBL626686,1,,1,,,,A,14500,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug
CHEMBL626687,1,,1,,,,A,14501,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug
CHEMBL624978,1,,1,,,,A,14502,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug
CHEMBL624979,1,,1,,,,A,14503,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug
CHEMBL624980,1,,1,,,,A,14504,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug
CHEMBL624981,1,,1,,,,A,14505,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug
CHEMBL624982,1,,1,,,,A,14506,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug
CHEMBL627564,0,,1,,,,A,14507,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)
CHEMBL627565,0,,1,,,,A,14508,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)
CHEMBL627566,0,,1,,,,A,14509,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood
CHEMBL627567,0,,1,,,,A,14510,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle
CHEMBL627568,0,,1,,,,A,14511,Autocuration,BAO_0000218,2106.0,U,,Spleen,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen
CHEMBL627569,0,,1,,,,A,14512,Autocuration,BAO_0000218,2113.0,U,,Kidney,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney
CHEMBL627570,0,,1,,,,A,14513,Autocuration,BAO_0000218,1255.0,U,,Urinary bladder,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder
CHEMBL627571,0,,1,,,,A,14514,Autocuration,BAO_0000218,178.0,U,,Blood,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood
CHEMBL627572,0,,1,,,,A,14515,Autocuration,BAO_0000218,1474.0,U,,Bone element,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone
CHEMBL627573,0,,1,,,,A,14516,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat
CHEMBL627574,0,,1,,,,A,14517,Autocuration,BAO_0000218,2113.0,U,,Kidney,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney
CHEMBL627575,0,,1,,,,A,14518,Autocuration,BAO_0000218,2107.0,U,,Liver,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver
CHEMBL627576,0,,1,,,,A,14519,Autocuration,BAO_0000218,2048.0,U,,Lung,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung
CHEMBL627577,0,,1,,,,A,14520,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle
CHEMBL627578,0,,1,,,,A,14521,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)
CHEMBL627579,0,,1,,,,A,14522,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood
CHEMBL627580,0,,1,,,,A,14523,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle
CHEMBL627581,0,,1,,,,A,14524,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)
CHEMBL627582,0,,1,,,,A,14525,Autocuration,BAO_0000218,,U,,,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood
CHEMBL627583,0,,1,,,,A,14526,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle
CHEMBL627584,0,,1,,,,A,14527,Autocuration,BAO_0000218,2106.0,U,,Spleen,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen
CHEMBL627585,0,,1,,,,A,14528,Autocuration,BAO_0000218,2367.0,U,,Prostate gland,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood
CHEMBL627586,0,,1,,,,A,14529,Autocuration,BAO_0000218,2385.0,U,,Muscle tissue,,,In vivo,,13257,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle
CHEMBL627587,1,,1,,,,A,14530,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635
CHEMBL627588,1,,1,,,,A,14531,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL628250,1,,1,,,,A,14532,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635
CHEMBL628251,1,,1,,,,A,14533,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL628252,1,,1,,,,A,14534,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635
CHEMBL628253,1,,1,,,,A,14535,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL628254,1,,1,,,,A,14536,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635
CHEMBL877493,1,,1,,,,A,14537,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL628255,1,,1,,,,A,14538,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL628256,1,,1,,,,A,14539,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL628257,1,,1,,,,A,14540,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL628258,1,,1,,,,A,14541,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL628259,1,,1,,,,A,14542,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL628429,1,,1,,,,A,14543,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL626862,1,,1,,,,A,14544,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635
CHEMBL626863,1,,1,,,,A,14545,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,In vivo,,15413,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined
CHEMBL625886,1,,1,,,,A,14546,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,15413,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum
CHEMBL625887,1,,1,,,,A,14547,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,15413,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.
CHEMBL625888,1,,1,,,,A,14548,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cortex
CHEMBL625889,1,,1,,,,A,14549,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.
CHEMBL625890,1,,1,,,,A,14550,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,15413,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus
CHEMBL625891,1,,1,,,,A,14551,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,15413,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.
CHEMBL625892,1,,1,,,,A,14552,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,In vivo,,15413,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus
CHEMBL625893,1,,1,,,,A,14553,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,In vivo,,15413,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.
CHEMBL625894,1,,1,,,,A,14554,Intermediate,BAO_0000218,2037.0,N,Rattus norvegicus,Cerebellum,10116.0,,In vivo,,15413,50597,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum
CHEMBL625895,1,,1,,,,A,14555,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,15413,50597,,Biodistribution of the [18F]-radiolabeled compound in rat cortex
CHEMBL625896,0,,1,,,,A,14556,Autocuration,BAO_0000019,,U,,,,,,,12404,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP
CHEMBL625897,0,,1,,,,A,14557,Autocuration,BAO_0000019,,U,,,,,,,568,22224,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)"
CHEMBL625898,0,,1,,,,A,14558,Autocuration,BAO_0000019,,U,,,,,,,568,22224,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)"
CHEMBL625899,0,,1,,,,A,14559,Autocuration,BAO_0000019,,U,,,,,,,568,22224,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)"
CHEMBL626124,0,,1,,,,A,14560,Autocuration,BAO_0000019,,U,,,,,,,12404,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP
CHEMBL628500,1,,1,,,,A,14561,Intermediate,BAO_0000218,,N,Escherichia coli,,562.0,,,,7624,50212,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity
CHEMBL857856,1,,1,,,,A,14562,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7624,50597,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity"
CHEMBL628501,1,,1,,,,A,14563,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7624,50597,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity"
CHEMBL628502,0,,1,,,,A,14564,Autocuration,BAO_0000019,,U,,,,,,,4643,22224,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system"
CHEMBL628503,0,,1,,,,A,14565,Autocuration,BAO_0000019,,U,,,,,,,11532,22224,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.
CHEMBL628504,0,,1,,,,A,14566,Autocuration,BAO_0000019,,U,,,,,,,11018,22224,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade
CHEMBL628505,0,,1,,,,A,14567,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined"
CHEMBL874452,0,,1,,,,A,14568,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM"
CHEMBL628506,0,,1,,,,A,14569,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined"
CHEMBL628507,0,,1,,,,A,14570,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined"
CHEMBL628508,0,,1,,,,A,14571,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM"
CHEMBL628509,0,,1,,,,A,14572,Autocuration,BAO_0000019,,U,,,,,,,8949,22224,,Michaelis constant (KM) was evaluated
CHEMBL628510,0,,1,,,,A,14573,Autocuration,BAO_0000019,,U,,,,,,,12404,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP
CHEMBL628511,0,,1,,,,B,14574,Autocuration,BAO_0000019,,U,,,,,,,7625,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase I
CHEMBL628512,0,,1,,,,B,14575,Autocuration,BAO_0000019,,U,,,,,,,7625,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase II
CHEMBL628513,0,,1,,,,B,14576,Autocuration,BAO_0000019,,U,,,,,,,7625,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase III
CHEMBL628514,0,,1,,,,B,14577,Autocuration,BAO_0000019,,U,,,,,,,7625,22224,,Substrate concentration for half maximal velocity was reported for yeast hexokinase
CHEMBL628515,0,,1,,,,A,14578,Autocuration,BAO_0000019,,U,,,,,,,12908,22224,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.
CHEMBL628516,0,,1,,,,A,14579,Autocuration,BAO_0000019,,U,,,,,,,10368,22224,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine
CHEMBL628517,0,,1,,,,A,14580,Autocuration,BAO_0000019,,U,,,,,,,13108,22224,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5)
CHEMBL628518,0,,1,,,,A,14581,Autocuration,BAO_0000019,,U,,,,,,,13108,22224,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5)
CHEMBL628519,0,,1,,,,A,14582,Autocuration,BAO_0000019,,U,,,,,,,15217,22224,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer
CHEMBL628520,0,,1,,,,A,14583,Autocuration,BAO_0000019,,U,,,,,,,15217,22224,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available
CHEMBL628521,0,,1,,,,A,14584,Autocuration,BAO_0000019,,U,,,,,,,10933,22224,,Binding constant was determined
CHEMBL630443,0,,1,,,,A,14585,Autocuration,BAO_0000019,,U,,,,,,,2363,22224,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade
CHEMBL630444,0,,1,,,,A,14586,Autocuration,BAO_0000019,,U,,,,,,,2363,22224,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined
CHEMBL857732,0,,1,,,,A,14587,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine
CHEMBL630445,0,,1,,,,P,14588,Autocuration,BAO_0000100,,U,,,,,,,14915,22224,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.
CHEMBL630446,0,,1,,,,A,14589,Autocuration,BAO_0000019,,U,,,,,,,8847,22224,,Catalytic rate constant of the compound
CHEMBL630447,0,,1,,,,B,14590,Autocuration,BAO_0000019,,U,,,,,,,15357,22224,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition
CHEMBL630448,0,,1,,,,A,14591,Autocuration,BAO_0000019,,U,,,,,,,2869,22224,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His)
CHEMBL630449,0,,1,,,,A,14592,Autocuration,BAO_0000019,,U,,,,,,,3484,22224,,Catalytic rate constant against phospholipase A2 was determined
CHEMBL630450,0,,1,,,,A,14593,Autocuration,BAO_0000019,,U,,,,,,,1373,22224,,"Compound was evaluated for catalytic constant, Kcat"
CHEMBL630451,0,,1,,,,A,14594,Autocuration,BAO_0000019,,U,,,,,,,8142,22224,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined
CHEMBL630452,0,,1,,,,A,14595,Autocuration,BAO_0000019,,U,,,,,,,14131,22224,,Kcat calculated from 0.693/T1/2
CHEMBL630453,0,,1,,,,A,14596,Autocuration,BAO_0000019,,U,,,,,,,17269,22224,,Kcat was determined
CHEMBL630454,0,,1,,,,A,14597,Autocuration,BAO_0000019,,U,,,,,,,3485,22224,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis
CHEMBL630455,0,,1,,,,A,14598,Autocuration,BAO_0000019,,U,,,,,,,3485,22224,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis
CHEMBL631487,0,,1,,,,A,14599,Autocuration,BAO_0000019,,U,,,,,,,3485,22224,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis
CHEMBL631488,0,,1,,,,A,14600,Autocuration,BAO_0000019,,U,,,,,,,5962,22224,,Kcat value was determined
CHEMBL876440,0,,1,,,,A,14601,Autocuration,BAO_0000019,,U,,,,,,,3133,22224,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated
CHEMBL631489,0,,1,,,,A,14602,Autocuration,BAO_0000019,,U,,,,,,,3133,22224,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated
CHEMBL857742,0,,1,,,,A,14603,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined"
CHEMBL631490,0,,1,,,,A,14604,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat"
CHEMBL631491,0,,1,,,,A,14605,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined"
CHEMBL631492,0,,1,,,,A,14606,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined"
CHEMBL631493,0,,1,,,,A,14607,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat"
CHEMBL631494,0,,1,,,,A,14608,Autocuration,BAO_0000019,,U,,,,,,,4892,22224,,Kinetic parameter for rate of conversion to PABA was determined
CHEMBL631495,0,,1,,,,A,14609,Autocuration,BAO_0000019,,U,,,,,,,3133,22224,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated
CHEMBL631496,1,,1,,,,A,14610,Intermediate,BAO_0000218,1988.0,N,Rattus norvegicus,Feces,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr"
CHEMBL631497,1,,1,,,,A,14611,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr"
CHEMBL631498,1,,1,,,,A,14612,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr"
CHEMBL629776,1,,1,,,,A,14613,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr"
CHEMBL629777,1,,1,,,,A,14614,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr"
CHEMBL629778,1,,1,,,,A,14615,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,11488,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr"
CHEMBL630456,1,,1,,,,A,14616,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats
CHEMBL630457,1,,1,,,,A,14617,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats
CHEMBL630458,1,,1,,,,A,14618,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats
CHEMBL630459,1,,1,,,,A,14619,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats
CHEMBL630460,1,,1,,,,A,14620,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats
CHEMBL876550,1,,1,,,,A,14621,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats
CHEMBL630461,1,,1,,,,A,14622,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats
CHEMBL630462,1,,1,,,,A,14623,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats
CHEMBL630463,1,,1,,,,A,14624,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats
CHEMBL630464,1,,1,,,,A,14625,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats
CHEMBL630465,1,,1,,,,A,14626,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats
CHEMBL630466,1,,1,,,,A,14627,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats
CHEMBL630467,1,,1,,,,A,14628,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats
CHEMBL630633,1,,1,,,,A,14629,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats
CHEMBL630634,1,,1,,,,A,14630,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats
CHEMBL630635,1,,1,,,,A,14631,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats
CHEMBL630636,1,,1,,,,A,14632,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats
CHEMBL630637,1,,1,,,,A,14633,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,11488,50597,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats
CHEMBL630638,1,,1,,,,A,14634,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)"
CHEMBL630639,1,,1,,,,A,14635,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h"
CHEMBL630640,1,,1,,,,A,14636,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h"
CHEMBL876551,1,,1,,,,A,14637,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h"
CHEMBL630641,1,,1,,,,A,14638,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)"
CHEMBL630642,1,,1,,,,A,14639,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h"
CHEMBL630643,1,,1,,,,A,14640,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h"
CHEMBL630644,1,,1,,,,A,14641,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h"
CHEMBL630645,1,,1,,,,A,14642,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h"
CHEMBL625599,1,,1,,,,A,14643,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)"
CHEMBL625600,1,,1,,,,A,14644,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h"
CHEMBL625601,1,,1,,,,A,14645,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h"
CHEMBL625602,1,,1,,,,A,14646,Intermediate,BAO_0000218,1988.0,N,Oryctolagus cuniculus,Feces,9986.0,,,,7132,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h"
CHEMBL627470,1,,1,,,,A,14647,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)"
CHEMBL627471,1,,1,,,,A,14648,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h"
CHEMBL627472,1,,1,,,,A,14649,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h"
CHEMBL627473,1,,1,,,,A,14650,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h"
CHEMBL627474,1,,1,,,,A,14651,Intermediate,BAO_0000218,1088.0,N,Oryctolagus cuniculus,Urine,9986.0,,,,7132,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h"
CHEMBL627475,1,,1,,,,A,14652,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13925,50597,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL627476,1,,1,,,,A,14653,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,13925,50597,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL627477,1,,1,,,,A,14654,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug
CHEMBL627478,1,,1,,,,A,14655,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug
CHEMBL627479,1,,1,,,,A,14656,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug
CHEMBL627480,1,,1,,,,A,14657,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug
CHEMBL627481,1,,1,,,,A,14658,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug
CHEMBL627482,1,,1,,,,A,14659,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug
CHEMBL627483,1,,1,,,,A,14660,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug
CHEMBL875636,1,,1,,,,A,14661,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug
CHEMBL625764,1,,1,,,,A,14662,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug
CHEMBL625765,1,,1,,,,A,14663,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug
CHEMBL625766,1,,1,,,,A,14664,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug
CHEMBL625767,1,,1,,,,A,14665,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug
CHEMBL625768,1,,1,,,,A,14666,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug
CHEMBL625769,1,,1,,,,A,14667,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug
CHEMBL625770,1,,1,,,,A,14668,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug
CHEMBL625771,1,,1,,,,A,14669,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug
CHEMBL625772,1,,1,,,,A,14670,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug
CHEMBL625773,1,,1,,,,A,14671,Intermediate,BAO_0000218,1088.0,N,Canis lupus familiaris,Urine,9615.0,,,,12582,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug
CHEMBL625774,1,,1,,,,A,14672,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug
CHEMBL625775,1,,1,,,,A,14673,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug
CHEMBL625776,1,,1,,,,A,14674,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug
CHEMBL625777,1,,1,,,,A,14675,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug
CHEMBL625778,1,,1,,,,A,14676,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug
CHEMBL625779,1,,1,,,,A,14677,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug
CHEMBL625780,1,,1,,,,A,14678,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug
CHEMBL625781,1,,1,,,,A,14679,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug
CHEMBL875637,1,,1,,,,A,14680,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug
CHEMBL626473,1,,1,,,,A,14681,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug
CHEMBL626474,1,,1,,,,A,14682,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug
CHEMBL626475,1,,1,,,,A,14683,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug
CHEMBL626476,1,,1,,,,A,14684,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug
CHEMBL634397,1,,1,,,,A,14685,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug
CHEMBL626477,1,,1,,,,A,14686,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug
CHEMBL631069,1,,1,,,,A,14687,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug
CHEMBL631070,1,,1,,,,A,14688,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug
CHEMBL631071,1,,1,,,,A,14689,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug
CHEMBL631072,1,,1,,,,A,14690,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug
CHEMBL631073,1,,1,,,,A,14691,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug
CHEMBL631074,1,,1,,,,A,14692,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug
CHEMBL631075,1,,1,,,,A,14693,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug
CHEMBL631725,1,,1,,,,A,14694,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug
CHEMBL631726,1,,1,,,,A,14695,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug
CHEMBL631727,1,,1,,,,A,14696,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug
CHEMBL631728,1,,1,,,,A,14697,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug
CHEMBL631729,1,,1,,,,A,14698,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug
CHEMBL631730,1,,1,,,,A,14699,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug
CHEMBL631731,1,,1,,,,A,14700,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug
CHEMBL631910,1,,1,,,,A,14701,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug
CHEMBL631911,1,,1,,,,A,14702,Intermediate,BAO_0000218,10000000.0,N,Rattus norvegicus,Hippocampus,10116.0,,In vivo,,15413,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus
CHEMBL631912,1,,1,,,,A,14703,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,In vivo,,15413,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus
CHEMBL631913,1,,1,,,,A,14704,Intermediate,BAO_0000218,1898.0,N,Rattus norvegicus,Hypothalamus,10116.0,,In vivo,,15413,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined
CHEMBL631914,1,,1,,,,A,14705,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631915,1,,1,,,,A,14706,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL875778,1,,1,,,,A,14707,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL631916,1,,1,,,,A,14708,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631917,1,,1,,,,A,14709,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631918,1,,1,,,,A,14710,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631919,1,,1,,,,A,14711,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631920,1,,1,,,,A,14712,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL631921,1,,1,,,,A,14713,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631922,1,,1,,,,A,14714,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631923,1,,1,,,,A,14715,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,12017,50597,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL631924,1,,1,,,,A,14716,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630234,1,,1,,,,A,14717,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630235,1,,1,,,,A,14718,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL630236,1,,1,,,,A,14719,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630237,1,,1,,,,A,14720,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630238,1,,1,,,,A,14721,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630239,1,,1,,,,A,14722,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630303,1,,1,,,,A,14723,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL630304,1,,1,,,,A,14724,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630305,1,,1,,,,A,14725,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,In vivo,,12017,50597,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630306,1,,1,,,,A,14726,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630307,1,,1,,,,A,14727,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630308,1,,1,,,,A,14728,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL630309,1,,1,,,,A,14729,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL629309,1,,1,,,,A,14730,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL629993,1,,1,,,,A,14731,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL629994,1,,1,,,,A,14732,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL629995,1,,1,,,,A,14733,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL631993,1,,1,,,,A,14734,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631994,1,,1,,,,A,14735,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631995,1,,1,,,,A,14736,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,12017,50597,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631996,1,,1,,,,A,14737,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL631997,1,,1,,,,A,14738,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631998,1,,1,,,,A,14739,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631999,1,,1,,,,A,14740,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL632000,1,,1,,,,A,14741,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL632001,1,,1,,,,A,14742,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL874424,1,,1,,,,A,14743,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL632002,1,,1,,,,A,14744,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL632003,1,,1,,,,A,14745,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL632004,0,,1,,,,A,14746,Autocuration,BAO_0000019,,U,,,,,,,3133,22224,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated
CHEMBL632005,0,,1,,,,A,14747,Autocuration,BAO_0000019,,U,,,,,,,2742,22224,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme
CHEMBL632006,0,,1,,,,A,14748,Autocuration,BAO_0000019,,U,,,,,,,2742,22224,,Compound was tested for amidase rate in the presence of N62C screen enzyme
CHEMBL632007,0,,1,,,,A,14749,Autocuration,BAO_0000019,,U,,,,,,,2742,22224,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme
CHEMBL632008,0,,1,,,,A,14750,Autocuration,BAO_0000019,,U,,,,,,,2742,22224,,Compound was tested for amidase rate in the presence of S166C screen enzyme
CHEMBL632009,0,,1,,,,A,14751,Autocuration,BAO_0000019,,U,,,,,,,2742,22224,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme
CHEMBL632010,0,,1,,,,A,14752,Autocuration,BAO_0000019,,U,,,,,,,2742,22224,,Compound was tested for esterase rate in the presence of N62C screen enzyme
CHEMBL857750,0,,1,,,,A,14753,Autocuration,BAO_0000019,,U,,,,,,,2742,22224,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme
CHEMBL632011,0,,1,,,,A,14754,Autocuration,BAO_0000019,,U,,,,,,,2742,22224,,Compound was tested for esterase rate in the presence of S166C screen enzyme
CHEMBL632012,0,,1,,,,A,14755,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM"
CHEMBL632013,0,,1,,,,A,14756,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM"
CHEMBL632014,0,,1,,,,A,14757,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM"
CHEMBL629622,0,,1,,,,A,14758,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM"
CHEMBL629623,0,,1,,,,A,14759,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM"
CHEMBL629624,0,,1,,,,A,14760,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM"
CHEMBL629625,0,,1,,,,A,14761,Autocuration,BAO_0000019,,U,,,,,,,17269,22224,,Ratio of Kcat to that of Km was determined
CHEMBL629626,0,,1,,,,A,14762,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat"
CHEMBL629627,0,,1,,,,A,14763,Autocuration,BAO_0000019,,U,,,,,,,2276,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat"
CHEMBL629628,0,,1,,,,A,14764,Autocuration,BAO_0000019,,U,,,,,,,15917,22224,,"Compound was evaluated for constant, Kd"
CHEMBL629629,0,,1,,,,A,14765,Autocuration,BAO_0000019,,U,,,,,,,10933,22224,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay
CHEMBL629630,0,,1,,,,A,14766,Autocuration,BAO_0000019,,U,,,,,,,10933,22224,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay
CHEMBL856030,0,,1,,,,A,14767,Autocuration,BAO_0000019,,U,,,,,,,14293,22224,,Dissociation Constant of compound determined
CHEMBL629631,0,,1,,,,B,14768,Autocuration,BAO_0000019,,U,,,,,,,6698,22224,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined
CHEMBL629632,0,,1,,,,B,14769,Autocuration,BAO_0000019,,U,,,,,,,6698,22224,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data
CHEMBL629633,0,,1,,,,P,14770,Autocuration,BAO_0000100,,U,,,,,,,4318,22224,,Dissociation constant of compound with Fructose was determined
CHEMBL629634,0,,1,,,,P,14771,Autocuration,BAO_0000100,,U,,,,,,,4318,22224,,Dissociation constant of compound with Fructose was determined; Not determined
CHEMBL629635,0,,1,,,,P,14772,Autocuration,BAO_0000100,,U,,,,,,,4318,22224,,Dissociation constant of compound with Lactulose was determined
CHEMBL629636,0,,1,,,,P,14773,Autocuration,BAO_0000100,,U,,,,,,,4318,22224,,Dissociation constant of compound with Lactulose was determined; Not determined
CHEMBL629637,0,,1,,,,P,14774,Autocuration,BAO_0000100,,U,,,,,,,14959,22224,,Dissociation constant of the Compound
CHEMBL629638,0,,1,,,,P,14775,Autocuration,BAO_0000100,,U,,,,,,,5913,22224,,Dissociation constant by non-linear regression analysis
CHEMBL629639,0,,1,,,,P,14776,Autocuration,BAO_0000100,,U,,,,,,,14218,22224,,Dissociation constant was determined
CHEMBL629640,0,,1,,,,P,14777,Autocuration,BAO_0000100,,U,,,,,,,10689,22224,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM
CHEMBL629641,0,,1,,,,P,14778,Autocuration,BAO_0000100,,U,,,,,,,13925,22224,,Dissociation constant was determined
CHEMBL631344,0,,1,,,,P,14779,Autocuration,BAO_0000100,,U,,,,,,,16359,22224,,Dissociation constant was determined
CHEMBL631345,1,,1,,,,A,14780,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,10944,50597,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle
CHEMBL631346,0,,1,,,,A,14781,Autocuration,BAO_0000019,,U,,,,,,,11080,22224,,The dissociation constant determined by fluorescence displacement assay
CHEMBL631524,0,,1,,,,A,14782,Autocuration,BAO_0000019,,U,,,,,,,17805,22224,,kd value surface plasmon resonance (SPR) method
CHEMBL631525,1,,1,,,,A,14783,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,10944,50597,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle
CHEMBL631526,0,,1,,,,F,14784,Autocuration,BAO_0000019,,U,,,,,,,16645,22224,,First dissociation constant of the binding of compound to V30M TTR
CHEMBL631527,0,,1,,,,F,14785,Autocuration,BAO_0000019,,U,,,,,,,16645,22224,,Second dissociation constant of the binding of compound to V30M TTR
CHEMBL631528,0,,1,,,,A,14786,Autocuration,BAO_0000019,,U,,,,,,,7793,22224,,"Compound was evaluated for equilibrium constant, Ke"
CHEMBL631529,0,,1,,,,A,14787,Autocuration,BAO_0000019,1898.0,U,,Hypothalamus,,,,,12199,22224,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus
CHEMBL631530,0,,1,,,,A,14788,Autocuration,BAO_0000019,1898.0,U,,Hypothalamus,,,,,12199,22224,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive
CHEMBL631531,0,,1,,,,A,14789,Autocuration,BAO_0000019,,U,,,,,,,9680,22224,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade
CHEMBL631532,0,,1,,,,A,14790,Autocuration,BAO_0000019,,U,,,,,,,9680,22224,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade
CHEMBL631533,0,,1,,,,A,14791,Autocuration,BAO_0000019,,U,,,,,,,9680,22224,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade
CHEMBL876552,1,,1,,,,A,14792,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13758,50594,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte
CHEMBL631534,1,,1,,,,A,14793,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13758,50594,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte
CHEMBL631535,1,,1,,,,A,14794,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13758,50594,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte
CHEMBL631536,1,,1,,,,A,14795,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13758,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte
CHEMBL631537,1,,1,,,,A,14796,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13758,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte
CHEMBL631538,1,,1,,,,A,14797,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13758,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte
CHEMBL631539,1,,1,,,,A,14798,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13758,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte
CHEMBL631540,1,,1,,,,A,14799,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,,,13758,50594,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte
CHEMBL625637,1,,1,,,,A,14800,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14393,50597,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats
CHEMBL625638,1,,1,,,,A,14801,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14393,50597,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats
CHEMBL625639,1,,1,,,,A,14802,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,15078,50597,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose"
CHEMBL625640,1,,1,,,,A,14803,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13925,50597,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625641,1,,1,,,,A,14804,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,13925,50597,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625642,1,,1,,,,A,14805,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13925,50597,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625643,1,,1,,,,A,14806,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,13925,50597,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625644,1,,1,,,,A,14807,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13925,50597,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625645,1,,1,,,,A,14808,Intermediate,BAO_0000218,2113.0,N,Rattus norvegicus,Kidney,10116.0,,In vivo,,13925,50597,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625646,1,,1,,,,A,14809,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13925,50597,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625647,1,,1,,,,A,14810,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,13925,50597,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625648,1,,1,,,,A,14811,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13925,50597,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625649,1,,1,,,,A,14812,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,13925,50597,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ
CHEMBL625650,1,,1,,,,A,14813,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13925,50597,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625651,1,,1,,,,A,14814,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,13925,50597,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625652,1,,1,,,,A,14815,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,13925,50597,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625653,1,,1,,,,A,14816,Intermediate,BAO_0000218,14.0,N,Rattus norvegicus,Zone of skin,10116.0,,In vivo,,13925,50597,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625654,1,,1,,,,A,14817,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,13925,50597,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625655,1,,1,,,,A,14818,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,13925,50597,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ
CHEMBL625656,1,,1,,,,A,14819,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat blood after 15 minutes of administration
CHEMBL625657,1,,1,,,,A,14820,Intermediate,BAO_0000218,178.0,N,Rattus norvegicus,Blood,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat blood after 2 minutes of administration
CHEMBL625658,1,,1,,,,A,14821,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat brain after 15 minutes of administration
CHEMBL625659,1,,1,,,,A,14822,Intermediate,BAO_0000218,955.0,N,Rattus norvegicus,Brain,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat brain after 2 minutes of administration
CHEMBL625660,1,,1,,,,A,14823,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat heart after 15 minutes of administration
CHEMBL625661,1,,1,,,,A,14824,Intermediate,BAO_0000218,948.0,N,Rattus norvegicus,Heart,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat heart after 2 minutes of administration
CHEMBL625662,1,,1,,,,A,14825,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat liver after 15 minutes of administration
CHEMBL625663,1,,1,,,,A,14826,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat liver after 2 minutes of administration
CHEMBL875621,1,,1,,,,A,14827,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat lung after 15 minutes of administration
CHEMBL628382,1,,1,,,,A,14828,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat lung after 2 minutes of administration
CHEMBL628383,1,,1,,,,A,14829,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat muscle after 15 minutes of administration
CHEMBL628384,1,,1,,,,A,14830,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,9712,50597,,Biodistribution of Compound in rat muscle after 2 minutes of administration
CHEMBL628385,1,,1,,,,A,14831,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13925,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins
CHEMBL875753,1,,1,,,,A,14832,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13925,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins
CHEMBL628386,1,,1,,,,A,14833,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,13925,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins
CHEMBL628387,1,,1,,,,A,14834,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat blood 2 minutes after intravenous injection
CHEMBL628388,1,,1,,,,A,14835,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat blood 2 hr after intravenous injection
CHEMBL628389,1,,1,,,,A,14836,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat blood 30 minutes after intravenous injection
CHEMBL632756,1,,1,,,,A,14837,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat blood 30 min after intravenous injection
CHEMBL628390,1,,1,,,,A,14838,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat brain 2 minutes after intravenous injection
CHEMBL631811,1,,1,,,,A,14839,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat brain 2 hr after intravenous injection
CHEMBL631812,1,,1,,,,A,14840,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat brain 30 minutes after intravenous injection
CHEMBL631813,1,,1,,,,A,14841,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat heart 2 minutes after intravenous injection
CHEMBL631814,1,,1,,,,A,14842,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat heart 2 hr after intravenous injection
CHEMBL631815,1,,1,,,,A,14843,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat heart 30 minutes after intravenous injection
CHEMBL631816,1,,1,,,,A,14844,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat kidney 2 minutes after intravenous injection
CHEMBL875758,1,,1,,,,A,14845,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat kidney 2 hr after intravenous injection
CHEMBL631817,1,,1,,,,A,14846,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat kidney 30 minutes after intravenous injection
CHEMBL631818,1,,1,,,,A,14847,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,6941,50597,,Organ distribution in rat liver 2 minutes after intravenous injection
CHEMBL631819,1,,1,,,,A,14848,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,6941,50597,,Organ distribution in rat liver 2 hr after intravenous injection
CHEMBL631820,1,,1,,,,A,14849,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,,,6941,50597,,Organ distribution in rat liver 30 minutes after intravenous injection
CHEMBL631821,1,,1,,,,A,14850,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat lung 2 minutes after intravenous injection
CHEMBL631822,1,,1,,,,A,14851,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat lung 2 hr after intravenous injection
CHEMBL631823,1,,1,,,,A,14852,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,6941,50597,,Organ distribution in rat lung 30 minutes after intravenous injection
CHEMBL631824,1,,1,,,,A,14853,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,6941,50597,,Organ distribution in rat muscle 2 minutes after intravenous injection
CHEMBL631825,1,,1,,,,A,14854,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,6941,50597,,Organ distribution in rat muscle 2 hr after intravenous injection
CHEMBL631826,1,,1,,,,A,14855,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,,,6941,50597,,Organ distribution in rat muscle 30 minutes after intravenous injection
CHEMBL631827,1,,1,,,,A,14856,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B)
CHEMBL631828,1,,1,,,,A,14857,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H)
CHEMBL631829,1,,1,,,,A,14858,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L)
CHEMBL875759,1,,1,,,,A,14859,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug
CHEMBL631830,1,,1,,,,A,14860,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug
CHEMBL631831,1,,1,,,,A,14861,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug
CHEMBL631832,1,,1,,,,A,14862,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug
CHEMBL631833,1,,1,,,,A,14863,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug
CHEMBL631834,1,,1,,,,A,14864,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug
CHEMBL631835,1,,1,,,,A,14865,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug
CHEMBL631836,1,,1,,,,A,14866,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug
CHEMBL631837,1,,1,,,,A,14867,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug
CHEMBL631838,1,,1,,,,A,14868,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug
CHEMBL631839,1,,1,,,,A,14869,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug
CHEMBL631840,1,,1,,,,A,14870,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug
CHEMBL631841,1,,1,,,,A,14871,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug
CHEMBL631842,1,,1,,,,A,14872,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug
CHEMBL631843,1,,1,,,,A,14873,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug
CHEMBL631844,1,,1,,,,A,14874,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug
CHEMBL631845,1,,1,,,,A,14875,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug
CHEMBL631846,1,,1,,,,A,14876,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug
CHEMBL875760,1,,1,,,,A,14877,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug
CHEMBL632199,1,,1,,,,A,14878,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug
CHEMBL631847,1,,1,,,,A,14879,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug
CHEMBL631848,1,,1,,,,A,14880,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug
CHEMBL628707,1,,1,,,,A,14881,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug
CHEMBL628708,1,,1,,,,A,14882,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug
CHEMBL628709,1,,1,,,,A,14883,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug
CHEMBL628710,1,,1,,,,A,14884,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug
CHEMBL628711,1,,1,,,,A,14885,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug
CHEMBL628712,1,,1,,,,A,14886,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug
CHEMBL628713,1,,1,,,,A,14887,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug
CHEMBL628714,1,,1,,,,A,14888,Intermediate,BAO_0000218,1088.0,N,Rattus norvegicus,Urine,10116.0,,,,12582,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug
CHEMBL628715,1,,1,,,,A,14889,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,7415,50597,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h"
CHEMBL629179,0,,1,,,,A,14890,Autocuration,BAO_0000019,,U,,,,,,,7313,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM
CHEMBL629180,0,,1,,,,A,14891,Autocuration,BAO_0000019,,U,,,,,,,7313,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM
CHEMBL875108,0,,1,,,,A,14892,Autocuration,BAO_0000019,,U,,,,,,,7313,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM
CHEMBL629181,0,,1,,,,A,14893,Autocuration,BAO_0000019,1235.0,U,,Adrenal cortex,,,,,7570,22224,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.
CHEMBL629182,0,,1,,,,A,14894,Autocuration,BAO_0000019,1235.0,U,,Adrenal cortex,,,,,7570,22224,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.
CHEMBL629183,0,,1,,,,A,14895,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.
CHEMBL629184,0,,1,,,,A,14896,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.
CHEMBL629185,0,,1,,,,A,14897,Autocuration,BAO_0000019,1235.0,U,,Adrenal cortex,,,,,7570,22224,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.
CHEMBL629186,0,,1,,,,A,14898,Autocuration,BAO_0000019,1235.0,U,,Adrenal cortex,,,,,7570,22224,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.
CHEMBL629187,0,,1,,,,A,14899,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.
CHEMBL629887,0,,1,,,,A,14900,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.
CHEMBL629888,0,,1,,,,A,14901,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.
CHEMBL629889,0,,1,,,,A,14902,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.
CHEMBL629890,0,,1,,,,A,14903,Autocuration,BAO_0000019,1235.0,U,,Adrenal cortex,,,,,7570,22224,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.
CHEMBL629891,0,,1,,,,A,14904,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.
CHEMBL629892,0,,1,,,,A,14905,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.
CHEMBL629893,0,,1,,,,A,14906,Autocuration,BAO_0000019,1235.0,U,,Adrenal cortex,,,,,7570,22224,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.
CHEMBL629894,0,,1,,,,A,14907,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.
CHEMBL629895,0,,1,,,,A,14908,Autocuration,BAO_0000019,,U,,,,,,,7570,22224,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.
CHEMBL875109,0,,1,,,,A,14909,Autocuration,BAO_0000218,,U,Canis lupus familiaris,,9615.0,,In vivo,,14122,22224,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma"
CHEMBL629896,0,,1,,,,A,14910,Autocuration,BAO_0000218,,U,Macaca fascicularis,,9541.0,,In vivo,,16449,22224,,Absolute bioavailability in male cynomolgus monkeys
CHEMBL629897,0,,1,,,,A,14911,Autocuration,BAO_0000218,,U,Rattus norvegicus,,10116.0,,In vivo,,16449,22224,,Absolute bioavailability in maleSprague-Dawley rats
CHEMBL629898,1,,1,,,,A,14912,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL630057,1,,1,,,,A,14913,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630058,1,,1,,,,A,14914,Intermediate,BAO_0000218,2107.0,N,Rattus norvegicus,Liver,10116.0,,In vivo,,12017,50597,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630059,1,,1,,,,A,14915,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630060,1,,1,,,,A,14916,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630061,1,,1,,,,A,14917,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL630062,1,,1,,,,A,14918,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630063,1,,1,,,,A,14919,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630064,1,,1,,,,A,14920,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630065,1,,1,,,,A,14921,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630066,1,,1,,,,A,14922,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL630067,1,,1,,,,A,14923,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630068,1,,1,,,,A,14924,Intermediate,BAO_0000218,2048.0,N,Rattus norvegicus,Lung,10116.0,,In vivo,,12017,50597,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631113,1,,1,,,,A,14925,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631114,1,,1,,,,A,14926,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL631115,1,,1,,,,A,14927,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL631116,1,,1,,,,A,14928,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630528,1,,1,,,,A,14929,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630529,1,,1,,,,A,14930,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630530,1,,1,,,,A,14931,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630531,1,,1,,,,A,14932,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL630532,1,,1,,,,A,14933,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630533,1,,1,,,,A,14934,Intermediate,BAO_0000218,2385.0,N,Rattus norvegicus,Muscle tissue,10116.0,,In vivo,,12017,50597,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630534,1,,1,,,,A,14935,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice blood after 120 hr
CHEMBL630535,1,,1,,,,A,14936,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice blood after 24 hr
CHEMBL630536,1,,1,,,,A,14937,Intermediate,BAO_0000218,178.0,N,Mus musculus,Blood,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice blood after 4 hr
CHEMBL630537,1,,1,,,,A,14938,Intermediate,BAO_0000218,10000001.0,N,Mus musculus,Bone,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice bone after 120 hr
CHEMBL630538,1,,1,,,,A,14939,Intermediate,BAO_0000218,10000001.0,N,Mus musculus,Bone,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice bone after 24 hr
CHEMBL630539,1,,1,,,,A,14940,Intermediate,BAO_0000218,10000001.0,N,Mus musculus,Bone,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice bone after 4 hr
CHEMBL630540,1,,1,,,,A,14941,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice heart after 120 hr
CHEMBL630541,1,,1,,,,A,14942,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice heart after 24 hr
CHEMBL630542,1,,1,,,,A,14943,Intermediate,BAO_0000218,948.0,N,Mus musculus,Heart,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice heart after 4 hr
CHEMBL630543,1,,1,,,,A,14944,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice kidney after 120 hr
CHEMBL630544,1,,1,,,,A,14945,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice kidney after 24 hr
CHEMBL630545,1,,1,,,,A,14946,Intermediate,BAO_0000218,2113.0,N,Mus musculus,Kidney,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice kidney after 4 hr
CHEMBL630546,1,,1,,,,A,14947,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice liver after 120 hr
CHEMBL630547,1,,1,,,,A,14948,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice liver after 24 hr
CHEMBL630548,1,,1,,,,A,14949,Intermediate,BAO_0000218,2107.0,N,Mus musculus,Liver,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice liver after 4 hr
CHEMBL630549,1,,1,,,,A,14950,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice spleen after 120 hr
CHEMBL630550,1,,1,,,,A,14951,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice spleen after 24 hr
CHEMBL876426,1,,1,,,,A,14952,Intermediate,BAO_0000218,2106.0,N,Mus musculus,Spleen,10090.0,,In vivo,,15045,50594,,Biodistribution in normal mice spleen after 4 hr
CHEMBL630551,1,,1,,,,A,14953,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630552,1,,1,,,,A,14954,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630553,1,,1,,,,A,14955,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL630554,1,,1,,,,A,14956,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630555,1,,1,,,,A,14957,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630556,1,,1,,,,A,14958,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630557,1,,1,,,,A,14959,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630558,1,,1,,,,A,14960,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)
CHEMBL630559,1,,1,,,,A,14961,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630560,1,,1,,,,A,14962,Intermediate,BAO_0000218,2106.0,N,Rattus norvegicus,Spleen,10116.0,,In vivo,,12017,50597,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL876427,1,,1,,,,A,14963,Intermediate,BAO_0000218,2046.0,N,Rattus norvegicus,Thyroid gland,10116.0,,In vivo,,12017,50597,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol
CHEMBL630561,1,,1,,,,A,14964,Intermediate,BAO_0000218,,N,Rattus norvegicus,,10116.0,,,,14941,50597,,The Kel values in female wistar rats.
CHEMBL630562,0,,1,,,,A,14965,Autocuration,BAO_0000019,,U,,,,,,,4646,22224,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade
CHEMBL630563,0,,1,,,,A,14966,Autocuration,BAO_0000019,,U,,,,,,,8847,22224,,Hydrolysis rate constant of the compound
CHEMBL629673,0,,1,,,,P,14967,Autocuration,BAO_0000100,,U,,,,,,,11778,22229,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer
CHEMBL629674,0,,1,,,,A,14968,Autocuration,BAO_0000019,,U,,,,,,,2363,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade"
CHEMBL629675,0,,1,,,,A,14969,Autocuration,BAO_0000019,,U,,,,,,,2363,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade"
CHEMBL629676,0,,1,,,,A,14970,Autocuration,BAO_0000019,,U,,,,,,,2363,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data"
CHEMBL629677,0,,1,,,,A,14971,Autocuration,BAO_0000019,,U,,,,,,,2363,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined"
CHEMBL629678,0,,1,,,,A,14972,Autocuration,BAO_0000019,,U,,,,,,,8371,22224,,Apparent inactivation rate constant was evaluated
CHEMBL629679,0,,1,,,,A,14973,Autocuration,BAO_0000019,,U,,,,,,,14883,22224,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.
CHEMBL629680,0,,1,,,,A,14974,Autocuration,BAO_0000019,,U,,,,,,,14883,22224,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade
CHEMBL629681,0,,1,,,,A,14975,Autocuration,BAO_0000019,,U,,,,,,,4643,22224,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5
CHEMBL629682,0,,1,,,,A,14976,Autocuration,BAO_0000019,,U,,,,,,,3519,22224,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.
CHEMBL629683,0,,1,,,,A,14977,Autocuration,BAO_0000019,,U,,,,,,,10600,22224,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine
CHEMBL629684,0,,1,,,,F,14978,Autocuration,BAO_0000019,,U,,,,,,,8501,22224,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events
CHEMBL629685,0,,1,,,,P,14979,Autocuration,BAO_0000100,,U,,,,,,,8505,22224,,Dissociation constant was determined
CHEMBL629686,0,,1,,,,P,14980,Autocuration,BAO_0000100,,U,,,,,,,9778,22224,,Dissociation constant was determined
CHEMBL872932,0,,1,,,,P,14981,Autocuration,BAO_0000100,,U,,,,,,,9778,22224,,Dissociation constant at pH 7.4
CHEMBL629687,0,,1,,,,P,14982,Autocuration,BAO_0000100,,U,,,,,,,9778,22224,,Dissociation constant in presence of 1 mM dithiothreitol
CHEMBL872931,0,,1,,,,A,14983,Autocuration,BAO_0000019,,U,,,,,,,13007,22224,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase
CHEMBL628151,0,,1,,,,A,14984,Autocuration,BAO_0000019,,U,,,,,,,13007,22224,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase
CHEMBL628152,0,,1,,,,A,14985,Autocuration,BAO_0000019,,U,,,,,,,13007,22224,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase
CHEMBL628153,0,,1,,,,A,14986,Autocuration,BAO_0000019,,U,,,,,,,13007,22224,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase
CHEMBL628154,0,,1,,,,A,14987,Autocuration,BAO_0000019,,U,,,,,,,11482,22224,,Kinetic constant for aromatization of androstenedione
CHEMBL628155,0,,1,,,,A,14988,Autocuration,BAO_0000019,,U,,,,,,,11482,22224,,Kinetic constant for aromatization of testosterone
CHEMBL628156,0,,1,,,,A,14989,Autocuration,BAO_0000019,,U,,,,,,,2303,22224,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12
CHEMBL628157,0,,1,,,,A,14990,Autocuration,BAO_0000019,,U,,,,,,,11964,22224,,Local inhibition constant was determined
CHEMBL857533,1,,1,,,,A,14991,Intermediate,BAO_0000218,,N,Saccharomyces cerevisiae,,4932.0,,,,3140,50347,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor
CHEMBL628158,0,,1,,,,P,14992,Autocuration,BAO_0000100,,U,,,,,,,10650,22224,,Dissociation constant value of the compound
CHEMBL628159,0,,1,,,,A,14993,Autocuration,BAO_0000019,964.0,U,,Cornea,,,,,4667,22224,,In vitro permeability through cornea without epithelium
CHEMBL875616,0,,1,,,,A,14994,Autocuration,BAO_0000019,964.0,U,,Cornea,,,,,4667,22224,,In vitro permeability through intact cornea
CHEMBL628160,1,,1,,,,A,14995,Intermediate,BAO_0000218,964.0,N,Oryctolagus cuniculus,Cornea,9986.0,,,,9199,50592,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits
CHEMBL628161,0,,1,,,,A,14996,Autocuration,BAO_0000019,,U,,,,,,,11966,22224,,Rate of enzyme inactivation for the compound was determined
CHEMBL628162,0,,1,,,,A,14997,Autocuration,BAO_0000019,964.0,U,,Cornea,,,,,4667,22224,,In vitro permeability through cornea without epithelium
CHEMBL628163,0,,1,,,,A,14998,Autocuration,BAO_0000019,964.0,U,,Cornea,,,,,4667,22224,,In vitro permeability through intact cornea
CHEMBL628164,0,,1,,,,A,14999,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628165,0,,1,,,,A,15000,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628166,0,,1,,,,A,15001,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628167,0,,1,,,,A,15002,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628168,0,,1,,,,A,15003,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628169,0,,1,,,,A,15004,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628170,0,,1,,,,A,15005,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628171,0,,1,,,,A,15006,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL627434,0,,1,,,,A,15007,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL627435,0,,1,,,,A,15008,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628110,0,,1,,,,A,15009,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628111,0,,1,,,,A,15010,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628112,0,,1,,,,A,15011,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628260,0,,1,,,,A,15012,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628261,0,,1,,,,A,15013,Autocuration,BAO_0000019,,U,,,,,,,8354,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6"
CHEMBL628262,1,,1,,,,A,15014,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M)
CHEMBL628263,1,,1,,,,A,15015,Intermediate,BAO_0000218,,N,Homo sapiens,,9606.0,,In vivo,,14439,50587,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells
CHEMBL628264,1,,1,,,,A,15016,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B)
CHEMBL628265,1,,1,,,,A,15017,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H)
CHEMBL628266,1,,1,,,,A,15018,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L)
CHEMBL628267,1,,1,,,,A,15019,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M)
CHEMBL628268,1,,1,,,,A,15020,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells
CHEMBL628269,1,,1,,,,A,15021,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B)
CHEMBL628270,1,,1,,,,A,15022,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H)
CHEMBL628271,1,,1,,,,A,15023,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L)
CHEMBL628272,1,,1,,,,A,15024,Intermediate,BAO_0000218,,N,Mus musculus,,10090.0,,In vivo,,14439,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M)
